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ORAL ABSTRACT SESSION 1: Food allergens • Anaphylaxis
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Introduction: Incidence of anaphylaxis is increasing. Data regarding 
anaphylaxis mortality are limited, but conflicting. Our objective was to 
document anaphylaxis mortality rate (deaths per million population), 
time trends and specificities according to triggers (iatrogenic, venom, 
food, unknown), age groups, sex and geographical regions (North and 
South) in France, between 1979 and 2011.
Methods: Data were obtained (1) from database of the National 
Mortality Center (CEPIDC) to collect cases in which anaphylaxis was 
included as a cause of death, sex, age, and geographic region of death, 
(2) from the database of the National Institute for Economical and Sta-
tistical studies (INSEE) to define the referent populations. We used a 
multivariable log-linear Poisson regression model to assess the impact 
of time period, age, sex and geographic region on anaphylaxis deaths.
Results: During the period study, 1603 deaths were collected: 1564 in 
adults and 39 in children (age <18 year). The overall prevalence of ana-
phylaxis fatalities was 0.84 per million population (95% IC 0.80–0.88), 
ranging from 0.08 per million (95%  IC 0.05–0.10) in pediatric popu-
lation to 1.12 per million (95%  CI 1.06 to 1.17) in adult population. 
Annual percentage change for case fatality rate was −2.0% (95%  CI 
−2.5 to −1.5; p < 10−4) indicating a decrease in case fatality rate dur-
ing the study period. Anaphylaxis fatality rate was higher in men (1.08 
per million [95%  IC 1.00 1.16] than women (0.86 per million [95%  IC 
0.80–0.92]) (p < 10−4). Triggers of anaphylaxis fatalities were iatrogenic 
(63%), mostly drugs, venom (14%) and food (0.6%). Unspecified ana-
phylaxis was frequent (23%). The highest rate was in persons aged 
>70 years (3.50 per million population per year [95% IC 3.25–3.76]) and 
the lowest in the pediatric population (p < 10−4). Only venom-induced 
mortality rate was higher in South of France (0.16 per million [95% IC 
0.13–0.19]) compared with the North (0.11 per million [95%  IC 0.09–
0.13]) (p =  0.004). Only 8 food-induced fatalities were recorded (age 
<35 years in 7 cases).
Conclusion: Overall anaphylaxis mortality rate is decreasing over the 
three last decades in France. We confirm that iatrogenic causes are the 
most frequent causes. Older age and male sex are risk factors of fatal 
anaphylaxis of any cause except for food-induced anaphylaxis.
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Diagnostic workup after severe anaphylaxis
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Introduction: After a severe anaphylactic reaction, a diagnostic 
workup is recommended to confirm or rule out the elicitor(s) in ques-
tion. The type of diagnostic chosen is usually based on the elicitor and 
severity of the reaction and might follow local experiences. We aimed 
to describe elicitor-specific diagnostic habits in the workup of severe 
anaphylaxis, comparing European countries.
Methods: The Network for Online Registration of Anaphylaxis (NORA) 
collected details about elicitors, symptoms and severity, treatment 
and the diagnostic workup of patients who experienced at least one 
episode of severe anaphylaxis, as documented within medical records 
of participating tertiary referral centres.
Results: Between June 2011 and April 2016, the registry collected 
data for 6465 cases of severe anaphylaxis, 74% of which reported 
to know the elicitor, with a remaining 20% having only a suspicion 
and 6% cases of idiopathic anaphylaxis. The allergen was known 
and confirmed by a diagnostic test in 4410 (92% of known elici-
tors). Of these, 68% had a reaction to this allergen for the first time, 
and 32% reported at least one earlier reaction to the same allergen. 
In first-time reactors (n  =  3001) 7% reported that the allergen was 
confirming by a diagnostic test already before this reaction, for food 
14%, insects 3%, drugs 2%, and 80% for SIT-induced anaphylaxis. Of 
cases with recurrent anaphylaxis (n = 1409), 30% had a test confirm-
ing the allergen before the reported reaction, for food 44%, insects 
16%, drugs 18%, and 91% for SIT-induced anaphylaxis. Of all diagnos-
tically confirmed cases of food-induced anaphylaxis (n = 1555), 78% 
were assessed by a skin test (SPT, positive in 93%), 90% by specific 
IgE (sIgE, 94% positive), 27% tryptase (7% positive), and 13% under-
went an oral food challenge (positive in 88%). Patients with anaphy-
laxis caused by drugs had the following tests (positives of these): SPT 
88% (49%), sIgE 31% (46%), tryptase 48% (11%), and provocation 19% 
(68%). For reactions against insect venom: SPT 79% (84%), sIgE 98% 
(97%), and tryptase 93 (8%). Irrespective of the elicitor, SPTs were per-
formed more often in Austria, Ireland and Greece (92, 96, and 99%, 
respectively), and less often in Italy (64%). Tryptase was almost never 
measured in Ireland, Greece and France, whereas determination of 
specific IgE was carried out similarly between European countries.
Conclusion: The choice of diagnostic measure depended on the elicitor 
and varied by country. Especially the assessment of tryptase is handled 
very differently between allergens in question and countries. These dif-
ferences may indicate aspects of the diagnostic workup with a certain 
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Primary sensitisation versus co‑sensitisation to hydrolysed wheat 
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Introduction: Wheat protein is responsible for various phenotypes of aller-
gic diseases. More recently an increased number of immediate type 1 aller-
gic reactions to hydrolyzed wheat proteins (HWP) have been reported.
The aim of this study was to characterize the clinical profile and evalu-
ate patients with a case-history of anaphylaxis related to ingestion of a 
product containing HWP. Furthermore, to describe patients with other 
types of wheat allergy co-sensitized for HWP.
Methods: From May 2010 to August 2015 we investigated 56 patients 
(31 female, 25 male, mean age 39.0 years [1.5–77.2]) sensitized to com-
mercialized HWP, either by specific immunoglobulin E (sIgE) (Ther-
moFischer, Uppsala, Sweden) and/or skin prick test (SPT). Based upon 
case-history patients were divided into 3 groups: (1) allergic reaction 
to ingestion of a HWP containing product (n =  9) (2) ingestion of a 
wheat product; WIA (n = 19), (3) ingestion of a wheat product in com-
bination with exercise; WDEIA (n =  28). All patients were orally chal-
lenged with the incriminated food.
Results: The total positive rate of sIgE to HWP was 47/56 (83.9%), SPT 
35/42 (83.3%) and BHR 22/42 (52.3%). Fourteen patients were triple posi-
tive to commercialized HWP of whom 7/9 patients in the HWP group. In 
total 9 (16%) patients were identified with a case-history of anaphylaxis 
related to a HWP containing product. Seven of 9 had a case-history to 
the same hydrolyzed wheat product (AMO Letbagt®). The average serum 
level of HWP-sIgE and the SPT were higher in patients with a case-his-
tory of HWP, respectively (median 5.3 kU/L ±6.8) (p < 0.05) and (median 
6.0  mm ±4.1) (p  <  0.05) compared to the WIA and WDEIA groups.  A 
complete negative pattern was determined with specific wheat pro-
teins normally associated with other phenotypes of wheat allergy, 
omega-5 gliadin (f416), gliadin (f98), High Molecular Weight (Tri a 26) and 
α-amylase trypsin inhibitor (Tri a 30). Basophil histamine release (BHR) for 
HWP was extremely positive in 8/9 HWP patients with activity retained to 
dilutions up to 10−12. The most striking finding was the ultrahigh sensi-
tivity of BHR in diagnosing allergy to HWP. It is, however, interesting, that 
the HWP patient tolerates ingestion of unmodified wheat.
Conclusion: Reactivity to HWP seems to be confined to patients spe-
cifically sensitized to this heterogeneous group of products without 
concomitant allergy to normal wheat. Irrelevant co-sensitization is also 
seen in classical wheat allergy.
OP04 
Actual adrenalin treatment in a specialised clinical setting, 
compared to administration as recommended by a built‑in 
algorithm in a severity scoring instrument in food allergy
Esben Eller, Henrik Fomsgaard Kjaer, Charlotte Mortz, Carsten 
Bindslev‑Jensen
Odense University Hospital, Odense, Denmark 
Correspondence: Esben Eller ‑ esben.eller@rsyd.dk
Clinical and Translational Allergy 2017, 7(Suppl 1):OP04
Introduction: One of the most used severity scoring instruments, 
the Sampson 1–5, includes a built-in algorithm indicating symptoms 
which necessitate adrenalin administration. These include grade 5 
anaphylactic symptoms, but also grade 3 and 4 such as laryngeal “puri-
tus, tightness, or dysphagia” and lower respiratory symptoms such as 
“wheezing, dyspnea or cyanosis”. Our aim was to compare the recom-
mended adrenalin administration with the actual administration in 
our clinic in relation to the underlying eliciting symptom.
Methods: Data from 2382 positive food challenges (mean age 11.6 years 
[range: 0.5–74.1y]) performed between Jan. 2000 and Dec. 2015 at the 
Allergy Centre, Odense, Denmark were included, and severity of reactions 
was assessed using the Sampson 1–5 severity instrument. All patients 
were evaluated by experienced specialists during challenge. Actual medi-
cations administered during the challenges, i.e. adrenalin, β2-agonist, 
corticosteroid, or antihistamine were compared with recommended 
adrenalin treatment according to the algorithm in Sampson 1–5.
Results: Out of 346 challenges scored as grade 4 anaphylaxis, 296 were 
terminated due to respiratory symptoms requiring adrenalin according 
to Sampson 1–5, i.e. “barky cough, hoarseness, difficulty swallowing” 
(laryngeal, n = 79), “wheezing, dyspnea, cyanosis” (lower resp. n = 181) 
or both (n = 36). Nine of the 115 patients with laryngeal symptoms were 
treated with adrenalin, all due to inspiratory stridor. No patients with 
lower respiratory symptoms received adrenalin, but the majority were 
treated with β2 agonists (188/217), whereas in 30 challenges, symptoms 
disappeared without treatment or only antihistamine for concomitant 
urticaria were used. Patients solely with laryngeal symptoms received 
β2-agonists in 16 challenges, but the majority of them (54/79) received 
no treatment or only antihistamine. The 36 patients with both laryn-
geal and lower respiratory symptoms were treated in same manner as 
patients with only lower respiratory symptoms, i.e. β2 agonist for their 
bronchial wheeze or asthma. Grade 5 anaphylaxis was seen in 11 chal-
lenges, 1 caused by non-adrenalin recommended “loss of bowel control”. 
In the remaining 10 cases, 7 patients were treated with adrenalin, either 
due to “hypotension < 90 mm Hg” (n = 3) or “unconsciousness” (n = 4). 
Three children fainted, but regained consciousness without administra-
tion of adrenalin. Grade 5 anaphylaxis should almost always be treated 
with adrenalin, whereas adrenalin only was administrated to inspiratory 
stridor and not to bronchial expiratory wheeze or asthma in grade 4 ana-
phylaxis. Respiratory signs were instead medicated according to symp-
toms, i.e. with β2-agonist to relieve bronchoconstriction. All patients 
were evaluated by experienced specialists, and therefore this practice 
should be addressed with care in less experienced settings.
Conclusion: Inspiratory stridor was the main cause of adrenalin treat-
ment in grade 4 anaphylaxis, whereas the majority of lower respiratory 
symptoms were treated with inhalant β2 agonists, thereby overcom-
ing the need for adrenalin. This needs to be considered in future treat-
ment recommendations.
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Do patients know how to use adrenaline auto‑injectors?
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Serviço de Imunoalergologia, Centro Hospitalar de São João, Porto, 
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Introduction: Adrenaline auto-injectors (AAI) are the first line treat-
ment for anaphylaxis in community settings. Two are currently avail-
able in Portugal (Anapen® and Epipen®).
Our aim was to evaluate patient’s ability to properly use AAIs; impact 
of device switching and patients’ preferences.
Methods: Patients who had been prescribed an AAI in our department 
were invited to demonstrate correct technique of AAI by simulating 
adrenaline administration using training devices. First, simulation with 
their prescribed AAI; second, evaluation of device switching, without 
any previous training, by simulating injection with a different AAI 
(Epipen® or Anapen®, as well as Emerade®-currently unavailable in 
Portugal). Finally, they were asked which device they liked the best.
Results: Thirty-two patients were enrolled, 16 (50%) females, with a 
mean (SD) age of 42.9 (±15.8) years; 18 (56%) with hymenoptera venom 
allergy and 14 (44%) food allergy. Anapen® was prescribed to 15 (47%) 
and Epipen® to 17 (53%). Six did not acquire any AAI; 21 (66%) admitted 
carrying it on a daily basis. Eleven (34%) could not demonstrate success-
ful adrenaline administration with their prescribed AAI, 5 with Anapen® 
and 6 with Epipen®. Nine (60%) of the 15 patients who were prescribed 
an Anapen® could not administer adrenaline with an Epipen®; 11 (65%) 
of the 17 with a prescribed Epipen® were unable to use an Anapen®. Only 
2 (6%) were incapable of properly managing an Emerade®. The most 
common error in patients switching from Epipen® to Anapen® was not 
removing the needle cap (9 patients). In the group switching Anapen® 
to Epipen®, the most common misuse was not massaging the injection 
site (10 patients); 6 tried to remove the orange tip as if it was a cap. The 
preferred AAI was Emerade® in 20 (63%) and Epipen® in 12 (37%).
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Conclusions: Patients at-risk for anaphylaxis are provided with port-
able auto-injectors, educated and trained on their use. One-third of 
the patients did not always carry them. More than one-third was una-
ble to successfully demonstrate adrenaline administration with their 
prescribed AAI. Almost two-thirds failed to simulate injection when 
switched to the alternative one available in Portugal without any train-
ing. Design appears to play a role in a successful switch since 94% of 
the patients changing from either Anapen® or Epipen® to Emerade® 
were able to correctly use it. It was also the overall preferred auto-
injector. These emergency medical devices should be patient friendly.
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Incidence, clinical features, triggers and management 
of anaphylaxis in the Pediatric Emergency Department of the Tel 
Aviv Medical Center
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Introduction: Anaphylaxis is a severe, life threatening systemic hypersen-
sitivity reaction. The diagnosis of anaphylaxis is not always easy to make 
in the pediatric emergency department (ED) setting. Therefore, children 
are often dangerously underdiagnosed and undertreated. There is sparse 
information on the incidence and triggers of anaphylaxis in Israel.
Our objective was to assess the true incidence of anaphylaxis treated 
in the Pediatric ED, to identify triggers associated with anaphylaxis, 
to describe the management of anaphylactic reactions and identify 
potential gaps in diagnosis and treatment.
Methods: A retrospective chart review of cases presenting to the 
Pediatric ED of the Dana-Dweck Children’s hospital, at the Tel Aviv 
Sourasky Medical Center between January 1st 2013 to December 31th 
2014, with a diagnosis of anaphylaxis or allergic reaction. The clinical 
features, causative agents, treatment administered and recommenda-
tions at discharge were recorded.
Results: During the study period, there were a total of 56,596 visits to 
the ED. 437 patients were diagnosed with an allergic or anaphylactic 
reaction. Of these 59 (13.5%) met the diagnostic criteria for anaphy-
laxis, but only 22 were given the correct diagnosis. The mean age of 
presentation was 6.9  years, with a male predominance of 66%. Food 
was the most common causative agent (78%). Specifically, exposure to 
treenuts (28% (and cow milk (24%) were responsible for a majority of 
the cases. The majority of children (78% (had known food allergies and 
presented with breathing difficulties (64%), followed by urticaria (62%). 
Twenty children (37.7%) were treated with IM adrenaline prior to ED 
arrival and only fifteen (26%) were treated with IM adrenaline in the ED. 
Most of the children (86%) were discharged home. Almost 30% were 
discharged without a prescription to an automated Adrenaline injector.
Conclusion: The rate of anaphylaxis in the study period was 0.1% of all 
visits to the pediatric ED. Most cases of anaphylaxis were underdiag-
nosed. As a result, treatment guidelines regarding the use of IM Adren-
alin were not always followed and many children were discharged 
without a prescription for an adrenaline auto-injector.
ORAL ABSTRACT SESSION 2: Clinical aspects • Diagnosis 
and treatment
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Almond allergy in a cohort of Dutch atopic children: results 
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Introduction: Tree nut allergies are common in children, whereas 
most reported allergic reactions are caused by hazelnut and cashew 
nut [1,2]. Reactions to these nuts may vary from mild oral allergy 
symptoms to anaphylaxis. Not much is known about the frequency 
and severity of almond allergy in children. We therefore evaluated the 
results of oral food challenges with almond in a large group of Dutch 
atopic children.
Methods: All open and double-blind placebo-controlled food chal-
lenges (DBPCFC) with almond, performed between 2009 and 2015 in 
two Dutch outpatient clinics were evaluated retrospectively. Skin prick 
tests (SPT) with almond were performed in most children. Information 
about previous reactions, reasons for avoidance of almond and pres-
ence of atopic diseases (eczema, asthma, allergic rhinitis) were taken 
from the medical records.
Results: A total of 189 almond challenges were analyzed. Median 
age of the children was 7.5 years (range 2.0–17.8 years). Almond was 
removed from the diet for the following reasons: a previous reaction 
to almond (3.7%), previous reaction to another nut (30.7%), previous 
reaction to peanut (22.2%), other food allergies (23.8%), a positive 
test (sensitization) to almond (12.2%), eczema (3.7%), allergic parents 
(1.1%) and unknown (2.6%). A positive SPT almond was found in 148 
children (78.3%). SPT was negative in 28 children (14.8%) and not per-
formed in 13 children (6.9%). 97/101 DBPCFC’s were negative, 2/101 
children had a mild reaction and 2/101 children had a doubtful reac-
tion.  86/88 open challenges were negative, 1 child had a mild reac-
tion and 1 child had a doubtful reaction. Reactions were treated with 
antihistamine. No correlation was found between the outcome of the 
challenge and SPT results. Sensitization to birch pollen was found in 
109 children (57.7%). Sensitization to almond is frequently found in 
Dutch atopic children. This study shows that most of these sensitiza-
tions appear to be clinically irrelevant. Only 6/189 children (3.2%) had 
a mild reaction and no anaphylaxis was seen. Sensitization might be 
explained partly by cross-sensitization with birch pollen.
Conclusion: In a large cohort of Dutch atopic children, almond allergy 
is extremely rare and allergic reactions are only mild.
References
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Introduction: Food allergy is assessed generally by IgE-mediated 
laboratory tests. For NFA, gastrointestinal allergy is mainly considered. 
However, NFA which appears as eczema in atopic dermatitis is also 
frequent. In this report, typical three groups for food allergy was pre-
sented, patients with anaphylactic food allergy (AFA) as a representa-
tive IgE-mediated food allergy, patients with NFA which are presented 
as eczema in AD and patients who had both AFA and NFA in AD. Oral 
immunotherapy (OIT) using IFN-gamma was conducted success-
fully in these three groups. The different diagnostic and therapeutic 
approaches according to the type of food allergy and the clinical and 
immunological significance are presented.
Case report: Two patients had AFA. Specific IgE for causative foods like 
milk or eggs are very high and skin prick test for causative foods is also 
strong positive. AFA was confirmed by oral food challenges. Patients 
received OIT using IFN-gamma according to the protocol and finally 
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they got the tolerance for causative foods completely. Five patients 
had food allergy which symptoms is appearing as eczema as AD. Spe-
cific IgE and skin prick test for causative foods were negative. Oral food 
challenges were performed and the appearance of the symptoms and 
signs of AD is confirmed and the diagnosis was made as NFA as causes 
of AD. Patients received OIT using IFN-gamma according to the rele-
vant protocol, successfully. Two patients had NFA in AD and AFA. The 
some foods caused AD by showing eczematous reaction and the other 
different food provoked anaphylactic reactions, together. The spe-
cific IgE and skin prick test for the causative foods is very high for the 
food allergens of AFA and those for the foods were negative for NFA 
in AD. OFC was done for the causative foods of AFA and NFA. Patients 
received OIT using IFN-gamma by the compatible protocol according 
to the types of food allergy successfully.
Conclusion: Food allergy may be assessed by differentiation as food 
allergies of IgE- and non-IgE-mediated type. The diagnostic and thera-
peutic approaches are different according to the types of food allergy. 
The immunopathogenesis and clinical approach should be done 
according to the differential diagnosis.
Consent to publish: Written consent provided for publication of this 
abstract.
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Introduction: Fish allergy is relevant in our pediatric population on a 
Mediterranean diet. Specific IgE (sIgE) tests aid in diagnosis, but oral 
food challenge is the gold standard. We sought to: (1) analyze the effi-
ciency of sIgE to Gad c 1 and fish whole extracts to avoid challenge 
and (2) to evaluate maintenance of tolerance of challenged patients 
at home.
Methods: Children sensitized to fish and/or Gad c 1 reporting or not 
clinical history of fish allergy were challenged (masked single blind, 
16 g protein for ≤12 year-old children and 22 g for older ones). Clinical 
history was reviewed and sIgE to Gad c 1, fish extracts (ImmunoCAP, 
ThermoFisher) and challenge test outcomes were analyzed. Tolerance 
at home was investigated.
Results: 83 patients (67.5% male, median [range] age at OFC: 8[2–15] 
years-old) were analyzed. 9.6% were only sensitized. Among those 
reporting symptoms, 26% were anaphylaxis, 43.4% urticaria, 4.8% atopic 
dermatitis, 8.4% gastrointestinal symptoms, 2.4% dyspnea. All patients 
were challenged. A total of 221 challenges were done: 71 canned tuna 
(CT), 72 fresh tuna (FT), 48 hake and 30 sole. Challenge was positive 
(OFC+) in 2.2% of patients for CT, 12.5% FT, 47.9% hake and 40% for sole. 
Gad c 1 sIgE was significantly higher in OFC+ patients for FT, hake and 
sole (p =  .0031, <.0001, .0003, respectively) comparing with OFC-ones. 
Similarly occurred with sIgE to the corresponding extracts in the case of 
hake and sole (p = .0014 and .0015, respectively). ROC-curve analysis of 
Gad c 1 and whole extracts tests provided sIgE cut-offs to predict OFC+: 
Gad c 1: >37.5  kU/L for OFC with FT (AUC:0.80, LH:6.9), >4.7  kU/L for 
OFC with sole (AUC:0.91, LH:6.6), >3.5 kU/L for OFC with hake (AUC:0.88, 
LH:7.1). Tuna extract sIgE >15.5 kU/L for OFC with FT (AUC:0.78, LH:6.4), 
hake extract sIgE >23.5 kU/L for OFC with hake (AUC:0.83, LH:6.6), sole 
extract sIgE >1.1 kU/L for OFC with sole (AUC:0.89, LH:7).The follow up of 
tolerance at home showed that 64 (77.1%) patients were not eating the 
challenged food at home, 25 (39%) mainly for fear or refusal. A total of 
49 reactions, of which 17 (34.7%) anaphylaxis, occurred in 39 patients (7 
children with several fish species).
Conclusion: Certain sIgE cut-offs for Gad c 1, tuna, hake and sole 
extracts may aid in fish allergy diagnosis and predicting OFC outcome 
in our pediatric population. A significant proportion of children that 
tolerate fish at challenge, suffer allergic reactions when eating fish at 
home, some of them severe.
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Introduction: Until recently, food allergy management involved com-
plete allergen avoidance, however, data now implies that this may 
not be required - for example, with regard to extensively heated egg 
or cow’s milk e.g. in cakes/biscuits. In many countries, oral immuno-
therapy (OIT) is used as a treatment modality for food allergy, particu-
larly to cow’s milk and increasingly, peanut. However, adverse events 
are common (occurring in up to 80% of patients). There is a need to 
develop systems to facilitate safe OIT and allow real-time communi-
cation between patients and their treating allergist. Almost 90% of 
patients/parents now own a smartphone, which can be used to facili-
tate communication between patients and the clinical team.
Methods: We adapted a digital App called “Tell the Doctor” to allow 
real-time reporting of symptoms (adverse events, AEs) occurring out-
side the hospital environment. The App is being tested in an OIT trial in 
46 peanut-allergic children. Focus groups were held to collect feedback 
from study participants, their parents, and members of the study team.
Results: The app was welcomed by both study participants and their 
families. Feedback was obtained relating to the following areas:
  •  AE reporting was modified to allow rapid and instant alerts to the 
study team of any significant reactions occurring at home.
  •  Neurological/behavioural changes were separated from cardio-
vascular symptoms, as there was no evidence that the former are 
related to the latter.
 •  Study participants were asked to confirm OIT doses taken on a 
daily basis, thus confirming adherence to study protocol. Patients 
could also opt-in to a reminder service to prompt them to take 
both their OIT dose and any asthma preventer medicines by a 
time of their choosing.
Conclusion: The app facilitates real-time reporting of AEs during OIT 
studies and was preferred by participants and study team compared 
to delayed manual paper reporting. We expect electronic reporting to 
improve the data integrity of OIT-related AEs, and simplify AE reporting, 
thus improving safety. The advantages of using contemporary/popular 
communication modalities such as smartphone apps should be consid-
ered in the performance of OIT, whether in research or in clinical practice.
Acknowledgements: “Tell the Doctor” App funded by the Nominet Trust.
Trial registration: ClinicalTrials.gov Identifier: NCT02149719
Consent to publish: Informed consent was obtained, NHS HRA 
approval 15/LO/0287.
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Introduction: Multiplex tests allow to detect specific IgE to several 
different preparations at once. They allow patient’s profiling tailoring 
decisions for interventions. The last ten years have seen the availability 
of new technologies and when combined can lead to increase diag-
nostic information from allergy tests.
Our aim was to report about the FABER nanotechnology-based test in 
food allergy diagnosis.
Methods: FABER 244 IgE test is a new multiplexed in  vitro test for 
specific IgE measurement having 122 molecular allergens and 122 
allergenic extracts. Allergenic molecules and extracts, produced in 
house or obtained from top quality providers in the field, are coupled 
to chemically activated nanoparticles. Coupling is individually opti-
mized to achieve maximum test performance providing high diag-
nostic accuracy for each spotted allergenic item. Once coupled they 
are arrayed to a solid phase matrix to form a one-step comprehensive 
array based testing solution, using 100 ul of patient serum or plasma.
Results: Extracts from 91 food-borne allergenic sources (fruits, veg-
etables, eggs, milks, meats, fishes, crustacean, mollusks, snails, mush-
rooms, anisakis) are arrayed together with 66 allergenic proteins 
obtained from the same sources. CCD-bearing proteins are included 
as markers to support test result interpretation, as well as allergenic 
molecular groups which cross-sectionally belong to food and inhalant 
sources. Extracts on FABER244 expand the panel overcoming missing 
of any not yet identified or available allergenic molecule, increasing 
diagnostic accuracy and comprehensiveness. Test interpretation is 
supported by CAAM Digital Reporting System (CDRS), a unique online 
tool available worldwide, allowing visualization on mobile devices of 
FABER test results. CDRS has been developed for patients to familiarize 
with the new extended molecule-based results. To be patient-friendly 
it uses local languages taking advantage of the Allergome platform 
as the multi-language source. Data on CDRS are shown with tables, 
graphs, images; comments are generated real time by experts using 
the Allergome and its external modules, InterAll and ReTiME.
Conclusion: FABER 244 is the most advanced in vitro test for specific 
IgE detection, including molecules and extracts. It makes available to 
the molecular allergist an unprecedented quantity of data. The inclu-
sion of allergenic extracts is strategic to confirm or complement results 
obtained with the single allergenic molecules.
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Introduction: The European Food Safety Authority (EFSA) and other 
international bodies (Codex) define approaches for allergenicity 
assessment of food and feed derived from biotechnology. As an out-
come of the allergenicity assessment, risk assessors estimate whether 
the novel protein is likely to be allergenic and whether the food 
derived from biotechnology is likely to be more allergenic than that 
derived from its appropriate comparator(s). Because it is challenging 
to predict the allergenicity of novel proteins, a weight-of-evidence 
approach is used to provide the assessor with a cumulative body 
of evidence to (a) reduce the uncertainty linked to the allergenicity 
assessment and, (b) enhance the reliability of predictions regarding 
the allergenic potential of novel protein(s).
Methods: Currently, EFSA is developing supplementary guidance to 
better define and clarify specific aspects of the allergenicity assess-
ment requirements. In particular, (i) non-IgE-mediated immune 
adverse reactions to foods; (ii) in vitro protein digestibility; and (iii) 
endogenous allergenicity, are addressed.
Results: Firstly, celiac disease is a well characterised non-IgE-mediated 
adverse immune reaction to food, and the food proteins involved, as 
well as the underlying molecular mechanisms, have been described in 
detail. Secondly, the outcome of in vitro protein digestibility studies is 
considered relevant information in the weight-of-evidence approach. 
To date, the “pepsin resistance test” is commonly accepted for the 
safety assessment considerations by risk assessors. However, EFSA has 
previously highlighted its limitations for the allergenicity assessment 
as well as for its capacity to reflect in vivo digestion conditions. Thirdly, 
high performance methodologies for protein identification and quan-
tification are available for endogenous allergenicity.
Conclusion: Firstly, based on the current knowledge EFSA is working 
on defining a strategy to be followed for the assessment of novel pro-
teins’ potential to cause celiac disease. Secondly, EFSA is proactively 
developing a complementary strategy in order to reduce the result-
ing uncertainty in the allergenicity assessment. This strategy will be 
based on state-of-the-art in science, aiming at proposing an enhanced 
and refined in vitro gastrointestinal digestion test where different 
physiological conditions will be taken into consideration and more 
informative read-out procedures will be recommended. Thirdly, high 
performance methodologies for protein identification and quantifica-
tion will be proposed as complementary/alternative methods to those 
based on human sera for the assessment of endogenous allergenicity 
within the comparative assessment analysis.
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Introduction: In an oral mouse food allergy model, concomitant gas-
tric acid suppression is associated with formation of antigen-specific 
IgE and anaphylaxis. Notably, we repeatedly observed non-responder 
animals protected from food allergy. Therefore, in this study we aimed 
to analyse the reasons for this protection.
Methods and Results: Out of 64 BALB/c animals being subjected to 
the oral ovalbumin (OVA) immunization protocol under gastric acid-
suppression, 10 animals (16%) did not show any elevation of OVA-spe-
cific IgE or IgG1 titers indicating protection from allergic sensitization. 
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In these animals, allergen challenges confirmed reduced antigen 
uptake and lack of anaphylactic symptoms, while in the non-pro-
tected allergic mouse group high levels of mouse mast cell protease-1 
(mMCP-1) and a drop of core body temperature were elicited, indica-
tive for anaphylaxis. Further, significantly lower numbers of CD4+ T 
cells and regulatory T cells were detected in the non-responders, as 
well as significantly lower levels of IL-4, IL-5, IL-10 and IL-13 in super-
natants from stimulated splenocytes, but comparable levels of IL-22. 
This was accompanied by significantly increased numbers of total lym-
phocytes and reduced numbers of monocytes, erythrocytes and hem-
atocrit in the peripheral blood of the non-responders. Comparison of 
microbiota finally revealed differences regarding the composition of 
bacterial communities on single bacterial Operational Taxonomic Unit 
(OTU) level between protected and allergic mice.
Conclusion: These data clearly indicate that protection from food 
allergy development was associated with significantly reduced Th2 
cytokine levels and IL-10, and increased numbers of blood cells in the 
periphery after anaphylaxis. Most importantly, analysis of single bacte-
rial OTUs indicated that a distinct microbiota composition was associ-
ated with a non-responding phenotype in this mouse model. The data 
propose that also microbiota might decide on the extent of a food-
anaphylactic response.
Acknowledgements: Supported by FWF grants P21884, P21577 
and KLI284 of the Austrian science fund FWF. HF is supported by the 
Deutsche Forschungsgemeinschaft (Cluster of Excellence “Inflamma-
tion at Interfaces” EXC 306).
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Introduction: To study an increasing number of peanut allergic chil-
dren with allergic reactions after having eaten food with curry or other 
mixed spices. All were sensitized to fenugreek (Trigonella foenum 
graeceum).
Methods: We have collected and reviewed data from 13 patients dur-
ing the last 5  years from our outpatient allergy departments. Eleven 
had reacted to food with curry and 2 to food with fajitas spice mix-
ture. All were sensitized to and regarded as allergic to fenugreek, an 
ingredient in both curry and the spice mixtures. Five reacted with an 
anaphylactic reaction. Six reported allergy symptoms such as urticaria, 
itching in the mouth, abdominal pain, vomiting and asthma.
Results: Mean age for the first reaction, when known, was 9  years. 
Seven boys and four girls. All 13 children were sIgE-positive to both 
fenugreek and to peanut as well as one or more of the recombinant 
peanut allergens Ara h 1, 2 or 3. Seven tested for Ara h 1 were all posi-
tive, in six of seven the dominant allergen was Ara h 1. The sIgE-results 
will be presented in detail. Our patients have not yet had a food provo-
cation test. Fenugreek belongs to the Fabaceae plant family (legumes). 
The dried seeds are used whole or ground to a yellow powder after 
roasting, most commonly as a spice in curry and other mixed spices 
but also as an ingredient in a variety of food. In the literature fenugreek 
allergy was first described 1993, a case with occupational asthma. We 
have found only two reports about fenugreek food allergy. In Nor-
way it is recommended to warn peanut allergic patients against food 
containing fenugreek and lupin. In Sweden there is no such warning 
either from our pediatric allergy society nor from The Swedish National 
Food Agency, but fenugreek as well as other peanut cross-reactive 
allergens are mentioned as a potential risk for allergic reactions. We 
plan to review of the history of reactions to curry or spices and add 
sIgE tests in follow up of our peanut allergic patients. The results may 
change our opinion about which advice to give to peanut allergic 
patients about fenugreek and mixed spices, eg curry.
Conclusion: For patients with fenugreek allergy and for cautious pea-
nut allergic patients it is a problem that fenugreek is not on the list of 
ingredients that should be declared according to the food labelling 
directive from the European Union and The Swedish National Food 
Agency.
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Introduction: To assess frequency and magnitude of IgE sensitization 
to Pru p 7 sIgE in patients complaining of peach allergy.
Methods: Sera from 117 outpatients (median age 20  years, range 
4–74; 44% males) having undergone sIgE work-up for peach extract 
and commercial component-resolved diagnostics (ImmunoCAP 250, 
Thermo Fisher Scientific, Uppsala, Sweden) between February 2012 
and June 2016 were assayed for sIgE to recombinant Pru p 7. The posi-
tivity threshold was set at 0.10 kUA/L.
Results: Of the 117 patient sera analysed, 111 (95%) tested posi-
tive to peach extract, 73 of which (66%) displayed sIgE reactivity to 
rPru p 7. In 45/68 (66%) cases, sIgE reactivity to Pru p 7 was isolated 
(no detection of sIgE to rPru p 1, rPru p 3, or rPru p 4). Among the 6 
peach negative sera, one was found positive to rPru p 7 (0.81 kUA/L). 
Quantitative analysis showed that levels of sIgE in the study popula-
tion were higher to Pru p 7 than to peach extract (median 5.5 vs 1.3 
kUA/L, range 0.10 to 30.7 vs 0.10 to 52.4, p = 0.003, coefficient of cor-
relation -0.12). 38/111 (32%) sera with detectable sIgE to peach extract 
did not display sIgE to rPru p 7, and 3 of these sera (peach sIgE 0.18 to 
0.20 kUA/L) did not display sIgE to any of rPru p 1, rPru p 3, rPru p 4, or 
MUXF3. Pru p 7 has been reported as a major allergen in peach allergic 
patients from Spain and Italy, and Pru p 7 sensitization appears to cor-
relate with a specific clinical presentation in Japanese patients. Here, 
we bring evidence that Pru p 7 is a major allergen in peach-sensitized 
patients from Southern France, including those with low sIgE to peach 
extract and seemingly independent of sIgE reactivity to peach compo-
nents currently available for diagnostic testing. Significant association 
with cypress pollinosis and severe peach-induced allergy have been 
observed in rPru p 7 sensitized patients.
Conclusion: Pru p 7 is needed for comprehensive component-
resolved diagnostics of peach allergy in Mediterranean patients. Pru 
p 7 sensitization may be a prognostic factor of peach allergy severity. 
From a pathophysiological perspective, Pru p 7 may shed light on the 
as-yet obscure relationship between peach and cypress pollen allergy 
in the Mediterranean region.
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Introduction: nsLTPs are pathogenesis-related proteins (PR-14) 
with antimicrobial activity, and represent important plant food aller-
gens, especially in fruits. Even if nsLTPs from different Rosaceae fruits 
are highly homologous and cross-reactive, they possess different 
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allergenic potentials, the strongest for Pru p 3 (peach), probably a 
primary sensitizer. This study aims at investigating the differences 
between Pru p 3 and Mal d 3 (apple), in relation to lipid-binding capac-
ity and immunoreactivity, and to evaluate how LTP-ligand interaction 
may affect IgE reactivity.
Methods: Proteins were produced in Pichia pastoris, their expression 
was monitored in the culture supernatants by SDS-PAGE and immu-
noblotting with anti-nsLTP antiserum. rLTPs were purified by IEC chro-
matography and analysed by MALDI-TOF MS. To assess the LTP-ligand 
binding, ANS displacement assay was performed with 7 different fatty 
acids (from C12 to C18), either saturated or unsaturated, at different 
concentrations (10–100  μM). The IgE reactivity of recombinant aller-
gens, alone or in complex with selected ligands, was analysed by ELISA 
assay using allergic patients’ sera.
Results: Both rLTPs migrate in SDS-PAGE between 10 and 15 kDa. MS 
analysis confirmed the identity of the purified proteins, providing 
9.138 kDa (rPru p 3) and 9.553 kDa (rMal d 3) and were recognized by 
anti-nsLTP antiserum. ANS assay showed a higher fluorescence in Pru p 
3 (+15%) compared to Mal d 3 and some differences in protein/ligands 
binding. However, both proteins had higher affinity for unsaturated 
fatty acids (e.g. ~50% fluorescence reduction with 10  μM oleic acid). 
ELISA test also evidenced higher IgE reactivity for rPru p 3 with respect 
to rMal d 3, as well as differences between the rLTPs alone and in com-
plex with ligands. Our results suggest that Pru p 3 and Mal d 3 have 
different IgE reactivity and affinity for the fatty acids tested, but both 
preferentially bind unsaturated fatty acids. This interaction has an effect 
on IgE binding, but at different extent for Pru p 3 and Mal d 3. This may 
be due to specific differences in their lipid-binding region.
Conclusion: Our preliminary data support the hypothesis of a role of 
specific food matrix components (e.g. fatty acids), in modulating specific 
IgE responses to different food allergens with antimicrobial activity.
Acknowledgements: Supported by Marie-Curie project CARAMEL 
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Introduction: One of the most frequent fruit and vegetable allergies 
in the Mediterranean area is non-specific-lipid transfer protein (nsLTP) 
syndrome where patients suffer allergies not only to peach but other 
plants-food related to nsLTPs. Specific immunotherapy (sIT) brings 
a new perspective to treat these patients however little is known 
whether sIT to one allergen can affect allergy to other plant-derived 
food. The aim was to evaluate the effect of sublingual immunotherapy 
(SLIT) with Pru p 3 (Pru p 3-SLIT) to other plants-derived-food in aller-
gic patients to vegetable.
Methods: In a group of 36 patients with allergy to peach, 30 (83.3%) 
had allergies to other plants-food related. Plant-food allergies were 
evaluated by compatible clinical history, prick-prick to fresh fruit and 
ImmunoCAPIgE. After one year of treatment with (enriched-Pru p 
3-SLIT) we evaluated reactivity to apple, hazelnut, strawberry and 
tomato by double blind placebo control food challenge (DBPCFC).
Results: In the total group of patients, 12 (33.3%) were allergic to apple, 
4 (33.4%) had anaphylaxis, 5 (41.6%) urticaria and/or angioedema and 
three (25%) OAS. Four (11.1%) were allergic to hazelnut, from these 3 
(75%) presented anaphylaxis and 1 (25%) urticaria and/or angioedema. 
Four (11.1%) to strawberry, all the patients presented OAS. Three (8.3%) 
were allergic to tomato, presenting anaphylaxis one patient (33.3%) 
and urticaria and/or angioedema 2 (66.75). Prick-prick with the cul-
prit food was positive in all of the patients (100%). sIgE with apple, 
strawberry and tomato was positive in all the cases (100%). Hazelnut 
was positive in three (75%). After one year of SLIT all the patients tol-
erated tomato with peel and 100 gr of strawberries. Regarding reac-
tivity to apple, 7 (58.3%) tolerated the whole apple with peel. Finally 2 
patients (50%) tolerated 15 units of hazelnut. These results showed that 
a percentage of patients with clinical symptoms to other plants-food 
related to nsLTP that can tolerate this food after receiving enriched-Pru 
p 3-SLITduring one year. Enriched-Pru P 3-SLIT could be a good tool to 
improve the clinical symptoms in patients with LTP-Syndrome.
Conclusion: These data show clinical changes after the first year of 
treatment with enriched-Pru p 3-SLIT, not only to peach but also to 
other food allergens as apple, hazelnut, strawberry and tomato.
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Introduction: Beside hazelnut, the English walnut (Juglans regia) 
belongs to the most important allergenic tree nuts across Europe. 
So far, four walnut allergens (2S albumin, vicilin, nsLTP, 11S globulin) 
are listed in the official IUIS allergen database. Although an associa-
tion of allergic reactions to walnut with birch pollen sensitization has 
been reported, no cross- reactive culprit walnut allergen has been 
described. The aim of the present study was to identify a Bet v 1-like 
protein in walnut and to investigate its allergenic properties.
Methods: Using a Bet v 1-homologous cDNA sequence from iron wal-
nut leaves (KJ598787) as template, a cDNA encoding a corresponding 
protein from Juglans regia kernels (Jug r PR10) was cloned by RT-PCR 
and 5’RACE. Recombinant® Jug r PR10 protein was expressed in E. coli 
and purified by a two-step chromatographic procedure. Purity and 
secondary structure were analyzed by SDS-PAGE and CD spectroscopy. 
Specific IgE levels to walnut extract, rBet  v  1 and rJug  r  PR10 were 
measured by ImmunoCAP™ in birch pollen allergics with concomitant 
allergy to walnut (n =  15), confirmed by a positive open or double-
blind placebo-controlled food challenge test. The presence of natural 
Jug r PR10 in walnut extract was analyzed by IgE immunoblot compe-
tition experiments using rJug r PR10 as inhibitor.
Results: Jug  r  PR10 (KX034087) was 100% identical in amino acid 
sequence to KJ598787, 67% to Bet  v  1.01 and up to 74% to PR10 
proteins from fruits, e.g. Mal d 1 (apple), Pru av 1 (cherry) and Pru p 1 
(peach). Recombinant Jug r PR10 displayed secondary structures simi-
lar to those of Bet v 1. Walnut sensitization was detected in 40% (6/15) 
and 47% (7/15) of the patients studied, by ImmunoCAP and skin test-
ing, respectively. In contrast, 93% (14/15) were reactive to rJug r PR10 
and 100% to Bet  v  1. The Bet  v  1 and Jug  r  PR10 specific IgE values 
correlated strongly (r2  =  0.93), even though lower IgE levels were 
observed for Jug r PR10 (median 12.9 kUA/L) than for Bet v 1 (median 
21.5 kUA/L). The presence of an IgE-reactive PR10 protein in walnut 
kernels was confirmed by immunoblot inhibition.
Conclusion: According to the established criteria, the PR10 protein 
from English walnut qualifies as major allergen. Low diagnostic sensi-
tivity of walnut extract for patients with birch pollen associated wal-
nut allergy might be due to small amounts of Jug r PR10 in walnuts. 
Recombinant Jug r PR10 may therefore become a useful tool for com-
ponent-resolved diagnosis.
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Introduction: The mammalian carbohydrate galactose-α1,3-
galactose (α-Gal) has shown to cause a novel form of food allergy, red 
meat allergy, where patients have severe allergic reactions several 
hours after red meat consumption. The number of diagnosed cases 
has increased significantly over the past few years and the α-Gal 
epitope is now an established clinically relevant glycan that should 
be taken into account in the diagnosis of food allergy. We have pre-
viously shown that red meat allergic patients have a selective IgE 
response to the pure α-Gal glycan that is unrelated to the carrier 
protein. The aim of this study was to explore the impact of digestion 
of α-Gal containing glycoproteins using a model system exposing 
the α-Gal containing protein bovine thyroglobulin to in vitro gastric 
digestion.
Methods: Bovine thyroglobulin was digested with pepsin. Digestion 
products were analyzed for stability and allergenic properties by SDS 
PAGE, immunoblot and ImmunoCAP using sera from ten red meat 
allergic patients, as well as with a peptidomics approach.
Results: During pepsinolysis of bovine thyroglobulin, a wide range of 
peptide bands could be observed during the first 10  min. Thereafter 
14–17  kDa peptides remained stable during the whole gastric phase. 
The presence of the α-Gal epitope on the obtained peptides was dem-
onstrated using an anti-α-Gal antibody as well as by IgE reactivity in sera 
from red meat allergic patients. The α-Gal peptides were able to inhibit 
at least 40% of the IgE-binding to bovine thyroglobulin (ImmunoCAP). 
The peptidomics approach showed that these peptides represent mostly 
internal and C-terminal parts of the protein, where a specific region from 
Arg1617 until Lys2230 contains complex type of glycans with the most 
potent IgE-binding α-Galactosyl residues. α-Gal containing food can elicit 
delayed severe allergic symptoms in red meat allergic patients. Here we 
show that peptides obtained after pepsinolysis of the model allergen, 
bovine thyroglobulin, contain α-Gal and remain stable during the whole 
gastric phase. Furthermore, these peptides contain specific α-Galactosyl 
recognition patterns and bind IgE from red meat-allergic patients.
Conclusion: The allergic response to α-Gal could depend on the type of 
α-Galactosyl residues on peptides obtained after gastric digestion, where 
complex type of glycans seems to have the most intense IgE-binding.
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Introduction: Double blind placebo-controlled food challenge (DBP-
CFC) is the gold standard to diagnose peanut allergy. In children sen-
sitized to peanut, the detection of allergen-specific IgE (sIgE) and/or 
basophil sensitivity to Ara h 2 and Ara h 6 could be an alternative way 
to predict clinical peanut allergy and thereby avoid burdensome and 
expensive challenges in part of the patients.
We aimed to prospectively evaluate the most accurate diagnostic 
approach in children with suspected peanut allergy using sensitization 
tests and the Basophil Activation Test (BAT) to peanut components, 
with focus on Ara h 2 and Ara h 6.
Methods: In this cross sectional prospective  diagnostic study (Janu-
ary 2012–May 2015), a total of 83 children (mean age 8.4 years) with 
suspected peanut allergy underwent diagnostic evaluation for peanut 
allergy including DBPCFC. The diagnostic value of sensitization tests 
and the BAT in predicting (severe) peanut allergy was evaluated.
Results: Peanut allergy was confirmed in 48 (58%) children, including 
15 (18%) with severe allergy. Ara h 2 and h 6 showed high discrimina-
tory capacity in sIgE and BAT. Ara h 6 had significant higher diagnostic 
value than Ara h 2 in the BAT. With sIgE to Ara h 2 we could classify 62% 
of children correctly as tolerant or allergic, when subsequently adding 
the BAT using Ara h 2 and Ara h 6 we could increase this to 80%.
Conclusion: This study shows that Ara h 2 and h 6 are both strong pre-
dictors of peanut allergy. A stepwise approach including sIgE to Ara h 
2 and subsequently the BAT to Ara h 2 and Ara h 6 is able to predict 
peanut allergic status in the majority of children.
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Introduction: Peanuts are rarely consumed in their native form and 
are most commonly, fried or roasted, conditions which favour the for-
mation of Maillard reaction products (MRP’s). Quantitative proteomic 
profiling of these modified proteins will enable MRP formation to be 
monitored during processing and markers identified. Thermal process-
ing is also thought to modulate the allergenic activity of peanuts by 
causing protein aggregation and decreasing solubility. The IgE reac-
tivity of thermally processed peanut proteins will be assessed using a 
panel of peanut-allergic patient serum.
Methods: Raw and processed peanuts were extracted under harsh 
denaturing conditions and subjected to proteomic profiling using 
data-dependent acquisition (DDA) on an Orbitrap Elite mass spec-
trometer. Data was processed using Progenesis-QI and peptides 
identified using a curated peanut database and a predetermined set 
of variable Maillard modifications in Peaks. Serum samples from pea-
nut allergic patients were obtained from the Manchester Respiratory, 
Allergy and Thoracic Surgery (ManARTS) Biobank and IgE reactivity 
assessed by immunoblotting, inhibition ELISA and histamine release.
Results: Mass spectrometric analysis revealed processing-induced mod-
ification of peanut allergens through the formation of Maillard reaction 
products and reduced solubility through aggregation. Extensive boiling 
(>2 h) had complex effects on allergen structure, and caused hydrolysis 
of allergens, and loss of Ara h 2 into the cooking water. Patients could 
be classified into those who were sensitised to several allergens and 
reacted towards aggregates, and those sensitised only to Ara h 2. Many 
of the latter patients were not reactive to boiled peanuts.
Conclusion: This work has identified a number of peptide markers in 
peanut which are characteristic of different types of thermal process-
ing. It also highlighted the ability of extensively processed protein to 
retain IgE reactivity in certain sensitised individuals whilst boiled pea-
nuts maybe less reactive in certain patients. Boiled peanuts may pro-
vide an alternative for oral immunotherapy with reduced side-effects, 
especially in patients only reactive to Ara h 2.
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Introduction: Food is one of the most common elicitors of anaphy-
laxis. Even small amounts of a food allergen can cause severe allergic 
reactions. Based on data from the NORA network, we aimed to ana-
lyze the source and amount of food ingested causing the anaphylactic 
episode.
Methods: The European data from the Network for Online Registra-
tion of Anaphylaxis (NORA) was analyzed, restricted to cases of food-
induced anaphylaxis.
Results: 2204 cases of food-induced anaphylaxis were registered 
between June 2011 and April 2016. The detailed questions for food 
induced anaphylaxis were answered in 1460 cases. Of these, 843 cases 
occurred to non-packed foods, and 617 cases to pre-packed foods. For 
744 the source of food elicitor was unknown. The origin of non-packed 
products was known in 72%, mostly from supermarkets (n = 116), buf-
fets (n = 108) and catered foods (n = 105). The origin was known in 78% 
for pre-packed foods namely cereal bar, peanut puffs or hazelnut spread. 
The responsible food allergen was listed in the list of ingredients in 89%. 
The amount of food causing the reaction was documented in 60% of 
all cases, more often when children were affected. In children, one tea 
spoon was the most frequently estimated amount, and a plate in adults.
Conclusion: Both, non- and pre-packed foods were frequent sources 
of allergens causing anaphylaxis. Despite, the allergen was explicitly 
stated in the list of ingredients in the majority of pre-packed foods, 
anaphylaxis occurred. Therefore, labelling alone is not sufficient to 
protect from severe reactions. Patients with food-induced anaphylaxis 
need detailed counselling about food allergen sources. Additionally, 
the differences in the amount of food allergen might not be age but 
rather depending on the major food allergen in this age group (chil-
dren - peanut and adults - wheat).
Acknowledgements: Network for Online Registration of Anaphylaxis 
(NORA) participating centers can be found under www.anaphylaxie.net.
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Introduction: Gastric digestion assays have been part of the weight-
of-evidence approach for evaluating the allergenic potential of pro-
teins expressed in GM crops since protein stability in such assays was 
suggested to correlate with the allergenic status of proteins. EFSA has 
provided guidance that more physiologically relevant digestion assays 
should be evaluated for their potential to support the allergenicity risk 
assessment.
Methods: Nine proteins (shrimp and porcine tropomyosin, peanut 
and green pea albumin, peach and strawberry LTP, fish and bovine 
collagen, and carp parvalbumin) were subjected to 9 different gastric 
digestion conditions (pH 1.2/2.5/4.0, with three pepsin/protein ratios 
[PPR] 10:1/1:1/1:10), followed by duodenal digestion. Samples were 
taken at different time points and analyzed by SDS-PAGE and immuno-
blotting (mono-specific polyclonal rabbit antisera).
Results: The idea behind the four protein pairs was to pairwise com-
pare an established strong allergen and a related non-allergen or weak 
allergen. Originally, we set out to do the same for fish parvalbumins, 
but purification of the hypothesized weak allergenic version from 
swordfish/tuna turned out to be extremely difficult due to the low 
content in the fish muscle (which is probably the more likely explana-
tion of the low allergenicity of these fish). For three of the four pairs 
(tropomyosins, albumins and LTPs), the allergenic protein presented 
as the more stable during gastric digestion. The optimal conditions 
for this were pH1.2 and/or pH2.5 in combination with higher physi-
ological PPRs (10 and/or 1). Gastric digestion at p 4.0 was clearly a less 
discriminative condition. Surprisingly, in case of the collagens, the 
allergenic one from fish was more labile than its bovine counterpart. 
Results from the duodenal digestion showed that, after gastric diges-
tion at pH2.5 and/or 4.0 (less so after pH1.2), all proteins including 
all established allergens, were completely digested, also if they were 
resistant to preceding gastric digestion.
Conclusions: Gastric digestion at low (i.e. optimal) pH still remains the 
more appropriate but not perfect tool to use in building weight of evi-
dence for the risk assessment of novel transgenes for GM crops. More 
physiological conditions, like higher gastric pH and/or inclusion of duode-
nal digestion may in fact be misleading with established strong allergens 
such as Ara h 2, Pru p 3 and Cyp c 1 being readily and completely digested.
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Introduction: It is known that parental anxiety & VAFA in siblings of 
an IC may affect the nutrition and quality of life (QOL). There is no evi-
dence to support investigation and challenge for food allergy in the 
unaffected siblings. This study explores VAFA, parental anxiety and 
parental response to possible measures for facilitating new food intro-
duction to the unaffected siblings of an IC.
Methods: The data was obtained from 40 families with proven food 
allergy in the IC attending a hospital in the UK. The parents were prac-
ticing VAFA in the unaffected siblings. The families with siblings suf-
fering from eczema and asthma were excluded from the study. The 
families were offered 3 options:
1. Continue VAFA
2.  Introduce suspected food in the hospital restaurant conveni-
ently located near A&E and wait for 2 h
3. Give the suspected food at home during the day time.
Results: The parental anxiety score (AS) was measured in Likert Scale 
(0 to 10). Parents of IC with multiple food allergies and strong family 
history have higher AS to introduce suspected food in the siblings. 
Peanut, tree nut, milk and fish allergy caused maximum AS. 16 parents 
with AS >5 requested for allergy test before making the decision. All 
16 parents choose to continue VAFA. Additionally, 5 parents in this 
group preferred VAFA to ensure allergen free household for safety of 
the IC & 4 witnessed anaphylaxis in the past (Table 1).
No allergic reaction was noted during food introduction. Parents 
reported reduction of AS post introduction. Parents felt less hesitant in 
introducing new food to the siblings in future.
Conclusion: This study highlights the effect of parental anxiety on 
VAFA. The novel innovative approach of introducing food within the 
hospital premises restaurant was perceived by parents as less risky and 
more reassuring. This option positively influenced parental decision to 







1. Continue VAFA 16 16 0
2. Introduce food in 
Hospital Restaurant
20 11 9
3. Introduce food at 
home
4 0 4
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Introduction: Allergen structure is often modified when heating 
foods. Aggregation is an irreversible modification of proteins with 
the formation of intermolecular bonds between unfolded proteins. 
Depending on the balance of attractive and repulsive interactions dur-
ing heating, aggregates of various morphologies may be generated. 
This study investigates how different way of aggregating ovalbumin 
modulates its allergenicity by comparing two morphologies of aggre-
gates obtained under opposite electrostatic conditions.
Methods: An ovalbumin solution was extensively heated (80°C for 6 h) 
under opposite electrostatic conditions to form small linear and large 
spherical-agglomerated aggregates. In a murine model of allergy, we 
compared the Ig production when sensitizing mice with the aggre-
gates and the subsequent elicitation phase upon an oral challenge 
with native ovalbumin. The reactivity of specific IgE in mice sera was 
characterized by ELISA, Rat Basophil Leukemia assay and pepscan 
analysis.
Results: IgE production was significantly lower for the small 
aggregates than for the large aggregates, whereas IgG1 and IgG2a 
productions didn’t change. In agreement with the IgE production, 
both symptoms upon oral challenge and basophil degranulation 
with native ovalbumin were reduced for mice sensitized with small 
compared to large aggregates. Pepscan analysis revealed two 
common linear IgE-epitopes but the aggregates were similarly or 
differently bound and cross-linked depending on the aggregate 
that had been used during sensitization. These results showed 
that small aggregates of ovalbumin formed under repulsive elec-
trostatic conditions displayed a lower allergenic potential than the 
large aggregates. The way ovalbumin aggregated also modified 
the IgE repertory.
Conclusion: This work illustrates links between food structure and 
allergenic potential on parameters from the sensitization phase with 
some consequences on the elicitation phase of the allergic reaction. 
For the first time, we show that the physicochemical conditions when 
heating ovalbumin and consequently the aggregated structure are 
important parameters to consider in the context of allergy.
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Introduction: Food allergy is causing adverse health effects arising 
from specific immune-mediated responses, occurring reproducibly 
upon oral exposure to a given food. In the absence of a cure, suffer-
ers have to rely on the accurate labeling of food to avoid allergens. 
Egg and cow’s milk proteins are common triggers of allergic reactions, 
especially in children. Following a multimethod comparative study 
about the latest approaches in food analysis using state-of-the-art 
technology (see our previous work), one specific goal of this study is to 
develop and validate a LC-MS/MS method for residual determination 
of cow’s milk and egg allergens in bakery products.
Methods: After sample homogenization, proteins are extracted, dena-
tured and reduced by TCEP. Free thiol moieties are then alkylated and 
proteins digested by trypsin. The peptide mixtures obtained are then 
purified by Solid Phase Extraction and analyzed by LC-MS/MS using 
Sciex Q-Trap 6500 mass spectrometer. For our purpose, a Multiple 
Reaction Monitoring (MRM) method specific for milk β-lactoglobulin 
(β-lg) and egg ovalbumin was set up.
Results: After spiking a mix of β-lg and ovalbumin into different bakery 
products, specific MRM signals were detected for both proteins. As an 
example, two XIC graphs for one of the MRM transitions investigated in 
β-lg are reported below (Fig. 1). The signal is clearly visible in the product 
spiked with as little as 0,05 mg/kg of β-lg (B), but is absent in the blank (A).
The efficacy of the MRM method was assessed by testing a certified 
material (cake mix, FAPAS) for milk’s presence. The material was previ-
ously used for a ring test involving different ELISA kits. As ELISA kits 
suffer from high kit-to-kit variability (as can be seen in many pro-
ficiency testing results) a quantitative comparison with the results 
obtained from ELISAs was not possible. In LC-MS/MS analysis, quan-
tification by MRM is generally more accurate as it is not reliant upon 
biological interactions like antibodies.
Conclusion: The LC-MS/MS approach, combined with an efficient 
extraction method, shows high sensitivity and selectivity under all 
evaluated conditions, without producing false negatives for neither 
egg nor milk. The developed method provides a valid alternative to 
the ELISA kits on the market, bypassing issues associated with anti-
gen-antibody interactions and retaining a low limit of quantification. 
The method will be validated and considered for accreditation.
Fig. 1 See text for description
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Introduction: To calculate optimal cut-off values for egg white and 
Gal d 1,2,3, and 4 -specific IgE (sIgE) predicting positive oral challenges 
in 100 Finnish children with suspected egg allergy.
Methods: 100 patients (age 1–19  years, mean 9.2, median 9.6  years) 
with suspected egg allergy underwent double-blind, placebo-con-
trolled (n  =  60) or open (n  =  40) food challenges with heated egg 
white. Serum IgE levels to egg white as well as the components Gal d 
1 (ovomucoid), Gal d 2 (ovalbumin), Gal d 3 (conalbumin) and Gal d 4 
(lysozyme) were measured by ImmunoCAP.
Results: Of the 100 challenges 75 were positive. Sensitization to Gal 
d 1 (ovomucoid) with a cut-off of value of >4.3 kU/L predicted a posi-
tive challenge with a specificity of 92% and sensitivity of 83%. The like-
lihood ratio was 10.3 In ROC analysis the area under curve was 0.92 
(95% CI 0.86–0.98). Gal d 1 sIgE levels were significantly higher in the 
challenge positive (mean 38 kU/L, median 15.8 kU/L) than in the chal-
lenge negative group (mean 2.4  kU/L, median 0.5  kU/L), p  <  0.0001. 
The diagnostic capacity of sIgE to egg white and Gal d 2, 3 and 4 was 
clearly weaker. In ROC analysis the AUC for egg white was 0.88, Gal d 2 
0.87, Gal d 3 0.78 and Gal d 4 0.76 (Fig. 2).
Component-specific IgE levels can be useful in predicting outcomes 
of oral food challenges, but optimal cut-off levels vary in different 
populations. Sensitization is influenced by many factors including age 
and geography, whereas challenge outcome is influenced by referral 
base and challenge procedures. Thus, optimal cut-off levels need to 
be determined for each population separately. Sensitization to Gal d 
1, which is relatively stable against heat and enzymatic digestion, pre-
dicts clinical reactivity to both raw and heated egg and is considered a 
risk factor for persistent egg allergy.
Conclusion: Ovomucoid-specific IgE is useful in distinguishing egg-
sensitized patients with clinically reactive egg allergy from those toler-
ant to heated egg. The optimal cut-off point in a Finnish population of 
100 children and adolescents was 4.3 kU/L.
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Introduction: Macadamia nut is reported to cause allergic reac-
tions in sensitized individuals, and the prevalence is expected to 
increase along with the increase in world production and popularity 
of macadamia nuts as an ingredient in pre-packaged foods. Despite 
several reports documenting macadamia nut allergies, the eliciting 
allergens have never been identified due to a lack of genomic and 
proteomic data on macadamia nut. Identification and characterization 
of allergenic proteins are crucial for developing effective component-
resolved diagnosis and management/treatment strategies.
We aimed to identify putative allergenic proteins in macadamia nut by 
combining patient IgE recognition with an allergenomics approach.
Methods: Five serum samples were collected from patients with clini-
cal allergy. Immunoreactive proteins were identified by immunoblot-
ting with the patient sera. A label-free shotgun proteomics approach 
was used to investigate the proteomic profile of macadamia nut. 
Briefly, the molecular weight distribution of proteins was determined 
by 1-dimentional and 2-dimensional gel electrophoresis. Following in-
gel digestion with trypsin, proteins were subjected to liquid chroma-
tography coupled tandem mass spectrometry.
Results: The label-free shotgun proteomics was used to predict 
putative macadamia nut allergens for the first time. The amino acid 
sequence homologies to 21 known allergens across different plant 
species were identified, which include lupin, latex, peanut, soy and rice 
allergens. The immunoblotting of the soluble proteins with the serum 
IgE revealed five reactive protein bands. The mass spectrometry analy-
sis of the IgE-reactive proteins showed matches to Miamp1 protein, 
Miamp2, vicilin-like protein, 11S-legumin like protein and lactoylglu-
tathione lyase amongst other proteins.
Conclusion:: The seed storage proteins belonging to 11S and 7S pro-
teins are likely to be biologically active allergens in macadamia nuts.
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Introduction: Pollen food syndrome (PFS) is heterogeneous with 
regard to triggers, severity, natural history, comorbidities and response 
to treatment. Our study aims to classify different endotypes of PFS 
based on IgE sensitization to panallergens.
Methods: We examined 1271 Italian children (age 4–18  years) with 
seasonal allergic rhinoconjunctivitis (SAR). Foods triggering PFS were 
acquired by questionnaire. Skin prick tests were performed with com-
mercial pollen extracts. IgE to panallergens: Phl p 12 (profilin), Bet v 1 
(PR-10) and Pru p 3 (nsLTP), were tested by ImmunoCAP FEIA. An unsu-
pervised hierarchical agglomerative clustering method was applied 
within PFS population.
Results: PFS was observed in 300/1271 children (24%). Cluster analysis 
identified five PFS endotypes linked to panallergen IgE sensitization: 
(1) Co-sensitization to ≥2 panallergens (“multi-panallergen PFS”); (2–4) 
sensitization to either profilin, or nsLTP, or PR-10 (“mono-panallergen 
PFS”); (5) no sensitization to panallergens (“no-panallergen PFS”). 
These endotypes showed peculiar characteristics: (1) “multi-panal-
lergen PFS”: severe disease with frequent allergic comorbidities and 
multiple offending foods; (2) “Profilin PFS”: OAS triggered by Cucurbi-
taceae; (3) “LTP PFS”: living in Southern Italy, OAS triggered by hazelnut 
and peanut; (4) “PR-10 PFS”: OAS triggered by Rosaceae; (5) “no-panal-
lergen” PFS: mild disease and OAS triggered by kiwifruit.
Conclusions: In a Mediterranean country characterized by multiple pol-
len exposures, PFS is a complex and frequent complication of childhood 
SAR, with five distinct endotypes marked by peculiar profiles of IgE sen-
sitization to panallergens. Prospective studies in cohorts of PFS patients 
are now required to test whether this novel classification may be useful 
for diagnostic and therapeutic purposes in the clinical practice.
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Introduction: To evaluate the digestibility as well as the immunogenic 
and sensitizing potential of thermally treated bovine caseins (TT caseins).
Methods: Caseins were dry heated for 30 or 60 min at 140°C. Native and 
TT caseins were digested in simulated gastric fluid pH 1.2 (10 U of pepsin 
activity/µg of test protein). Samples of 200 µl were removed after incuba-
tion at 37°C. The reaction was quenched by addition of 70 µl of 200 mM 
NaHCO3, pH 11, and 70 µl 5× Laemmli buffer. The zero time points were 
prepared by quenching the pepsin in the solution before adding the 
test protein. The samples were subjected to SDS-PAGE electrophore-
sis using 10–20% polyacrylamide Tris-glycine gels. BALB/c mice (n = 6/
group) were sensitized intraperitoneally without adjuvants through the 
administration of native or TT caseins in 250 µl of PBS. Sensitizations were 
performed at days 0, 3, 6, 9, 12, and blood was drawn on day 28. Casein-
specific IgG and IgE antibodies were evaluated using ELISA.
Results: There was no effect of incubation of caseins in simulated gas-
tric fluid for 60 min in the absence of pepsin. However, caseins, either 
native or TT caseins, were very unstable in the presence of pepsin, 
with a marked loss of full length protein after 0.5  min of incubation. 
Native and TT caseins were both immunogenic and allergenic at the 
dose tested (0.05 mg/mouse). Casein-specific IgG and IgE titers were 
higher in the group of mice sensitized with TT caseins for 30  min 
than the other groups (p < 0.05). There were no differences between 
the groups sensitized with native caseins and TT caseins for 60  min 
(p  >  0.05). Specific IgE antibodies in sera from mice sensitized with 
native casein strongly recognized TT caseins and vice versa (p > 0.05). 
Extensively heated cow’s milk is an alternative to accelerate tolerance 
acquisition in some milk allergic cases. This is in line with our digest-
ibility results, an indirect parameter of allergenicity, as TT caseins 
remains as digestible as native caseins. However, there was no reduc-
tion of the sensitizing potential of TT caseins. Although this potential 
was similar between TT caseins for 60 min and native caseins, longer 
thermal treatments are not suitable for the study because of the loss 
of protein solubility.
Conclusion: Thermal treatment of caseins alone does not reduce 
their allergenic potential highlighting that heat-induced interactions 
between milk proteins and other milk components are required to 
reduce their allergenic potential.
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Introduction: Anaphylaxis is still under-recognized and the treatment 
is often inadequate with underutilization of adrenaline even by medi-
cal personnel.
Our aim was to assess physician’s knowledge regarding diagnosis and 
management of anaphylaxis in children and to identify the reasons for 
the gaps.
Methods: Physicians were asked to respond a two-part questionnaire 
during continuing medical education: 1. A clinical scenario-based 
questionnaire involving a child experiencing a food-induced anaphy-
laxis with 5 of 9 true/false questions considered as key questions for an 
optimal management; 2. Demographic data and questions exploring 
determinants of an appropriate management.
Results: 318 physicians (GPs, 28%; pediatricians, 23%; allergists, 10%; 
school-mother and child care doctors, 19%; and junior doctors, 20%) 
were enrolled. They had private (29%), hospital (31%), or both practice 
(7%) or others (33%).
Part 1: 70% of participants agreed that the scenario was consistent 
with anaphylaxis but 24% refused because hemodynamic or respira-
tory disorders were missing; 31% chose to administer first adrenaline 
intramuscularly and 30% agreed with both diagnosis and treatment 
with adrenaline; 74% chose to administer first antihistamine and bron-
chodilators. Only 50% chose to call immediately the emergency num-
ber. Nearly a third estimated that a one-hour observation period was 
enough. Only 19% had all 5 key responses correct.
Part 2: A correct diagnosis was associated with pediatric spe-
cialty (p  <  10−4) and hospital practice (p =  0.02); the use of adrena-
line in the scenario with a correct diagnosis (p  <  10−4), pediatric 
specialty (p  <  10−4), a recent continuing medical education on food 
allergy (p =  0.005) and experience of adrenaline injection in real life 
(p  =  0.02); all the 5 key responses correct with pediatric specialty 
(p  <  10−4) and a recent continuing medical education (p =  0.04).  In 
case of anaphylaxis in a child, 59% of physicians would immediately 
inject intramuscularly adrenaline, 22% only after calling an emergency 
physician, 18% only in case of vital disorders, 3% only in the presence 
of an emergency physician; 5% would refuse to inject adrenaline 
themselves (never done or feared side effects).
Conclusion: A large proportion of doctors seem to be unaware of the 
diagnosis criteria and the recent updated EAACI recommendations on 
Page 13 of 79 Clin Transl Allergy 2017, 7(Suppl 1):10
anaphylaxis management. Medical specialty and continuing medical 
education improve anaphylaxis management.
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Introduction: Hydrolyzed wheat proteins (HWP) were used as ingre-
dients in food and cosmetics. From the 2000’s severe food allergy to 
HWP has been reported in individuals elsewhere tolerant to native 
wheat proteins. Denery et  al. demonstrated that deamidation of 
wheat proteins, a consequence of acid hydrolysis, generate essential 
neo-epitopes in these particular allergy to wheat [1]. More recently in 
Japan, an acid-HWP preparation (a-HWP), named GluPearl 19S, elicited 
severe skin reactions and food allergy in more than 1800 individu-
als and was likely to contain deamidated gluten proteins [2]. Level of 
deamidation depends on treatment intensity; a-HWP preparations 
with either low or high level of deamidation can be found as ingredi-
ent [3]. This study aimed at exploring the impact of deamidation level 
of wheat proteins on the degranulation of basophils sensitized with 
IgE from patient allergic to a-HWP.
Methods: Impact of the deamidation level of gliadins and a-HWPs 
upon IgE reactivity of 8 a-HWP allergic patients was determined by 
ELISA. Impact of deamidation on basophil degranulation was also 
explored with humanized Rat Basophil Leukemia cells passively sen-
sitized with IgE from patients and subjected to crosslinking with a set 
of deamidated samples. Finally IgE Repertoire specific to deamidated 
wheat protein was then explored by inhibition with INRA-DG1, a 
mouse monoclonal antibody specific for deamidated gliadins.
Results: Intensity of binding of patient IgE onto a-HWP and the degranu-
lation potency were correlated with level of deamidation. Pre-incubation 
of deamidated gluten with INRA-DG1 mAb inhibited half of its degranu-
lation capacity with patient IgE. These results suggested that the patient 
IgE repertoire specific for deamidated gluten proteins is likely to be lim-
ited to a very few specificities. GluPearl 19S, involved in the Japanese 
cases, was determined as highly deamidated. It was the most recognized 
sample among the 5 deamidated glutens tested in this study.
Conclusion: Although differences exist between French and Japanese 
cases (such as the tolerance of native wheat proteins), this result sug-
gested that Japanese and French cases suffered from the same uncon-
ventional allergy to wheat.
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Introduction: Cutaneous exposure to food allergens seems to be an 
important way of sensitization. It has been shown that household 
consumption of peanut is a risk factor for the development of pea-
nut allergy. Furthermore, peanut protein was found in house dust. Yet 
there is only little data on other food allergens; therefore, we wanted 
to investigate whether hen’s egg (HE) protein could be found in 
domestic areas.
Methods: 8 households were included in the study. All households 
were asked to consume a meal of scrambled eggs in their habitual 
eating areas. Before and 48 h after hen’s egg consumption dust sam-
ples were collected in the habitual eating areas and from bed sheets, 
using a special vacuum cleaner device. HE protein was extracted and 
HE allergen levels were measured with a commercially available ELISA 
(limit of detection: 0.05 µg/g). Wilcoxon rank test was used to compare 
HE levels before and after HE consumption.
Results: HE protein was detectable in all 8 households in the habitual 
eating areas as well as on bed sheets. At baseline, there was a median 
of 13.05 µg/g HE protein (range 6.5–13.4 µg/g) in the habitual eating 
area and a median of 12.9  µg/g HE protein (range 2.0–18.4  µg/g) on 
the bed sheets. 48 h after consumption of scrambled egg significantly 
increased levels were measured with a median of 214.0 µg/g HE protein 
(range 17.0–2409.4 µg/g; p < 0.05) for the eating area and a median of 
50.3 µg/g HE protein (range 5.9–247.0 µg/g; p < 0.05) in bed sheets. HE 
allergens were detectable in the house dust of all households not only 
in dining areas but also in the bed where HE is usually not consumed, 
indicating a spreading of food allergens. Furthermore, an increase in 
protein levels measured after consumption of a HE meal was shown. 
For infants, who spent most time in bed, house dust containing food 
allergens could be an important risk factor for food sensitization.
Conclusion: HE allergen was found in house and bed dust with high 
levels following HE consumption, indicating a potential risk factor for 
the development of HE sensitization. Nevertheless, further research is 
necessary to proof whether HE allergens in house and bed dust can 
cause sensitization and whether there is a correlation between aller-
gen levels and the level of sensitization.
PD20 
Native gliadins stimulate the local anaphylactic response 
in Ussing chamber as studied in murine model of wheat allergy
Youcef Bouferkas, Younes Belabbas, Djamel Saidi, Omar Kheroua, Kamel 
Eddine El Mecherfi
Laboratory of Physiology of Nutrition and Food Safety, Department 
of Biology, Faculty of Natural and Life Sciences, University of Oran 1 
Ahmed Ben Bella, Oran, Algeria 
Correspondence: Youcef Bouferkas ‑ youcef35@gmail.com
Clinical and Translational Allergy 2017, 7(Suppl 1):PD20
Introduction: The objective of this study is to investigate the impact 
of the native gliadins on the intestinal electrophysiological parameters 
as studied in murine allergy model.
Methods: Two groups of mice (n = 10 per group) were established: 
the first group (control) was sensitized with aluminum hydroxide 
(Alum) diluted in PBS, the second was sensitized with 10 µg of native 
gliadins adsorbed on alum (NG). Intraperitoneal (IP) sensitizations 
were performed at days 0, 10, 20 and 30. One week after the last 
boost, the jejunum fragments were withdrawn and used for histo-
logical analysis and the evaluation of the local anaphylactic responses 
in Ussing chamber by an ex vivo challenge allowing the contact of 
jejunums with sensitizing antigen and the measurement of electro-
physiological parameters (short-circuit current (Isc) (µA/cm2) and con-
ductance (G) (mmho/cm2).
Results: Intraperitoneal injection of native gliadins induced sig-
nificant increase of the short circuit current (Isc µA/cm2) (P < 0.001) 
and conductance (G) values (P  <  0.05). The histological observa-
tions of jejunum fragments of sensitized mice show an alteration 
in intestinal barrier (villous atrophy, Lymphocytes infiltration) com-
pared to the control group. The Isc increase in sensitized mice is 
probably due to a secretory response and might well reflect local 
anaphylactic responses. The increase of conductance indicate that 
immunization alters the tight junctions and increases the paracel-
lular permeability of the intestinal epithelium [1]. Several published 
studies show that food allergy in mice is characterized by villous 
atrophy and goblet cell hyperplasia, as well as infiltration of IgE-
positive mast cells [2].
Conclusion: Our results suggest that the native gliadins modify per-
meability of the intestinal tract in native gliadin mice which confirm 
the allergenic potential of native gliadins
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Introduction: The objective of this work is to check if royal jelly could 
prevent the allergic response and reduce the clinical manifestations of 
mice to bovine milk proteins.
Methods: Forty female Balb/c mice at 4 weeks and fed with a standard 
diet were divided into 5 groups. Four groups received orally royal jelly 
for 7 days at doses of 0 g/kg (positive control), 0.5, and 1.5 g/kg and are 
then sensitized intraperitoneally with (β-lactoglobulin) β-Lg adsorbed 
on Alum. Group 5 received no treatment (negative control). At the 
end of the experiment, in vivo provocation test (observation of clini-
cal signs 30 min after intraperitoneal injection: 1 mg β-Lg/mouse) and 
ex vivo provocation test in Ussing chamber by contacting the jejunum 
with the sensitizing antigen and measurement of electrophysiological 
parameters: short-circuit current (Isc, μA/cm2) were carried out.
Results: Our results show that the majority of mice pretreated with 
royal jelly dose showed no clinical signs after challenge compared with 
positive control mice (CL+). A secretory response reflecting local intes-
tinal anaphylaxis was evident in sensitized mice, as indicated by an 
increase in Isc (p < 0.001). However, no significant changes in the val-
ues of the short circuit current (Isc) were observed after β-Lg challenge 
in mice that received royal jelly at 0.5, 1 and 1.5 g/kg and immunized 
with β-Lg. Oral administration of royal jelly at different dose prevents 
the appearance of clinical signs and the development of anaphylactic 
local. This effect is probably due to the presence of compound having 
immunomodulatory activity which may reduce T-cell proliferation, Th2 
cytokine production, histamine release from mast cells and antibody 
IgE and IgG production (Vucevic et al. 2007).
Conclusion:
Oral administration of royal jelly decreases the allergic and inflamma-
tory response in mice and can be considered as a preventive strategy 
against Cow‘s milk allergy (CMA).
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Introduction: Our objective was to describe what Portuguese bee-
keepers do after being stung. The secondary aim was to evaluate their 
knowledge on adrenaline auto-injectors (AAI), bee venom immuno-
therapy (VIT), and the medical specialty of Immunoallergology.
Methods: Cross-sectional study using a structured questionnaire 
including beekeepers present in an apiculture meeting. Data on 
demographic characteristics, number of stings, reaction description 
and conduct when stung (treatment, admission to ER) were collected. 
Awareness of AAI, VIT and the medical specialty of Immunoallergology 
was also questioned.
Results: A total of 114 beekeepers were included; 91 (80%) male with 
a median (interquartile range, IQR) age of 40 (17) years. The median 
(IQR) time of beekeeping was 3 (7.3) years. Nighty-nine (87%) were 
amateur beekeepers. All had been stung in the last 12  months; 45 
(40%) had systemic reactions (11 anaphylaxis) and 41 had local reac-
tions, including 22 large local reactions. Only 19 (42%) of those with 
systemic reactions went to the ER. Nine out of the 11 who had anaphy-
laxis went to the ER, but only one was treated with adrenaline. On dis-
charge, an AAI was prescribed to one beekeeper, 4 reported to already 
have AAI and solely 2 were referred to an Allergist. Twenty-five (22%) 
used alternative treatments on the sting site, namely, metal, lemon 
or grape, ammonia, alcohol, vinegar and urine. Forty-one (36%) were 
aware of the existence of AAI, 35 (30%) of VIT and 32 (28%) of the med-
ical specialty of Immunoallergology. Beekeepers with systemic reac-
tions have demonstrated a better knowledge of AAI and VIT, p < 0.01 
and p = 0.03, respectively. Awareness of AAI, VIT and Immunoalergol-
ogy was not significantly different between gender, age and education 
groups.
Conclusions: This group of Portuguese beekeepers showed insuffi-
cient knowledge on proper management of sting reactions. Approxi-
mately one fifth used alternative treatments. Adrenaline underuse, 
underprescription, as well as an inefficient referral to a specialist, was 
evident in the ER. There is a rise in beekeeping in Portugal and so it is 
imperative to promote education on the risks, sting prevention meas-
ures and correct treatment of stings. The increasing awareness of the 
medical specialty of Immunoallergology and the existence of bee 
venom immunotherapy should assure a prompt referral in case of sys-
temic reactions which is crucial in this population.
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Introduction: Eosinophilic esophagitis (EoE) is an inflammatory dis-
ease of the esophagus characterized by symptoms related to esoph-
ageal dysfunction, eosinophilic recruitment and infiltration of the 
esophageal epithelium. A combined mechanism of IgE dependent/
cellular mediated hypersensitivity reactions to foods is thought to con-
tribute to disease pathogenesis.
Our aim was to assess food sensitization in EoE patients with atopy 
patch tests (APT); A secondary aim was to find any relation between 
the results of APT, skin prick tests (SPT) and/or specific IgE (sIgE) with 
response to the six-food elimination diet (SFED).
Methods: A longitudinal study of adult patients diagnosed with EoE 
was carried out. Patch tests were performed with 9 foods: cow’s milk, 
hen’s egg, wheat, soy, peanut, walnut and hazelnut were applied 
undiluted, 1/10 dilution and 1 drop of allergen extract; shrimp and 
cod were applied raw, cooked and 1 drop of allergen extract. The APT 
were delivered using 8 mm Finn Chambers®. Occlusion time was 48 h 
and the results were read 20 min and 24 h after removal. Endoscopy 
results, SPT, sIgE, medical management and patients’ responses were 
collected.
Results: Twelve patients agreed to participate, 3 were female with a 
median (interquartile range, IQR) age of 23 (9) years age, 8 with allergic 
rhinitis and 2 asthma; 8 were sensitized to aeroallergens, 6 to house 
dust mites and 4 to pollens. Seven patients had positive food SPT 
and/or sIgE (3 cow’s milk, 2 wheat and 2 LTPs). Ten patients presented 
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clinical and histological improvement with the SFED and in 8 symp-
toms and eosinophils recurred on food reintroduction (6 with cow’s 
milk and 3 with wheat). Only 2 patients presented positive APT: 1 to 
undiluted hazelnut, who was previously sensitized to LTP; and the 
other to undiluted soy, which was not clinically relevant since the 
patient frequently eats soy without any immediate symptoms or wors-
ening of EoE.
Conclusions: Standardization on food APT is lacking. In this series, we 
did not observe any clinical utility for identifying food sensitivity with 
atopy patch tests in adult patients with Eosinophilic esophagitis.
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Introduction: Component-resolved diagnosis (CRD) has been shown 
to improve hazelnut allergy diagnosis. Some allergens have been 
associated with severity of hazelnut allergy, however few studies have 
reported the classification accuracy of the markers in discriminating 
between mild and severe subjects, especially in adults.
Our aims were:
1. to analyze the association between sensitization to single hazel-
nut allergens and clinical symptom severity;
2. to evaluate their ability to discriminate between mild and severe 
hazelnut allergy.
Methods: Subjects (n = 731) from 12 European cities reporting reac-
tions to hazelnut (83.6% adults) were included. In all subjects, sensi-
tization against hazelnut extract and in 423/731, IgE against seven 
single components (rCor a 1, rCor a 2, rCor a 8, nCor a 9. nCor a 11, 
nCor a 12, rCor a 14) and CCD was measured. Additionally 124/731 
underwent a DBPCFC of which 86 were reactive. Symptoms to hazel-
nut were categorized into mild, moderate and severe symptoms. Asso-
ciations between sensitization to hazelnut and severity were analyzed 
using multinomial regression analyses. The discriminative ability of 
hazelnut allergens was evaluated by Receiving operating curve (ROC) 
analysis.
Results: Cor a 9 and Cor a 14 were both positively related with severe 
symptoms (OR 2.89[1.31–6.34] and OR 4.67[1.76–12.37] respectively) 
and Cor a 11 and Cor a 12 showed a positive trend in severity. Cor a 
1 and 2 were negatively associated with severity (OR 0.36 [0.20–0.64]) 
and 0.50 [0.24–1.04], respectively). ROC analysis showed a poor to 
moderate ability to discriminate between reported mild and severe 
hazelnut with AUCs ranging from 0.50–0.62. However, AUCs for Cor a 9, 
Cor a 11 and Cor a 14 was significantly better in children, the DBPCFC 
group and using the combination of these allergens (AUC 0.70–0.86). 
Sensitivities for Cor a 9 and Cor a 14 were low (24%). Around 75% of 
the severe subjects with confirmed hazelnut allergy was not sensitized 
to these allergens.
Conclusion: Sensitization to Cor a 9 and Cor a 14 is associated with 
severity of hazelnut allergy however, the classification power was 
moderate in our adult dominated population. Unidentified allergens 
might elicit the severe symptoms but further research is needed to 
identify these allergens and to confirm their clinical relevance.
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Introduction: Our aim was to assess the performance of basophil acti-
vation testing (BAT) as a diagnostic marker for mugwort pollen-associ-
ated peach allergy.
Methods: Peach allergic (n  =  89), peach-sensitized but tolerant 
(n  =  52) and non-peach-sensitized nonallergic (n  =  10) patients 
underwent sIgE to peach and its components. BAT was performed 
using flow cytometry.
Results: The patients with peach allergy had higher IgE levels for 
peach and Pru p 3 than peach sensitized population (P  <  0.01). By 
stimulation with peach extract, BAT in peach-allergic patients showed 
a significant dose-dependent upregulation of CD63 compared with 
peach sensitized but tolerant and non-peach-sensitized nonallergic 
patients. While stimulated with Pru p 3, BAT could also discriminate 
between peach allergy and tolerance. Receiver operating charac-
teristic curves showed basophil reactivity had larger area under the 
curve than IgE to peach (AUC 0.744, 95%  CI 0.550–0.937, P =  0.039) 
and Pru p 3 (AUC 0.865, 95%  CI 0.705–1.000, P  =  0.002); while BAT 
stimulated with Pru p 3 had the largest area at 0.981 and stimulation 
with peach extract (100 ng/ml) at 0.942. Previous studies concerning 
pollen-associated food allergy have compared between healthy con-
trols and food allergic patients, without addressing the possible effect 
of immunologic cross-reactivity on the performances of BAT. In this 
study, we performed a comparative analysis with peach-sensitized but 
tolerant patients. BAT stimulated with the major allergen is better than 
that with the crude allergen extract in discriminating between peach 
allergy and tolerance.
Conclusion: BAT stimulated with Pru p 3 is superior to other diagnos-
tic tests in diagnosis of mugwort pollen-associated peach allergy.
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Introduction: Food Allergy (FA) is a common disease and it is esti-
mated prevalence world-wide ranges between 2–10% with an increas-
ing trend. Peanuts and tree nuts are frequent causes of FA and may 
albeit rare result in fatal reactions. The diagnosis of FA is based on the 
personal history, in vivo skin-testing (e.g. SPT), in vitro IgE-testing and 
oral challenges. The double-blind placebo controlled food challenge 
(DBPCFC) is the gold standard for diagnosing and categorizing FA. 
DBPCFC’s are time consuming and bear a risk for the patient. Moreo-
ver, sometimes the interpretation of test reactions is difficult. The 
aim of this study was to analyze mast cell mediators like histamine, 
tryptase, cys-LTs and 9α11β-PGF2 in serum samples from patients who 
underwent oral food challenges (OFC) and correlate these parameters 
with the reaction-severity.
Methods: 32 patients from the Allergy-Center with a history of FA to 
peanuts or tree nuts were recruited. 40 OFCs were performed. Reac-
tion severity was determined by using the grading according to 
Ring&Messmer. Severe reactions were observed in 23 cases (grade = 2 
in 10 patients, grade = 3 in 13 patients). Blood samples were collected 
before OFC (T1), 5–10 min after the reaction (T2) and 2 h post-onset 
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(T3). Histamine (LDN, Nordhorn, Germany), cys-LTs (LTC4, LTD4, LTE4) 
and 9α11β-PGF2 (both Cayman Chemical, Ann Arbor, USA) were deter-
mined by ELiSA. Tryptase was kindly measured by Thermo Fisher Sci-
entific, Freiburg, Germany.
Results: We observed a significant increase of tryptase, cyc-LTs and 
9α11β-PGF2 after food provocation but not histamine in sera from 
patients with positive OFC. Tryptase levels correlated significantly with 
the severity of the reaction and a positive tendency of this correlation 
was also observed for histamine- and 9α11β-PGF2-levels, but not cys-
LTs values.
Conclusion: The studied markers differ in their reliability. Histamine 
does not support evidence for a positive OFC. By contrast, tryptase 
but also 9α11β-PGF2 (alone or combined) may be used as supportive 
markers for diagnosing FA. Whether the total increase of the markers 
helps to predict severity in a given patient will need to be assessed in 
future studies.
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Introduction: The double-blind, placebo-controlled food challenge 
test (DBPCFC) is the gold standard in cashew nut allergy. This test is 
costly, time-consuming and not without side effects. Analysis of IgE-
reactivity to cashew nut components may reduce the need for food 
challenge tests.
Methods: In a prospective and multicentre study, children with sus-
pected cashew nut allergy underwent a DBPCFC with cashew nut. 
Specific IgE to total cashew nut and to the components Ana o 1, 2 and 
3 were determined. A skin prick test (SPT) with cashew nut extract was 
performed. The association between the outcome of the food chal-
lenge test and specific IgE to Ana o 1, 2 and 3 was assessed with logis-
tic regression analyses, unadjusted and adjusted for other diagnostic 
variables. Discriminative ability was quantified with a concordance 
index (c).
Results: 173 children (103 boys, 60%) with a median age of 9  years 
were included. 79% had a positive challenge test outcome. A steep 
rise in the risk of a positive challenge was observed for specific IgE to 
each individual component Ana o 1, 2 and 3 with estimated risks up 
to approximately 100%. Specific IgE to Ana o 1, 2 and 3 better distin-
guished between cashew-allergic and tolerant children (c = 0.87, 0.85 
and 0.89 respectively), than specific IgE to cashew nut or SPT (c = 0.76 
and 0.83 respectively). In the multivariable models inclusion of sIgE to 
Ana o 1, 2 or 3 increased the c-index of history and gender from 0.67 
to 0.89 maximally, with increases up to 0.92 and 0.93, respectively 
when also specific IgE to cashew nut or both IgE and SPT were added.
Conclusion: The major cashew nut allergens Ana o 1, 2 and 3 are each 
individually predictive for the outcome of food challenge tests in 
cashew-allergic children.
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Introduction: To assess the prevalence and describe the cases of 
anaphylaxis to iodinated contrast media (ICM), evaluated in our Drug 
Allergy Unit (DAU) in the last 6 years.
Methods: Retrospective analysis of medical records of patients 
assessed in our DAU for suspected hypersensitivity reactions (HSR) to 
ICM between Jan/10 and Dec/15 (n = 54). Skin prick tests (SPT) were 
performed with potassium iodate (PI), iodopovidone, and a panel of 
available non-ionic ICM (iohexol, ioversol, iobitridol, iopromide, iome-
prol, iodixanol, amidotrizoate, meglumine); intradermal tests (IDT) 
were also performed with ICM diluted 1/100–1/10, and undiluted (not 
in all cases).
Results: Eighteen (33.3%) patients presented with anaphylaxis (10 
females, median age 65.5  years, interquartile range 43.0–72.0  years). 
The clinical manifestations were respiratory (n = 15, 83.3%), mucocu-
taneous (n = 12, 66.7%), cardiovascular (n = 11, 61.1%) and gastroin-
testinal (n = 5, 27.8%). No fatal outcomes occurred. Suspect ICM were 
iobitridol (n  =  4, 22.2%), iopromide (n  =  3, 16.7%), ioversol (n  =  2, 
11.1%), iomeprol (n = 1, 5.6%), iohexol (n = 1, 5.6%), and unknown in 
7 (38.9%) cases. SPT with iodopovidone and PI were all negative. One 
patient (anaphylactic shock to iopromide) had a positive SPT (iopro-
mide). In IDT, 4 patients had positive test results to ICM at 1/10 (includ-
ing the suspect): (1) iopromide and iomeprol; (2) ioversol, iobitridol, 
iodixanol and amidotrizoate; (3) iobitridol and iopromide; (4) iohexol. 
The patient with anaphylactic shock to iopromide reacted at 1/100. 
Other 8 patients had positive IDT only to undiluted solution, with at 
least 1 of the ICM tested (including the suspect); 6 of these patients 
were tested to other undiluted ICM with negative results. Skin test-
ing with a panel of ICM is recommended by the ENDA group in these 
patients, not only to confirm the culprit drug but to assess cross-reac-
tivity and find safe alternatives. The ENDA position paper (2013) makes 
a weak recommendation to avoid undiluted ICM for skin tests as it may 
be irritative. Six of eight patients with a positive IDT to the undiluted 
suspected ICM had a negative test to at least two other undiluted ICM.
Conclusion: In this study we report 30% of ICM HSR fulfilling anaphy-
laxis criteria, and 70% of these patients had a positive diagnostic work-
up. The authors raise the question of whether the IDT should routinely 
be performed including an undiluted solution, since some potentially 
allergic patients may be missed otherwise.
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Introduction: Lipid transfer protein (LTP) Syndrome is a primary food 
allergy with high prevalence in South Europe population. Its clinical 
characteristics and prevalence are not well established in the paediat-
ric population.
Methods: A retrospective-descriptive study from Jan 2013 to Dec 
2015 of children with sensitization to Specific IgE to Pru p 3 and clinical 
manifestation in a third-level paediatric hospital was conducted. It was 
aimed to study and compare the clinical patterns of sensitization.
Results: Eighty-three allergic children with sensitization to Pru p 3 
were found. Forty-nine male (59%) and thirty-four females: (41%) were 
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assisted. The average age of first reaction: media: 5.3  years +/−3.6 
STD. The history of atopic diseases were: rhinitis 39%, asthma 14% 
with a broad spectrum of pollen sensitization (Grass pollen: 55.4%, 
Olea 49.3%, plane tree 25%, Cypress 24%, mugwort 21%) and atopic 
dermatitis: 32%. The first food trigger involved were peach 36.2% (35), 
peanut 15.2% (14) walnut 12.2% (11), others fruits 11.2% (10), other 
legumes 9.2% (8) and other nuts 6.2% (5). The most common first 
clinical manifestation found was: urticarial 44.2% (43), following of oral 
allergy syndrome: 15.2% (14), anaphylaxis: 14.2% (13) and cutaneous 
rash: 12.3% (11), The exercise was a cofactor in a 3% of the population 
and NSAIDs were not involved. All patients were positive skin prick test 
and high levels of IgE specific levels to pru p3 median; 8.5 (14.58) IQR.
Conclusion: Severe plant food unrelated independent of peach are 
involved in LTP Syndrome. Grass and olea pollen are the main aeroal-
lergen in our population. Peach and peanut are the main food elicitors. 
Urticarial symptoms are the most common clinical manifestation.
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Introduction: Despite outgrown CMA, we have previously found that 
many families continue to experience nutritional related problems at 
a six-month follow-up [1]. Some may develop other food allergies or 
atopic diseases follow ing the atopic march, and some may fail to pro-
gress to unrestricted diet.
Our aims were to assess impact on nutrition related issues at a 7 year 
follow-up in relation to the development of CMA over time.
Methods: Families of children with CMA, who participated in the vali-
dation of the Food hypersensitivity famiLy ImPact questionnaire (FLIP), 
were re-approached 7 years later for follow-up and administered the 
FLIP.
Results: Of the original families (n  =  94), at 7-year follow-up 84% 
(n = 79) agreed to participate. The children had a mean age 8.5 years 
(r = −11 years) and n = 30 (38%) were girls. The majority (n = 49.62%) 
no longer needed to follow a cow’s milk free diet. The remaining chil-
dren (n = 0) were still following a special diet due to CMA exclusively 
(n = 7.9%) or in combination with other food allergy (n = 9.11%) and 
other food allergy excluding CMA (n =  14.18%). Most children were 
healthy (n  =  67) but n  =  8 (10%) had developed other atopic dis-
eases or other non-atopic diseases (n = 3). These findings are in line 
with those from others [2]. A mixed linear model for the FLIP Nutri-
tion subscale across three time points (baseline, 6-month and 7-year 
follow-up respectively) in relation to allergy status at 7-year follow-
up (i.e. outgrown vs. persistent) showed only a marginally significant 
improvement in nutrition related issues for the group outgrown CMA 
(p = 0.07) at 7-year follow-up. For the group with persistent CMA there 
was no difference in the experienced impact. Despite outgrown CMA, 
n  =  13 children in the group outgrown CMA had a restricted con-
sumption of dairy due to fear of reactions (n = 4) or dislike of milk as 
a drink (n = 6), or both as a drink and when contained in food (n = 3). 
The latter group were still consuming non-dairy special products.
Conclusions: There is only a small improvement in nutrition related 
issues despite outgrown CMA at 7-year follow-up. Many families con-
tinue to serve a restricted diet despite outgrown CMA. Nutritional 
counselling should be considered to all families with children with 
persistent as well as outgrown CMA in order to ensure optimal nutri-
tional intake, development of eating behaviour and progression to 
unrestricted diet preventing unnecessary limitations in daily life.
Acknowledgements: Financial support: FoU VG-region post-doctoral 
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Introduction: Self-reported food allergies (srFA) have increased in 
US  adults over the past decade. Information on how this population 
perceives allergen exposure risks is lacking. We sought to identify 
adults with srFA and assess responses to questions about allergen 
advisory statements and thresholds.
Methods: We analyzed FDA 2016 Food Safety Survey data in 4619 
adults  to identify survey respondents with srFA, including reported 
doctor-diagnosed cases (ddFA). Respondents were asked about 
knowledge of thresholds or reaction risks and about consumption of 
products with certain advisory statements or trace allergen amounts.
Results: Weighted prevalence of srFA among survey respondents was 
13.5% with ddFA representing 8.0%. The most common foods associ-
ated with srfA and ddFA were shellfish, milk, fruits, tree nuts, peanuts, 
wheat, fish and egg. Prior anaphylaxis history was reported in 24.8% 
of respondents. With regards to allergen exposure risk, only 33.2% of 
srFA respondents were aware of the concept of threshold levels, yet 
59.0% reported belief that a level existed below which allergic reac-
tion would not occur. 43.7, 39.0 and 48.8% of respondents reported 
having consumed or likely to consume products with advisory state-
ments of “may contain”, “made with same equipment” or “produced 
in same facility” respectively, and 38.2% of respondents reported that 
they would consume products with trace amounts of the food aller-
gen if there were assurances that allergen amount would not trigger 
reaction. No significant differences in responses were noted between 
srFA respondents with or without ddFA except ddFA respondents were 
more likely to view trace allergen amounts as posing higher risk for 
severe reactions. Respondents with prior anaphylaxis, shellfish or fish 
allergy were more likely to avoid products with one or more advisory 
statements while those with peanut, tree nut, milk or wheat allergy 
were more likely to have consumed these products. Survey data of 
adults with self-reported food allergies reveal different perceptions of 
thresholds and individual  exposure risks. More education on under-
standing allergen exposure risks is needed for this population.
Conclusion: Survey data suggest that only one third of srFA respond-
ents understand what allergen thresholds represent, yet over 40% 
report consuming foods with certain advisory statements. Differences 
in risk perception may depend on having a ddFA, a prior history of 
anaphylaxis or on type of food allergen.
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Introduction: Oral immunotherapy using IFN-gamma (OIT) for ana-
phylactic IgE-mediated food allergy (AFA) has been done more than 
10  years successfully. In this study, a tolerable dose was introduced 
during tolerance induction with interferon gamma, and its effective-
ness and theoretical meaning was evaluated.
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Methods: The study population comprised 30 AFA patients. Blood sam-
ples were taken for analysis, including complete blood count with dif-
ferential counts of eosinophils, serum total IgE levels, and specific IgE 
for allergenic foods. Skin prick tests were conducted with the allergens. 
Oral food challenges were performed to diagnose AFA. Fifteen patients 
received OIT, 5 received classic OIT without tolerable dose, 5 received 
OIT without interferon gamma, and 5 were not treated (controls).
Results: Patients treated with OIT using IFN-gamma became tolerant 
to the allergenic food with and without introducing tolerable dose. 
The tolerable dose was introduced successfully in OIT using IFN-
gamma. It was meaningless to introduce tolerable dose in OIT without 
IFN-gamma. Following the introduction of tolerable dose, the systemic 
reaction to oral intake subsided, but the local skin reaction to contact 
with the allergenic food persisted. Tolerable dose was successfully 
introduced during the oral immunotherapy using IFN-gamma. Con-
ventional oral immunotherapy without using IFN-gamma, the con-
cept of tolerable dose is meaningless because the therapeutic dose is 
the same or less than the tolerable dose. However, using IFN-gamma, 
therapeutic dose is escalated much more than that without using IFN-
gamma. From the successful introduction of tolerable dose, the nature 
of tolerance induction was unveiled. Also, the exact meaning of desen-
sitization and tolerance is clarified. By introducing tolerable dose, doc-
tor and patient can confirm the progress of getting tolerance.
Conclusion: Introduction of tolerable dose improved the protocol for 
OTI using interferon gamma for AFA. In food allergy, the concept of tol-
erance and desensitization is clearly defined. Tolerance is the result of 
desensitization to allergens. The local skin reaction and systemic reac-
tion to oral intake were dissociated following OIT for AFA.
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Introduction: The immune health status is strongly determined dur-
ing early life stages. Many immune-related diseases are thought to 
find their origin in adverse shifts in immune balances during preg-
nancy or the first 2–3 years of life, including atopic diseases. Therefore, 
immune health interventions during these stages of life may be most 
effective in reducing the loss of health, loss of quality of life and costs 
to society due to immune-related diseases and disorders. Several start-
ing points for immune health interventions have been identified and 
are being developed into prophylactic or therapeutic approaches, 
particularly targeted at the early life stages. Unfortunately, there is no 
consensus on which parameters should be addressed to assess the 
safety and/or efficacy of the interventions and how all the available 
data should be interpreted at the end. Hence, it would be extremely 
helpful to address this issue by developing a pragmatic, flexible and 
science-based risk-benefit assessment.
Methods: We adapted the risk-benefit approach [1], to develop a 
framework for risk-benefit assessment of immune health interven-
tions during early life stages. As case studies, we collected all available 
in vitro/vivo/silico and human data on galacto-oligosaccharides (GOS) 
and fructo-oligosaccharides (FOS).
Results: The severity of hazard and beneficial effects observed and 
the incidence at which such an effect may be considered acceptable, 
were used to weigh the risk and beneficial effects. Dose response rela-
tionships can be converted to 50% effect doses which, combined with 
the severity of the effect underlying the dose response curve and con-
current acceptable incidence of this effect, can be used for weighing 
benefit and risk. In the FOS/GOS case study, several prerequisites of 
(pre-)clinical data were identified. This risk-benefit framework enables 
us to evaluate all intervention data available and forms the basis to 
derive the optimal dose levels of intake.
Conclusion: This novel approach enables risk assessors to take the 
multitude of different types of data available covering toxicity and effi-
cacy studies at early life stages into account, by ranking and weighing 
all available data. Ultimately, this assessment will help to determine 
optimal beneficial and safe dose levels of nutritional immune inter-
ventions during early life.
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Introduction: FABER 244 is a new in vitro multiplex test for specific IgE 
detection using 122 molecular allergens and 122 allergenic extracts, 
coupled to chemically activated nanoparticles. Allergenic prepara-
tions, either produced in house or obtained from commercial provid-
ers, are individually coupled to nanobeads by means of optimized 
protocols to achieve maximum test performance.
Aim was to measure the diagnostic accuracy of FABER 244-122-122 
01 by comparing with the ImmunoCAP ISAC 112 (TFS, Sweden) in 
patients allergic to LTP proteins shared by both tests.
Methods: A real life study as been set by analyzing the clinical 
records, and the FABER and ISAC test results from 94 consecutive 
patients referred to CAAM from March 2015 to August 2016. Data 
were extracted from the electronic medical record InterAll. The 
diagnostic accuracy measurement and test comparison were per-
formed on 3 LTP proteins (Cor a 8, Jug r 3, Pru p 3) adopting the 
patients’ symptoms as gold standard and MedCalc as software for 
statistical analysis. ISAC test Limit of Detection (LoD) was set to 0.3 
ISU whereas FABER LoD was set to 0.01 FIU. In the overall analysis 
attention has been put on additional information coming from non-
shared LTPs, Tri a 14 and Ara h 9 for ISAC, and Act d 10, Pun g 1, Sola 
l 6, Tri a 7 k-LTP, Zea m 14 plus peanut and wheat extracts available 
on FABER.
Results: Both tests appear to be accurate and well aligned to each 
other for all three analyzed LTP proteins. In terms of sensitivity FABER 
performs better than ISAC on Cor a 8 (100 vs 73%), same as ISAC on 
Jug r 3 (100% both) and FABER better than ISAC on Pru p 3 (96 vs 91%). 
In terms of specificity FABER performs better than ISAC on Cor a 8 (96 
vs 94%), same as ISAC on Jug r 3 (96%), whilst ISAC performs better 
on Pru p 3 (97 vs 92%). IgE detection by ISAC Ara h 9 and Tri a 14 was 
compensated by the peanut and wheat extracts, whereas info on addi-
tional food LTPs could be obtained from the FABER extended panel 
including 25 extracts from plant-derived foods bearing LTPs.
Conclusions: FABER test is a new in  vitro test for specific IgE detec-
tion, including molecules and extracts. Considering the food allergen 
group belonging to the LTP, FABER appears to be accurate and in good 
agreement with ISAC results. The specific advantage of FABER relies on 
the chance of testing patients to a broader panel of LTP as well as to a 
large number of extracts, complementing the results on single aller-
genic molecules.
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Introduction: Previous studies have shown that the qualities of 
the matrix containing an allergenic food may impact the severity of 
reactions during DBPCFCs. The aim of this study was to examine the 
impact of the matrix fat content during DBPCFCs to peanut and its 
effect on the severity of the reaction and eliciting dose.
Methods: Data was collected from the food challenge unit database 
at the University Medical Center Groningen (November 2002–May 
2014), where DBPCFCs were performed as part of routine clinical care. 
All children during this period with a positive DBPCFC to peanut were 
included in the analysis. The food challenges were included if they 
were performed with the two most frequently used recipes (n =  11 
excluded). The recipes used were peanut in cookies and peanut in 
gingerbread, with a fat content of 23.9% and 5.9% respectively. In chil-
dren with multiple DBPCFCs, only the first test was included (n = 37 
tests excluded). 14 cases were excluded due to missing data. For the 
severity of reaction during the DBPCFC a previously published scor-
ing system was used, with a severity index ranging from 0 to 12. The 
influence of the matrix on the severity of reaction and eliciting dose 
was analyzed by linear regression analysis, with correction for possible 
confounders. A variable was considered a confounder if it changed the 
beta coefficient by more than 10%. The alpha significance level was set 
at 0.05.
Results: 210 children were included in the analysis, 141 children were 
challenged with peanut in cookies (high fat) and 69 children with pea-
nut in gingerbread (low fat). Children challenged with peanut in cook-
ies had more severe reactions during the DBPCFC (β =  0.15, 95%  CI 
1.49–0.06, p = 0.03), compared to children challenged with peanut in 
gingerbread. However, there was no significant difference in eliciting 
dose (β = 0.03, 95% CI-31.91-51.11, p = 0.65). These results were not 
confounded by age, gender, sIgE, severity of the most severe previ-
ous accidental reaction, history of atopic dermatitis, asthma or allergic 
rhinoconjunctivitis.
Conclusion: Children receiving a high fat matrix peanut challenge 
have more severe reactions than children receiving this test in a low 
fat matrix. This supports the role of the food matrix as an augmenta-
tion factor which may enhance the severity of both diagnostic as well 
as accidental reactions. It also raises the possibility that matrix effects 
during oral immunotherapy with peanut could be a cause of adverse 
events during such treatment.
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Introduction: Annually number of reports about anaphylaxis caused 
by food products increases. The development of IgE-mediated reac-
tions to food that is well tolerated in the past, now, sometimes is a 
true diagnostic and therapeutic challenge for the patient and the doc-
tor. An example of such allergies is delayed allergy to red meat that 
is associated with the formation of IgE antibody to the oligosaccha-
ride galactose-alfa-1,3-galactose (Alfa-gal). During evolution human 
body formulated the immunological tolerance to Alfa-gal production 
through IgG. Factor launch IgE-mediated process are tick bites, which 
linked the spread of geographical features of this type of food allergy 
(FA). Proved that serious manifestations of anaphylaxis occur in condi-
tions of consumption of fatty meat or large quantities of meat. Deter-
mined that Alfa-gal epitope transmitted through the milk that gives 
grounds to say about later reaction to this product. It is believed that 
the alternative cause of sensitization to Alfa-gal infection are different 
types of parasites.
The aim of our study was to determine the probability of distribution 
associated Alfa-gal allergy among Ukrainian patients.
Results: We conducted a comparative assessment of different com-
ponents of the ticks saliva, on which was identified allergic reactions 
to Alfa-gal in the USA (Amblyomma americanum), Australia (Ixodes 
holocyclus) and Europe (Ixodes ricinus). The same ingredients not 
found in these types of ticks, but each of them has a specific immu-
notropic action. In particular, I. ricinus, prevalence of which in Ukraine 
in recent years increased by 14–18% containing biological substances 
that intensified alternative pathway of complement activation, Th2-
response, inhibited proliferation of B lymphocytes.
Conclusion: Ukraine has a high probability of spreading Alfa-gal asso-
ciated FA. The arguments are the same: rising prevalence of I. ricinus, 
Ukrainian traditional consumption of fatty foods and dairy products, 
high prevalence of parasitic invasions. There is a necessity of compo-
nent diagnostics Alfa-gal, which today is not performed. In this case 
the only way to diagnose is carefully collected history.
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Introduction: Hen’s egg (HE) allergy is the most common food allergy 
in early childhood. Although there is a good prognosis, reported 
data on the development of clinical tolerance vary between studies. 
The aim of our study was to analyze the natural history of HE allergy 
among children with challenge proven HE allergy.
Methods: Data of children undergoing double-blind, placebo-con-
trolled food challenge (DBPCFC) in our center were prospectively 
recorded. Children who had a DBPCFC with raw HE between 01/2010 
and 06/2014 were further evaluated. When data on repeated DBPCFC 
with either raw or baked egg of the children were not available in our 
data bank, parents were questioned by telephone with a standardized 
questionnaire whether their child tolerates raw and/or baked HE in 
their diet.
Results: 110 children with a positive DBPCFC to HE could be included 
(41 girls and 69 boys with a median age of 1.4 years (0.4 to 9.8 years) at 
the first DBPCFC with raw HE). After a median period of 34 months (9 
to 96 months), 54/110 children (49%) tolerated raw HE (45 had a sec-
ond DBPCFC to raw HE without reaction, 9 reported complete toler-
ance in the interview). Of the remaining 56 children without known 
tolerance to raw HE (still allergic n = 40, unknown n = 12), more than 
half (54%, n = 30) could tolerate heated HE after a median period of 
26 months (20 had a negative DBPCFC to heated HE, 10 reported tol-
erance to heated HE in the telephone interview). Altogether 29/69 of 
the boys (42%) developed clinical tolerance to raw HE within a median 
period of 36 months (9 to 96 months), while 25/41 of the girls (61%) 
tolerated raw HE already after a median period of 26  months (11 
to 66  months). Tolerance development to raw HE in this study was 
slightly longer than reported from the EuroPrevall birth cohort. This 
might be explained that re-challenges were not scheduled on yearly 
basis as in EuroPrevall but on request of the child’s physician.
Conclusion: Around half of the children with challenge proven HE 
allergy develop tolerance to raw HE within a median period of 3 years 
and even more to heated HE. Girls seem to have better chances to 
develop tolerance to HE in a shorter period of time than boys, but 
larger trials are necessary to confirm these observation.
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Introduction: Improving safety of egg oral immunotherapy (OIT) is a 
source of concern. Our group has previously published data regarding 
safety in a protocol to raw egg (RE)-OIT, reporting adverse reactions 
in 7.6% of doses and adrenaline use in 26%. To evaluate the safety of 
boiled egg (BE)-OIT in egg allergic children and compare it with previ-
ous data on RE-OIT.
Methods: Medical records of children following the protocol from 
January 2015 to July 2016 were reviewed. Retrospective data were 
collected for demographics, adverse events at oral food challenge 
(OFC) and during induction phase. Specific-IgE (s-IgE) and skin prick 
test (SPT) were expressed with median and range (min-max). Writ-
ten informed consent was signed. Open OFC with BE was performed, 
confirming allergy. Anaphylaxis was defined following EAACI position 
paper criteria.
Results: 21 patients were enrolled, 76.2% boys, median age 9  years 
(5–15). At OFC: All had adverse reactions and 9/21 presented anaphy-
laxis. Total IgE 1141 kU/L (97–3814), ovalbumin-sIgE 3.19 kU/L (0–667), 
ovomucoid-sIgE 4.47  kU/L (0.89–1480), egg white-sIgE 6.6  kU/L 
(0–1350); ovalbumin SPT 7.9  mm (2.8–14.7), ovomucoid 9.7  mm 
(4.2–16.9), egg white 10.4  mm (4–15.6). OIT induction phase: 57.1% 
(12/21) had adverse events: 42.8% gastrointestinal, 28.5% respiratory 
and 19% cutaneous. 61.9% (13/21) completed induction reaching 
at least 5.6 gr of BE (700 mg of protein). 3 patients were excluded for 
not reaching this dose. 1309 doses were administered and 28 reac-
tions occurred (2.14% of OIT doses). 7/18 had anaphylaxis, 2 patients 
required adrenaline use (10.5%), 5 withdrew during induction phase 
(4 due to anaphylaxis and 1 for poor adherence). Egg OIT is still an 
experimental treatment and aims to modify clinical reactivity in persis-
tently egg-allergic children. BE-OIT enhances children’s diet by includ-
ing baked and various quantities of fully cooked egg thus improving 
families quality of life. However, complete tolerance to raw-egg is not 
attempted. Initial parameters at OFC were comparable to previous RE-
OIT group. Adverse events are still a source of concern even with the 
modified BE-protocol.
Conclusions: Gastrointestinal symptoms were the most frequent 
adverse reactions and anaphylaxis the most common cause of with-
drawal. Within similar populations, BE-OIT showed an improvement in 
safety profile with fewer adverse reactions and less use of adrenaline; 
proving to be a better OIT alternative for egg allergic children.
Consent to publish: Written informed consent was obtained.
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Introduction: Food allergy (FA) is often associated to asthma. We 
aimed to investigate the impact of FA on asthma control. Exacerba-
tions, maintenance treatment, and lung function were also evaluated.
Methods: Longitudinal prospective study conducted between 
August 2015 and March 2016. Allergic asthmatic Children, ≥7  years 
old, with or without confirmed FA, were included during a scheduled 
visit. Asthma and FA characteristics were recorded. Asthma control 
was defined according to GINA criteria. Asthma Control Test (ACT) or 
pediatric-ACT, asthma exacerbation rate, oral corticosteroids courses 
(OCC), hospitalisations in the previous year, GINA maintenance treat-
ment level and ICS dose, lung function (FEV1, FEV1/FVC, FeNO) were 
compared between children with FA and those without.
Results: 212 asthmatic children (mean age: 11.5 years), were included; 
57 of them had FA (27%) (nuts = 26, peanut = 23, egg = 11, milk = 3, 
other = 20, multiple FA = 41). History of life threatening asthma was 
not different between the 2 groups (p = 0.4). History of food anaphy-
laxis was documented in 39 patients. 31 children (15%) were treated 
with Omalizumab, 10 of them with FA. Good control was observed in 
38 children with FA (67%), and 94 children without FA (61%) (p = 0.42); 
there was no difference for ACT or pACT score (p =  0.26), exacerba-
tion rate [mean: 1.2 (+/−2.04) if FA vs 2,22 (+/−3.65) if asthma only 
(p = 0.1)], OCC (p = 0.08), hospitalisations (p = 0.41), GINA treatment 
level (p = 0.17), ICS dose (p = 0.16). FEV1/FVC (mean: 84% if FA vs 83%; 
p = 0.12) and FeNO (median: 42 ppb if FA vs 24 ppb (p = 0.55)] were 
not different. The type of food allergen, the number of FA, the sever-
ity of food reaction had no effect on asthma control. The subgroup 
of patients with “asthma-atopic dermatitis-FA” (A-DA-FA) had a higher 
number of exacerbations (p =  0.009) and daily ICS (p =  0.017) com-
pared to patients with asthma, FA and no AD. We did not observe that 
FA was associated to worse asthma control or morbidity as previously 
reported [1,2]. Regular follow-up in a tertiary care centre may explain 
the results. However, we observed that children with FA and AD had a 
more severe asthma than those with FA but no AD.
Conclusion: Our study does not provide evidence for increase asthma 
morbidity in children with any FA. The association of A-DA-FA charac-
terized a specific phenotype.
References
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Introduction: The aim of our study was to examine whether the loss 
of positive skin prick test (SPT) reactions to egg white or egg yolk pre-
dicted the development of spontaneous clinical tolerance in children 
with egg allergy.
Methods: We recruited children with egg allergy, as positive oral food 
challenge with egg (OFC) or suggestive history and positive SPT reac-
tions to yolk egg and/or egg white. All children underwent SPTs with 
egg white and yolk extracts. Children whose SPT results to both egg 
white and egg yolk became negative during follow-up were included 
in group 1, those with persistent positive SPT results in group 2. The 
acquisition of tolerance to hen’s egg was ascertained by open OFC 
in both groups with escalating doses every 20  min of hard-boiled 
egg. The adverse reactions were considered immediate when they 
appeared within 2 h and delayed after 2 h. In case of negative TPO, the 
egg was administered at home for 4 days, with control of any adverse 
reactions. In case of unclear symptoms to TPO, it was performed a dou-
ble-blind test, placebo-controlled trial.
Results: Seventy-five egg-allergic children (44 males), aged 
3–78 months, were enrolled. Among them 23 were assigned to group 
1 (negative SPT to yolk and egg white) and 52 in group 2 (positive SPT 
for yolk and/or egg white). In group 1, a child (4.3%) experienced posi-
tive OFC, in group 2, 13 children (25%) did not pass OFC (p < 0.03). In 
all cases manifestations were immediate, most frequently cutaneous 
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(78%). Persistence of positive SPT was significantly associated with 
allergic symptoms (atopic dermatitis, oculorhinitis, other food aller-
gies). There was no correlation between persistence of positive SPT, 
age at first or last egg reaction time interval between the last clinical 
response and OFC, time interval between the first and last SPT per-
formance, type of symptoms. The diagnostic accuracy of SPT showed 
best results for sensitivity (0.92) and negative predictive value (0.95).
Conclusion: Children with egg allergy are more likely to tolerate the egg 
in case of negative SPT, compared to subjects with persistently positive 
SPT. So, loss of positive SPT may be a predictive marker of tolerance and 
reduce the need for OFC. However, 1 of 23 children with negative SPT 
had reactions during OFC (4%). Larger population studies are therefore 
needed to examine possible mild reactions at OFC in case of negative 
SPT.
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Introduction: Children with cow’s milk allergy (CMA) have an 
increased risk to develop other allergic manifestations. We performed 
a randomized controlled trial (RCT) to test whether the early adminis-
tration of an extensively hydrolyzed casein formula (EHCF) containing 
L.rhamnosus GG (LGG) can reduce the 3-year incidence of other aller-
gic manifestations in these patients.
Methods: A parallel-arm RCT was performed in children aged 1 to 
12  months with IgE-mediated CMA. Patients were allocated to one of 
two groups of dietary interventions: EHCF (Nutramigen®, Mead John-
son, Evansville, IN, USA) and EHCF+LGG (Nutramigen LGG®, Mead John-
son, Evansville, IN, USA). All subjects were evaluated during a 36 months 
follow-up. Other allergic manifestations (atopic eczema, allergic urti-
caria, asthma and oculorhinitis) were diagnosed using standard criteria 
by pediatricians blinded to group assignment. Tolerance acquisition was 
evaluated every 12 month by the result of oral challenge.
Results: 220 subjects (147 male, 67%) with a mean (SD) age of 5.7 
(3) months were randomized, 110 to EHCF and 110 to EHCF+LGG. 
Binomial regression using intention-to-treat analysis revealed that 
the absolute risk difference (ARD) for the occurrence of at least one 
allergic manifestation over 36  months was −0.22 (95%  CI −0.35 to 
−9%, p < 0.001) for EHCF+LGG vs. EHCF. The ARD for the occurrence 
of atopic eczema was −0.13 (95% CI −0.25 to −1%, p < 0.05), −0.14 
(95% CI −0.25 to −2%, p < 0.001) for allergic urticaria, −0.11 (95% CI 
−0.22 to 0%, p > 0.05) for asthma, and −0.17 (95% CI −0.29 to −6%, 
p  <  0.01) for oculorhinitis in EHCF+LGG vs. EHCF group. Binomial 
regression for repeated measures using per-protocol-analysis with 
Bonferroni’s correction for 3 comparisons (contrasts) revealed that the 
ARD for the acquisition of cow’s milk tolerance was 0.20 (95% CI 0.05 
to 0.35, p < 0.01) at 12 months, 0.24 (95% CI 0.08 to 0.41, p < 0.01 at 
24 months and 0.27 at 36 months (95% CI 0.11 to 0.43, p < 0.001) for 
the EHCF+LGG vs. the EHCF group.
Conclusion: Compared to EHCF, EHCF+LGG reduces the incidence 
of other allergic manifestations in children with IgE-mediated CMA. 
Moreover, the use of this hypoallergenic formula increases the rate of 
tolerance acquisition at 12, 24 and 36 months.
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Introduction: The prevalence of peanut allergy is around 2% in chil-
dren. Current guidance from the European Medicines Agency (EMA) 
requires any medication containing soya-based products (including 
soya oil) to state that the product is contra-indicated in peanut-aller-
gic individuals, since both are legumes. While clinical allergy to soya 
in peanut-allergic individuals is considered to be uncommon, only 
limited published data are available to substantiate this. We therefore 
sought to determine the rate of soya allergy in children with chal-
lenge-proven peanut allergy.
Methods: We performed open food challenges to soya (total 4.0  g 
protein) in children with peanut allergy proven through double-blind 
placebo-controlled food challenge (DBPCFC). All challenges were con-
ducted according to PRACTALL consensus criteria. Where a participant 
experienced any symptoms during the soya challenge, DBPCFC to 
soya was undertaken to exclude placebo reactors. Local ethical and 
regulatory approval was granted, and informed consent was obtained. 
ClinicalTrials.gov Identifier: NCT02149719.
Results: 38 children (median age 13.5  years, range 8–17  years, M:F 
1.3:1) with peanut allergy (confirmed by DBPCFC) participated in this 
study. Over half had a history of previous anaphylaxis to peanut, and 
24% developed anaphylaxis during DBPCFC to peanut. Skin prick test 
to peanut extract ranged from 5 to 22  mm (median 10  mm), with a 
median peanut-specific IgE of 46 kU/L. SPT to soya extract was nega-
tive in 31/38 children; in the remaining 7 children, SPT varied from 2 to 
4 mm. 37/38 (97%) tolerated the open challenge to soya; 1 child expe-
rienced oral pruritus which was reproduced during DBPCFC—interest-
ingly, this child tolerated an open challenge to unroasted soya protein. 
One child developed oral symptoms to roasted but not unroasted 
soya; this child was also sensitised to birch pollen. There was no evi-
dence of systemic soya allergy in this cohort of peanut-allergic chil-
dren at challenge.
Conclusion: Co-allergy to soya is uncommon in peanut-allergic chil-
dren. These data suggest that the EMA requirement for labelling of 
medicines containing low levels of soya as contraindicated in peanut-
allergic individuals is unwarranted.
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Introduction: Cow’s milk (CM) allergy is a rising problem worldwide. 
Poor prognostic risk factors such as casein sensitization are well 
described. Nowadays we have not yet clear clinical markers to differ-
entiate in early stages patients with good prognosis. We analyze the 
clinical characteristics of patients who present only mild gastrointes-
tinal symptoms.
Methods: We selected pediatric patients who refered only mild gas-
trointestinal symptoms after CM intake in the last 2  years. Skin prick 
test (SPT) with commercial extracts were performed with whole CM, 
casein (CAS), alphalactoalbumin (ALA) and betalactoglobulin (BLG). 
Measurement of total IgE and specific IgE against milk proteins in 
patients sera were performed (ImmunoCAP, Sweden). Families have 
been asked about their tolerance with both whole CM and dairy prod-
ucts. All patients performed an open challenge with CM to confirm 
clinic. Celiac disease and lactose intolerance was ruled out.
Results: From a total of 645 pediatric patients referring food adverse 
reaction, in 96 patients (4.3 ± 3 y.o.) have been confirmed mild gastro-
intestinal symptons after CM intake. The most prevalent symptom was 
abdominal cramps (n = 72), followed by abdominal bloating (47), mild 
chronic diarrhea (n = 38) or feed refusal (n = 21). A positive SPT to CM 
was achieved only in 35 patients (36.4%), with positive BLG in only 
21 cases. Milk sIgE showed low rates generally, but BLG sIgE seems 
like the most prominent. It was noted that in a third of cases sIgE to 
CM was negative and in almost 25% only BLG showed positive sIgE. 
All patients identify CM such as the triggering food, although almost 
a third were still tolerating yogurt. Thus in the remaining patients we 
performed a subsequent open challenge test with yogurt, showing 
good tolerance nearly 80% of them. Interestingly only after 1  year, 
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more than a half of patients reached whole CM tolerance. The broad 
dietary restriction in patients with CM allergy involves important limi-
tations in everyday life. The identification of different clinical pheno-
types may have relevant implications for the clinical management, and 
a potential better short-term prognosis.
Conclusion: We describe a new CM allergy phenotype characterized 
by mild abdominal symptoms and lower CM sIgE, showing BLG sIgE as 
a key biologic marker in our population. The identification of this syn-
drome may be clinically relevant in the management and prognosis of 
CM allergic patients.
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Introduction: Peanut OIT can dramatically improve the quality of life 
for allergic children but the molecular and immunological changes 
that occur during treatment are poorly understood.
Methods: Whole blood samples were collected pre- and post-oral 
food challenge to peanut at baseline and at 6 months from 15 peanut 
allergic patients  participating in a double-blind, placebo-controlled, 
randomized trial of peanut Oral Immunotherapy (POIT). Basophil acti-
vation test (BAT) using CD203c expression was performed after stimu-
lation with different concentration of peanut extract. Peanut-reactive 
CD4+ T cell response were monitored using the CD154-based assay 
following stimulation with pool of Ara h 1, 2, 3, 6, 8 and 9 peanut com-
ponent. Sorted peanut-reactive CD4+ T cells were then run on the Flu-
idigm 96.96 dynamic array chip to assess changes in gene expression.
Results: Positive reactions to the BAT and presence of peanut-reactive 
effector TH2A cells lacking CD27 expression reflect the status of sensi-
tization to peanut, proved by Oral food challenge. Oral food challenge 
to peanut drastically increase the frequencies of peanut-reactive CD4+ 
T cells before POIT but at a lower extent in the active group post treat-
ment. Changes in the frequency, phenotype and molecular signa-
ture of peanut reactive T cells are predictive of early clinical responses 
induced by POIT. Our results also confirmed that allergen-specific TH2 
cells exhibit an “exhausted”phenotype and are preferentially targeted by 
allergen immunotherapy.
Conclusion: These results reveal novel immunological and transcrip-
tional signatures as surrogate markers of successful immunotherapy.
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Introduction: Allergic sensitisation to foods may occur in infancy 
without prior oral exposure to the offending food. This has led to the 
assumption that food allergy sensitisation may occur through alterna-
tive routes, such as via the skin. Recently, concerns have been raised 
regarding the safety of use of cosmetic and personal care products 
containing hydrolysed wheat proteins. The aim of this study was to 
develop a skin sensitisation model in naïve Brown Norway (BN) rats.
Methods: A high IgE-responder BN rat strain bred on a gluten-free 
diet for several generations were used as an animal model and two 
different products, unmodified gluten and acid hydrolysed glu-
ten were used as model proteins. Rat abdominal skin was shaved, 
lightly scratched with sandpaper and exposed to one of the prod-
ucts. The animal model was optimised for duration of skin exposure, 
the amount of product applied as well as for the post-immunisation 
regime. Skin conditions were evaluated by histology and water evap-
oration. At different time points sera were collected and analysed for 
the level, avidity and cross-reactivity of specific antibodies by different 
ELISAs. The antibody specificity was evaluated by immunoblotting and 
the functionality was examined by an ear swelling test.
Results: Both products were able to induce a specific immune 
response and sensitise through the slightly damaged skin without any 
use of adjuvant. This was evident before any post-immunisations. The 
sensitisation response depended on the duration of the skin applica-
tion as well as on the amount of products applied to the skin. Differ-
ences in dose-response relationship were seen between products. The 
results confirm previous studies showing that acid hydrolysis induced 
new epitopes while maintaining original epitopes. Antibody avidity 
differed greatly between the products and showed that the shared 
epitopes induced antibodies with highest avidity. Oral and i.p. post-
immunisation induced different outcomes, with a surprisingly higher 
response after oral compared to i.p. post-immunisations. The aim of 
the study, developing an animal model for studying food allergy skin 
sensitisation, was fulfilled. The model was able to detect differences 
in the induced response between the two products and further indi-
cated homing of skin immune cells to the gut.
Conclusion: In BN rats non-tolerant to gluten, unmodified and acid 
hydrolysed gluten has sensitising capacity through the skin.
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Introduction: Food allergies result from a complex immune response 
involving both innate and adaptive immune cells. Major proteins of 
wheat flour, gliadins, appear as important allergens and have a spe-
cial role in wheat-dependent exercise-induced anaphylaxis. Allergen 
characteristics can influence the allergic response. In this context, 
chemically modified gliadins by industrial processes impact immune 
mechanisms orchestrating allergic reaction in an undefined manner. 
Our study investigates immune reaction development during food 
allergy with gliadins under native, deamidated or hydrolyzed forms.
Methods: Mice were sensitized with native (NG), deamidated (DG) or 
hydrolyzed gliadin (HG). Subsequently, mice were challenged by oral 
gavage with the corresponding allergens. Then, organs were collected 
at different time points and analyzed for immune and physiological 
parameters such as gastro-intestinal functions, cytokine secretion or 
allergenspecific IgE.
Results: Preliminary data clearly show an increase of specific IgE and 
IgG1 level in serum after challenge when mice were sensitized with 
DG compared with NG and a level comparable to un-sensitized mice 
with HG. This was accompanied with an increase of intestinal perme-
ability and histological score reflecting intestinal integrity. Moreover, a 
more pronounced Th2-polarization together with a decrease in regula-
tory immunosuppressive response was observed in lymph nodes from 
mice sensitized with DG compared with NG sensitized mice.
Conclusion: Altogether, our data tend to demonstrate that industrial 
processes such as deamidation or hydrolysis impact food allergenicity 
through immune modulation and help us to develop tools to define 
how they can influence this reaction and encourage or decrease aller-
gic reactions.
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Introduction: At present, the main treatment for egg allergic patients 
is based on food avoidance, which poses a risk, since egg is used as 
an ingredient in a wide range of food products. Oral immunotherapy 
(OIT) is a promising treatment option, although the use of intact aller-
gens produces frequent side effects. In this respect, egg white protein 
hydrolyzates are thought to be safer to induce protective mechanisms 
leading to oral tolerance. The aim of this study was to determine the 
immunomodulatory effects of pepsin-hydrolyzed ovalbumin (OVA) 
administered as OIT in a BALB/c model of egg allergy.
Methods: BALB/c mice were orally sensitized during 6  weeks with 
5 mg of raw egg white (EW) using cholera toxin as adjuvant. On week 
7, mice underwent an immunotherapy protocol with either intact or 
pepsin-hydrolyzed OVA during 3 weeks and were subsequently chal-
lenged with EW. The severity of the anaphylactic response was evalu-
ated (clinical signs and body temperature drop) and serum levels of 
mMCP-1 were determined by ELISA. Allergen-specific antibodies, IgE 
and IgG1, were monitored throughout the OIT. The expression of the 
genes TSLP, IL-33, IL-25, TGF-β and IL-10 was analyzed by RT-qPCR in 
the small intestine. Furthermore, cytokine responses were measured 
in allergen-stimulated splenocytes and changes in cellular populations 
(Th1, Th2 and T reg) were assessed in the mesenteric lymph nodes 
(MLNs) using flow cytometry.
Results: Mice orally treated with pepsin-hydrolyzed OVA were sig-
nificantly protected from anaphylactic reactions compared with the 
groups of untreated mice and mice treated with intact OVA, which 
showed anaphylactic signs and a marked decrease of body tempera-
ture. Similarly, serum levels of mMCP-1 were lower in mice treated 
with the hydrolyzate. Desensitization of the allergic mice induced by 
the hydrolyzate was accompanied by a significant reduction in the 
levels of EW-specific IgE and IgG1. Administration of hydrolyzed OVA 
also downregulated the intestinal expression of TSLP, IL-33 and IL-25, 
and led to higher levels of IL-10 expression. However, the group that 
received intact OVA showed similar expression levels than untreated 
control mice. Desensitization by pepsin-hydrolyzed OVA was associ-
ated with a shift in the Th2 profile, as shown in ex vivo stimulated sple-
nocytes and flow cytometry analysis of T cell subsets in the MLNs.
Conclusion: OIT with pepsin-hydrolyzed OVA desensitizes and pre-
vents allergen-induced anaphylaxis in mice allergic to EW more effec-
tively than the intact protein.
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Introduction: Inconsistencies in findings on food allergy prevention 
by breastfeeding may result from variations in duration of breastfeed-
ing induced protection. Here, we assessed in mice how long food 
allergy was prevented by breastfeeding induced oral tolerance, and 
whether oral TGF-β supplementation after weaning would prolong it.
Methods: We first quantified ovalbumin (OVA) and OVA specific immu-
noglobulins levels (ELISA) in milk from the French EDEN birth cohort. 
Since OVA specific Ig were found in all milk samples, we assessed 
whether OVA-immunized mice exposed to OVA during lactation could 
prevent allergic diarrhea in their 6 and 13-week-old progeny. In some 
experiments, a supplement of TGF-β enriched formula was given after 
weaning.
Results: We found that, at 6 weeks, only 17% of symptom scores were 
≥ 3 (diarrhea) during the last 3 oral OVA challenges in the group of 
mice breastfed by mothers immunized to OVA and exposed to OVA 
during lactation versus 43% in the group of mice breastfed by naïve 
mothers. However, at 13 weeks, the percentage of diarrhea increased 
to 28%. Supplementation with TGF-β after weaning allowed maintain-
ing a strong protection from allergic diarrhea in 13-week-old mice 
breastfed by OVA-exposed mothers (13% of diarrhea only). This pro-
longed protection was only observed in mice rendered tolerant by 
breastfeeding and was associated with an improved gut barrier.
Conclusions: In mice, prevention of food allergy by egg antigen expo-
sure through breast milk is of limited duration. Nutritional intervention 
by TGF-β supplementation after weaning could prolong beneficial 
effects of breast milk on food allergy.
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Introduction: Understanding the mechanisms how the host recog-
nizes countless foreign antigens and remains unresponsive to self, 
have opened many questions in the field of immunological tolerance. 
The most specific marker that distinguishes regulatory from conven-
tional T cells is forkhead box transcription factor (Foxp 3). Predominant 
cell types that expressed Foxp 3 are CD4+CD25+ and characteristic of 
subpopulations which are Foxp 3 negative are their regulatory func-
tion lacked. Natural Tregs have the possibility to suppress multiple cell 
types involved in immunity and inflammation by inhibition the prolif-
eration, immunoglobulin production, the blocking of NK and NKT-cell 
cytotoxicity, as well as, the function and maturation of dendritic cells. 
It seems that the efficacy of Treg-based therapy depends on the anti-
gen specificity of these regulatory T cells. The most common use of 
Tregs is described in the prevention of allergic diseases, autoimmun-
ity and in possibility to moderate transplantation tolerance. NKT cells 
represent a unique sublineage of innate lymphocytes, which share the 
properties of natural killer cells and conventional T cells. Hypothesis 
about regulatory network of Tregs and NKT cells was studied by flow 
cytometry, analyzing the characteristics of human Tregs and NKT cells 
of patients with food allergy, compared to healthy volunteers.
Methods: A total of 30 children with food allergy were investigated. 
None of them was taking any systemically administered medications 
for at least 3 months before testing. Venous blood samples were taken 
and peripheral blood leukocytes (PBL) were isolated. Phenotype of 
lymphocytes was analyzed using intracellular and surface immuno-
fluorescence and flow cytometric analysis (FACSCalibur).
Results: Our preliminary study was shown a significant increased in 
a percentage of regulatory T lymphocytes and NKT cells in peripheral 
blood of people with described food allergy. Tregs have the ability to 
suppress allergic immune response. NKT cells perform an important 
subpopulation of cells which can play both roles: as effectors and as 
regulatory cells in a wide range of disease settings.
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Conclusion: We can talk about the new kind of cells NKT-reg cells, 
whose monitoring may lead to important early diagnosis and/or prog-
nosis of food allergies.
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Introduction: A direct effect of nonsteroidal anti-inflammatory drugs 
(NSAIDs), but not selective cyclooxygenase (COX)-2 inhibitors, on 
basophils using a human model of peach lipid transfer protein (Pru p 
3) allergy enhanced by NSAIDs has been recently reported. In patients 
with food dependent exercise induced anaphylaxis, the administration 
of misoprostol, a prostaglandin (PG) E1 analog, was reported to inhibit 
the allergic response. We sought to evaluate the effect of PGE2 in an 
in vitro model of basophils of patients with Pru p 3 allergy enhanced 
by NSAIDs.
Methods: A basophil activation test, measured as expression of CD63 
(Flow2CAST™, Bühlmann Laboratories AG®, Switzerland) is performed 
strictly following the manufacturer’s procedure. Stimuli used are: Pru p 
3 (1.120 ng/mL), anti-IgE, lysine acetylsalicylate (L-ASA; 3.38 mM) and 
PGE2 (10–4 M) at several concentrations and in combinations.
Results: A BAT to 6 consecutive patients with Pru p 3 allergy enhanced 
by NSAIDs has been performed. In all of them, we observe the enhance-
ment of basophil activation caused by the L-ASA in combination with 
the allergen compared to the activation caused by the allergen alone, 
as previously described by our group. PGE2 not only diminishes the 
effect of L-ASA on basophil activation (median CD63+ basophils (%) 
after stimuli Pru p 3+L-ASA vs Pru p 3+L-ASA+PGE2: 60.25 vs 44.60, 
p = 0.031) but also the activation caused by the antigen alone although 
not statistically significant (median CD63+ basophils (%) after stimuli 
Pru p 3 vs Pru p 3+PGE2: 58.2 vs 37.3, p = 0.063). In 4 of these patients 
the same experiment was done but using anti-IgE instead of Pru p 3 
and the same effect of PGE2 was observed (median CD63+ basophils 
(%) after stimuli anti-IgE+L-ASA vs anti-IgE+L-ASA+PGE2: 83.7 vs 62.3, 
p = 0.016; anti-IgE vs anti-IgE+PGE2: 76.3 vs 58.2, p > 0.05).
Conclusion: Preliminary results show that PGE2 diminishes basophil 
activation in  vitro in our patients with food anaphylaxis dependent 
of NSAIDs. Confirmation of this observation is required with a larger 
cohort of patients.
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Introduction: We recently described a unique Th2 cell subset specifi-
cally involved in all allergy disease (TH2A cell subset). We investigate 
the cellular and molecular mechanisms behind clinical heterogeneity 
of peanut allergic responses.
Methods: We combined a CD154-based assay and a single-cell tran-
scriptomes analysis to assess ex vivo and at a single cell level the spe-
cific CD4+ T cell responses to each peanut allergic components (Ara h) 
in adults with or without peanut allergy.
Results: Pathogenic responses (Th2 response) were specifically associ-
ated with short life terminally differentiated allergen-specific CD4+ T 
cells, which dominate in allergic subjects but are absent in non-allergic 
subjects. Protective responses in non-atopic individuals were associ-
ated with peanut-specific TH1/TH17 cell responses. Within the peanut 
allergic group, we observed inter-individual variations of the specific 
immune response to each peanut allergic component. No direct link-
age between CD4+ T cell response and IgE responses against each 
individual peanut allergic component.
Conclusions: Ability to identify immunogenicity and type of response 
elicited by each peanut allergic component appears to be critical to 
future success in vaccine development against peanut allergy. Under-
standing the type of cellular response and the role of genetic restric-
tion may allow to target immune response to critical peanut allergen 
and to uncover the optimal type of cellular immune response neces-
sary for protection.
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Introduction: Interactions between immune and inflammatory 
responses may play a crucial role in the development and progression 
of allergic diseases, autoimmune and chronic progressive inflamma-
tory disease. The matrix metalloproteinases (MMPs) play a key role in 
angiogenesis together with migration and/or invasion of endothelial 
cells in surrounding stroma and tissues. MMPs are involved in degrad-
ing of extracellular matrix (ECM), which consequently lead to facili-
tate invading of endothelial cells and in the same time stimulate the 
releasing of extracellular matrix-sequestered proangiogenic factors 
(ECM-sequestered proangiogenic factors), integrins, adhesion recep-
tors and different growth factors and receptors. The members of the 
matrix metalloproteinase (MMP) family are involved in angiogenesis 
and vascular remodeling, consequently leading to the progression of 
numerous vascular diseases such as atherosclerosis, varicose veins, 
hypertension, abdominal aortic aneurysm, preeclampsia, etc. The aim 
of this study was to examine the values of enzyme matrix metallopro-
teinase-2 and 9 in urine from children with described food allergies.
Methods: We analyzed 30 patients with children with described food aller-
gies. The method of enzyme immunoassay (ELISA) was used to determine 
enzymes expression of matrix metalloproteinase-2 and 9 (MMP-2 and 9).
Results: The children with described food allergies had a statistically 
significantly increased level of MMP-2 and 9 in the urine in comparison 
with healthy volunteers.
Matrix metalloproteinases (MMPs) play a key role in the physiology 
of connective tissue development, in morphogenesis and in wound 
healing and their unregulated activity has been implicated in numer-
ous disease processes including arthritis, tumor cell metastasis and 
atherosclerosis.
Conclusion: Our data has showed a large increase in the enzyme 
MMP-2 and 9 in the urine of children with described food allergies, 
which may be an easy marker for the monitoring of the development 
of food allergies in children.
Acknowledgements: This work was supported by grants from Univer-
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Introduction: Secretion of antibodies belonging to IgG, IgA and IgM 
class is a natural response of host organism to any protein antigens 
including those introduced with food. Production of IgE may, however, 
indicate on sensitivity of the immune system to a particular protein. 
Bacteria present in food continuously influence the host body inter-
acting with the immune system. Last reports indicate on possible 
adverse, IgE-dependent reaction of human immune system with pro-
teins from lactic acid bacteria (LAB), namely Lactobacillus casei. The 
aim of the study was to investigate whether proteins from LAB species 
commonly used in food industry react with human both IgG and IgE 
antibodies.
Methods: Whole cell extracts of two LAB strains Lactobacillus del-
brueckii subsp. bulgaricus 151 (L151) and Lactobacillus casei LcY (LcY) 
were a source of proteins. Two pooled human sera were used as a 
source of human primary antibodies: serum A obtained by pooling 
seven sera from allergic patients and serum B obtained by pooling 
sera from ten allergic patients. As a control, a pool of sera from six 
healthy participants with negative serum parameters for allergy diag-
nostic tests, with no allergic manifestations and with defined negative 
family histories of atopy was used. Bacterial proteins were separated 
(Tricine SDS-PAGE), then transferred onto nitrocellulose membranes. 
The membranes were probed with human sera (primary antibod-
ies) and then with fluorescently labelled secondary antibodies: goat 
anti-human IgG antibodies already conjugated with IRDye® 800CW 
(Li-COR) and mouse monoclonal anti-human IgE antibodies (Sigma) 
labelled using the IRDye®680RD Protein Labelling Kit (Li-COR). Signal 
detection was carried out with the Odyssey Infrared Imaging System.
Results: Analyses carried out with pooled serum A showed only one 
protein fraction (ca. 36 kDa) in LcY strain reacting with both IgG and 
IgE. With the use of pooled serum B, however, IgG and IgE reactive pro-
teins were detected in both LcY and L151 strain. Differences in profiles 
of immunoreactive proteins obtained with the examined sera indi-
cated that bacterial proteins are characterized by different immuno-
logical determinants with different affinity to human antibodies.
Conclusions: Immunoreactivity of bacterial proteins, which may be in 
contact with the human immune system, and studies on immunore-
activity of proteins from bacteria used in food production technology 
and those comprising the human microbiome should be continued.
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Introduction: Cow’s milk allergy (CMA) is the most common food 
allergy in infancy. Fundamental to the management of food allergy 
is complete elimination of the offending proteins. However, due to 
dietary elimination CMA patients are at risk for inadequate nutri-
tional intake. Management approaches in infants and young children 
include the use of hypoallergenic formulas that need to be fully tol-
erated, support normal growth and also assure adequate nutritional 
status in these patients. Dietary management of CMA with a hypoaller-
genic amino acid-based formula (AAF) has been proven to be effective 
and safe. Data on mineral status after dietary management by AAF are 
however scarce.
Methods: In a prospective, randomized, double-blind controlled 
study, full term infants with diagnosed CMA received an AAF (n = 110) 
with or without synbiotics (neutral and acidic oligosaccharides, Bifido-
bacterium breve M-16 V) for 16 weeks. Primary outcomes were growth 
and formula tolerance and have been reported previously [1,2]. Min-
eral status was assessed by analyses of blood samples obtained at 
baseline and 16 weeks, which included calcium, phosphorus, chloride, 
sodium, potassium, magnesium and total iron. Total protein, albumin, 
prealbumin, hemoglobin and ferritin were also determined. Formula 
intake was recorded through diaries at weeks 0, 4, 8 and 16 during the 
study.
Results: Average age of infants at inclusion was 4.5  ±  2.4  months 
(mean ± SD). Median study product intake ranged from 704 ml/day in 
the first week to 789 ml/day at week 16. At baseline, averages (mean, 
median) of blood levels of calcium, phosphorus, chloride, sodium, 
potassium, magnesium and iron were within reference ranges. After 
16 weeks on AAF, the averages of all mineral blood levels were again 
within the specified reference ranges set for the corresponding infant 
ages. Also the averages of total protein, albumin, prealbumin, hemo-
globin and ferritin were within reference ranges. For some minerals, a 
number of individual values at baseline were below references, i.e. cal-
cium (n = 1), phosphorus (n = 1), chloride (n = 1), and sodium (n = 1), 
whereas at week 16 none of these minerals had individual values 
below reference ranges.
Conclusion: This study shows that an AAF with or without synbiotics, 
which have been reported previously to be equally tolerated and to 
support normal growth [1,2], are effective in managing an adequate 
mineral status in CMA infants.
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Introduction: Serious life-threatening food allergy is still difficult to 
treat and usually results in a social life with restrictions. Pre-treatment 
with Anti-IgE has lately been suggested in order to start desensitiza-
tion for food allergy in some patient cases. The conventional allergy 
tests though, are not always enough for monitoring the treatment 
with Anti-IgE and desensitization process. Here, we present a case 
report of desensitization against serious allergy to milk and monitor-
ing with basophil activation test (BAT) and IgG4.
Case report: A 70-years old female patient with serious allergy to milk, 
allergic asthma who was previously treated with immunotherapy for 
allergy to pollen and animal dander, was referred for allergological 
assessment and for possible treatment with desensitization to milk 
allergy. The patient reacted previously with anaphylaxis due to inges-
tion of traces of milk protein, even due to airborne milk protein and 
with contact urticaria due to milk. In 2015 the patient started pre-treat-
ment with Anti-IgE, in a dose of 450 mg every 2 weeks, and was moni-
tored with BAT before eventually desensitization. Before the treatment 
with Anti-IgE, BAT with prick-test extract for milk (PT) (Soluprick, ALK) 
was 1.148 units (U) and with fresh milk 467.29 U. After six months of 
treatment with Anti-IgE, BAT analysis was found very low, compared 
to the values before starting pre-treatment with Anti-IgE (BAT with PT-
extract for milk at 1.5U and with fresh milk at 1.8 U), indicating a start-
ing point for desensitization against milk allergy. In addition, sIgE tests 
showed for milk 580 kU/L, IgG4 for casein 1.55 kU/L after six-months 
of treatment with Anti-IgE and before starting the desensitization. 
The patient started desensitization with slow build-up by ingesting 
fresh milk once a week with target of reaching the cumulative dose of 
200  ml after 16  weeks. After 12  weeks of desensitization the patient 
reacted with mild skin redness in the face and neck when she ingested 
the dose of 50 ml of fresh milk, and therefore the patient started con-
tinuous treatment with H1-antagonstist and anti-leucotrienes daily 
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along with Anti-IgE treatment. New BAT analyses with PT-extract and 
fresh milk was turned out negative after 12 weeks of ongoing desen-
sitization while IgE for milk showed 390  kU/L and IgG4 for casein 
2.51  kU/L. The patient reached the dose of 200  ml fresh milk after 
16 weeks and continued consuming daily dairy products without any 
further reactions by now.
Conclusion: In some patients with serious life-threatening food 
allergy, pre-treatment with Anti-IgE is required and BAT is suggested 
as monitoring tool for indicating the starting-point for the desensiti-
zation process. BAT along with IgG4 may be used in order to monitor 
successfully the patient’s acquired tolerance for the food allergen dur-
ing the desensitization and during the follow-up later on, even when 
Anti-IgE medication would have been suspended.
Consent to publish: The patient has given consent for presentation 
and publication of the case.
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Introduction: Food allergy is reported to affect approximately 2% of 
the adult population, with the majority having had onset during child-
hood. There is an increasing recognition of adult onset food allergy, 
however these typically are associated with pollen-plant association, 
and are more often food- dependent, exercise-induced, anaphylaxis 
(FDEIAn). According to recent consensus statements, mast cell activa-
tion syndromes are divided into 3 subtypes: Primary Mast Cell Activa-
tion Syndromes (MCAS), Secondary MCAS, and idiopathic MCAS. A 
mast cell activation disorder requires clinical symptomatology that is 
in keeping with the disorder, a transient, measurable increase in either 
serum tryptase or other markers of mast cell mediators and a response 
to agents that interfere with mast cell mediators. Recent attempts 
have been made to standardize an approach to suspected mast cell 
disorders, in order to appropriately classify individuals with evidence 
of mast cell activation that did not meet diagnostic criteria for sys-
temic mastocytosis.The combination of adult onset food allergy with 
an underlying mast cell disorder has not been described previously in 
the literature, and this case report demonstrates the investigation of 
an elderly gentleman who presented with first onset anaphylaxis due 
to food ingestion with evidence of a suspected underlying mast cell 
activation syndrome.
Case report: A 75-year-old male presented to the local emergency 
department exhibiting symptoms consistent with anaphylaxis. When 
found by his son in law he was reported to be flushed and unrespon-
sive. On arrival of emergency medical personnel he was found to be 
hypotensive with blood pressure values of 80/60, hypothermic at 
34.7°C orally, and hypoxemic with a sPO2 of 88% by pulse oximetry. He 
received a 500 cc IV normal saline bolus with EMS. In the emergency 
department a blood pressure of 71/44 was recorded. He was treated 
with 3L of IV crystalloid, epinephrine 1:1000 0.3 mg IM once, diphen-
hydramine 25 mg IV with a second 50 mg IV dose, ranitidine 150 mg 
IV once, and methylprednisolone 250 mg IV once with improvement. 
He suffered a type 2 MI related to anaphylaxis associated hypotension 
that was manifested by tropinemia.
He had no previous history of anaphylaxis, atopy, lymphoprolifera-
tive disorder or other neoplasm. His daily medications included aspi-
rin 81 mg daily, and this in addition to his other regular medications 
were continued post reaction. He did not take additional doses of aspi-
rin, over the counter or herbal products on the day of reaction. There 
was no family history of atopy. The Allergy and Clinical Immunology 
Service was contacted by the emergency physician, at which time 
the food intake history was unclear, and given his profound hypoten-
sion at presentation a concern of a MCAS was raised. This is consist-
ent with suggestions to investigate for MCAS in patient’s presenting 
with anaphylaxis with profound cardiovascular derangement and 
lacking documented uritcaria, even if likely attributed to an IgE medi-
ated reaction. He was therefore discharged on cetirizine 10 mg daily, 
prednisone 50  mg orally for five days, diphenhydramine 25–50  mg 
orally q6 h as needed, and an epinephrine auto-injector. He was sub-
sequently followed in the Adult Allergy and Clinical Immunology out-
patient clinic.
Between the anaphylactic episode and his appointment at the Allergy 
Clinic [approximate time 1 month] he consumed Atlantic cod without 
reaction. A food history revealed his initial event had developed 3  h 
following ingestion of a mixed fish and shellfish stew, which he had 
consumed without reaction on a regular basis. Due to the concern of 
a potential underlying MCAS and the severity of his initial reaction, it 
was felt safest to continue H1 receptor antagonist therapy, as such skin 
prick testing was deferred for use of ImmunoCAPⓇ [serum specific IgE 
(Phadia, Sweden)] for shellfish, finned fish and hymenoptera venom. 
A serum tryptase was evaluated. He was given an epinephrine auto-
injector to be used in the event of subsequent anaphylactic reaction. 
At follow up his serum specific IgE was high positive for Shrimp at 13.7 
kUA/L, and Crab at 7.3 kUA/L, moderately positive for Lobster at 2.9 
kUA/L and Clam at 0.9 kUA/L, while testing negative with values <0.35 
kUA/L for Salmon, Walleye Pike and Whitefish. A serum tryptase level 
was 15  ng/ml [with a normal range from 1 to 11.4  ng/ml], an eleva-
tion not diagnostic of systemic mastocytosis, but suggestive of a mast 
cell activation disorder. A creatinine obtained demonstrated a value of 
92, corresponding to an eGFR of >60 ml/min, ruling out reduced renal 
clearance as a cause of accumulation of serum tryptase.
To further evaluate for a potential mast cell disorder, a 24  h urine 
methylhistamine level was obtained, demonstrating a value of 103 
ug/g Cr (normal range 30–200 ug/g Cr). A serum protein electropho-
resis demonstrated no evidence of an M protein. He was seen by the 
Adult Hematology/Oncology Service at CancerCare Manitoba to defin-
itively exclude a diagnosis of systemic mastocytosis, for which a bone 
marrow biopsy and c-KIT testing were completed. His c-KIT was nega-
tive. A bone marrow biopsy demonstrated normal trilineage hemat-
opoiesis with normal differentiation and maturation without definitive 
morphological evidence of mastocytosis or lymphoma, specifically 
revealing no large lymphoid aggregates, abnormal plasma cells, or 
spindle cells suggestive of mastocytosis. Accompanying flow cytom-
etry demonstrated revealed a sample composed of 23% lymphocytes, 
of which 84% were T cells, 8% NK cells, and there was a CD4/8 ratio of 
0.9. Remaining cells were polyclonal B cells without evidence of lym-
phoma, plasma cell neoplasm, or mastocytosis. Tryptase was consist-
ently elevated at 17 ng /ml on repeat testing.
Given his elevated tryptase, he was maintained indefinitely on ceti-
rizine, and continued to avoid both fish and shellfish, but did require 
emergency department monitoring following administration of his 
epinephrine auto injector in January 2015 following ingestion of a 
perogy, of which the precise constituents were unknown, and devel-
opment of a diffuse urticarial rash. He was treated with a 3 day course 
of 50 mg of oral prednisone.
He fulfills the proposed diagnostic criteria for diagnosis of a suspected 
MCAS based on guidelines published by Valent and colleagues, how-
ever we acknowledge the challenge of establishing the diagnosis 
in the context of a documented IgE mediated food allergy, and he 
may be best classified as a Secondary MCAS [IgE-dependent disease 
related].
Conclusions: The combination of food allergy with a mast cell acti-
vation syndrome with onset in the elderly population represents a 
novel combination that is not well described. It is unclear whether 
the patient in this case had an underlying mast cell disorder that was 
previously quiescent and was detected only due to his presentation, 
or whether this was related to a newly acquired population of non-
clonal mast cell hyperplasia secondary to an as yet undiscovered or 
subclinical triggering source such as malignancy, infection, subclinical 
thrombosis, an underlying autoimmune condition, increased stimula-
tory cytokines, or increased vasoactive peptides; as all are postulated 
triggers of mast cell activation.
The increasing prevalence of food allergy worldwide, and the height-
ened propensity for life threatening anaphylactic reactions in those with 
underlying mast cell reactivity highlights the importance of an educated, 
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stepwise, evidence -based diagnostic approach to older adults present-
ing with anaphylaxis. This further supports the importance of a high level 
of suspicion for clonal mast cell disorders in patient’s presenting with 
anaphylaxis with profound cardiovascular manifestations and limited 
cutaneous manifestations. A case such as this emphasizes the impor-
tance of an approach with thorough investigation of all potential aller-
gen exposures, including those to which a patient has been exposed on 
multiple occasions without systemic or local reaction.
It could be theorized that new sensitization to previously tolerated 
food antigens with resultant anaphylaxis could be associated with 
underlying mast cell activation disorders in adults without a history of 
atopy, particularly when presenting with profound hypotension. Fur-
ther research is needed into the incidence of adult onset IgE mediated 
food allergies, anaphylaxis, and the rate at which it is associated with 
underlying mast cell activation, particularly given the association with 
MCAS and a heightened risk for a more severe anaphylactic reaction.
Consent to publish: The individual described in the above case report 
has completed and signed a consent form for publication and presen-
tation, currently stored at the Allergy and Immunology clinical offices 
in the Health Sciences Centre, Winnipeg, Manitoba, Canada. A copy 
can be made available if required.
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Introduction: Carmine (E120) is a red dye extracted from dried female 
cochineal arthropods (Dactylopius coccus cacti) commonly used in 
foods, drugs and cosmetics. Reports of IgE-mediated carmine allergy 
are limited.
Case report: A 56-year-old female experienced 2 anaphylactic reac-
tions after eating chicken tikka masala and after a croissant with wild 
berries topping. She showed immediate nausea, vomiting and diar-
rhea followed by urticarial rash and facial edema several hours later. 
Afterwards, patient had, with exception of the wild berries topping, 
the same food again but without complaints. Skin and immunoCAP 
(Thermofisher-Phadia) testing were negative with all food allergens 
relevant to the history, including Tri a19 and galactose-alpha-1.3-ga-
lactose. Idiopathic anaphylaxis was diagnosed and an adrenalin 
auto-injector was prescribed. Several months later, after performing 
an urea breath test for Helicobacter pylori with a Fortimel® energy 
strawberry (Nutricia) drink, which contains as potential allergens milk, 
rape seed oil, sunflower seed oil, soy lecithin and carmine acid, patient 
experienced immediate epigastric pain followed by dyspnea, facial 
edema and generalized urticaria. Skin testing with Fortimel® energy 
strawberry was clearly positive (negative in 5 controls) and negative 
for milk and soy milk. Specific IgE showed positivity for cochineal 
extract (2.77  kU/L) (retrospective serum analysis one month before: 
IgE 1.92 kU/L). Flow cytometric analysis of activated peripheral blood 
basophils (CD63+CD123 +HLA-DR−), including a positive control (anti-
IgE), a negative control (without allergen), carmine (Sigma-Aldrich) 
and fast green (E143), showed clear CD63 positivity after stimulation 
with carmine and not with fast green (Fig. 3). This response was absent 
in the control patient.
Conclusions: A rare case of carmine-induced food allergy is 
described and confirmed by sIgE, skin prick test and basophil acti-
vation test. Carmine, used as a natural red dye, can cause severe 
allergic reactions at very low concentrations, with an uncharacteris-
tic time delay between exposure and clinical manifestations, poten-
tially hours later. Unclear episodes of anaphylaxis may be due to 
sensitization to carmine. Carmine should be included in the allergy 
work-up of idiopathic (food-induced) anaphylaxis as it can act as a 
hidden allergen.
Consent to publish: Informed consent of the patient is obtained.
Fig. 3 Basophil activation test
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Introduction: Immunological adverse reaction to wheat may be either 
IgE-mediated, either T-cell-dependent. In patients with IgE -mediated 
allergy to wheat protein there is no specific therapym, except oral 
immunotherapy (OIT). There are few data regarding OIT with wheat 
protein in wheat allergic patients.
Case report: A 32  years old female with a history of allergic rhinitis 
of 12 years developed asthma after 4 years. The patients had a severe 
persistent rhinitis with a step 4 partially controlled asthma, sensitized 
to house dust mites and grass pollen. In the last 5 years she developed 
a severe chronic urticaria, and in the last 2 years her asthma worsened 
having frequent exacerbations. She was evaluated for the cause of 
urticaria and of asthma exacerbations. A wheat allergy was confirmed 
with skin prick test (12  mm diameter), specific IgE (18.6 kUI/l) and a 
double-blind placebo-controlled food challenge (DBPCFC). An elimi-
nation diet was introduced for 2  months. Her urticaria and asthma 
symptoms improved, but she was unsatisfied with her diet. The patient 
underwent wheat OIT with cooked pasta. Up-dosing phase started 
with 1  g pasta in the allergy office and was given at home daily for 
6 days. The increasing of the dose was performed weekly in the allergy 
department, for 8 weeks, by double the quantity up to 120 g. The dose 
was maintained daily for 6  months. During maintained period, the 
patients did not have urticaria and asthma exacerbation. She reduced 
the dose of glucocorticosteroids (nasal and inhaled). At the end of the 
maintained period, the patient underwent DBPCFC with no symp-
toms. Specific IgE to wheat decreased to 3.2 kUI/l. She was allowed to 
eat bread and other foods containing wheat proteins, with no urticaria 
and no asthma exacerbation, during the 6 months followed up.
Conclusion: A wheat OIT was safe and produced an improvement in 
allergic rhinitis, asthma and urticaria female patient allergic to wheat. 
Wheat OIT may induce tolerance to wheat proteins.
Consent to publish: Our patient gave consent for presentation and 
publication.
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Introduction: Termites are insects in the Isoptera suborder, Blattodea 
family, with 3106 described species. They live in worm regions, includ-
ing Africa, South America, South Europe and Australia. Besides their 
use as a dietary supplement in non developed regions, they have 
become popular in western countries as delicacy.
Case report: A 30-year-old Caucasian woman presented at the emer-
gency department with cough, wheezing and urticaria immediately 
after termites’ ingestion, accompanied by epigastric pain and diz-
ziness 30  min later. It was the first time she consumed termites. The 
patient had a history of two anaphylactic reactions after honeycomb 
ingestion. Between the first two episodes she was consuming honey, 
honeycomb and propolis with no reaction, but subsequently she has 
banned them. “Slight discomfort” with crustaceans’ consumption was 
also reported. Skin prick tests to food and aeroallergens were positive 
to grasses, Bermuda grass, Blatella germ, Derm. Pter., Derm. Far., shrimp, 
crab and shellfish. Additionally prick to prick tests performed with raw 
and boiled termites turned out positive contrary to 5 negative con-
trols. Total IgE was slightly elevated and baseline tryptase was normal. 
Specific IgE antibodies for shrimp, fish, grape, latex, honey bee venom 
and tropomyosin were negative, unlike Bermuda grass, Blat. germ, 
Derm. pter. and Derm. far. which were positive.However our patient 
has neither personal or family history of atopic diseases. According 
to history and laboratory evaluation, we speculated that the common 
allergen is a minor panallergen, like a calcium-binding protein, com-
mon in pollens (Bermuda) Cyn d 7 but also in crustaceans Cra c 4, cock-
roach Bla g 6, mite Der f 17 and honey bee (calcium binding protein 
39), although, to our knowledge, no cross reactivity between animals 
and plants has been described. Unfortunately, for lack of means, we 
couldn’t identify the common allergen. Accidental exposure in related 
species could also be a reason for sensitization.
Conclusion: This is the first case report of an anaphylactic reaction to 
termites’ ingestion. It is challenging how the food consumption from 
different cultures and ambient could increase the appearance of new 
food allergic reactions.
Consent to publish: Consent was obtained from the patient for publi-
cation of this case report.
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Introduction: Food allergy is the most common cause of anaphylaxis 
in children. Banana is not considered a highly allergenic food and it is 
usually one of the first fruits introduced in the diet of infants.
Case report: A 2-year-old boy had an anaphylaxis episode immedi-
ately after eating a banana. He presented with oral discomfort, facial 
and tongue angioedema, emesis and rash on his legs. On route to 
the emergency department, his aunt, an Allergist, gave instructions 
to administer dimethindene and betamethasone with symptom 
improvement. He remained in observation at the hospital and an 
adrenaline auto-injector, antihistamine and oral steroid were pre-
scribed on discharge. He had eaten bananas before, but always in 
small quantities because he did not like bananas and he would refuse 
to eat them. He tolerates apple, pear, mango, pineapple, melon, clem-
entine and vegetables. His medical history includes atopic dermatitis 
and the use of a helmet during six months for the correction of plagio-
brachycephaly under the supervision of neurosurgery. Skin prick tests 
(SPT) with commercial extracts were positive for kiwi and banana; and 
negative for D. pteronyssinus, grass pollens, Pru p 3 and latex. The skin 
prick-prick tests with banana were also positive. Total IgE and basal 
trytpase were normal; specific IgE to banana 2.85  kU/L and negative 
to latex. Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) immunoblotting with banana extract and the patient’s 
serum was performed and an IgE-binding band with a molecular mass 
of 20 kDa was detected which suggests sensitization to banana.
Conclusion: Although banana allergy is well established in adults, 
often associated with latex allergy in the latex-fruit syndrome, there 
are few case reports of anaphylaxis to banana in children. Banana 
pulp is rich in thaumatin-like protein (TLP), an allergen with 20 kDa of 
molecular mass; it is probably the sensitizer in this case. Curiously, SPT 
with kiwi extract was positive although he never ate kiwi. This may be 
explained by the cross-reactivity described among the TLPs.
Consent to publish: We hereby declare that the boy’s parents author-
ized the authors to publish these findings.
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Introduction: Omalizumab (anti-IgE antibody) is an effective treat-
ment for asthma and chronic spontaneous urticaria, but relatively few 
reports exist of use for prevention of uncontrolled systemic allergic 
reactions in adults. We report the case of an adult patient with allergy 
to lipid transfer proteins (LTP) who was successfully treated with 
omalizumab.
Case report: A 34-year-old Caucasian female started to experience 
anaphylactic reactions to red wine in 2009, with abdominal cramps, 
vomiting, urticaria, lips and tongue angioedema. She subsequently 
experienced pharyngeal discomfort with difficulty in breathing after 
eating grapes. Over the next 3  years she progressed to similar reac-
tions after eating numerous fruits and vegetables. We first became 
involved in her case in 2012. She underwent investigation with skin 
tests to a wide range of fruits/vegetables, component and ISAC test-
ing. A diagnosis of LTP allergy was made. She was provided with an 
anaphylaxis management plan. She continued to have recurrent and 
frequent reactions despite extensive dietitian input and then anti-
histamine prophylaxis, with repeated use of adrenaline injector and 
emergency department attendances. Her dietary intake became 
heavily restricted and quality of life was significantly affected, both as 
a result of allergic reactions but further compounded by new depres-
sive and anxiety symptoms. A decision was made to undertake a trial 
of subcutaneous omalizumab therapy. She underwent a positive 
baseline double blinded placebo controlled food challenge (DBPCFC) 
with raisin, developing nasal congestion and abdominal pain that was 
reproduced when re-challenged with the same dose (20 mg) but not 
placebo. Treatment was then initiated with omalizumab (300 mg once 
monthly), in accordance with the asthma dosage recommendation 
for weight and total IgE. The DBPCFC was repeated after 6 months of 
omalizumab and a final dose of 600 mg of raisins was fully tolerated. 
She has subsequently undergone multiple open oral food challenges 
to previous trigger foods, which have now been reintroduced into her 
diet. She continues to receive regular omalizumab and has not experi-
enced a recurrence of systemic allergic reactions.
Conclusions: There is currently little data to confirm omalizumab use 
in patients with anaphylaxis to foods outside of the oral immunother-
apy setting. To our knowledge this is the first reported case of omali-
zumab being used to successfully manage systemic allergic reactions 
to LTP.
Consent to publish: Written informed consent was obtained from the 
patient for publication of this abstract and any accompanying images.
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Introduction: Hen’s egg is the second most common allergen with 
a mean incidence of allergy of 1.23% (95% CI 1.27–3.47) in the Euro-
Prevall birth cohort. There are little data on the risk factors for egg 
allergy. In this study we aimed to assess the risk factors for egg allergy 
in the Europrevall birth cohort with a particular focus on eczema.
Methods: The EuroPrevall birth cohort was established across nine 
European countries and children were followed up to 2  years. Ques-
tionnaires were undertaken at 12 and 24  months. Children with sus-
pected egg allergy were invited for skin prick testing, measurement of 
specific IgE and double-blind, placebo-controlled challenge (DBPCFC) 
to hen’s egg if allergy was suspected. Each egg allergy case (positive 
DBPCFC or egg induced anaphylaxis) was allocated two age-matched 
controls. Statistical analysis was undertaken in SPSS version 22 (IBM, 
New York, USA) and STATA SE 13 (StataCorp, College Station, USA).
Results: 12,049 infants were recruited into the EuroPrevall birth cohort 
and 9336 (77.5%) were followed until 2  years. 86 infants had egg 
allergy (98% via DBPCFC) and were matched with 140 controls. Cases 
were evaluated at a mean age of 11 months. Infants with egg allergy 
were significantly more likely to have eczema than controls (76 vs 39%, 
p < 0.001). Cases were significantly more likely to report rhinitis (26 vs 
9%, p < 0.001), to have mould in their home (15.5 vs 6.5%, p = 0.038) 
and to have received any skin cream, lotion or powder (87.2 vs 70.9%, 
p = 0.001); they were less likely to be Caucasian (83 vs 93%, p = 0.027). 
Factors that were independently associated with egg allergy in this 
analysis were current eczema (adjusted OR 24.08, 95% CI 7.41–78.22), 
current rhinitis (2.68, 1.02–7.04), antibiotics in the first week of life 
(7.71, 2.15–27.64) and male gender (2.44, 1.16–5.26). Increasing 
eczema severity was associated with an increasing risk of egg allergy 
and eczema was reported to have started an average (SE) of 3.6 (0.5) 
months before egg allergy was evaluated.
Conclusions: Eczema, rhinitis, antibiotics in the first week of life and 
male gender are the key risk factors for developing egg allergy. The 
onset of eczema is temporarily related to developing egg allergy with 
infants with more severe eczema being more likely to develop egg 
allergy. This provides potential preventative strategies for egg allergy.
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Introduction: The prevalence of the allergologic diseases (AD) is 
increasing, being an important health problem. WHO classifies the AD 
between the first 6 pathologies in the world. These, restrict the daily 
activities of the patient, their life quality and it have a high social and 
economic impact. Also of the correct diagnose and treatment of the 
AD, it’s important to do an adequate record in the patient’s history 
being the mistakes at this level can cause mistakes relates with drug 
prescription and increase the costs.
Methods: The aim is to evaluate the quality of the computerized 
record of the allergies in the medical clinic history by the physicians 
in the health centers of Pamplona, reviewing the clinic history of the 
patients and by random selection, choose 1 patient of 4, between 
15/02/2016 and 14/04/2016.
Results: Have been analyzed 1408 medical histories. Of these, 
275 (19.5%) had no record of allergies. In 1133 (80.4%) it had a spe-
cific record of allergies, 824 (72.7%) without known allergies. In 309 
patients have had recorded allergies and/or secondary effects (Fig. 4).
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In the analysis of the histories with positive data, in 142 (45.9%) it was 
diagnosed with a specific allergy (allergologic report or suggestive 
clinical data) and 167 (54.1%) had diagnosed with secondary known 
effects or they were registered improperly (recorded without any 
documents that support it). In these 167 medical histories, 289 records 
were documented (1.7 average/patient), clinical histories with more 
than one improperly registration, not mandatorily related between 
them. Among the wrong registered records (without documents, side 
known effects or intolerance), 69 (49.6%) were antibiotics, 36 (25.9%) 
NSAIDs, 34 (24.4%) other allergens (Fig. 5).
Given the clinical, social and economical importance it is a signifi-
cant fact that 19.5% of the clinical histories revised there is no sign of 
allergy. In the ones that’s is registered, almost half of them have their 
record incomplete or insufficient, being the most frequent the antibi-
otics and NSAIDs, which condition the prescription and it can lead to a 
rise of the costs, having to use alternative drugs.
Conclusion: The interest of the physicians by allergies it seems is not 
the expected; a proper register of the allergies/intolerances, as well 
as a allergologic diagnose when it is indicated, it is fundamental for a 
good medical practice, quality of the prescription, higher security for 
the patient and decrease the costs.
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Introduction: Sensitization to food allergens in patients with persis-
tent allergic asthma followed in a tertiary clinic center.
Methods: A cross-sectional study was conducted with asthma patients 
in a regular follow-up in a tertiary clinic in São Paulo, Brazil. The study 
included patients older than 18  years with allergic asthma, with or 
without suggestive history of food allergy. Sensitization to aeroaller-
gens, and food allergens was assessed by the skin prick test and/or spe-
cific serum IgE. Food allergens included: milk, egg, wheat, soy, shrimp, 
fish and peanuts. Data was also researched through clinic’s registration 
system, total IgE levels and severity of asthma, according to Gina 2015.
Results: We studied 41 patients with a mean age of 39.5  years and 
73% were women. When assessing the severity of asthma, 39% had 
severe asthma, 39% moderate, and 20% mild asthma. Fourteen per-
cent of the patients had suggestive history of food allergy. The mean 
total serum IgE was 1171.8 IU/mL. Thirty-nine percent of the patients 
had sensitization to some of the tested food allergens. Of these, milk 
and eggs accounted for 25% each, followed by shrimp—20%. Wheat 
and peanuts accounted for 10% each of them, and soy and fish, 5% 
each of them. The group sensitized to food allergens had a higher 
total IgE level (1597  IU/mL), when compared to the group that was 
not sensitized to food allergens (912  IU/mL). It is well established in 
the literature that asthma is associated to different phenotypes, and 
therefore may be associated with varying degrees of treatment diffi-
culties. It has been reported in the literature that food allergy might 
be a risk for complicated or poorly controlled asthma, not only in chil-
dren but in adults as well, and was associated with asthma morbidity, 
including risk of hospitalizations and oral steroid use. Nevertheless, 
the prevalence of food allergy in adults with asthma is still not known. 
This study showed that nearly 40% of the allergic asthmatic patients 
with or without history of food allergy, had sensitization to major food 
allergens. These patients sensitized to food allergens also had higher 
levels of total serum IgE when compared with non-sensitized patients.
Conclusions: Due to the difficulty of control in some cases of asthma, 
different risk factors should be investigated, including food allergy. 
More studies should be performed to research these findings in large 
population. And it would have implications for the management of 
asthmatics, particularly those with severe disease.
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Introduction: Legumes play a major role in the induction of food aller-
gic manifestations. Allergy to red gram has been reported in allergic 
rhinitis as well as BALB/c mice. Information about the atopic derma-
titis (AD) like symptoms induced by red gram is yet to be explored. In 
this study, attempts have been made to elucidate the AD like symp-
toms induced by red gram proteins following intraperitoneal route of 
exposure.
Methods: To establish the correlation between red gram allergy and 
AD, we have studied the coexistence of AD and food allergy in red 
gram allergic patients (n  =  210) and healthy individuals (n  =  10 as 
a control) at the Department of Respiratory Medicine, King George 
Medical University (KGMU), India. Further, BALB/c mice were sensi-
tized with red gram crude protein extract (CPE) via intraperitoneal 
route to explore the red gram induced AD like symptoms. Serum 
levels of specific IgE and IgG1 antibodies were measured by indirect 
ELISA. Anaphylactic signs and symptoms were evaluated 40 min after 
the challenge by two investigators using the scoring. Histopathologi-
cal responses were analyzed in the skin of treated mice. Further, mast 
cell count was performed in the skin. Moreover, expression levels of 
cytokines, transcription factors and filaggrin were studied in the skin 
of treated mice.
Results: To observe the clinical prevalence of AD in red gram sen-
sitized patients, 210 allergic patients were screened. Out of which 
Fig. 4 Total allergies registration
Fig. 5 Total allergies registration
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3.33% patients showed possible symptoms of AD, followed by posi-
tive SPT for red gram allergen. In the Balb/c mice, elevated levels of 
specific IgE and IgG1 in the serum along with symptoms of anaphy-
laxis were found in the treated mice when compared to their respec-
tive controls. Further, histopathological analysis of skin revealed 
characteristics of AD in the treated groups. Significantly enhanced 
numbers of mast cells were observed in the skin of treated mice as 
compared to control. Mixed profiles of GATA-3, T-bet, IL-4 and IL-13 
at the mRNA were found in the skin of treatment groups when com-
pared to their respective controls. Similarly, enhanced expressions of 
GATA-3, T-bet as well as filaggrin were observed at the protein levels 
in the skin of treated mice. We have endeavored to understand the 
allergenic potential of red gram in the context of AD because in our 
previous study, we have observed the health concern related to skin 
in the pigeon pea’s allergic patients. Increased levels of specific IgE 
and IgG1 antibodies were evident in treated group as compared to 
control group; illustrate the allergenic potential of red gram CPE. In 
our study, treated group mice have shown significantly fall in body 
temperature (4–5  °C) as well as symptoms of systemic anaphylaxis 
upon challenge with red gram CPE. Histopathological results showed 
the AD like pathological changes, including epidermal thickening, 
mixed inflammatory cellular infiltration along with hyperplasia indi-
cating that these changes may be evidences for AD. In this study, 
elevated levels of mast cells were found in the skin, suggesting the 
massiveness bearing of red gram specific IgEs bound to mast cell 
receptors. Further, treated skin also over expressed with IL-4 and 
IL-13 and associated transcription factors like GATA-3 and reduced 
expression of T-bet at mRNA level, suggesting that local skin expres-
sion of Th2 cytokines have crucial role in the development of AD. 
Present study showed decreased level of filaggrin in the skin, sup-
porting our finding related to the prevalence of AD induced by red 
gram.
Conclusion: Little is known regarding the association between food 
allergy and atopic dermatitis. In this report, intraperitoneal exposure 
of red gram proteins may lead to symptoms of atopic dermatitis in 
BALB/c mice.
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Introduction: The Atopic Dermatitis caused by nutrition allergy is 
noticed in most of children till one year and from the etiological 
spectrum a nutritious sensitization frequently is caused by cow’s milk 
protein.
Our aim was the evaluation of clinical effectiveness of specialized, 
hydrolyzed cow’s milk albumin in children of early age diseased by 
atopic Dermatitis (AD).
Methods: There were under observation 20 children from 30 day up 
to one year, with AD. The including criteria were age, artificial feeding 
and existence of AD. The excluding criteria were: an individual intol-
erance of formula and mother’s refusal. The basis of diagnostics was 
a diagnostic algorithm of AD by Hanifin and Rajka [1]. A heaviness of 
AD is evaluated by means of standard criteria according to universally 
recognized SCORAD system.
Results: 16 children—first group with mild form of AD, in which 
SCORAD index amounted to 35.5–65.5 score,14 one-second group 
with moderate form-SCORAD index was 65.5–78.5 score. In 52% of 
observed children has been diagnosed IgE-depended allergy, in 
20%—an increase of specific IgG4 antibodies level towards cow’s milk 
albumin, but in 28% a mixed variant. Hence is follows, that for the 
purpose of diet-therapy, the children with AD have been taking spe-
cialized hypo-allergic formulas, which is made on basis of hydrolyzed 
cow’s milk protein. The medicinal effectiveness of formula has been 
evaluated according to SCORAD index.
The results of research show, that in both groups have been noted a 
decreased of subjective showings in particular of itch and sleep dis-
order. In children who taking a hypo-allergic formula, are noted a 
good indicator of body’s weight and surplus of length, which points 
in favour of good endurance of formula. In 82% of diseased after 
1–3  weeks from the beginning of diet-therapy, is noted a clinical 
improvements-decreased of skin’s inflammatory process has been 
proved according to subjective (itch, insomnia) and objective (ery-
thema, dryness, humidity, excoriation) showings, which are fairly 
shown under SCORAD index.
Conclusion: A convincing and reliable results of a conducted research 
give a opportunity to make a conclusion, that to use a formula of diet-
therapy in children with AD is expedient in specialized arsenal of chil-
dren’s nutrition.
Reference
1. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm 
Venereol Suppl (Stockh) 1980;92:44–7.
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Introduction: The aim of this study is to evaluate the degradation over 
time of B Cell Activating Factor (BAFF) and Platelet-Activating Factor 
(PAF) in collected dried blood, evaluating the differences between two 
kinds of sample collectors: Whatman 903 Neonatal card (CARD) and 
Copan Nylon Swab (SWAB).
Methods: A dried blood spot is a common, moderately-invasive 
method for collecting patient blood from finger pricks. The blood 
samples are collected from 18 individuals. The collection of the sam-
ples is carried out in triplicate for both devices. Samples were stored 
at room temperature in the dark until serum extraction and analy-
sis. Samples are assayed by Enzyme-Linked Immuno-Sorbent-Assay 
(ELISA) for BAFF (R&D Systems) and PAF (Elabscience). Serum extrac-
tion and ELISA assay were carried out 2 days (T2), 7 days (T7), 14 days 
(T14), 21  days (T21) and 28  days (T28) after collection. Results were 
presented as mean ± SEM.
Results: PAF values were stable over the time up to 21  days both 
for CARD and SWAB. At 28  days there was a reduction of up to 
54.3 ± 6.76% for SWAB and up to 36.6 ± 5.5% for CARD (p < 0.001). 
As regards BAFF, values were stable until T21 while at T28 there was 
a decrease of up to 77.1 ± 6.3% for SWAB and up to 63.7 ± 4.5% for 
CARD (p < 0.001). According to Finkelman, there is a pathway of acti-
vation of immune system mediated by IgG, FcγRs, macrophages, and 
PAF. BAFF is a member of the tumor necrosis factor superfamily and 
an important regulator of peripheral B cell survival, maturation and 
immunoglobulin class-switch recombination. Many studies suggest 
that BAFF might modulate immune inflammation and could probably 
be one of the cornerstones of this IgG pathway of immune reaction. 
BAFF and PAF have both already been linked in non-atopic subjects 
to food reactions, supporting the possibility that these inflammatory 
molecules could be involved in non-IgE-mediated allergic reactions.
Conclusion: The data presented in this study should be considered for 
both clinical and research applications. The higher degradation of PAF 
compared to BAFF could be attributed to the different chemical nature 
of these two inflammatory molecules, lipid and protein respectively. 
The degradation over time of BAFF and PAF also depends on the type 
of technological support used for the collection of the specimen. Sam-
ples should be analysed as soon as possible and no later than 21 days 
from the time of collection to ensure greater stability of the values.
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Introduction: Literature reviews showed that FA clinical manifesta-
tions on the skin of various degrees of severity related to foods inges-
tion can arise as a result of a number of disorders and only some of 
which can be defined as allergic.
The aim of the research was to identify diagnostic approaches to the 
differentiating food allergies from food intolerances in children.
Methods: Skin elements were identified in complex with anamnesis 
data and results of the laboratory data. Hypersensitivity to food was 
detected by the skin tests (patch and prick), levels of the specific IgE 
and/or oral challenge test. Gut permeability was identified with 6-h 
lactulose urinary excretion.
Results: 56 patients (age 1–36  months old) with food allergy with 
typical allergic symptoms related to food intake were included into 
the study in the outpatient department. Major part of the parents 
(67%) couldn’t clearly identify the causative product. Only 15 chil-
dren (26%) had positive specific IgE to milk and/or egg. Skin tests 
were positive in 10 of the patients (17.8%). Oral challenge test with 
milk and/or egg was positive only in 7 children (12.5%). Skin lesions 
vary from urticaria to papulation. Commonly non-immune reactions 
were nonspecific, not itching and not intense. Nevertheless of the 
type of the food intolerance mechanism skin dryness was presented 
in the major part of the patients. Moreover lactulose was detected in 
urine in 76.7% of cases both in group with immune and nonimmune 
reactions. There was no association of the lactulose level with type of 
the skin lesions. But intestinal permeability correlated with skin dry-
ness (p < 0.05).
Conclusion: The study revealed that gut permeability in children with 
skin manifestations of food allergy often overlapping with symptoms 
found in nonimmune disorders such as disorders of absorption. Skin 
dryness can be its’ phenotypical marker. Gut permeability is the pur-
pose for additional dietary corrections in children with FA.
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Introduction: The aim of this study is to validate food hypersensitiv-
ity (FH) phenotypes in the survey using data of the 6-year examination 
and allergic sensitization assessment at 1, 3, and 6 years.
Methods: 196 children with FH symptoms diagnosed on the 1st and 
2nd year of life were recruited in the outpatient department and com-
pleted 6-year follow-up. Skin prick testing and specific IgE detection 
was performed at 1, 3 and 6 years (n = 98, 53, 24, respectively). Using 
questionnaire and clinical examination and laboratory data at 6  m, 
12 m, 2, 3 and 6 years we classified children into FH phenotypes: tran-
sient early, persistent, late-onset.
Results: It was found that non-immune FH mechanisms were commonly 
seen in patients with late-onset and persistent phenotype (p  <  0.05). 
Children with transient FH symptoms both were as allergic, as non-
allergic. Early onset phenotype patients more often had clear association 
with causative product and in almost ¾ developed food tolerance.
Conclusion: Immune FH more often manifests during first year of life. 
Late onset, especially after 2 y.o. as usual associated with food intoler-
ance reactions, particularly if clear cause of the reactions is not seen.
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Introduction: The aim of this study is to evaluate the percentage 
change of the diagnostic-therapeutic choice in complex polysensi-
tized patients affected by food allergy, after using CRD compared to 
a first level survey (medical history and skin tests), along with an eco-
nomic analysis of the patient’s overall management according to the 
two different approaches (assessment of higher costs and savings).
Methods: In this multicenter study in real life, 187 patients polysensi-
tized to skin tests and with clinical symptoms related to an IgE medi-
ated food allergy were recruited. Each patient was submitted to skin 
prick tests (SPT) with a standard panel of food allergens and to a blood 
sample in order to detect specific IgE against food recombinant mol-
ecules (CRD), which were chosen according to medical history and 
positivity to SPT, by ImmunoCAP method (Thermo Fisher Scientific®, 
Uppsala, Sweden) or, when not available, by Microarray ISAC 112 aller-
gens system (Thermo Fisher Scientific®, Uppsala, Sweden). Then the 
first diagnostic-therapeutic hypothesis, based only on medical his-
tory and skin tests, was recorded for each patient and, after that, the 
second diagnostic-therapeutic choice (final) was made, the one which 
would be implemented considering the CRD outcome. Therefore, an 
evaluation of the change of the diagnostic-therapeutic choice was 
carried out, in percentage, between the first hypothesis and the final 
choice, analyzing statistically the results by the agreement coefficient 
(k index) and the Chi square test. Finally, a detailed analysis was con-
ducted on the economic impact of a molecular approach to the overall 
management of the allergic patient in order to evaluate whether the 
increase in the diagnostic costs would be compensated and eventually 
exceeded by savings coming from the increasing diagnostic-therapeu-
tic appropriateness.
Results: A change in the prescription of self-injected adrenaline has 
been observed in about 50% of patients (k index 0.56) and an overall 
saving of financial resources along with a higher diagnostic-therapeu-
tic appropriateness has been pointed out too.
Conclusion: In this study there is only moderate agreement concern-
ing prescription of self-injected adrenaline before and after perform-
ing CRD: as a result, it is highlighted the usefulness of CRD, at least 
in complex polysensitized patients, in indicating risk assessment and 
therefore the correct therapy of food allergy, thus resulting in a cost-
saving approach.
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Introduction: A dried blood spot is a common, moderately-invasive 
method for collecting patient blood from finger pricks. The aim of this 
Page 33 of 79 Clin Transl Allergy 2017, 7(Suppl 1):10
study is to evaluate the long-term stability in the collection and detec-
tion of food-specific IgG antibodies comparing two different kinds of 
sample collectors: Whatman Neonatal card 903 (CARD) and Copan 
Nylon Swab (SWAB). The blood samples are tested by IgG Enzyme-
Linked Immuno-Sorbent-Assay (ELISA) for precision and accuracy.
Methods: The blood samples are collected from 18 individuals (10 
females and 8 males). The collection of samples is carried out in triplicate 
for both devices. Serum samples are assayed for food-specific IgG. The 
specific IgG antibody responses are analyzed on a customized ELISA plate 
(Immunolab GmbH) wich detects total IgG for 33 food antigens in serum. 
Samples were stored at room temperature in the dark. Serum extractions 
and ELISA assays were carried out after 2 days (T2), 7 days (T7), 14 days 
(T14), 21  days (T21) and 28  days (T28). Since the Kolmogorov–Smirnov 
normality test revealed non-normal distribution of the parameters, results 
were presented as median and interquartile range (IQR).
Results: Over time, analyses show progressively smaller results both 
as regards the CARD and the SWAB (p  <  0.001). While between T2 and 
T7 there were no statistically significant changes, in T14 there was a sig-
nificant reduction of −17% (−0.45 to +0.03) to the initial value that is 
maintained up to T21. Between T21 and T28, there were no statistically 
significant differences regarding CARD, while for SWAB there was a fur-
ther reduction of values of up to −29% (−0.46 to −0.08). As discussed 
by Ligaarden, the concentration of specific IgG for food reflects the use 
of that food in the diet. In addition, Finkelman showed a IgG-dependent 
mechanism of anaphylaxis which involves IgG, FcγRs on macrophages, 
basophils and neutrophils, complement-derived peptides C3a e C5a, B cell 
Activating Factor (BAFF) and Platelet Activating Factor (PAF). For a more 
accurate study of the possible interaction between these mechanisms 
associated with IgG, it is important to know precisely the advantages and 
disadvantages of the most used methods in this area of investigation.
Conclusion: Considering the deterioration of biological samples over 
time it is important that the dosage of food IgG antibodies in dried 
blood is carried out as quickly as possible and in any event within 
21 days of collection.
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Introduction: The gluten intolerance is associated with celiac disease 
and Allergy to gluten, the criteria for the differential diagnosis of which 
is still insufficiently developed.
The aim of this study is the development of a diagnostic algorithm for 
gluten intolerance in children for the purpose of adequate diet ther-
apy application to prevent development of complications and severe 
forms of the disease.
Methods: Under supervision there were 42 children with chronic diar-
rhea and symptoms of impaired intestinal absorption. The diagnos-
tic algorithm consisted of the following stages. The first stage—the 
detection of the risk groups for gluten enteropathy. These include: (1) 
immediate relatives of patients with celiac disease; (2) close relatives 
with allergic diseases; (3) children with gastrointestinal symptoms 
resistant to standard therapy; (4) children, lagging in physical devel-
opment and with symptoms of impaired intestinal absorption; (5) 
patients with dermatitis herpetiformis and diseases that can be asso-
ciated with celiac disease. At the second stage children included in 
the risk group were subjected to screening diagnostics. We used the 
BIOCARD TM Celiac Test (Finland), which allows to determine antibod-
ies to tissue transglutaminase (IgA). Patients with a confirmed diag-
nosis of celiac disease and positive (BIOCARD TM Celiac Test) test was 
not included in further examination. The third stage of gluten intoler-
ance diagnostics was in-depth examination of children with gastroin-
testinal and skin manifestations of Allergy, including anamnesis and 
clinical symptoms, determination of total IgE, IgG, IgA, IgM and spe-
cific IgG and IgE antibodies in the blood serum.
Results: Three groups of patients were identified. The first group con-
sisted of 23 children with positive allergen-specific IgE antibodies to 
gluten and wheat and to cow’s milk protein in serum. In 10 children 
from the second group IgE and IgG antibodies to gluten and wheat 
serum were identified at the same time. They had gastrointestinal 
symptoms within a few hours after eating a certain amount of foods 
containing gluten (individual for each child). The third group of 
patients included 9 children with IgG antibodies to gluten and wheat 
serum. Clinically they mainly had skin rashes.
Conclusion: The staged diagnostic algorithm for gluten intolerance in 
children allows to determine the mechanism of gluten intolerance and 
to prescribe required elimination diet and treatment aimed at preven-
tion of serious complications.
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Introduction: Plant food allergy diagnosis is challenging due to the 
different implicated foods, clinical manifestations and geographic 
diversity. We aimed to assess the diagnostic accuracy of single food 
allergenic proteins combined with plant and food skin prick test 
extracts (SPT) to evaluate plant food allergy.
Methods: This is a cross-sectional retrospective study. All SPT per-
formed in an allergy department of Porto, Portugal from 09/2014 to 
12/2015 (n = 3141 patients) were included and those evaluating sen-
sitization with extracts to fresh fruits (soy, watermelon, banana, apple, 
peach, kiwi, avocado, fig), nuts (walnut, hazelnut, almond, pinenut, pea-
nut and chestnut), lipid transfer proteins (LTP), profilin and latex were 
selected (n =  189 patients). Clinical and demographic data, sIgE, SPT 
with fresh foods, and open food challenges (OFC) results were reviewed 
from patients records. Plant food allergy syndromes were identified 
and the accuracy of the skin tests were calculated using medical diag-
nosis as the gold standard. Continuous data are presented as median 
and interquartile range and categorical as n(%). Mann-whitney and Chi 
square were used to compare differences between groups.
Results: Of all the tests, 89(48%) were performed due to plant food 
allergy suspicion and in 58(65%) diagnosis was confirmed: profilin medi-
ated allergy (n = 17); LTP allergy syndrome (n = 20); both profilin and LTP 
(n = 2); birch-plant food syndrome (n = 4), latex-fruit (n = 4); and to spe-
cific foods (peanut n = 3; walnut n = 1; banana n = 1; kiwi n = 4; wheat 
n = 1; blackberry n = 1). Most were women 41(71%), with a median age 
of 22 [18;32] years, 43(74%) had rhinitis and 15(26%) asthma. Oral allergy 
symptoms (OAS) were the most common complaint 27(47%), followed by 
anaphylaxis 15(26%) and urticaria/angioedema 14(24%). LTP mediated 
syndrome had more anaphylaxis and a lower number of OAS compared 
with profilin mediated syndrome (10 vs 1, p = 0.003; 3 vs 14, p < 0.001). 
The sensitivity and specificity of using combined SPT extracts was 83.0 CI 
95% [69.7;91.5] and 95.7[76.0;99.8], respectively. Using only LTP and profilin 
improved specificity 100.0[82.2;100.0] but not sensitivity 71.7[57.4;82.8].
Conclusion: LTP and profilin plant food mediated allergy syndrome 
were the most frequently encountered in our population. LTP sensi-
tization was associated with more severe reactions. SPT with extracts 
including LTP and profilin were useful as a first line diagnostic tool to 
identify plant food allergy syndromes.
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Introduction: In Phase II/III clinical development, the Double Blind Pla-
cebo Controlled Food Challenge (DBPCFC) is the generally accepted 
primary measure to evaluate the effectivity of immunotherapy with 
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relevant food allergens. The DBPCFC is a challenge procedure with 
increasing doses of food allergen to determine the reactivity and 
threshold dose to food a specific food allergen and serves as the gold 
standard to confirm diagnosis of food allergy. HAL Allergy is devel-
oping a chemically modified peanut allergen preparation for immu-
notherapy and requires a standardised, pharmaceutical-grade oral 
challenge test to determine efficacy during clinical development.
Methods: A systematic literature search was performed to grade (scale 
0–11) the relevance and quality of food challenge tests being pub-
lished to define a standardised food challenge protocol, an adequate 
methodology for standardised DBFPCFC. Grading was performed 
independently by two viewers.
Results: Peanut material should be roasted and ground into a powder. 
The allergens will be administered to the patient in a matrix. Matrices 
(such as vanilla, cinnamon and cocoa) need to be capable of blinding the 
sensory properties of the food in a small volume compatible with use in 
the target patient group. Hypoallergenic pudding, applesauce or oatmeal 
are very suitable vehicles. The amount of incremental steps in a DBPCFC, 
with a dosing interval of preferably 20  min, should not exceed 10 dos-
ages. For our peanut immunotherapy clinical studies, a dosing schedule 
ranging from 0.1–300 mg is proposed for the DBPCFC before treatment 
and from 1 to 3000  mg (or possibly 6000  mg) of peanut protein post-
treatment. Placebo and active should be administered on separate days 
in random order, with at least 48 h between challenges. DBPCFCs need 
standardisation regarding the interpretation of objective and subjective 
symptoms. Standard criteria to define a positive challenge outcome do 
not exist and the variability in symptom assessment is relatively high.
Conclusions: The literature search has resulted in recommendations 
for the design of the food challenge protocol to be used in our pea-
nut immunotherapy in upcoming Phase II/III clinical studies, especially 
with regards to dosing schedules, matrix, physical and psychological 
health, contraindications and other logistic considerations. Further 
research is needed to standardize signs and symptoms to define a 
positive food challenge.
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Introduction: DBPCFC (Double Blind Placebo Controlled Food Chal-
lenge) is considered the golden standard for investigation of food 
hypersensitivity especially if allergy tests are negative and the patient 
history is vague. Many recipes used for this purpose includes elimi-
nation diet products and /or are not validated in adult subjects with 
regard to taste, volume and blinding procedure.
Our aim was to develop an allergen adapted and blinded recipe for 
wheat protein for DBPCFC use in adult patients, using ordinary staple 
foods. Another aim was to evaluate the recipes with regard to taste 
and acceptance.
Methods: The study consisted of three parts:
1. Development of recipe
For the development of recipes, several food items were tested in 
different amounts to mimic a smoothie drink. Standard heat treated 
wheat flour was used as a base for the food challenge. Rice-, coconut-, 
oat- or soydrinks were tested as base flavoured with either fruit purées, 
cacao or vanilla, both for active and placebo drink development.
2. Acceptance test
An acceptance test was performed in a small group of eight students 
and employees at Gothenburg University, during a strict setting. All 
subjects filled in taste and acceptance evaluation using a 9- grade 
hedonic scale.
3. Triangle test
Triangle test took place in a separate setting. Thirty-eight adults (non 
smokers and non allergic) took part in the test. The test was performed 
following standard proceedings. The critical value for a statistical dif-
ference (n = 38): 19 correct answers; p = 0.05).
Results: Development of recipe: a recipe using coconut milk, wheat 
flour or gluten free mix, milk free chocolate powder, vanilla flavoring 
was considered usable for further testing and evaluation. The chal-
lenge drink contains 220 kcal and measures around 270 ml in portion 
size, comparable to a commercial smoothie drink.
Acceptance test: Both taste and volume got acceptable results in the 
test. The mean value for taste was 5.6 out of 9 and for acceptable vol-
ume 7.9 out of 9. Triangle test: Out of 38 subjects, 16 pointed out the 
odd sample in the test i.e. p  <  0.05 and the challenge drink and the 
control drink were thus not possible to identify in a blinded test.
Conclusions: This study has shown that it is possible to develop a 
blinded recipe for use of DBPCFC using an “adult portion” of wheat 
protein. The recipe has acceptable portion size, few ingredients, con-
tains ordinary staple foods and has low cost. Further recipes for other 
allergenic foods will be developed using the same model.
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Introduction: The aim of this study was to explore the epidemiologi-
cal characteristics and sensitization patterns in children with pollen 
food syndrome (PFS) at a specialist allergy clinic in Mexico City.
Methods: We enrolled in this study every patient aged between 6 
and 18 years reviewed at the Pediatric National Institute Allergy clinic 
between March 2015 and March 2016. Diagnosis of PFS was made 
according to PFS diagnostic questionnaire and algorithm by Skypala 
et al. Skin prick testing (SPT) to pollens and prick by prick testing (PPT) 
to fresh foods were performed in a subset of patients with PFS. Those 
negative to PPT, underwent open oral food challenge (OFC).
Results: Within the studied population prevalence of PFS was 5.4%. 
Their average age was 10+/−3, 60% between 6 and 10  years, 35% 
from 11 to 14 years and only 5% between 15 and 18 years; 45% were 
women and 55% men. Apple (55%), peach (50%) and banana (50%), 
were the foods most commonly implicated. Rosaceae family was 
responsible in 75% of the cases, followed by Musaceae with 50%, Lau-
raceae with 45% and Cucurbitaceae and Fabaceae with 40%. All but 
one patient had allergic rhinitis, 50% had asthma, 35% atopic derma-
titis, 25% had all three and 10% had other type of food allergy. In the 
subset of patients with PPT to fresh foods, 90% had a positive result 
and 10% had a negative one, these patients underwent open OFC 
which turned out positive. Sensitization to Quercus robur and Alnus 
glutinosa were the most frequents (40%), followed by Fraxinus excelsior 
(35%) and Betula verrucosa (30%). There is little knowledge about FPS 
in Mexico and there are no previous studies in pediatric population. 
We found that FPS affects males and females equally, being more fre-
quent between 6–10 years. When compared with international litera-
ture, the prevalence is similar and we also found apple and peach as 
the most frequent foods implicated. Although, we also found banana 
as a frequent food responsible for FPS, similar to what is reported in 
the Mexican study performed in adults. Contrary to studies performed 
worldwide, we found birch sensitization in only 30% in FPS, being 
more frequent other Alnus glutinosa and Quercus robur.
Conclusions: It appears to be a significant difference in sensitization pat-
terns to aeroallergens in Mexican pediatric population with FPS. Foods 
implicated seem to be similar to national and international reports. More 
studies are required to known the real characteristics of FPS in Mexico.
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Introduction: The association between food allergy and celiac disease 
(CD) and Non celiac Gluten sensitivity (NCGS) is still to be clarified. 
Gluten-related disorders have gradually emerged as an epidemio-
logically relevant phenomenon with a global prevalence that is esti-
mated around 5%, drawing the attention of the scientific community. 
Epidemiological studies estimate a worldwide prevalence of CD of 
approximately 1:100 individuals, with a considerable proportion of 
patients remaining undiagnosed and untreated. According to a study 
performed by the National Health and Nutrition Examination Survey 
in the United States, the prevalence of self-prescribed GFD in an unse-
lected population of subjects aged 6 years or older was 0.5%. Epide-
miological studies report a prevalence of WA in American population 
of around 0.4% untill 0.6%. The diagnosis of WA is classically based on 
skin prick tests (SPT), in vitro specific Immunoglobulin E (sIgE) assays 
and functional assays. SPTs and sIgE in  vitro assays are the first-level 
diagnostics for WA. However, they are affected by a low predictive 
value. In particular, their low sensitivity can be explained by the fact 
that the commercial test reagents are mixtures of water/salt-soluble 
wheat proteins that lack allergens from the insoluble gluten fraction.
Case report: In our unit of celiac disease and related conditions to 
gluten we visited in one year about 400 patients. Of these 113 they 
were not celiac but were investigated for suspected non-celiac glu-
ten sensitivity. After in  vitro tests for the exclusion of celiac disease, 
the same patients underwent allergologic workup consists of: skin 
prick tests for foods including wheat (Alk-abello), LTP (lipid transfer 
protein) (peach Alk abello), alpha amylase, wheat flour, barley, corn, 
rice, grass pollen and histamine. Also all they performed patch tests 
for suspected allergy to nickel, if they reported reactions after a few 
hours of ingestion of gluten. Molecular-based allergy (MA) diagnostics 
could overcome some limitations of sIgE in  vitro assays using wheat 
flour extracts. We have used omega-5 gliadin (Tri a 19) and nsLTP (Tri 
a 14), gliadin, wheat, gluten that are available in the ImmunoCAP™ 
assay, whereas the alpha-amylase/trypsin inhibitor (Tri a aA/TI) is avail-
able only in the microarray ISAC™ assay. The sIgE to omega-5 gliadin 
assay is highly reliable and now widely used to identify the patients 
with WDEIA.
Conclusion: Of a total of 104 patients with a history of immediate 
reactions and not immediate after ingesting gluten, we found wheat 
protein sensitization in 14 patients (13%). In addition of 300 celiac 
patients we also found 5 patients with allergy to wheat or wheat pro-
tein (1.5%) different percentage than that reported in the literature.
Consent to publish: Authors confirm that the individual(s) described 
have authorized them to publish the findings related with these cases.
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Introduction: The prevalence of food allergy (FA) is increasing and 
many factors may contribute to these results. The aim of this study was 
to perform a clinical examination of patients with FA in Brazil.
Methods: Cross-sectional study applying a written questionnaire 
(WQ) to parents of children presenting with food allergy in ten Pediat-
ric Allergy Centers in Brazil.
Results: We evaluated 120 WQ from children aged 1–18  years-old. 
Median age for onset of symptoms was 7.8 months and 56.5 months 
by the time of WQ performance. The most frequently referred foods 
were: cow’s milk (86%), egg (32%), wheat (4.1%), soybean (3.3%), 
peanuts (2.5%) and seafood (2.5%). Allergies to a single food were 
observed in 71.6% and 28.3% described multiple food allergies. 
The most prevalent symptoms were urticaria (44%), atopic dermati-
tis (AD) (29%), anaphylaxis (22.5%), eosinophilic esophagitis (2.5%) 
and wheezing (1.7%). The severity of food allergy was mild in 33.3%, 
moderate in 29.1% and severe in 37.5%; 17.5% were hospitalized 
due to food allergy. Food restriction was applied in 100% of patients. 
Regarding to other allergies, 47.5% of patients referred asthma/rhi-
nitis associated. Skin prick test was performed in 37.5% of children, 
with positive results in 88.8%. Oral food challenge was performed on 
36% and 70% failed the test. Patients with AD performed the Scoring 
Atopic Dermatitis (SCORAD), averaging 40. Risk factors significantly 
associated with severe food allergy were family history of rhinitis 
(OR =  4.1; 95%  CI =  1.41–4.5), asthma (OR =  2.5; 95%  CI =  1.5–3.7) 
and smoking (OR = 1.4; 95% = = 1.1–2.0). In this sample, the symp-
toms began in the first year of life in congruence with most studies. 
The most reported food was cow’s milk and egg, as well as reported in 
the literature, especially in children. Despite the WQ had been applied 
to patients up to 18 years, the mean age of them was 4 years old. The 
major limitation of this study was that the WQ was completed in spe-
cialized services with more severe patients.
Conclusions: Due to the increasing prevalence of FA, knowledge 
about food-related allergies, diagnostic tests and possible risk factors 
in specific population are important keys to create strategies for pre-
vention and possible treatment options beyond food exclusion.
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Introduction: Oral allergy syndrome (OAS) is a clinical expression of 
food allergy mainly caused by foods of plant origin. The culprit aller-
gens are cross-reacting proteins, like profilin, that are also present in 
pollen, triggering allergic respiratory symptoms. The aim of our study 
was to detect the foods of plant origin that are referred as responsible 
for OAS in Greek adults.
Methods: 264 atopic adult patients, with allergic respiratory symp-
toms and/or food allergy were interviewed in our study. A complete 
record of their atopic medical history was obtained; symptoms of 
allergic rhinitis, asthma and signs of atopic dermatitis, as well as their 
family history of atopy. Information regarding any symptoms of food 
allergy and the type of reaction (OAS or systemic reaction) were col-
lected. The foods that patients considered responsible were registered.
Results: 79/264 of our atopic patients (30%) referred symptoms of 
OAS, while 50/264 patients (18.9%) had experienced systemic reac-
tions. Foods of plant origin implicated in OAS symptoms were: peach; 
23/79 (29%), walnut; 21/79 2(6.5%), kiwi; 17/79 (21.5%), banana; 14/79 
(17.7%), hazelnut; 9/79 (11,4%), peanut; 8/79 (10%), eggplant/apricot; 
7/79 (8.8%), melon; 6/79 (7.5%), strawberry/almond/cherry; 5/79 (6%), 
cabbage/tomato/watermelon/apple/pineapple/grape/orange/pista-
chio/spinach; <5/79 (3–5%). Finally, less common foods, each referred 
only once by our patients, were: sesame/sunflower seed/pear/cashew 
nut/brazil nut/lemon/cucumber/bell pepper/mustard/chestnut/fig/
mango/papaya/plum/onion/lentil/peas. Our results in Greek adults 
show some similarities but also some diversities in comparison with 
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the relative ones from other Mediterranean countries. Similarities are 
found between Greek and Spanish populations, which refer fruits of 
the Rosaceae family as the most common cause of OAS, followed by 
kiwi, peach alone, melon and banana. On the contrary, Italian studies 
mention melon as the most common culprit food, followed by water-
melon, tomato, banana and pineapple.
Conclusions: Peach, walnut, kiwi, banana and hazelnut are the top 5 
foods referred as responsible for OAS in Greece.
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Introduction: To investigate the prevalence of food allergies and to 
identify the most common causes of the allergies in the population of 
preschool children from the city of Batumi.
Methods: The study was conducted with children population, in 
Batumi. The random sampling was applied in the study to ensure 
representative sample and the cross section method of epidemio-
logical survey was used. At the first stage of the survey 840 children 
aged from 6  months to 7  years, were questioned. Data were col-
lected through the face-to-face and phone interviews. At the sec-
ond stage of the survey, the subjects of study were the part of the 
population, who revealed the clinical signs of food allergy for the last 
12 months. The causal factors were revealed on the basis of answers 
to the questionnaire, anamnesis data, specific IgE measurements 
and skin prick tests. The risk factors were studied on the basis of case 
control studies.
Results: Skin manifestation (76%) of food allergy was significantly 
(p < 0.05) higher than the rate of gastrointestinal symptoms (24%) in 
the studied population. The most common causes of food allergies 
in the study population were different food addi-tives (29.2%), fish 
(22.6%), eggs (22.3%), milk (18.6%), honey (13.7%;) and nut (4.3%). 
Such factors as inheritance from mother (OR 13.69; 95% CI 7.08–27.04), 
excess weight of newborn (OR 1.08; 95% CI 0.30–3.82) and bottle feed-
ing (OR 5.29; 95% CI 3.30–8.51) are associated with higher risks of food 
allergies. IgE mediated reactions to the food allergens were identified 
in 98% of the patients. The prevalence of parentally reported allergy 
was 15.8%, while proven allergy cases were 6.1% positive on the basis 
of IgE/STP. Thus, the allergy presence is significantly overestimated by 
parent (p  <  0.01). This problem can be explained by lack of informa-
tion and education about food allergy in parents. Allergy to nut is sig-
nificantly higher in children between 3 and 5 years than in children of 
younger age, while allergy to milk and eggs was same in all ages.
Conclusions: In the childhood, allergic skin manifestation of food 
allergy is high. According to the data on obtained in the study, man-
agement of the risk factors as well as education of parents and car-
egivers play significant role in the focused and effective prevention of 
disease.
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Introduction: Oral food challenges (OFC) are the gold standard for the 
diagnosis of food allergy. They are also the method of choice to assess 
the resolution of food allergies. In clinical practice, most centres use 
open OFC for diagnostic purposes. OFC’s are logistically demanding 
and not without risk. It has therefore been suggested that between 
30–40% of OFC’s should result in a positive challenge; of these posi-
tive reactions only a few should result in anaphylaxis requiring treat-
ment with adrenaline. The aim of this study was to study in detail the 
clinical characteristics of anaphylaxis and time after first exposure to 
first symptoms in comparison with allergic background of the child.
Methods: A chart review study of 3979 patients undergoing the food 
challenge was conducted at tertiary Allergy Centre. We identified 
all patients for whom adrenaline was administered for food-induced 
anaphylaxis between 2008 and 2016 year and analyzed demographic 
characteristics such as age, gender, type of food given in the chal-
lenge, time after first exposure to first symptoms, treatment required, 
skin prick test, specific lgE and allergic co-morbidities.
Results: 32 patients had anaphylaxis for which adrenaline administra-
tion was required. Of the patients who developed these severe symp-
toms, 22 (68.75%) males and 10 (31.25%) females, median age was 
4.9 years. Six (18.75%) of these reactions occurred to cow’s milk of which 
4 (66,6%) were to baked milk and 2 (33,4%) to fresh milk. Ten (31.25%) 
children reaction to nuts, 1 (3.13%) to soya, 3 (9.38%) to egg, 4 (12.5%) 
to sesame, 4 (12.5%) children to wheat. Children, who were allergic to 
nuts reacted sooner after exposure than that recorded for other foods. 
The most common co-morbidities were other food allergies in 23 cases 
(71.9%), 17 (53.2%) with eczema, 10 (31.3%) with asthma, 7 (21.9%) 
with allergic rhinitis.Of those children for whom adrenaline was admin-
istered, five required repeat adrenaline administration.
Conclusions: This audit reveals that anaphylaxis during OFC’s in a 
bust tertiary Allergy Centre seldom results in the need for adrenaline 
administration for the treatment of allergic reactions. However, all 
foods are capable of producing anaphylaxis in this setting of which 
milk was the commonest cause. Reactions can occur soon after aller-
gen exposure, especially when the challenge is undertaken to nuts. It 
is difficult to predict who is most at risk for severe allergic reactions; 
all children in this audit had allergic co-morbidities and food allergy 
was the most frequent one. Children who have both asthma and a 
food allergy are at greater risk for anaphylaxis. Severe reactions requir-
ing treatment with adrenaline was common, but few children required 
multiple doses of adrenaline. OFC’s, which serve as the gold standard 
diagnostic modality are generally safe but severe reactions do rarely 
occur for which adrenaline treatment is required.
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Introduction: Tree nut and peanut allergy are responsible for a large 
number of severe IgE-mediated reactions. Almond is widely used in 
manufactured and homemade sweets or as a snack, while peanuts, 
alone or in other products are increasingly consumed in the Greek 
diet.
We aimed to assess sensitization and reactivity patterns to peanut and 
almond in children with a reported immediate reaction after consum-
ing nuts or peanuts (cashew, pistachio, walnut, hazelnut, peanut and 
almond).
Methods: We retrospectively studied data on sensitization patterns 
by means of skin prick tests (SPTs) and specific (s) IgE in children with 
symptoms suggestive of IgE mediated allergic reaction following con-
sumption of tree nuts or peanut, confirmed by positive IgEs and/or 
SPTs, visiting our Unit between 2012 and 2015.
Results: 204 children were included, 136 males, mean aged 
8.2 ± 3.2 years, in whom 264 reactions were recorded. The most com-
mon provocative agent was pistachio (24.9%) and cashew (24.5%), 
while hazelnut and walnut were associated with 16.1% and 15.4% 
of the reactions respectively. Almond was the least reported (2.7%, 
n = 7), followed by peanut (13.6%, n = 36). Among the 7 patients with 
a reported reaction to almond sIgE was 27.4 kU/L (SE = 12.31), while 
SPT max diameter was 5 mm [3.22, 6.77]. 93 of the sensitized children 
to almond (with no reported reaction), had sIgE of 2.6  kU/L [1.75, 
3.45], while SPT max diameter was 5.16  mm [4.68, 5.64]. Open food 
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challenges (OFCs) in this population were negative. 36 children with 
a reported peanut reaction, had sIgE to peanut 45.93  kU/L, 95% CI 
[31.75, 65.11] and SPT and max diameter was 10.8 mm [9.12, 12.49]. 53 
of the sensitized children to peanut (with no reported reaction), had 
sIgE of 2.32 kU/L [1.57, 3.07] while SPT max diameter was 4.6 mm [3.96, 
5.25]. Open food challenges (OFCs) in this population were negative. 
To notice, a large proportion (50%, n = 102) of our study population 
was sensitized to almond; although small number reported reaction. 
Regarding peanut, 48.5% (n =  99) of the total population were sen-
sitized with slightly more than one third of that group (36.7% of the 
peanut sensitized children) reporting immediate type of reaction.
Conclusions: Almond and peanut have a considerably high sensitiza-
tion rate among children visiting our Unit with reaction to nuts, how-
ever true reactors were only few. Peanut reactions are less frequent 
than these to tree nuts, however cannot be overlooked.
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Introduction: The aim of the study was an attempt to assess the fre-
quency of the use of probiotics in the group of subjects in the light of 
the Epidemiology of Allergic Diseases in Poland project.
Methods: The study group consisted of 4.783 subjects aged 6–7 years, 
13–14  years and adults (20–44  years) from the eight largest Polish 
urban centres. The method that was used was the ECRHS II and ISSAC 
survey questionnaire as well as additional studies including those con-
cerned with the problems related to the range of probiotics’ uses.
Results: The probiotics used were very popular in the group of sub-
jects with diagnosed allergic diseases and were not only combined 
with antibiotic therapy but also supplemented with kefir and yogurt. 
The protective action could be observed especially at the age above 
14  years. The preventive effect was not observed at the age of early 
childhood.
Conclusions: Probiotics have relatively often used in the population 
under study and a health-improving effects was mainly observed at 
the age over 14 years old.
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Introduction: Autism spectrum disorders and food allergies are con-
ditions with increasing prevalence. Studies have investigated the link 
between intake of certain food among ASD patients and onset of 
adverse reactions. Results of these studies are varied and conflicting. 
This is the first local study on the prevalence of food allergies among 
these patients.
This study aims to determine the prevalence of food sensitization, IgE-
mediated and non-IgE-mediated food allergies among pediatric ASD 
patients. It also aims to determine the prevalence of perceived food 
allergies, and its triggers and the types of reactions of perceived food 
allergies and on open food challenge.
Methods: This is a cross-sectional, prospective study. Pediatric 
patients diagnosed with Autism Spectrum Disorders were enrolled in 
the study. Excluded were: children with uncontrolled asthma, with a 
recent anaphylactic reaction, and those on chronic high dose steroid 
therapy. Required sample size is 92. Complete history and PE were 
obtained and previous reactions to food and suspected allergens were 
duly noted. All patients underwent skin prick testing (SPT) to cow milk, 
wheat, soy and other perceived food allergens. Those with perceived 
food allergies underwent open food challenge to specific food aller-
gens. Frequencies and proportions were determined to analyze the 
different variables.
Results: Data were gathered from 84 patients diagnosed with ASD. 
32/84 (38%) have perceived food allergies, mostly to milk (31.3%), 
chocolate (25%), and egg (18.8%). Most commonly perceived allergic 
reactions to food allergens were: hyperactivity (53.1%), loose stools 
(25%), pruritus (15.6%), and wheals (12.5%). A total of 17 (20.2%) 
patients had (+) skin prick test result, hence food sensitization, to at 
least 1 food allergen, mostly to soy (41.2%) and milk (35.3%). Of these 
patients, 8 had perceived food allergies. 6 of these patients underwent 
open food challenge and all of them had (−) results.
Conclusions: Prevalences of perceived food allergies and food sensi-
tization are higher among ASD patients in this study compared to the 
general population. The most common perceived food allergens are 
similar with that of other children. Notably, the common perceived 
allergic reactions to food were behavioral or gastrointestinal symp-
toms, which may be non-IgE mediated or not food allergies at all. 
Hence, ASD patients with adverse food reactions are recommended to 
undergo complete, systematic evaluation and possible restrictive diets 
should be based on well-documented food allergies
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Introduction: In 2015, the 11% of the total population in Madrid was 
foreign, being the Latin American origin the most frequent followed 
by Asia, East Europe and in fourth place by other EU countries. In our 
working area, the foreign population average was even higher: 19%. 
Racial disparities in food sensitization have been described.
The aim of this work was to study the clinical characteristics of food 
allergy in children of immigrants from Latin American countries born 
in Spain.
Methods: In our study population 474 children reported allergy to 
food (cow’s milk and hen’s egg allergy not included) between 2012 
and 2016. We analyze all the children from Latin American origin who 
were born in Spain evaluated in our center. Clinical history, skin tests 
and quantitation of specific IgE antibodies were performed as well as 
oral food challenges.
Results: A group of 29 children were included with an age range of 
1–14 y.o., (Mean 7). Most of them were male (69%).Familiar atopy his-
tory: Rhinoconjunctivitis/Asthma was the most frequent entity (66%) 
followed by Atopic Dermatitis (16%). Most of the patients reported a 
personal history of Rhinoconjunctivitis/Asthma (51%) caused by pol-
len in 59% of cases; and AD (48%). Concerning food allergy, Latex-fruit 
group was the most frequent (25%), being Melon the most com-
mon, followed by Banana and Kiwi. Treenuts were the second family 
involved (21%), being Walnut the most common, followed by Peanut. 
Fruits belonging to the Rosaceae family were also involved (19%), 
being Peach the most frequent followed by Cherry. Shellfish (17%) 
was the forth family, Prawn was the most common, and Fish (11%) the 
fifth family, Hake was the most common. Finally, Legumes (7%) were 
the sixth group involved in allergy episodes, being Bean the most fre-
quent. Describing Clinical Manifestations, Urticaria/Angioedema was 
the most frequent entity (59%), OAS the second (35%) followed by 
Anaphylaxis (4%).
Conclusions: In this study, Rhinoconjunctivitis/Asthma was the most 
frequently reported entity of personal history of atopy, whereas in 
Spanish children Atopic Dermatitis is the most common. Latex-fruit 
group was the most frequently involved food in allergy episodes in 
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contrast to what occurs in the Spanish native children, where the fruits 
of the Rosaceae family are the most common.
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Introduction: The eosinophilic esophagitis (EE) is a chronic inflam-
matory disease, with an immunological component. The relation 
with food allergy has been reported in a crescent number of studies, 
demonstrating the key role that food restriction has on symptomatic 
improvement in these patients.
Methods: Retrospective analysis of clinical records of pediatric 
patients diagnosed with EE, confirmed histologically in our hospital 
from 2009 to 2015.
Results: 7 cases of EE were diagnosed with an average age of 
14.5 years, the number of male patients was superior (n = 6). The clini-
cal presentation was complaints of dysphagia and food impaction in 
all patients, with mean age of presentation at 12.5  years. Patients 
underwent upper gastrointestinal endoscopy, and the biopsies 
demonstrated in all patients, the presence of numerous eosinophils 
(>15 per high power field) in the lamina propria and in transepithe-
lial migration. There was an increase of total IgE (172–877 kU/l) in 4 
patients, 3 of whom had positive phadiatop to inhalant allergens. 
The inhalant allergens were negative in the remaining patients. Food 
allergens and specific IgE for food were negative. Skin tests (milk, egg, 
soy, wheat, peanuts, hake, shellfish) were positive for wheat in just one 
patient, all the others were negative. It was empirically established a 
restrictive diet in 2 patients, since there was no clinical improvement 
with drug therapy alone (fluticasone 500  μg bid). The exclusion of 
cow’s milk, beef, egg and soy in a patient’s diet and cow’s milk, soy and 
egg on another patient’s diet resulted in a significant clinical and histo-
logical improvement.
Conclusions: EE pathogenesis seems to be related to atopy and its 
control should include a dietary component as an adjunct to the phar-
macological therapy instituted. Although skin tests may be negative, 
dietary restriction of certain foods can improve symptoms and histol-
ogy on these patients.
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Introduction: Numerous discussions related to the justification for 
the use of certain formulas in infants with asymptomatic sensitization. 
The problem is that a balanced and rational nutrition in realization of 
metabolic programming is necessary for proper growth and develop-
ment of the child, on the other hand - there is a risk of transition latent 
sensitization in clinical manifestations of food allergy.
Our aim was to study goat milk formula effectiveness in healthy infants 
with asymptomatic sensitization.
Methods: The study included 110 healthy children aged between 2 
and 8 months of age who were bottle-fed. The duration of observation 
was 6–8 months. Prior to transfer to artificial feeding all children were 
breast-fed. Children received casein dominant formula based on whole 
goat milk. ELISA. used to identified allergen-specific IgE antibodies to 
the protein of cow milk, casein, ß-lactoglobulin, α-lactalbumin and 
goat milk protein in coprofiltrates.
Results: Frequency of latent sensitization to cow milk protein and 
its fractions, as well as to a protein of goat milk in healthy children 
was maximal at 2–3 months of age. Observation of the children who 
received casein based formula showed positive dynamics, which is 
expressed in reducing allergen-specific IgE antibodies to cow’s milk 
and its fractions, as well as the goat’s milk to 7–8 months of life.
Conclusion: Using goat milk casein based formula was effective in 
artificial feeding in children with asymptomatic sensitization.
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Introduction: Food-specific IgE (sIgE) determines the sensitization to 
food but oral food challenges are necessary to determine the clinical 
relevance of a food allergy in most cases. Therefore the identification 
of other biomarkers could be of great interest. Previously, chemokine 
levels have been correlated with the severity of eczema and the sen-
sitization status to food allergens. The aim of this study was to analyze 
if chemokine levels could predict a positive or negative outcome of a 
food challenge with hen’s egg.
Methods: 37 children sensitized to hen’s egg were included in the 
study. They underwent an oral food challenge with hen’s egg to proof 
its clinical relevance. Serum chemokines (CCL17 and CCL20) as well as 
total and sIgE were measured using an ELISA kit (R&D Systems) and 
the ImmunoCAP250 System® (Phadia) respectively. For statistical anal-
ysis the Mann-Whitney-U-test and the Spearman rank correlation were 
computed.
Results: The median age of the children (59.5% male and 40.5% 
female) was 2.6 years (range 0.8–14.9 years). 89.2% (33/37) of the chil-
dren had eczema. 19 children (51.4%) had a positive hen’s egg chal-
lenge and therefore a clinically relevant hen’s egg allergy whereas 18 
children (48.6%) were clinically tolerant. Median sIgE in the allergic 
patients was 1.9 kU/L (range 0.43–33.9 kU/L) and in the tolerant ones 
0.6  kU/L (range 0.03–4.76  kU/L). Hen’s egg allergic children showed 
significantly higher serum levels of CCL17 (median 655.4 pg/ml; range 
183.6–1394.4  pg/ml) compared to tolerant ones (median 501.6  pg/
ml; range 172.8–1027.8  pg/ml) (p =  0.030). Furthermore there was 
a significant correlation of CCL17 with sIgE (rs =  0.377, p =  0.014) 
and with the ratio of sIgE/total IgE (rs = 0.455, p = 0.004). Regarding 
the chemokine levels of CCL20 there was no significant difference 
seen. Our previous studies have shown a strong correlation between 
serum levels of CCL17 and the severity of eczema in food-sensitized 
infants. In this study the serum levels of CCL17 could be significantly 
correlated to the level of hen’s egg-specific IgE and were significantly 
elevated in children with clinically relevant hen’s egg sensitization in 
comparison to clinically tolerant ones.
Conclusions: CCL17 might not only be a biomarker for severe eczema 
but also for clinically relevant hen’s egg allergy. However larger studies 
are necessary to prove these findings. Furthermore, determination of 
CCL17 will not be able to replace oral food challenge tests.
PP035 
The influence of the order of food challenge days on DBPCFC 
outcomes in children
Faisal R. Bakhsh, Kollen Boudewijn, Anne‑Marie Oomkes‑Pilon, Dorien Van 
Ginkle, Anthony E. J. Dubois
Department of Pediatric Pulmonology and Pediatric Allergology, Uni‑
versity Medical Center Groningen, GRIAC Research Institute, University 
of Groningen, Groningen, the Netherlands 
Correspondence: Faisal R. Bakhsh ‑ faisal.r.b@hotmail.com
Clinical and Translational Allergy 2017, 7(Suppl 1):PP035
Introduction: The double-blind placebo-controlled food challenge 
(DBPCFC) is the most reliable diagnostic test in food allergy for several 
reasons including reduction of patient and operator or observer bias, 
thus decreasing the chance of false-positive outcomes. In DBPCFC, the 
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order of the challenges with verum or placebo food are randomized. 
It is currently unknown whether there is a significant difference when 
initiating the DBPCFC with a placebo challenge or with an active food 
challenge.
The study aims to explore whether there is a significant difference 
when initiating the DBPCFC with a placebo challenge or with an active 
challenge DBPCFC in children
Methods: In this study, a total of 1680 patients who underwent DBP-
CFC were analyzed. Differences between test day reaction frequencies 
were assessed with the Mcnemar test. Subjective and objective reac-
tions were considered together and separately. Events occurring on 
placebo days were also assessed separately.
Results: There was no significant difference between the frequency of 
reactions on test day 1 and day 2 (p-value = 0.160). This was also the 
case for subjective and objective reactions considered separately (p 
= 0.640 and 0.193, respectively). When considering only placebo chal-
lenges, 58 patients experienced events on the first day and 47 patients 
on the second day. This difference was significant (p = 0.000).
Conclusions: Patients tend to experience spurious events more often 
during the first challenge day than the second challenge day, perhaps 
because of pre-conceived notions about the test and greater anxiety. 
However, this has no significant impact on the overall diagnostic accu-
racy of the test, even in patients where the diagnosis is made on the 
basis of subjective reactions.
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Introduction: Outgrowing of cow’s milk or egg allergy might be 
related to differences in IgE-dependent basophil function. We sought 
to investigate if the level of allergen specific basophil response is 
associated with the clinical tolerance among a cohort of children with 
cow’s milk or egg allergy.
Methods: Sixty children were classified as milk or egg-reactive and 
milk or egg- outgrowing (tolerant) based on the results of oral food 
challenges (38 milk and 22 in egg group). Serum was analysed for 
allergen-specific IgE and IgG levels, basophil response was assessed in 
whole blood stimulated with serial dilutions of milk or egg white and 
yolk protein (all 0.33–33.3 ng/ml) and with anti-FcεRI stimuli. Skin prick 
tests (SPTs) to commercial extracts were also performed.
Results: Milk-reactive subjects’ basophils showed significantly higher 
response (median fourfold, at 33.3 ng/ml) to milk allergen stimulation 
than basophils from milk- tolerant individuals. There was also a sig-
nificantly higher response to anti-FcεRI stimuli (twofold). On the other 
hand, in egg group no significant differences in egg white, yolk or anti-
FcεRI basophil response, in sIgE to egg white or yolk, and in SPT were 
demonstrated between egg-reactive versus egg-tolerant children. 
However in egg-tolerant children we demonstrated a significantly 
higher level of specific IgG to egg white.
Conclusions: We showed that children with outgrowing versus reac-
tive cow’s milk allergy can be distinguished by basophil activation 
test. These observations could not be confirmed for children with egg 
allergy.
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Introduction: The primary aim of this study is to evaluate the percent-
age of anaphylactic reactions treated with epinephrine during a food 
challenge test and to identify associated factors for the administration 
of epinephrine.
Methods: Children who underwent a food challenge test with peanut, 
hazelnut, cow’s milk, hen’s egg or cashew nut in the period 2005 to 
2015 at the department of Allergology Erasmus Medical Center Rot-
terdam in the clinical setting or in a research setting (IDEAL-study, col-
laboration of three tertiary care centers for food allergy, trial number 
NTR3572) were evaluated. The children with reactions meeting the 
criteria for anaphylaxis according to the EAACI Guidelines for Food 
Allergy and Anaphylaxis and/or who were treated with epinephrine 
were included. Possible factors associated with the administration of 
epinephrine such as age, gender, symptoms consistent with asthma, 
history of an allergic reaction to the tested allergen and the type of 
symptoms during the anaphylactic reaction were investigated with 
logistic regression analysis.
Results: A total of 92 children (40 boys, 44%) with a median age of 
7  years (range 1–17  years) who met the criteria for anaphylaxis (n = 
85) or who were treated with epinephrine (n = 7) were included in 
this study. Thirty-three children (39%) with anaphylaxis were treated 
with epinephrine. Factors significantly associated with epinephrine 
treatment were younger age (p = 0.001) and lower airway symptoms 
(p  =  0.001). Gastro-intestinal symptoms and a history of an allergic 
reaction to the tested allergen were significantly associated with the 
lack of epinephrine treatment (p < 0.001 and p = 0.043, respectively). 
The most severe allergic type of reaction during a food challenge test 
is anaphylaxis, for which the recommended treatment is epinephrine. 
However, only about half of the children with anaphylaxis received 
epinephrine during the food challenge tests in our study. Treatment 
of anaphylaxis during food challenge test does not correspond to the 
indication for such treatment as delineated in the EAACI Guidelines. 
Further analysis is warranted to ascertain the cause of this discrepancy.
Conclusions: Anaphylaxis occurring during challenge tests seems to 
be undertreated with epinephrine.
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Introduction: Nowadays allergies are among the most common of 
medical disorders. It is estimated that more than one in every five peo-
ple suffer from some form of allergy in the world. Allergic pathology in 
children is usually manifested by food allergy (FA). This problem starts 
in infancy and is most likely to arise when atopic diseases run in the 
family. Food allergens are major components of sensitization structure 
in children under one year. Our purpose wat to select high-adapted 
nutrition mixtures for infants with allergic manifestations.
Methods: 116 artificially fed infants with the signs of allergic consti-
tutional dermatitis and children’s eczema. Programme contemplated 
estimating efficiency of the nutrition mixture. “NAN Lactose free” was 
administered as main nutrition for 78 and “NAN Soy”—for 38 infants. 
If they proved ineffective “Acidophilic NAN” and “Alfare” were given. 
Adequacy of nutrition was determined by the dynamics of skin sta-
tus and simultaneous analysis of the character of sleep, presence of 
gastro-intestinal changes, microbiological profile of feces, and specific 
allergodiagnosis in vitro.
Results: Soy-bean nutrition proved effective in 56%. “NAN Soy” com-
bined with “Acidophilic NAN” led to stabilization of intestinal motility 
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in 80% of infants with a good tolerance to this mixture. Application of 
“NAN Lactose free” caused positive dynamics in 63%. The rest (37%) 
were transferred successfully to a combined nutrition “NAN Soy” + 
“Acidophilic NAN”. In case “NAN Soy” and “NAN Lactose free” (33%) 
were ineffective, mixture “Alfare” or its combination with “Acidophilic 
NAN” were tested. Positive dynamics of FA course was observed in all 
infants.
Conclusions: Thus, at the absence of breast milk, infants with FA mani-
festations are expedient to feed with the following mixtures:
  • with complete protein hydrolysis (Alfare);
  • acidophilic (Acidophilic NAN);
  • alactic (NAN Lactose free);
  • soy-bean (NAN Soy).
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Introduction: Our aim was to investigate the anti-allergic and immu-
nomodulatory effects of Lactobacillus reuteri in a murine model of food 
allergy.
Methods: BALB/c mice were sensitized with ovalbumin (OVA) plus 
alum and subsequently challenged with OVA by gavage to induce 
food allergy. The mice were daily administered with L. reuteri (1 x 109 
CFU/mouse) and/or MRS broth (as vehicle) throughout the entire 
period of experiment. Allergic diarrhea was monitored after each OVA 
challenge, and the mice were sacrificed post the last OVA challenge to 
collect serum samples, spleen and duodenal tissues for immunological 
and histopathological analysis.
Results: L. reuteri administration attenuated the occurrence of diar-
rhea, intestinal mast cell activation, and serum IgE production. Fur-
thermore, both the production of IFN-γ and IL-4 by splenocytes was 
suppressed by L. reuteri. Concordantly, a decreased expression of IL-4, 
IFN-γ, GATA3 and T-bet were observed in the duodenum. However, the 
expression of IL-10, TGF-β and Foxp3 was augmented. These findings 
demonstrate that oral administration with L. reuteri attenuated allergic 
responses and down-regulated both T helper (Th)1 and Th2 immune 
responses, which was closely associated with the enhanced reactivity 
of regulatory T cells.
Conclusions: L. reuteri may be used as a functional probiotic for 
managing intestinal disorders associated with exaggerated immune 
responses, especially food allergy.
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Introduction: The children’s allergy service in Leicester continues to 
work with local authorities (LAs) to ensure there are guidelines in man-
aging allergy, including emergency action plans. The aim of this survey 
was to ascertain whether school staff had the appropriate infrastruc-
ture in place to manage children with allergies.
Methods: Two LAs were sent a link to an online questionnaire to 
all schools under their jurisdiction (377 schools). The schools were 
requested to circulate the questionnaire to all members of staff to 
complete.
Results: 
  •  234 staff members completed the survey. Off those 166 taught 
children <11 yrs old.
  •  86.2% of staff state there is a school policy relating to managing 
allergy.
  •  The responsibility for checking the expiry dates of Adrenaline 
autoinjectors (AAIs) lies with parents (37.9%), administration 
staff (23.7%), teacher (12.9%), other (23.8%), Unsure/no proce-
dure (1.7%). 85.1% of respondents maintain a clear log with 65.8% 
checking expiry dates at least once a term.
  •  AAIs are kept with the child (19.2%), unlocked central location 
(36.2%), locked central location (25.8%), Classroom (37.1%)
  •  AAIs are taken on the school playing fields 52% of the time, but 
96.5% of the time for visits off the school premises.
 •  Schools request the following number of AAIs per child; one AAI 
(55.8%), two AAI (24.3%) and leave it for the doctor to decide 
(19.9%).
Conclusions: 
  •  Most schools have policies in place relating to managing allergy 
in schools.
  •  More guidance surrounding storage of AAI and checking expiry 
date may prevent out of date AAIs as well as AAIs being locked 
away, which in an emergency could prove problematic.
  •  Schools appear to be influencing AAI prescription practices by 
specifying numbers of AAIs they require.
  •  Ongoing partnership between the allergy clinic, LAs and school 
nurses are required to further improve the infrastructure for 
managing allergy in schools.
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Introduction: The children’s allergy service in Leicester has worked 
with local school nurses to produce educational material on the rec-
ognition and treatment of allergic reactions. School nurses deliver 
this package to school staff. The aim of this survey was to ascertain 
whether staff felt they were able to manage children presenting with 
an allergic reaction.
Methods: 377 schools under the jurisdiction of two local education 
authorities were sent a link to an online questionnaire. The schools 
were requested to circulate the questionnaire to all members of staff 
to complete.
Results:
  •  Training for the management of allergic reactions was provided 
by a LEA school nurse (75.1%), first aid training provider (16.7%) 
and other including no training (8.2%)
  •  75.4% of school staff had received training in recognition and 
management of allergic reactions within the last 12  months, 
14.2% within 12–24 months and 10.4% >24 months.
  •  91.1% felt confident in the recognition of an allergic reaction, 
while 89.3% felt confident in being able to manage an allergic 
reaction, including the use of an AAI.
 •  30.4% and 22.9% respectively felt they needed more training on 
recognition of an allergic reaction and administration of an AAI.
Nearly all members of staff completing the survey had received train-
ing within the last 2  years and feel confident in the recognition and 
management of allergic reactions. Significant numbers of staff feel fur-
ther training would be beneficial.
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Conclusions: Continued resources are required to maintain staff train-
ing in managing allergy. Additional training resources such as DVD, 
trainer pens & useful websites should be provided with the current 
training package to provide ongoing training.
POSTER SESSION 2: Management of food allergy
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Introduction: A negative oral food challenge (OFC) should normally 
be followed by its reintroduction in the diet. However, this fails in a 
subset of children.
Aims: (1) To analyse the rate of occurrence and the reasons for failure 
of reintroduction of the implicated food after negative OFC in children; 
(2) To determine the proportion of food avoidance in children who did 
not undergo OFC.
Methods: A retrospective study of children with an OFC scheduled 
between January 2012 and December 2015 was performed. Clinical 
records were reviewed and the food consumption status (FCS) was 
obtained using a short structured phone or paper enquiry answered 
by the caregivers.
Results: Data of 127 children (59% male; median age [interquartile 
range, IQR] 5 [7] years); 64% atopic (48% allergic rhinitis; 38% asthma 
and 27% atopic eczema); was collected. A total of 235 OFC were sched-
uled during this period and only 186 were performed and 137 were 
negative. The major foods tested were with cow’s milk (29%), hen’s egg 
(26%), fish (14%) and crustaceans (11%). Data on FCS was obtained 
in 97.3% of the total 235 OFC scheduled during the study period. The 
mean time (±std) between the OFC and the assessment of FCS was 
13 ± 6.9 months. Food avoidance was maintained in 26.3% of the 137 
negative OFC. Food rejection was the main reason (44%), followed by 
the fear of reaction by caregivers (35%). Food avoidance was related 
with the suspected food group (p < 0.01). Further comparison of chil-
dren’s FCS revealed no significant differences with respect to gender 
(p =  0.651), age (p =  0.07), clinical manifestation of the index reac-
tion (p = 0.627) or the presence of allergic comorbidities (p = 0.133). 
Eviction of the suspected food was maintained in 61.2% of the 49 OFC 
scheduled that were not performed, in contrast to the 37.1% when an 
OFC was performed, independently of its result; p < 0.001.
Conclusions: Avoidance of the offending food is still the mainstay of 
management and so, children with suspected food allergy often present 
with a long-lasting elimination diet. Despite a negative challenge out-
come and advice to re-introduce the food in the diet, 26.3% of the chil-
dren were still avoiding the implicated food. Almost two thirds (61.2%) 
of the patients who did not undergo OFC maintained avoidance of the 
suspected food. These data highlight the importance of performing an 
OFC in preventing unnecessary restrictive diets as well as alert to the 
need of assessing food consumption after a negative OFC.
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Introduction: Oral immunotherapy (OIT) combined with omalizumab 
(O) can be an effective and safe approach treatment to rapid desensi-
tization in children with severe cow’s milk allergy (CMA). We report our 
experience.
Objective: To evaluate the safety and efficacy of OIT combined with O.
Methods: Volunteers with severe CMA that had previously interrupted 
a conventional OIT because of dose—related severe anaphylactic reac-
tions were enrolled. Informed written consent was obtained by the 
respective parents before the treatment. As off label treatment, O was 
administered according to the package insert for asthma treatment. 
Each pts undertook s.c. injections of O for 8 weeks prior to and 8 weeks 
following the initiation of OIT. On the initial escalation day, dosing 
began at 1.5 ml of cow’s milk (CM, 5 mg of proteins) and were slowly 
increased until the pt reached a final dose of 200 ml or if any adverse 
event (AEs). The highest tolerated dose (i.e. with no clinical reactivity) 
determined the pt’s starting daily home dose. The pts returned to the 
clinic every 2  weeks for a dose escalation visit. OIT protocol did not 
advance according to a fixed calendar, but, rather were individualized 
according to pts’ allergic reactions and safety outcomes. After the up-
dosing regimen the maintenance phase was performed (200 ml of CM 
daily and dairy products ad libitum).
Results: We have enrolled 6 children (n male = 4), aged 9.8 ± 2.31 
yrs (mean  ±  SD) suffering from severe CMA. 4 children had con-
comitant allergic asthma (A) and one of the latter atopic dermatitis, 
too. Efficacy: 2 pts reached the maintained dose of CM 200 ml after 
17  weeks; 1 reached the dose of 150  ml of CM and dairy products 
after 7  months. All of them are going on daily maintenance intake 
since 12 months. 3 pts interrupted OIT during the build- up phase: 
1 for severe AE (2 ml CM); 1 for concomitant severe A; 1 for personal 
problem. Safety: 2 pts developed severe anaphylactic reactions after 
dose intake: 1 at the increasing dose of 2 ml [rhinitis (R), cough, A, 
angioedema-urticaria (U), hypotension]; 1 at the maintenance dose 
of 150 ml (U&A). All of them have history of A. The same 2 pts devel-
oped mild AEs during the induction phase of OIT: 1 reacted at the 
8  ml dose (R) and 25  mL dose of CM (U); another at 150  ml of CM 
(R&U).
Conclusions: This combined approach could allow for a more success-
ful and safer desensitization in children with high-risk CMA that had 
failed a conventional OIT protocol. However, in pts with concomitant 
A, it could be less effective.
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Introduction: Risk is a function of hazard and exposure. For food 
products, allergens are a well-known hazard and exposure scenarios 
are calculated based on the concentration of unintended allergen in 
combination with the amount of food consumed. At the moment, 
food consumption data from the general population are used for 
calculating exposure scenarios in food allergen risk assessments. A 
reasonable assumption is that if a food product is chosen to be con-
sumed, the population distributions of amounts of a food product 
consumed at one eating occasion are comparable between the aller-
gic population and the general population. A second assumption is 
that the frequency of consumption for certain product categories may 
differ between the allergic and general populations. However, struc-
tured data are lacking to underpin these assumptions and research 
initiatives are needed to fill in the current data gaps.
Methods: Based on the US National Health and Nutrition Examina-
tion Survey, a statistical comparison was made between the food 
consumption distribution at a single eating occasion of allergic and 
non-allergic individuals. Two allergic identifiers were studied, serum 
IgE to the specific food (NHANES 2005–2006) and self-indicated food 
allergy (NHANES 2009–2010). The food allergens studied were: shrimp, 
wheat, cow’s milk, egg, fish, shellfish, peanut and other nuts. Food 
consumption was compared at the food group level. A total of 103 
food groups were defined. The statistical difference was tested with 
ANOVA or Chi squared test.
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Results: Overall, the results indicated that the criteria for allergy were 
not strong enough in the NHANES survey and that non-allergic indi-
viduals were mixed with the allergic population.
Conclusion: It was not possible to make a conclusion about the valid-
ity of the assumptions applied in risk assessment when using food 
consumption data from the general population. More comprehensive 
and structured studies are needed to ascertain the differences in con-
sumption patterns of allergic and non-allergic individuals. Ideally, any 
future study should identify clinically-diagnosed food-allergic indi-
viduals and measure their food consumption patterns using the same 
method as the general population.
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Introduction: In early 2011, the VITAL® (Voluntary Incidental Trace 
Allergen Labeling) Scientific Expert Panel of The Allergen Bureau 
of Australia & New Zealand (ABA) reviewed individual NOAELs and 
LOAELs obtained from over 1800 clinical food challenges in an effort 
to guide advisory labeling decisions for use on food labels. Reference 
Doses were established for 11 allergenic foods including peanut, cow’s 
milk, egg, hazelnut, soybean, wheat, cashew, shrimp, sesame seed, 
mustard and lupine (in terms of mg of total protein). Reference Doses 
were not established for fish, celery or other tree nuts due to a lack of 
sufficient quality data at the time. As part of the VITAL® update process, 
the threshold database was supplemented with additional data col-
lected from 2011 to 2016. The results of that update are presented here.
Methods: Individual NOAELs and LOAELs from published clinical lit-
erature were reviewed and verified by scientists at the Food Allergy 
Research & Resource Program (FARRP) at the University of Nebraska 
and at TNO in the Netherlands. Publications from 2011 to 2016 were 
selected based upon previously outlined criteria and focused on low-
dose oral food challenges. Additional unpublished clinical records 
from TNO and FARRP collaborators were also used to supplement the 
published data. Where possible, population based threshold distribu-
tions were updated.
Results: Over 1300 data points were added from data made avail-
able during 2011–2016. The TNO-FARRP allergen threshold database 
now contains over 3100 individual NOAELs and LOAELs from clinical 
food challenges for 32 allergens, including 15 priority allergens from 
different international labelling regulations. However, limited data 
restricted distribution calculations for a number of non-priority foods. 
In general, the newly calculated population threshold distributions did 
not significantly vary for a majority of allergens between the 2011 and 
2016 datasets.
Conclusions: The results from this study indicate that the population 
thresholds generated for most VITAL® allergens are stable and were 
not significantly altered with the addition of new data. These results 
should enable government and food industry risk managers to pro-
ceed with allergen risk management systems based on the VITAL® ref-
erence doses.
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Introduction: Our aim was to determine eliciting doses (EDs) in wal-
nut allergic adults and to compare with previously established thresh-
old data in peanut and tree nuts.
Methods: Prospectively, adult subjects with a suspected walnut 
allergy were included and underwent a low-dose double-blind, pla-
cebo-controlled food challenge (DBPCFC). Individual no observed and 
lowest observed adverse effect levels (NOAELs/LOAELs) were deter-
mined and Log-Normal, Log-Logistic and Weibull models were fit to 
the data. Estimated eliciting dose (ED) values were calculated for the 
ED5, ED10 and ED50, the dose respectively predicted to provoke an 
allergic reaction in 5, 10 and 50% of the walnut allergic population.
Results: Fifty-seven subjects were challenged and 33 subjects were con-
firmed to be walnut allergic. Objective symptoms occurred in 20 of the 
positive challenges (61%), varying from angioedema of the lip to severe 
dyspnea. The lowest cumulative LOAEL for objective symptoms was 
0.31 mg of walnut protein, leading to repeated coughing in one subject. 
Data from 13 subjects with only subjective symptoms were right cen-
sored. The cumulative eliciting doses in the three distribution models 
ranged from 3.1 to 4.1 mg for the ED05, from 10.6 to 14.6 mg walnut pro-
tein for the ED10 and from 590 to 625 mg of walnut protein for the ED50.
Conclusions: Population EDs for walnut are slightly higher compared 
to those previously found in peanut and hazelnut allergy. Additionally, 
previous ED estimates for cashew from a limited number subjects (31) 
was also higher when compared to hazelnut (202 subjects), indicating 
that threshold levels for hazelnut could be used as a conservative esti-
mate for risk assessment of other tree nuts where little or no food chal-
lenge data is available.
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Introduction: Unexpected allergic reactions to food are frequently 
occurring, with even severe and fatal reactions.
Our aim was to analyze the type of food products and possible pres-
ence and levels of allergens involved in unexpected reactions in daily 
life of patients.
Methods: A prospective cohort study in adults with a doctor diag-
nosed food allergy. Patients reporting an unexpected allergic reaction 
were asked to provide information on the food product, the label and 
estimated consumed amount, and a sample to determine the pos-
sible culprit allergenic substances and their concentrations. This was 
combined with individual patient food allergies and products were 
analysed using ELISA or qPCR for different allergens. Results were ana-
lyzed and compared with the Reference Doses as established by Taylor 
et al (Food and Chemical Toxicology 63, 2014, 9–17).
Results: Patients experiencing an unexpected allergic reaction 
reported a very diverse range of food products. A significant part of 
the unexpected reactions, 78% (118 out of 151), was attributed to a 
specific product by the patients. In 22% the reaction was caused by 
a composite meal. A total of 53 food samples were received and ana-
lyzed for 28 different allergens, ranging from 1 to 15 allergens per 
product, and on average 5–6 measurements per product. In 40% of 
the products 1 to 4 allergens were detected per product, other aller-
gens analyzed were not present or under the limit of detection. In 
60% of the received samples no unexpected allergenic substance was 
detected. Levels ranged from 0.2 ppm up to 5000 ppm allergen pro-
tein/kg food product. The levels of peanut, hazelnut, sesame, cow’s 
milk and hen’s egg were all above action levels determined using the 
Reference Doses. Walnut, pecan nut, cashew nut and celeriac were 
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also detected. The severity of the reactions for the 21 products ranged 
from mild to moderate (Muller score 0–3). In part of the unexpected 
reactions it was difficult to attribute to a specific food product or aller-
gen. Reasons could be that meals consisted of multiple products, aller-
gens might not be present or are not equally distributed in the food, 
or the wrong product was provided by patients.
Conclusions: Levels of unexpected allergen and estimated doses taken by 
patients did not exceed the Reference Doses for precautionary labeling as 
described in Taylor et al 2014.
PP051 
Home based oral immunotherapy with baked egg protocol
Kristian Bravin, David Luyt
University Hospitals of Leicester NHS Trust, Leicester, United Kingdom 
Correspondence: Kristian Bravin ‑ kristian.bravin@uhl‑tr.nhs.uk
Clinical and Translational Allergy 2017, 7(Suppl 1):PP051
Introduction: Hen’s egg (HE) allergy is one of the commonest food 
allergies in young children with a natural history to resolve, although 
recent evidence suggests a greater prevalence and more persistent 
nature. Treatment strategies of allergen avoidance anticipating that 
the child will grow out of the allergy are being replaced by interven-
tions like oral immunotherapy (OI). The recipes used in HE OI are 
however in forms of egg not commonly ingested and are therefore 
considered experimental and not suitable for widespread clinical 
application.
Methods: We developed a recipe of baked egg biscuits for use in HE 
OI and implemented a home-based slow up-dosing programme. Five 
recipe stages were provided to create enough doses to allow gradual 
increases in allergen exposure. Eligible subjects were recruited at rou-
tine allergy clinic visits. Persisting HE allergy was confirmed mostly by 
recent contact symptoms or, if not, by a positive baked egg challenge. 
As allergic symptoms are frequent in OI, families had ready access to 
dietetic advice on dosing and symptom treatment.
Results: Fifteen subjects (9 boys) age from 6 to 17  years (median 
11 years 2 months) were treated. Eight achieved full tolerance (equiva-
lent to one egg), 5 became partially tolerant allowing them to include 
dietary traces and 2 failed. Allergic symptoms during OI were mild 
with oral pruritus, abdominal pain, nausea and vomiting and urticaria 
or eczema flares, successfully treated with antihistamines.
Conclusions: We have demonstrated the efficacy and safety of a HE 
OI programme using an easy-to-make baked egg recipe. As the biscuit 
form of egg presentation is widely ingested, we propose the recipe to 
enable HE OI be more widely clinical available.
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Introduction: Allerg-e-Lab is a semantic web service initiative for the 
documentation and exchange of information related to food aller-
gies. The data dictionary—controlled medical vocabulary is essential 
to identify and characterise the semantic relationship of variables and 
is key to interpreting data. This study will analyse and compare exist-
ing standard terminologies used to describe oral food challenges, and 
develop a structured approach to collating meta data required for 
modelling dose distributions from clinical data from double blind pla-
cebo controlled food challenges.
Methods: Data harmonization - integrating data into the Allerg-e-
Lab is a five step process which is being based on the DataSHaPER 
approach (quality, quantity, and harmony) used for bio clinical studies. 
The data annotation tools (software and user interface) are being used 
to annotate data, attaching metadata, and referring to terms from a 
controlled vocabulary for importing EuroPrevall and iFAAM study data 
sets into the Allerg-e-Lab platform.
Results: The initial focus for developing the EuroPrevall-iFAAM data 
dictionary has been to develop a controlled medical vocabulary which 
describes the protocols and clinical symptoms recorded during food 
challenges undertaken in the EuroPrevall-iFAAM studies. Differences in 
protocols and definitions between the two projects will be described, 
and their application to developing data sets to allow compari-
son in the development of dose distributions based on pooled data 
described.
Conclusions: The EuroPrevall-iFAAM data dictionary will be imple-
mented within the Allerg-e-lab environment and used to investigate 
the effect of age on threshold dose distributions for peanut, egg and 
milk from the EuroPrevall and iFAAM projects.
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Introduction: The Irish Food Allergy Network (IFAN) created the IFAN 
egg ladder, along which increasingly lightly cooked egg can be intro-
duced into the diet of egg allergic children. Our hospital allergy clinic 
has been providing, step by step instructions and recipes to parents of 
egg allergic children, considered appropriate for home introduction. 
The purpose of this study was to retrospectively examine the success 
and safety of this practice.
Methods: 139 children, who commenced home introduction of baked 
egg were identified as suitable candidates. A retrospective chart 
review was performed and a questionnaire was completed by parents 
via telephone interview.
Results: 75 cases were included in the study. Only 5 had not intro-
duced any form of egg; 4 of these due to refusal by the child. Almost 
50% deviated from provided instructions. 41 (54.7%) reported a reac-
tion during home challenge. 35 (46.7%) had immediate reactions with 
n = 17 given an anti-histamine, and 1 patient seen by a GP. 6 reported 
worsening eczema. Only 1 subject had a severe reaction.  60% of 
patients introduced egg in forms less baked than cake or muffin, such 
as pancake, egg pasta, egg noodle and hardboiled egg. 54.7% stated 
that finding time to bake goods was a barrier to introduction. More 
regular ingestion of egg was associated with greater success. The num-
ber of egg products in the diet was directly associated with increased 
peace of mind socialising, reduced worry and increased meal options. 
Home introduction of egg containing products at an earlier age may 
be important. The process is associated with allergic reactions, primar-
ily mild. Increased egg introduction appears to improve aspects of 
QoL. Simplifying challenges to include bought produce needs to be 
considered.
Conclusions: Home introduction of egg containing food in a step by 
step manner is achievable and allows for provision of options for chil-
dren, more appealing to parents than cake.
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Introduction: The recently published Consensus Communication on 
Early Peanut Introduction recommends at-home introduction of pea-
nut into diets of skin prick test negative, high risk (egg allergy and/
Page 44 of 79Clin Transl Allergy 2017, 7(Suppl 1):10
or severe eczema) infants. The communication states that, if deemed 
appropriate, in-office observed peanut ingestion can be performed 
before initiating at-home ingestion. We sought to examine the success 
of home introduction of peanut in our clinical cohort.
Methods: Our study was a two cycle audit; the first cycle consisted of 
verbal instruction to all parents of non-sensitised high risk children 
to introduce at least 6 g of peanut protein per week with a follow up 
phone-call; the second cycle (for parents of children who had not 
started peanut) included a repeat skin prick test and a meeting with 
a member of the clinical team to address parental concerns. Written 
instructions were also provided. Parents were subsequently contacted 
by phone one month later.
Results: 25 of 38 families (66%) introduced peanut and 13(34%) did 
not; Infants successfully commenced on peanut consumed a median 
2.5 g of peanut protein per week. 2 parents who had their own diag-
nosis of peanut allergy requested hospital observed introduction. The 
remaining 11 non-ingestors returned to clinic. Repeat skin test was 
negative in each case. Each agreed to home introduction. 10 were con-
tactable. 5(50%) had introduced peanut. Post-intervention a median 
4 g of peanut protein was consumed per week. Nearly 80% (79%) of 
parents introduced peanut at home without an initial hospital chal-
lenge. Medians of 2.5 g & 4 g of peanut protein were consumed per 
week in our study; the LEAP study reported a median 7.7 g consump-
tion. Reasons (Table 2) for non-introduction show peanut refusal as a 
major issue. The LEAP study addressed this with regular telephone 
calls, food frequency questionnaires and extra clinics. Our limited 
resources hinder such high level of supervision.
Conclusions: Initiation of peanut ingestion by home introduction 
is successful in most cases. Clear written instructions, including tips 
on how to conceal are likely to improve compliance. Early follow up 
to identify those unable to introduce is necessary. Those with family 
members with peanut allergy are less likely to introduce without prior 
hospital observed introduction. Ongoing adherence is unlikely to 
be achieved in the clinical setting at levels equivocal to the research 
setting.
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Introduction: Our aim was to assess the perceived impact in daily life 
of food allergy (FA) in our population.
Methods: A medical records review of all patients assessed in our 
Food Allergy Unit from 2013 to 2015 (n  =  187) was performed and 
those with confirmed FA after diagnostic work-up (n = 51, 27.3%) were 
selected. These food-allergic patients or their caregivers were then 
interviewed by telephone; only 21 (41.2%) patients responded and 
these were included in the final analysis.
Results: A total of 21 food-allergic patients (66.7% females, mean ± SD 
age 28.1 ± 15.7 years; 7 aged under 18 years) were included. The main 
culprit food groups were crustacean (25.8%), fish (19.4%), fruits (19.4%), 
and tree nuts (16.1%); 9 patients were allergic to foods from more 
than one group. Reactions were immediate in 20 (95.2%) cases and 12 
(57.1%) presented as anaphylaxis. Two (9.5%) patients confessed to be 
not fully avoiding foods from the sensitizing group and one had recur-
rent allergic reactions (oral allergy syndrome); 7 (33.3%) patients admit-
ted not always carrying their emergency medication and 1 had already 
needed it. Eleven (52.4%) patients stated that they had changed their 
vacation plans due to FA. Five (23.8%) referred to never or rarely reading 
food labels and 4 (19.0%) patients had a food allergic reaction following 
accidental exposure. Five (23.8%) referred to have increased monthly 
expenses due to FA and another 10 (47.6%) felt somehow impaired by 
their FA. Interestingly, all patients mentioned to be more confident with 
the diagnosis and management after an Allergist’s evaluation. Food 
allergy continues on the rise. The negative practical and psychologi-
cal impairment associated with FA in both adults and allergic-children 
caregivers has been recently assessed. A negative impact on daily life 
was also evident in our patients and this needs to be addressed in order 
to improve disease management in all aspects. In this group, half of 
them admitted to changing vacation plans; almost one quarter had 
increased expenses because of their FA; almost one-fifth had a reaction 
following accidental exposure and almost half admitted feeling some-
how impaired by their FA. All of the patients stated feeling more confi-
dent after consultation with a specialist.
Conclusions: The scope of an Allergist should also include helping 
patients cope with FA and reduce its interference in daily life.
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Table 2 Reasons given for not introducing peanut at home 
(13 patients)
Patient Initial reason Post intervention 
reason
1 Child refused peanut butter Refusing peanut but‑
ter (even hidden)
2 Child refused peanut butter Acid reflux and so 
excluded all dairy/
egg/nut from diet
3 Child refused peanut butter
4 Refused peanut butter and sibling has 
nut allergy
5 Parents prioritised home based graded 
baked milk exposure




7 Parents prioritised home based graded 
baked egg exposure and suspected 
eczema worsening
S Did not understand advice given at 
initial clinic visit
9 Did not understand advice given at 
initial clinic visit
10 Sibling has peanut allergy Parental decision to 
maintain nut free 
house
11 Parent has peanut allergy (subsequently 
requested clinic based introduction)
12 Parent has suspected peanut allergy 
(subsequentlyrequested clinic based 
introduction)
13 Maternal anxiety Parental decision
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Introduction: The treatment of food allergy is the exclusion diet. 
Oral immunotherapy (OIT) can be a therapeutic alternative, however 
described immediate adverse reactions during its implementation. 
The eosinophilic esophagitis (EoE) is a chronic disease: Esophageal 
dysfunction and infiltration Eosinophilic ≥ 15 eosinophils (eos/hpf) 
field in 4 fields. Some recent studies describe it as secondary adverse 
long-term reaction to the OIT.
Case report: 7  year old male patient with an atopic dermatitis his-
tory, debuts with urticaria and angioedema after egg tortilla and 
fish ingestion at 12 months of life. 3 years old: IgE 360UI/ml, Ovomu-
coid 1.61  kU/L, Egg white 14.5  kU/L, Egg yolk 1.59  kU/L, Ovalbu-
min 15.61  kU/L, Cod 10.4  kU/L, Tuna 21.4  kU/L, Hake 7.24  kU/L, Sole 
6.47 kU/L, Four-spot megrim 7.06 kU/L. Prick: Egg white 6/5, Egg yolk 
3/5, Egg 3/5, Ovalbumin 2/5, Ovomucoid 3/5, Cod 7/5, Sole 6/5, Hake 
5/5. Oral challenge (PPO) to boiled egg was negative, so diet is indi-
cated with egg cooked 3 times a week and without fish. Later the 
patient concerns hives after eating Peach, practiced prick: LTP 5/6, 
Profilina 0/6, Egg white 8/6, Egg yolk 5/6, Egg 2/6, Ovalbumin 2/6, 
Ovomucoid 4/6, Peach 2/6, Cod 8/6, Sole 7/6, Hake 6/6. IgE 404 IU/ml, 
Prup3 LTP Peach 4.49 kU/L, Ovomucoid 0.83 kU/L, Egg White 8.95 kU/L, 
Ovalbumin 8.62 kU/L, Egg Yolk 1.59 kU/L, Four-spot megrim 3.82 kU/L, 
Cod 5.1 kU/L, Hake 4.4 kU/L, Tuna 5.35 kU/L, Sole 5.52 kU/L. Practiced 
PPO Omelette was positive, so begins desensitization with egg white, 
diet without peach and fish. At 7  years old, patient describes food 
impactation, so endoscopy was performed > 40 (eos/hpf). Treatment: 
Fluticasone 250mcg BID, Omeprazol, diet without egg, fish and peach.
Conclusion: The present case can suggest the implication between 
EoE and the reintroduction of allergic food so recommendation of 
stretch following of this patients should be performed after an OIT.
Consent to publish: Patient consented to the publication of this 
abstract.
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Introduction: Mild to severe adverse reactions to food in the commu-
nity are under-researched, and bio-psychosocial risk factors are poorly 
understood. An online system has been developed to allow for real-
time reporting of incidents for food allergic patients in seven Euro-
pean countries under auspices of the iFAAM (Integrated Approaches to 
Food Allergen and Allergy Risk Management) project.
Our aim was to develop and validate a real-time, multilingual, online-
based reporting system to capture real-world circumstances and 
determinants of food-allergic incidents across Europe.
Methods: The Allergic REACTions (AlleREACT) is an international com-
munity-based intervention using a prospective multi-site design. 
Adults, adolescents and parents of children with food allergies in the 
UK, Ireland, Germany, Spain, France, Belgium and Poland will report 
food allergic incidents using a validated online reporting tool between 
April-December 2016.
Results: Following experts’ consultations and Patient Organisations’ 
(POs) workshops, a short version of a previously validated reporting 
tool ‘Allergic Reactions in the Community’ (AlleRiC) was adapted for 
international use. The new measure has already been tested online 
and piloted in the English language by adults and parents of children 
with food allergies (N  =  37). Translation and back-translation have 
been completed in German, Spanish, French and Polish and the sys-
tem has now been launched. The resulting tool “AlleREACT’” is a com-
prehensive (42 items), user-friendly and takes only 10 min to complete.
Conclusions: AlleREACT builds on e-Health and community-based 
research frameworks. It will provide novel findings in areas not pre-
viously researched in depth, and promote understanding of food 
allergic incidence with implications for risk assessment and risk man-
agement across Europe. It is intended that the tool will be used by 
patient groups and individuals within the community and managed 
by POs from participating countries.
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Introduction: Our aim was to evaluate the outcome of oral immuno-
therapy (OIT) in cow’s milk allergy 7–11 years after starting the OIT.
Methods: A real-life follow-up study on OIT to milk was started in 2005 
by a protocol presented in detail earlier [1]. By March 2009, 67 chil-
dren had participated in OIT (Table 3). Information about current milk 
consumption and side effects to milk were collected from 63 patients 
between January to April 2016 with a questionnaire, phone calls, or 
from medical records (Table 4).
Results: At the 1-year follow up visit, 51 (76%) patients consumed milk 
daily (Fig.  6) and 23 (45%) of them reported side effects to the milk. 
The side effects were mostly mild and they required no medication 
Table 3 See text for description
Baseline characteristic before milk OIT (n = 67)
Male/Female 37 (55%)/30 (45%)
Age (y), median (InterQuartile Range, IQR) 9.9 (5.8–17.4)
Median age when cow’s milk allergy was diagnosed 
(months)
7
Asthma, [n (%)] 51 (76)
Allergic rhinitis, [n (%)] 41 (61)
Atopic dermatitis, [n (%)] 30 (45)
Baseline milk IgE (kUA/L), median (IQR) 17.2 (0.2–1390.0)
Baseline milk skin prick test score (mm), median (IQR) 10.0 (4.0–20.0)
Table 4 See text for description
Long-term follow-up data collection (n = 67)
Median follow‑up time (years) 8.7 (7.0–11.1)
Questionnaire 35 (52.2%)
Phone 15 (22.4%)
Medical records (recent 6 months) 13 (19.4%)
Lost in the follow up 4 (6%)
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or only antihistamine. One patient had an anaphylactic reaction dur-
ing the OIT build-up phase. After the reaction, the patient continued 
OIT and is now consuming 5 dl milk a day without reporting any side 
effects. At the 7–11 years follow-up, 48 (72%) patients consumed milk 
daily (Fig. 6) and 18 (38%) of them reported side effects to milk dur-
ing the last 12  months. Side effects were mostly mild requiring no 
medication, or only antihistamine, but two patients reported using 
adrenalin to allergic reaction after consuming milk. Information about 
side effects was not available for 6 (13%) patients. Five patients, who 
were previously consuming milk, had discontinued its consumption 
because of the symptoms. However, two of them recently had a nega-
tive oral food challenge (OFC) to milk. Five patients who previously 
failed in milk OIT, and were on a milk-avoidance diet, consumed milk 
at the long-term follow up. They had started using small amounts of 
cheese daily by escalating doses or had a negative OFC to milk or had 
started milk OIT again. Our results suggest that performing a long-
term follow-up after milk OIT is important, irrespective of the outcome 
of the OIT.
Conclusions: After milk OIT, the milk consumption can change over 
time and allergic reactions may appear even after 7 years or more of 
daily milk consumption.
Reference
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Introduction: FPIES is a non-IgE-mediated food allergy, often unrec-
ognized, attributed to a variety of foods, with cow’s milk (CM) and fish 
to be considered two of the most common culprit foods.
Our aim was to evaluate diagnostic and management procedures in 
children with FPIES attributed to CM and fish, in a reference Allergy 
Unit of a tertiary Hospital in Greece.
Methods: This is a retrospective study on records between 10/2010 
and 10/2015. Diagnosis was based on self-reported clinical his-
tory, however oral food challenges (OFCs) were performed in case 
of unclear history. Age at diagnosis and resolution of the syndrome 
were recorded. For the assessment of potential tolerance, OFCs were 
performed, in a wide range of time, in dependence of patients’ acci-
dental exposures, and not according to conservative approach (every 
18–24 months) as recommended.
Results: 47 patients (23 males) were diagnosed with FPIES, 27 to CM 
and 20 to fish (median age: 5 and 18  months, IQR 2–7 and 12–22.5 
respectively). We performed 45 OFCs in total (18 to fish), 41 to evalu-
ate potential tolerance (17 to fish). As regards OFCs performed to 
assess potential tolerance, 11 out of 17 (64.7%) OFCs to fish were 
positive, while corresponding ratio to CM was 4/24 (16.7%). Median 
time between diagnosis and OFC was 24  months in total (IQR 16.5–
36.7), while regarding patients with negative OFC outcome (toler-
ance), the corresponding time was 22  months (IQR 15.9–30.4). In 
children still with active disease at re-evaluation, it was noted that in 
respect to fish even though they have been challenged in older age 
(fish 73.3 ±  25.9  months vs CM 22.6 ±  6.8  months, p =  0.002), they 
had in their majority positive OFCs. A significant association regard-
ing the interval between diagnosis and OFC with OFC outcome 
(fish 51.1  ±  25.5  months vs CM 14.7  ±  2.2  months, p  =  0.015) was 
also noted. Out of 41 children with FPIES diagnosis at presentation, 
63.4% (n = 26) were tolerant by means of OFCs (6 to fish). In respect 
to the interval from diagnosis to tolerance, correlation with food 
type was noted (fish median 27.7 months, IQR 22–73.5 vs CM median 
20 months, IQR 15.1–26.9, p = 0.044).
Conclusions: There is heterogeneity in the resolution of FPIES 
depending on the implicated food. FPIES caused by fish has a delayed 
remission. Ιt is more cost-effective for both the patients and the medi-
cal staff to avoid early OFCs, compared to time of diagnosis, as regards 
fish or more delayed concerning CM.
Fig. 6 See text for description
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Introduction: Children and adolescents with food allergy are the 
group most at risk of serious and fatal reactions from accidental inges-
tion of an allergen. Ways in which they cope with their food allergy 
could explain this increased risk. A systematic review was conducted 
of published papers looking at coping strategies used by children and 
adolescents with food allergy to explore current knowledge and iden-
tify gaps for future research.
Methods: Electronic searches were conducted using the following 
databases: MEDLINE, PsycINFO, SCOPUS, Science Direct, Web of Sci-
ence. Papers including data from participants aged 8–16  years old 
with a food allergy or hypersensitivity were retrieved and analysed. 
Thematic analysis was used to synthesise the findings.
Results: Twelve studies were selected from 4672 papers after a review 
of abstracts and full texts. These papers underwent data extraction, 
quality appraisal and thematic analysis. Six key themes were identi-
fied: (1) Coping with risk (2) Using auto-injectors (3) Education, knowl-
edge and understanding (4) Social support (5) Taking responsibility 
and (6) Coping with emotions. Adaptive coping strategies were iden-
tified such as problem-solving and planning; maladaptive coping 
strategies such as mental or behavioural disengagement were also 
apparent. Education and knowledge regarding allergies and its treat-
ment varied and influenced how well patients coped, as did attitudes 
towards the allergy. Social and peer support was important for cop-
ing but can be limited for children and adolescents with food allergy. 
Many felt that their needs were not fully understood, even at school, 
and some felt pressured by peers or social situations to ignore the 
risks. Coping with food allergy by children and adolescents is a com-
plex multifaceted process and the type of strategy used is dependent 
on the individual’s perception of risk, the situation or environment 
they are in, the influence and attitude of others, and the individual’s 
age and gender. Participants in the review were mainly teenagers; 
therefore further research on how younger children cope with food 
allergy is needed.
Conclusions: Ways of teaching adaptive coping strategies from point 
of diagnosis need to be investigated. The impact of social influences 
should be considered when supporting this population particularly 
as they get older, with age-appropriate strategies that facilitate confi-
dence in being able to cope with and manage their food allergy.
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Introduction: This general population based RCT aims at answering 
two major hypotheses: First, systematic early introduction of solid 
foods decreases the incidence of food allergy and dietary restrictions 
by the age of one year. Second, stimulation with the symptom-elic-
iting food rather than avoidance will induce tolerance in babies with 
non-severe allergic symptoms.
Methods: All new born babies living in the city of Oulu are recruited 
to the study (n =  1380) at their first health nurse visit (at or before 
1 month of age) in the local primary care child health clinics. Families 
in the intervention group will get an instruction booklet including 
information on early systematic introduction of solid foods starting 
at the age of 4 months, with foodstuff from all major groups in diet 
by the age of 6  months (vegetables and fruits, wheat and other 
grains, meat, fish, egg, dairy products). Furthermore, the booklet 
includes information and instructions on food related symptoms and 
atopic eczema. Babies with mild symptoms are encouraged to con-
tinue the symptom-eliciting food. All families fill out monthly inter-
net-based questionnaires on food diary, symptoms, diagnoses and 
health care visits until the age of 1 year. Dietary restrictions and food 
allergy diagnoses are verified at the age of one year. The primary 
outcome measures will be the incidence of diet restrictions, parent-
reported and doctor-verified food allergies and atopic eczema by the 
age of 1  year. The secondary outcomes will be the need for health 
services and the family experienced distress during the first year of 
life.
Results: The study has started in March 2014. Currently, 1317 babies 
have been recruited and 645 children have completed the entire study 
by the end of April 2016. According to the preliminary data from ques-
tionnaires at the age of 6 months, 70.6% of 425 children in the inter-
vention group and 74.1% of 444 children in the control group were 
still on breast-feeding (p =  0.256). Furthermore, 45.9% of children in 
the intervention group and 23.3% in the control group (p < 0.001) had 
2 or more potentially allergenic food (wheat, egg, fish or fermented 
milk products) in their diet before the age of 6 months.
Conclusions: The study protocol seems to be feasible at a popula-
tion level and does not affect the rate of breastfeeding during the first 
6 months of babies. INTO-study will provide invaluable data on early-
feeding strategy in primary and secondary prevention of food allergy.
PP066 
Adherence and safety in home doses in oral specific tolerance 
induction
Eva Lasa1, Carmen D’Amelio2, Sara Martínez1, Alejandro Joral1, Gabriel 
Gastaminza2, Maria Jose Goikoetxea2
1Hospital Universitario Donostia, San Sebastián, Spain; 2Clinica Universi‑
dad de Navarra, Pamplona, Spain 
Correspondence: Eva Lasa ‑ evamarialasa@gmail.com
Clinical and Translational Allergy 2017, 7(Suppl 1):PP066
Introduction: Egg and milk allergy is the main food allergy in the 
paediatric population in our country. In recent years, as an alterna-
tive to egg and milk avoidance a novel and promising treatment has 
appeared consisting in induction of oral tolerance. Allergenic food 
doses are increased progresively from a minimun amount of egg/milk. 
Doses are increased in the hospital and the same dosis are maintained 
at home. The procedure is not free of risk even when doses are taken 
at home.
We aim to evaluate the adherence to desensitized food doses and 
patient safety at home.
Methods: One-hundred and twenty patients treated by specific oral 
tolerance induction (SOTI) to milk or egg from two hospitals were 
invited to fill an anonymous survey via web. Similar recommendations 
were given to the patients under SOTI in these two hospitals and full-
time access to anallergist was available by e-mail or telephone. Survey 
asked about adherence to treatment, cofactors avoidance and confi-
dence about treating reactions at home.
Results: 109 patients answered the survey. 70% of the patients never 
forgot to take the dose. Whereas 82% never forgot to take premedi-
cation (antihistamines), 40% forgot to take asthma medication. Most 
of the patients always avoided cofactors (89% avoided fasting, 90% 
NSAIDs, 78% exercise) and 88% of the patients were correctly moni-
tored after taking the doses always. However, regarding reactions at 
home, at least in one reaction, 53% of the patients did not know if the 
reaction suffered should be treated and 26% did not know the type 
of medication required for that reaction. Most of the patients showed 
good adherence to the treatment and correct cofactors avoidance 
however, patients do not feel confident when a reaction occurs.
Conclusions: Patients need to be teached in managing reactions 
before starting a food SOTI.
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Introduction: This study investigated the effects of a new amino acid-
based formula (AAF) with pre-and probiotics (synbiotics) in infants 
with suspected non-IgE mediated CMA.
Methods: In a prospective, randomised, double-blind controlled 
study (registered as NTR3979), infants with suspected non-IgE medi-
ated CMA were enrolled to receive either an AAF (control n = 36) or 
an AAF with synbiotics (oligofructose, long-chain inulin, Bifidobac-
terium breve M-16 V) (test n = 35) for 8 weeks. Faecal samples were 
collected at baseline and weeks 8, 12 and 26 after initiation of dietary 
management. Faecal samples from non-randomized healthy breastfed 
infants, which were age-matched with CMA infants at wk 8 of inter-
vention, were collected as a reference group. Primary outcomes were 
bifidobacteria and the Eubacterium rectale/Clostridium coccoides 
group (ER/CC) as percentage of total faecal bacteria determined by flu-
orescent in situ hybridization. To monitor intestinal inflammation and 
immune status secondary and exploratory outcomes included faecal 
Calprotectin (FC) and Eosinophilic Cationic Protein (ECP) and faecal 
α1-antitrypsin (A1A).
Results: Average age (±SD) of CMA infants (n  =  71) was 
6.00 ± 2.98 months at inclusion of the study and 7.84 ± 3.25 months 
in the reference group (n = 51). Of the CMA subjects, 90% presented 
predominantly GI symptoms and 10% dermatological symptoms; 
stratification was based on these manifestations. Sixty CMA infants 
completed the 8  weeks intervention (control n  =  32; test n  =  28). 
Using the intention-to-treat data set and ANCOVA technique, levels of 
bifidobacteria at 8 weeks were significantly higher in the test (35.6%) 
vs. control group (14.7%) (p < 0.001) and ER/CC was significantly lower 
in the test (12.1%) vs. control group (26.6%) (p < 0.001). Determined 
bacterial proportions in the test group were close to levels observed in 
the healthy reference group. Median FC and A1A were lower in week 
8 compared to week 0, but were not significantly different between 
groups at week 8 (p = 0.815 and p = 0.717, respectively). Additional 
outcomes, including healthy reference data, will be presented.
Conclusions: This study shows that an AAF with specific synbiotics 
significantly affects the gut microbiota composition of non-IgE CMA 
infants. Determined bacterial proportions in the test group were close 
to levels observed in the healthy reference group. Median levels of FC 
and A1A decreased in both study groups at week 8 of intervention.
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Introduction: Food allergy (FA) has a significant impact on the 
patient’s quality of life, namely on travelling. We aimed to assess the 
ability of the commercial airlines to support passengers with FA.
Methods: A worldwide commercial airlines on-line survey, includ-
ing 841 companies, from 216 countries, addressing their preparation 
to support passengers with FA was performed. A total of 721 airlines 
were reached by 2 reminders (3 refuse to participate and contact failed 
with 117). Additionally, the Top 100 Airlines, according to the World 
Airlines Awards 2015, were contacted to reply to a simulated reserva-
tion for a passenger with FA addressing staff training, the availability 
of special meals for FA on board, and the possibility to travel with their 
own food and medication. The information available on the airline’s 
website was also analysed. Statistical analysis included descriptive 
statistics.
Results: 3 out of 721 companies completed the survey and reported 
to have trained staff to deal with emergencies and no restrictions for 
travelling costumers with FA concerning to food or medication carry-
ing. From the remaining, 713 failed to reply and 5 reported not being 
able to provide requested information. Considering the simulated res-
ervation, 22 out 100 replied. Six reporting to have the information on 
their website, 8 having special food allergy menus, 2 staff training for 
emergencies, 9 allowed passengers to carry their epinephrine injec-
tor; 11 allowed to bring food and 8 highlighted that cannot guarantee 
allergen-free flights, regarding the risk of cross-contact. Concerning 
the Top 100 website information, only 4% mention that the flight crew 
are trained, 67% have special FA menus, 40% recommend the carriage 
of medication and 26% refer it is possible to carry food on board.
Conclusions: Most of the commercial airlines are not prepared or even 
warned about the impact of an in-flight allergic reaction. Our results 
aware for a priority on airline’s education and training in FA order to 
increase the family’s confidence to travel and afford the life safety on 
board.
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Introduction: Food allergy is a growing problem in the school aged 
children It is a common cause of anaphylaxis [1], with an estimation of 
1 in 25 children at school affected [2]. Surveys indicate that 16 to 18% 
of children with food allergy experience a reaction in school [3,4]. In 
UAE, 8% of children suffer from food allergy [5].
The objectives of this study was to look for School readiness to treat 
anaphylaxis to food allergy, how are they managed, and to identify any 
scope for further improvement.
Method: Data was collected retrospectively from schools in Sharjah, 
A validated questioner (on epinephrine administration) was distrib-
uted in English and Arabic to all Schools which was filled by the School 
clinic nurse /doctor for those children’s who encountered life threaten-
ing reactions to food and required epinephrine administration during 
2013–2014. 33 out of 80 schools in Sharjah completed the epinephrine 
administration form. An official approval from Ministry of Education, 
Sharjah was obtained for this study.
Results: Eighty schools in emirate of Sharjah have been invited to 
participate in the survey 33 schools responded by filling up the ques-
tioner. The survey showed the following results:
  •  Number of the schools that have Epi pen available: 3 schools (9%).
  •  Number of the schools that have emergency response activated 
team: 3 schools (9%).
 •  Number of food allergy cases reported 14 cases; 2 cases were 
managed with Epi pen adminstration, and 12 cases were man-
aged with antihistamines and transferred immediately to hospital 
as epi pens were not available.
Page 49 of 79 Clin Transl Allergy 2017, 7(Suppl 1):10
Time required for treatment of the two cases treated with Epi pen was 
within 3to 5 min, one given by the student and the other by the school 
doctor.
Conclusions: Our survey showed that Anaphylactic reaction in schools 
are not uncommon. Management of such cases need clear policies to 
recognize and treat allergic reactions and anaphylaxis. Epi pen avail-
ability, food allergy action plans and school nurse training and educa-
tion are vital to ensure the safety of such children.
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Introduction: This study was performed to identify the critical success 
factors (CSFs) of an anaphylaxis app to support patients in an emer-
gency situation.
Methods: CSFs were identified through a literature study, by analyzing 
existing anaphylaxis apps and by surveying a sample of patients who 
visited the website of the Dutch Anaphylaxis Network. An expert inter-
view was used to further reflect upon the findings.
Results: Five existing anaphylaxis apps were found, with different fea-
tures, most were for the UK or US market, available for free or at low 
costs. The literature presents the following CSFs that influence the 
adoption of mobile technology for allergic patients: 1. being context-
aware through scanning of physical items; 2. automating the retrieval 
of product-related allergy information; 3. helping to improve the 
patient’s understanding of their condition in general; 4. ensuring medi-
cal validation of given advice; 5. being tailored to patient’s medications 
and 6. providing advice in a patient-sensitive manner, based on age 
and level of experience. The survey yielded 276 responses, 80% was 
female, mean age of 40.96 (sd  =  11.2) years and an average of 9.81 
(sd = 7.5) years of experience with anaphylaxis. The desirability of an 
app to support anaphylaxis patients was rated with an average of 8.34 
on a scale of 1 to 10 (sd = 1.8), while the probability of the respondents 
using such an app was rated with an 8.75 (s = 1.9). Most important fea-
tures of an app according to the respondents was Clarity of information 
(6.68); Medical validation (6.62) and Emergency procedure informa-
tion (6.48). Less important features were Interactivity of the app (4.50); 
Allergy knowledge quiz (3.33) and use of games (2.66). The expert men-
tioned that the app should be available at no cost to boost its use.
Conclusions: An app that includes medically validated and clear 
information on allergy symptoms and treatment procedures has 
great potential to fill a gap in the support of anaphylaxis patients. Rel-
evance for daily practice. An app in Dutch language will be developed 
to support patients or caregivers in emergency situations. The app 
will be patient-tailored, so that a patient can import his own emer-
gency medication and personal information. The main feature is a 
step-wise approach to cope with allergic reactions. Besides general 
information about the most important causes for anaphylaxis: food 
allergy or insect sting allergy will be given. The app will be built in 
cooperation with Allergy patient’s organizations, the Dutch derma-
tologists’ association and the University Medical Centre Utrecht, the 
Netherlands.
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Introduction: Nutritional deficiencies have been reported in food-
allergic children. The aim of our study was to assess the actual food 
intakes and nutritional status of children with suspected or proven 
multiple food allergies when elimination diet was not supervised by 
continuing dietitian follow-up.
Methods: 22 children (8 girls, 16 boys; mean age 5.0 ± 4.1 years) with 
proven (19 children) or suspected only (3 children) multiple food aller-
gies were studied retrospectively. Twenty children presented with 
atopic dermatitis, eight with anaphylaxis, two with hives and four with 
gastrointestinal symptoms. Two children had additional conditions 
that influenced nutritional status (one cromosomopathia, one hista-
mine intolerance). Nutritional intakes assessment was passed on exact 
questioning on actual food avoidance. Children’s weight, height, labo-
ratory data for nutritional parameters were assessed.
Results: In 18 (82%) children additional questioning revealed their 
diet was extended from advised by physician. Fourteen children (64%) 
did not eat milk, egg and wheat and in addition numerous variable 
foods were also avoided in their diets- in nine of animal origin and in 
twelve of plant origin (most often peanuts and tree nuts). Two children 
did not consume egg and milk and excluded also some plant and/or 
animal foods, two children avoided numerus plant foods, one child 
did not eat cow milk and some plant foods and one child had no spe-
cial food restrictions. In described group of 22 children the means for 
anthropometric measures were below the average for age (41.P for 
height and 35.P for weight). Three children were <−3% for relative 
height and two children were <−3% for relative weight. Lower serum 
levels of levels of albumin/iron/zinc/selenium/vitamin B12 were found 
in 5/8/11/10/1 children, respectively. Three children had osteoporosis 
and one had osteopenia. Eleven children (50%) had multiple nutri-
tional deficits. Combined diet without cow milk, egg and wheat (14 
children) was always associated with nutritional deficits.
Conclusions: Multiple food elimination diet (e.g. without cow milk, 
egg and wheat) has negative impact on nutritional status of food-
allergic children if not supervised continually by experienced physi-
cian and dietitian.
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Introduction: One of the most important implications of a multiplex 
assay such as ISAC assay should be its ability to distinguish between 
allergy and asymptomatic sensitisation due to cross reactivity which 
could ex. influence the decision for performing a food/latex challenge 
in children with multiple allergies.
Methods: Test results of food and latex recombinants in 53 ISACs were 
retrospectively analysed and compared in allergic versus tolerant 
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children. Allergy was confirmed by typical clinical history and deter-
mination of specific IgE/skin prick test, by provocation test or by very 
high values of specific IgE/skin prick tests. When analysing potential 
cow’s milk/egg/soy/wheat/peanut/hazelnut/fruit/latex allergy 1/2 /8 
/1 /14 /15 /3 /3 children were excluded because of unknown clinical 
allergic status (e.g. waiting/refusing provocation test).
Results: 12 egg allergic children had significantly higher specific 
IgE to nGal d 1, nGal d 2 and nGal d 3 than 39 egg tolerant children 
(p  <  0.0001). 12 cow’s milk allergic children had significantly higher 
specific IgE to nBos d 4, nBos d 5 and nBos d 8 than 40 cow milk tol-
erant children (p < 0.0001). 16 peanut allergic children had higher spe-
cific IgE to rArah 1, n/rArah 2, n/r Arah 3, nArah 6, rArah 8 and rArah 9 
than 23 peanut tolerant children (p from <0.0001 to < 0.05). 14 hazelnut 
allergic children had higher specific IgE to rCor a 8 and rCor a 9 than 25 
hazelnut tolerant children (p = 0.006 and p = 0.0009, respectively) and 
significantly lower specific IgE rCor a 1 than hazelnut tolerant children 
(p < 0.0001). Three soy allergic children had significantly higher specific 
IgE to nGly m 5 and nGly m 6 than 42 soy tolerant children (p < 0.001 
and p = 0.003, respectively). Two wheat allergic children differed from 
50 wheat tolerant in rTri a 19, rTri a 14, tTri a aA_TI (p from < 0.001 to< 
0.05). 6 children with anaphylaxis to different fruit had significant higher 
n/r Pru p 3 than 25 fruit tolerant children (p =  0.03). 18 children with 
OAS associated with fruit had significantly higher specific IgE to rPru p 
1, rMal d 1 and rApi g 1 than 25 fruit tolerant children (p < 0.0001). Four 
children allergic to latex had significant higher specific IgE antibodies to 
rHev b 6.01 than 46 latex tolerant children (p = 0.005).
Conclusions: ISAC differentiated allergic from tolerant children when 
analysing recombinants of cow’s milk egg, peanut, hazelnut, soy, 
wheat, fruit or latex.
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Introduction: To describe the frequency and evolution of esophageal 
eosinophilic infiltration in patients with cow’s milk protein allergy 
(CMPA) submitted to oral desensitization.
Methods: A descriptive study involving pediatric patients with CMPA 
submitted to desensitization protocol from 2012 to 2016. This protocol 
included daily intakes of increasing diluted amounts of cow milk until 
120–200 ml of non-diluted milk. The mean initial dilution was 10−7 and 
the average time of progression from diluted milk to non-diluted milk 
was 3  months. Patients reported symptoms daily, and when persis-
tent gastrointestinal symptoms occurred, endoscopy was performed. 
Abnormal findings (endoscopy and histology) suggestive of eosino-
philic infiltration (eosinophils ≥15HPF) demanded appropriated treat-
ment with proton-pump inhibitor (PPI) for 8 weeks. Swallowed topical 
corticosteroids (STC) was initiated if inadequate response.
Results: 19 patients were enrolled (11 F: 8 M), mean age of 10,25 years 
at baseline. All patients had previous history of anaphylaxis and posi-
tive specific IgE to cow milk and casein. Nine patients (9/15) presented 
specific IgE levels to cow milk and casein higher than 100  kU/L. Five 
patients developed gastrointestinal symptoms during treatment, all of 
them receiving non-diluted milk being abdominal pain the most fre-
quent complaint, followed by vomiting and dysphagia. All patients had 
abnormal macroscopic findings, and increased eosinophils (mean = 20 
HPF Eo). Four patients (P1, P2, P3, P4) received PPI as initial therapy, and 
one patient lost follow up (P5). Endoscopy was repeated and eosino-
phils were normal in two patients and clinical symptoms disappeared 
(P1, P2) but symptoms returned in one (P1). Another patient had milk 
excluded (P3) and P4 is waiting second endoscopy. STC was necessary 
in two patients with distinct evolution (P1, P3). One patient kept milk 
ingestion and STC (P1) and the other persisted with endoscopic abnor-
malities despite milk exclusion and STC treatment (P3).
Conclusions: Esophageal eosinophilic infiltration is a described compli-
cation in patients submitted to oral desensitization, but it seems more 
prevalent in patients with severe allergy and presents different out-
comes. It is necessary continuous follow up of these patients for long 
periods to understand the disease and provide the best management.
POSTER SESSION 3: Anaphylaxis • Experimental and socioeconomic 
aspects • Molecular mechanisms
PP084 
Vitamin D levels in patients with anaphylaxis with or 
without asthma compared to the general Saudi population
Abdulhadi Al‑Qahtani, Rand Arnaout, Agha Rehan Khaliq, Rashid Amin, 
Farrukh Sheikh
King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia 
Correspondence: Abdulhadi Al‑Qahtani ‑ Dr.abdulhadi@outlook.com
Clinical and Translational Allergy 2017, 7(Suppl 1):PP084
Introduction: Vitamin D is known for its role in the bone metabolism 
but it also has immune-modulatory properties. Most of the evidence 
points towards a causal relationship between low vitamin D levels and 
the development of asthma and allergies but the results are not con-
clusive. We studied the vitamin D levels of patients who presented to 
our hospital with anaphylaxis with or without asthma and compared it 
to previously published vitamin D levels in Saudi population.
Methods: All patients given new Adrenaline auto injector prescrip-
tions for anaphylaxis between the periods of 1/1/2010 and 31/12/2011 
were included in this study. Their medical records were also screened 
for diagnosis of asthma.
Results: A total of 238 patients were identified. Data about Vitamin 
D level was available for 121 of those patients. 84 out of these 121 
patients were also being treated for asthma. There was no evidence 
of any difference in vitamin D levels between those with or without 
asthma presenting with anaphylaxis. Vitamin D levels compared in 
patients with anaphylaxis to the general population revealed that 
while there was no significant difference in terms of vitamin D defi-
ciency, patients who presented with anaphylaxis had a higher chance 
of either having a normal or higher than normal vitamin D level.
Conclusions: When compared with the general population, patients 
with anaphylaxis have more chance to have normal vitamin D level. Vita-
min D deficiency was not found to be a significant risk factor for anaphy-
laxis in our patients compared with the general Saudi population.
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Introduction: Early recognition and epinephrine administration are 
essential in anaphylaxis management since delays in its diagnosis 
and treatment have been associated with fatal anaphylaxis. Vali-
dated 5-level paediatric triage systems prioritize anaphylaxis to Level 
I (Resuscitation) or II (Emergent). Inadequate triage of these patients 
may worsen their prognosis. We analysed the quality of the triage of 
children with anaphylaxis.
Methods: Retrospective review of the triage charts (local adaptation 
of the Canadian Paediatric Triage and Acuity Scale) of a cohort of chil-
dren attended for anaphylaxis at a Paediatric Emergency Department 
(PED) between 2012 and 2016. According to their final triage level, we 
compared: demographics, waiting time for physician, initial triage level 
according to the initial assessment (Paediatric Assessment Triangle 
[PAT]), symptomatic patients during medical examination and epineph-
rine administration at PED and observations recorded by triage staff.
Results: We analysed 137 charts. Final triage levels were: Level I: 18.1%, 
Level II: 15.2%, Level III: 56.9% and IV:9.5%, respectively. Median ages 
were: 8.83 (IQR: 13.41y); II: 4.45 (IQR:13y); III: 4.5 (IQR:14.5y) and IV: 5.58 
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(IQR: 5.58y) (p = 0.09). Median waiting times for physician were: Level 
I: 0 (IQR: 22 min); Level II: 7 (IQR:22 min); III: 10 (111 min) and IV: 17 (IQR: 
72 min) (p = 0.01). Patients with initial triage level V (stable PAT): Level 
I: 68%; II:71.4%, III: 91%; IV:92.3%(p  =  0.006). Rates of symptomatic 
patients during medical examination and epinephrine administra-
tion at PED: Level I: 80%/76%; II: 57.1%/61.9%; III:48.6%/51.3% and IV: 
53.8%/46.2% (p = 0.056 and p = 0.089). Symptoms compatible with 
anaphylaxis were recorded by triage staff in 28% of Level I, 33.3 of II, 
39.7% of III and in 7.6% of level IV triage charts (p = 0.134)
Conclusions: Only 33.3% of the triage patients were triaged correctly. 
A significant number of the charts contained sufficient information to 
suspect an anaphylaxis. Inadequate triage delayed medical attention 
and treatment. Symptom recognition should be stressed out to triage 
possible anaphylaxis. Specific risk discriminators for anaphylaxis are 
needed to improve its identification during triage procedure.
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Introduction: Conflicting results have been obtained regarding roles 
mast cells and other effector cells in models of active systemic ana-
phylaxis (ASA). In part, this might reflect the choice of adjuvant used 
during sensitization, as various adjuvants might differentially influence 
the production of particular antibody isotypes. Moreover, in humans, 
sensitization generally occurs in the absence of an artificial adjuvant. 
We therefore developed an adjuvant-free mouse model of ASA, and 
compared pathways of anaphylaxis in this model vs. in an ASA model 
using adjuvants for sensitization.
Methods: Mice were sensitized intra-peritoneally (i.p.) with ovalbumin 
(OVA) at weekly intervals for 6  weeks (adjuvant-free ASA model), or 
once i.p. with OVA together with Alum and Bordetella pertussis toxin 
(ASA model using adjuvants). Mice were then challenged i.p. with OVA 
two or three weeks later, respectively.
Results: Wild-type (WT) mice developed immediate hypothermia in 
both models, but significant mortality was only observed in the ASA 
model using adjuvants for sensitization. Depletion of monocytes/mac-
rophages with clodronate liposomes significantly reduced anaphylaxis 
in both models. Depletion of neutrophils using anti-Gr-1 antibodies 
reduced anaphylaxis in the ASA model using adjuvants, but had no effect 
in the adjuvant-free ASA model. By contrast, anaphylaxis developed in 
mast cell-deficient KitW-sh/W-sh mice in the ASA model using adjuvants, 
while it was markedly reduced in both KitW-sh/W-sh mice and Cpa3-Cre; 
Mcl-1 fl/fl mast cell-deficient mice in the adjuvant-free model. Finally, we 
found that combined treatment with the anti-histamine triprolidine and 
the platelet-activating factor (PAF) receptor antagonist CV-6209 almost 
entirely blocked anaphylaxis in the adjuvant-free ASA model.
Conclusions: Our data demonstrate that components of both the 
“classical” and “alternative” pathways contribute to anaphylaxis in the 
adjuvant-free ASA model. Monocytes/macrophages contribute to ana-
phylaxis regardless of the presence or absence of adjuvant during the 
sensitization, but the use of adjuvant in effect masks any non-redundant 
contribution of mast cells while revealing a contribution of neutrophils.
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Introduction: To assess changes in WBC count (WBC-C) occurring dur-
ing an episode of anaphylaxis in human subjects.
Methods: We conducted a search for hospitalizations in any unit of 
our institution (tertiary hospital) between Jan/10 and Jul/15 with an 
ICD9 code of anaphylaxis (995.0, 995.6, or 999.4). Medical records were 
reviewed and patients not fulfilling the currently accepted diagnostic 
criteria (Sampson HA et al. 2006) were excluded, as well as those with-
out WBC-C performed during the episode.
Results: From Jan/10-Jul/15, 35 inpatients had one of the searched 
ICD9 codes. We excluded 9 (25.7%) patients not fulfilling anaphy-
laxis criteria, and 5 (14.3%) with no WBC-C, leaving 21 (60.0%) to be 
included in the analysis (61.9% females, 52.1 ± 25.6 years). Seventeen 
(81.0%) patients had anaphylactic shock. There were cardiovascular 
(CV) manifestations in 19 (90.5%) patients; 12 (57.1%) had mucocu-
taneous involvement and 12 (57.1%) respiratory signs/symptoms. 
Adrenaline was scarcely used. Drugs were the main suspect (n = 17, 
81.0%); only 7 (33.3%) patients were referred to an Allergist. Tryptase 
levels were determined in 4 (19.0%) patients and were increased in 3. 
During the anaphylactic episode, 12 (57.1%) patients presented a de 
novo increase in peripheral relative and absolute neutrophil counts 
(mean  ±  SD: 85.8  ±  5.9% and 13.8  ±  7.1  ×  10−9/L, respectively), 8 
(66.7%) also with leucocytosis; 5 (23.8%) patients had a fall in blood 
neutrophils. Two (9.5%) fatal outcomes occurred (1 with neutrophilia). 
The limited sample size may be explained by the decision of including 
only hospitalized patients, fact that may justify the greater percentage 
of anaphylactic shock. Our analysis revealed clear reduced tryptase-
dosing rates and adrenaline underuse. Although it is the common 
understanding that anaphylaxis associates with blood neutropenia, an 
increase in systemic neutrophils has been previously described in non-
human anaphylaxis models and changes in blood-leukocyte popula-
tions were pointed as possible markers for severe shock in mice.
Conclusions: To the authors’ knowledge this is the first study to 
describe the occurrence of systemic neutrophilia in humans in the 
context of anaphylaxis. Despite the limited sample size, our study 
is ongoing and the authors believe that this is a promising field of 
research in understanding the complexity of anaphylaxis.
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Introduction: To establish the knowledge that exists among ado-
lescents in our region about anaphylaxis and its treatment. To deter-
mine the usefulness of a theoretical and practical workshop on the 
management of anaphylaxis and adrenaline auto-injectors among 
adolescents.
Methods: We conducted two methodological approaches: a descrip-
tive study of knowledge about anaphylaxis in a cohort of secondary 
students through a questionnaire; an analytical quasi-experimental 
study comparing the previous results with those obtained after con-
ducting a workshop on anaphylaxis. The workshop consisted of a the-
oretical and practical training of 45 min.
Results: We included 115 teenagers from 13.74  years on average, 
being the 13.9% of them allergic to some food. Before the workshop, 
the 82.6% of teenagers recognized anaphylaxis symptoms. Later, this 
percentage reached the 87.2%. The 41.7% of them considered the 
adrenalin as a treatment, a slightly higher (56%) percentaje among 
allergic. After the workshop, the 100% of respondents considered 
the adrenalin as a first choice, which means a statistically significant 
change. With regard to the correct use of auto-injectors, it was well 
identified by the 42.6% of students before the workshop and by the 
97.2% of them thereafter. The most frequent cause of error was the 
location of the injection, followed by the device clamping. In the 
questions formulated as a clinical case before the workshop, the 
41.7% of respondents would administer adrenalin to a patient with 
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anaphylaxis. This figure increased among allergic up to 50%; they 
would then reach the 99.1%, which is a statistically significant change. 
It is common for adolescents to develop their activities accompanied 
by other teenagers, without the presence of their family and caregiv-
ers. Hence the importance of a universal education in anaphylaxis 
in school. We plan to carry out our study on a pilot basis, in order to 
assess its expansion to other schools in our region. We observed a sta-
tistically significant increase in adolescents that identify anaphylaxis 
and properly use adrenaline.
Conclusions: There is a significant lack of knowledge about anaphy-
laxis among teens in our sample. The development of a theoretical 
and practical workshop on Anaphylaxis and the management of self-
injectable epinephrine in their education significantly increases their 
knowledge and makes us consider its universalization.
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Introduction: Anaphylaxis in children and adults differs with regard 
to elicitors and clinical picture. Little is known about anaphylaxis in 
elderly patients. We aimed at characterizing typical features of ana-
phylaxis in this group of patients.
Methods: Data from the Network for Online Registration of Anaphy-
laxis (NORA) were analyzed for German speaking countries (Germany, 
Switzerland and Austria). We compared data from patients aged ≥65 
(elderly) with data from patients aged 18–64 (main adult group) in 
terms of elicitors, clinical symptoms, comorbidities and emergency 
treatment.
Results: Between July 2007 and March 2016, anaphylaxis was regis-
tered in 939 elderly and 4665 of other adult patients. Insect venom 
was the most frequent trigger in both groups (elderly: 60% vs. adults: 
52%), followed by drugs (24% vs. 21%) and food items (10% vs. 17%). 
Within the group of insects yellow jacket (72% vs. 73%) and in the 
group of drugs analgesics (38% vs. 40%) were the most common 
elicitors. For food anaphylaxis hazelnut (16%) was the most frequent 
elicitor in the elderly, and wheat (16%) in the other adults. Cardiovas-
cular symptoms were slightly more prevalent in the elderly (77% vs. 
73%) and the reactions are more severe with 46% (36% compared to 
other adults) experiencing a grade III/IV reaction. Noteworthy, 60% of 
the elderly had a preexisting cardiovascular comorbidity compared 
with 18% of the other adults. First line treatment by professionals 
included mainly corticosteroids (89%) and antihistamines (82%) in 
both groups. Epinephrine was only used in 24% (elderly) versus 19% 
(other adults).
Conclusions: Compared to adults aged below 65 years, the symptom 
pattern in the elderly was characterized by cardiovascular symptoms 
and more severe reactions. Epinephrine was used more frequently in 
the elderly compared to younger adults but was still only used in less 
than one out of four patients.
Acknowledgements: Network for Online Registration of Anaphy-
laxis (NORA) participating centers can be found under www.anaphy-
laxie.net.
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Introduction: Improvement of the knowledge of teachers about ana-
phylaxis after training workshops.
Methods: In 2014 we conducted a questionnaire to 2481 teachers, 
where it became evident that the knowledge about anaphylaxis was 
scarce [1]. Only 40.5% knew what anaphylaxis was, and only 11% said 
that they knew how to administer adrenaline auto-injector, for this 
reason we conducted training teachers with theory and practice, with 
demonstration videos and developing action protocols in schools.
Results: After a year we made training to 296 teachers of the Balearic 
Islands, with a theoretical practical course of 4  h, at the end we had 
a questionnaire on knowledge of anaphylaxis and all passed the test. 
According to the EAACII 1 in 300 Europeans suffer anaphylaxis at some 
point in their life and most European schools have at least one child 
at risk of anaphylaxis food allergy. It is very important that teachers 
are trained in the recognition and early treatment of an anaphylactic 
reaction
Conclusions: The training of teachers is important along with videos 
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Introduction: The iFAAM project is investigating whether the passage 
of allergen into the circulation may contribute to determining the 
severity of an allergic reaction by comparing uptake in healthy indi-
viduals and individuals undergoing oral food challenge. A mass spec-
trometry based method to detect the presence of peanut allergens in 
serum samples is being developed which will allow confirmation of 
peanut allergens in serum identified by other methods such as immu-
noassay and mediator release.
Methods: A set of heavy labelled tryptic peptide targets for detection 
of peanut allergens Ara h 1, Ara h 3 and Ara h 2, 6 and 7 have been 
used to develop a targeted mass spectrometry (MS) method using 
multiple reaction monitoring, for detection of peanut in serum. Using 
serial isotopic dilution (SID) series and blank serum spiked with a pea-
nut protein extract, initial validation studies have been undertaken 
exploring the use of different depletion methods to remove the most 
abundant serum proteins. MS analysis has made use of different TOF 
and triple quadrupole platforms.
Results: Undepleted serum samples had a marked matrix effect on 
SIDs, likely due to the presence of other serum peptides causing sup-
pression effects on peanut peptide ionisation. These effects were less 
marked in depleted serum samples. Analysis of peanut spiked into 
blank serum and analysed after depletion showed differential matrix 
effects, with some peanut peptides having been lost during the 
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depletion process. The general limit of detection of peanut peptide 
targets was achieved in the femtomolar range, on column.
Conclusions: Further method development is required to optimise 
serum depletion, trypsin digestion and chromatographic separation 
steps to allow detection of peanut at levels likely to be found in human 
subjects after ingestion of peanut. This mass spectrometry method 
shows promise as a complimentary tool to immunoassay methods to 
detect the presence of peanut in serum.
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Introduction: The aim of this study is to determine the incidence of 
anaphylaxis, acute urticaria and angioedema during of years 2012–
2015 in patients with diabetes mellitus type 2.
Methods: We performed a prospective study of the frequency of ana-
phylaxis, acute urticaria and angioedema during of years 2012–2015 
in patients with diabetes mellitus type 2. A total of 83 patients with 
diabetes mellitus type 2 of the district of Plovdiv were included in the 
study.
Results: With a history of anaphylaxis were 4.8% from diabetics. With 
history of acute urticaria and angioedema were 26.5% diabetics. In 
all diabetics with a history of anaphylaxis, the symptoms were due 
to drugs (antibiotics and general anesthetics). In all diabetic patients 
with a history of urticaria and angioedema, the symptoms also due 
to drugs (antibiotics 36.3%, sulfonamide 13.6%, ACE inhibitors 13.6%, 
alpha-lipoic acid 13.6%, general anesthetics 9.1% and other) except 
one who reported insect bites. 9.1% of patients with a history of 
urticaria and angioedema were reported symptoms of anaphylaxis. 
Comorbidity and increased incidence of infections requiring antibiotic 
and concomitant treatment, most likely causes an increase in the risk 
of developing hypersensitivity reactions induced by drugs.
Conclusions: The most frequent causes of anaphylaxis, acute urticaria 
and angioedema in patients with diabetes mellitus type 2 are antibiot-
ics, general anesthetics, sulfonamide, ACE inhibitors and alpha-lipoic 
acid.
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Introduction: The objective was to understand and evaluate patient 
characteristics, concordance with post discharge care, health care 
resource utilization and repeated events among adults and children 
with an inpatient or Emergency Department (ED) claim for food or 
non-food induced anaphylaxis in the United States.
Methods: For retrospective analysis the Truven Healthcare MarketS-
can® Commercial and Medicare Supplemental and COB Databases was 
used to (1) identify the patient profiles with inpatient or ED claims for 
anaphylactic shock, stratified to food-based allergic reactions and to 
allergic reactions due to non-food or unknown causes; (2) examine the 
event characteristics and healthcare resource use (HCRU) related to 
the event and (3) assess Epinephrine Auto-Injector (EAI) prescriptions 
pre- and post-event and the HCRU associated with these prescriptions.
Results: The study comprised 10,189 adults (age >18) and 3891 pedi-
atric patients (age <18). Those patients treated in the ED present with 
acute respiratory failure (3.8%), hypotension (5.0%), and in rare cases 
cardiac arrest (0.3%). While in the ED, intervention included resusci-
tations (25.4%), intubation (1.6%), tracheostomy (2.0%), epinephrine 
administration (13.2%), and cardiopulmonary resuscitation (0.1%). 
11.7% of patients seen in the ED were admitted to inpatient care and 
spent 2.7  days on average in the hospital. At the time of the index 
event 83.3% of patients did not have a prescription for an EAI filled. 
Only 12.1% of patients had the minimum of 1 EAI prescription refill. 
The mean number of days from last prescription to anaphylactic event 
was 2350  days. A significant portion of patients are transitioned to 
inpatient care from the ED resulting in greater healthcare utilization. 
The data indicate that patients demonstrate suboptimal maintenance 
of EAI prescriptions placing them at risk for life threatening events and 
questioning the preparedness of patients and caregivers for the man-
agement of an anaphylactic event. Given the low active prescription 
level it appears patients are not proactively prepared for an anaphy-
lactic event which may lead to costly ED visits and hospital admissions.
Conclusions: Current educational programs and safety information 
delivered to patients and caregivers regarding the use of EAIs to treat 
anaphylaxis are not effective.
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Introduction: Intramuscular epinephrine (adrenaline) is classified 
as first-line treatment of choice for anaphylaxis in international and 
national guidelines. Patients at risk are recommended to be prescribed 
2 epinephrine auto-injectors (EAIs) which they should carry with them 
at all times. A prospective, web-based survey was conducted to obtain 
insight into adherence to treatment recommendations according 
guidelines, and post-anaphylaxis behavior in patients at risk for ana-
phylaxis and their caregivers.
Methods: 505 patients aged 18–65 years (mean = 30.4; 26.1% male) 
and 448 caregivers of individuals under aged 18 years (mean = 24.4; 
33.3% male) were recruited in the United States between the 15th and 
30th of November, 2015. All participants had been prescribed an EAI 
for self-administration or for administration as a caregiver.
Results: At home, 16.8% of patients and 14.3% of caregivers had no 
EAI and 61.0% of patients and 58.5% of caregivers indicated 1 EAI was 
available. At their workplace, 81.8% of patients did not have access to 
at least 1 EAI and 32.6% of caregivers reported that their child did not 
have access to at least 1 EAI at school. Only 9.6% of caregivers iden-
tified that 2 EAIs were available for their children at school. Of those 
who received emergency care, 4.6% received their first dose of epi-
nephrine in the Emergency Department. 6.0% of patients reported 
having to call emergency services due to the lack of a secondary EAI 
with 2.8% being admitted to inpatient care. Following utilization of 
an EAI, 23.8% of patients and 21.4% of caregivers did not seek follow-
up medical attention. Given the lifesaving ability of EAIs, the effect of 
treatment according to guidelines is imperative to successful manage 
anaphylactic events. The data call into question the efficacy of current 
educational programs and safety information delivered to patients 
and caregivers regarding the access to and the use of EAIs to treat 
anaphylaxis.
Conclusions: This survey revealed poor guideline adherence by 
patients and caregivers: most patients did not carry the guideline rec-
ommended number of 2 EAIs and did not seek emergency treatment 
after using an EAI. Reasons for this behavior should be investigated in 
further studies to improve the utilization of this life saving treatment.
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Introduction: A prospective, web-based study was conducted to 
understand causes for utilization problems of epinephrine auto-injec-
tors (EAIs) among patients and caregivers of patients with anaphylaxis.
Methods: 505 patients aged 18–65 years (mean = 30.4; 26.1% male) 
and 448 caregivers of individuals under aged 18 years (mean = 24.4; 
33.3% male) were recruited in the United States. All participants had 
been prescribed an EAI for self-administration or for administration 
by a caregiver. The survey took place between the 15th and 30th of 
November, 2015.
Results: The most common administration problems included: EAI 
was pressed too firmly against the skin (11.1%), needle was bent 
during injection (7.4%), and did not allow enough time for the injec-
tion to complete (8.7%). When asked to identify factors contributing 
to the cause of injection problems, caregivers were more likely to 
attribute problems to improper training (p  =  0.01), lack of under-
standing on how to use the EAI after training (p =  0.03), and diffi-
culty in use (p = 0.003) as compared to patients. Only 16.4% of all 
participants reporting a problem immediately realized there was an 
issue with the EAI injection while 6.0% of participants realized the 
EAI did not work properly upon the worsening of symptoms. Results 
indicate that the causes of injection problems were similar among 
patients and caregivers. The findings call into question the efficacy 
of current educational programs and safety information deliv-
ered to patients and caregivers regarding the use of EAIs to treat 
anaphylaxis.
Conclusions: Education of patients and caregivers about current 
anaphylaxis treatment guidelines and the safety and easy use of an 
EAI that is directed at health care professionals may not be working 
well. Reasons for non-adherence to anaphylaxis treatment guidelines 
should be further assessed in future studies.
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Introduction: Anaphylaxis is a medical emergency and professional 
first-line treatment is administered mainly by emergency physicians in 
most studies.
Our aim was to compare emergency management of paediatric ana-
phylaxis in three different hospital settings—a joint adult and paediat-
ric ED associated with the national referral centre for paediatric allergy 
versus specialized paediatric ED versus general ED.
Methods: As part of the NORA European Anaphylaxis initiative, we 
undertook a project on the incidence of anaphylaxis in Irish children. 
Hospital emergency response was assessed looking at early use of i.m. 
adrenaline, use of second-line medication, and discharge planning/
prescription of emergency drugs.
Results: 133 cases of paediatric anaphylaxis were reported to attend 
EDs in Ireland between August 2013—May 2015: 51 cases (38.3%) pre-
sented to the national referral centre for paediatric allergy with a ter-
tiary hospital general ED, 46 cases (34.6%) to a children’s hospital with 
a paediatric ED, and 36 (27.1%) to a regional hospital with general ED. 
There was no statistically significant difference in first line administra-
tion of i.m. adrenaline between centres (55.6% of cases overall, Fisher’s 
Exact Test p  =  0.48). All cases were prescribed AAIs in the national 
allergy centre, compared to 62.8% in the paediatric ED, and 77.7% in 
the general ED.
Conclusions: Attendance to the ED associated with an allergy centre 
improves AAI prescription but does not improve adrenaline use for the 
presenting emergency. Usage of i.m. adrenaline as first line treatment 
needs to be improved.
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Introduction: Oral immunotherapy using IFN-gamma has been done 
for more 10  years successfully. The dosage modulation of treatment 
including initial dose and incremental dose for the treatment is abso-
lutely necessary in the clinical field. Dosage modulation is also the 
issue during the treatment. For these issues, the theoretical and clini-
cal backup is also needed. The aims of this study are the built up the 
dosage modulation by dosage calibration during oral challenge test 
and during the treatment for the precise oral immunotherapy using 
IFN-gamma for anaphylactic food allergy. Also, the theoretical princi-
ple is also suggested.
Methods: Patients who had anaphylactic food allergy for milk, eggs, 
soybean and wheat were selected. Basic allergic laboratory tests were 
done including allergen-specific IgE and skin prick tests. Oral food 
challenge tests were conducted. Especially, the minimal dose and clin-
ical severity were checked during oral immunotherapy. The initial dose 
was determined by the minimal dose and incremental dose was deter-
mined by the clinical severity. During the treatment, the incremental 
doses were escalated according to the patient’s responses to dosage. 
The duration and effectiveness of treatment is compared and evalu-
ated between the classic methods and the advanced methods apply-
ing the concepts of calibration and modulation of dosage.
Results: The trial of calibration is proper for oral immunotherapy 
using IFN-gamma for anaphylactic food allergy. By dosage calibra-
tion, the duration and the effectiveness of oral immunotherapy using 
IFN-gamma was much improve, significantly. By dosage increment, 
the incremental dose was escalated exponentially. The basic theory 
of oral immunotherapy using IFN-gamma is depending on the tolero-
genic effects of IFN-gamma. The allergy provocation strength should 
be within the range of tolerogenic effects of IFN-gamma. During 
oral immunotherapy using IFN-gamma for anaphylactic food allergy, 
patients were getting tolerance for last therapeutic dose. The mean-
ing of allergy provoking dose and strength did not follow the absolute 
dose. The allergy provoking dose seems to be the dose of difference 
between the therapeutic dose and tolerable dose.
Conclusions: For more precise and effective treatment of oral immu-
notherapy for anaphylactic food allergy, the dosage calibration during 
oral challenge test is absolutely necessary for the determination of ini-
tial dose and incremental dose for the treatment. Also, modulation of 
dosage should follow the coverage range of tolerogenic effects of IFN-
gamma. From the results of clinical application of dosage modulation, 
the framework for the dosage modulation was built up with several 
terminologies for the theoretical and clinical setting.
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Introduction: Anaphylaxis is a severe and pottentialy life-threatening 
systemic hypersensitivity reaction and patients (pts) should be closely 
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monitored. At discharge it’s important to assure follow-up in order to 
assess culprit(s) agent(s).
Our aim was to characterize follow-up of pts admitted for anaphylax-
is’s surveillance at the Imunoallergology Department.
Methods: Retrospective analysis of clinical files of pts admitted for 
anaphylaxis between January 1, 2005 and April 30, 2016.
Results: 144 pts were admitted for anaphylaxis in our department 
(57% female sex; mean age 44.8 years). 129 pts were referred for fol-
low-up (remaining 15 had already follow-up in other centers). Inves-
tigation was started in 92 (37 missed first appointment). Suspected 
etiologies were: drugs (43; 3 during drug challenge or desensitization; 
>1 drug suspected in 2 pts), foods (36; 1 during oral food challenge; 
>1 food involved in 5 pts), foods or drugs (3), hymenoptera venom 
(1) and iodinated contrast media (ICM) (1). Etiology was unknown in 
8 cases. Suspected drugs were betalactams (15), other antibiotics (6), 
nonsteroidal anti-inflammatory drugs (15), acetaminophen (4), local 
anesthetics (1), proton pump inhibitors (1) and angiotensin 2 recep-
tor antagonists (1). The suspected drug was confirmed in 6 cases and 
excluded in 3; 12 pts are still under investigation and 22 were lost to 
follow-up. Suspected foods were fresh fruits (13), seafood (11), fish (3), 
nuts (4), milk (2), seeds (4), spice (2), wheat (2) and honey (1)—sus-
pected etiology was confirmed in 24 cases, excluded in 9 and under 
investigation in 3; 7 cases were lost to follow-up. In 3 pts with both eti-
ologies suspected, only one of them was confirmed for each (food-2; 
drug-1). The hymenoptera suspected by clinical history was wasp but 
we confirmed sensitization to polistes. The investigation in ICM reac-
tion was negative. Regarding the 8 pts with unknown etiology, 4 are 
being studied, 3 were lost to follow-up and 1 revealed food allergy 
(LTP sensitization). Overall, from the 92 pts that came to a first appoint-
ment after hospital discharge, 42 have a confirmed anaphylaxis’s etiol-
ogy; 32 pts were lost to follow-up.
Conclusions: Long-term management of patients who experienced 
anaphylaxis may be long and time-consuming but it’s crucial to iden-
tify the etiologic agent in order to avoid the culprit and minimize the 
risk of further reactions. In our cohort more than half of the pts doesn’t 
have a confirmed culprit allergen, mainly due to a high dropout rate.
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Introduction: Anaphylaxis is the most severe manifestation of an aller-
gic reaction and recent data indicates a continuous increase of cases. 
The aim of this study was to evaluate the characteristics of anaphylaxis 
in 150 patients who had been studied by allergists in a geographical 
area.
Methods: This descriptive study involved a retrospective review of 
records of 150 patients who had suffered from anaphylaxis and had 
been carefully studied in our center. All of them belonged to the same 
geographical area. The median age was 31.59 years, from 0 to 80 years. 
81 of them were female.
Results: 52 of them were caused by food, 40 cases were due to drug 
allergy and diagnosis agents or immunotherapy. In addition, 29 
patients had anaphylaxis because of hymenoptera allergy. Only 18 of 
them were related to exercise-induced, idiophatic etiology or Anisakis 
simplex. On the other hand, the majority of patients had only suffered 
from one anaphylactic reaction. The 72.01% of successive episodes 
were related to food allergy. The average of episodes by patient was 
1.44 with a range from 1 to 10. 44.29% suffered from pollen allergy. 
Most of them happened in the springtime. The average of serum basal 
tryptase levels was 1.39 µg/l, range 0.1–40. More than 50% of patients 
carried their epinephrine auto-injector with them at all times.
Conclusions: Anaphylaxis is a relatively common problem and it 
is quite necessary to improve the current understanding would be 
through. In our opinion, food allergy is the most important trigger 
of anaphylaxis including recurrent episodes. Unfortunately a lot of 
patients do not carry their self-administered epinephrine injector, 
underusing it in the treatment of anaphylactic reactions. On the other 
hand, an improved understanding of this disorder would aid ongoing 
efforts to reduce it and could provide clues for its prevention.
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Introduction: Anaphylaxis to paracetamol is rare and the underlying 
mechanisms are poorly understood. We aimed to review the cases of 
anaphylaxis to paracetamol in our Drug Allergy Unit (DAU) in the last 
five years.
Methods: The authors did a retrospective analysis of all cases of ana-
phylaxis to paracetamol studied in our DAU between January 2011 
and December 2015. The data were analysed using SPSS, version 21.
Results: Twelve adult patients with anaphylactic reaction to paraceta-
mol were studied (67% males, aged 18–72y), 25% had allergic respira-
tory disease. All patients were medicated with oral paracetamol for pain 
relief. Six patients also had anaphylaxis to nonsteroidal anti-inflamma-
tory drugs (NSAID’s): acetylsalicylic acid (n = 4), ibuprofen (n = 3), nap-
roxen (n = 1), nimesulide (n = 1) and diclofenac (n = 1). Nine patients 
had immediate reactions (75%), and 3 (25%) late reactions (onset 
3–12  h). Eleven patients (92%) had mucocutaneous involvement, 11 
respiratory manifestations, 3 (25%) cardiovascular and 1 (8%) gastro-
intestinal. None had anaphylactic shock. Only 8 (67%) patients were 
admitted to the emergency department (ED), none was treated with 
adrenaline nor had tryptase determined. Because the in vivo work up 
of these patients is very limited, they all underwent an oral challenge 
(OC) with an alternative drug (etoricoxib) and tolerance was confirmed. 
In the 6 cases of multiple-reactors, the authors postulate an underly-
ing COX-1 inhibition mechanism since paracetamol is a weak inhibitor 
of COX-1.In the cases of single-reactors (SR) IgE-mediated mechanisms 
may be involved. A possible explanation for the late anaphylaxis (12 h) 
in a SR is COX-1 inhibition; alternatively, IgE involvement may be con-
sidered if this “late anaphylaxis” is in fact the late manifestation of a bifa-
sic response. The in vitro study of this patient is in progress.
Conclusions: Paracetamol is a widely used drug, available over-the-
counter in most countries, but not entirely without risks. The allergy 
diagnosis work-up in cases of anaphylaxis to paracetamol is difficult 
and mostly based on a detailed clinical history. Skin tests are not 
standardized and positive results are doubtful. In vitro assays such 
as specific IgE and Basophil Activation Test have poor specificity and 
sensitivity. Moreover OC with the culprit drug are contraindicated in 
anaphylaxis.
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Introduction: Lipid transfer proteins are a wide spread family of food 
allergens. Sensitization usually occurs through the consumption of 
LTP containing food and the primary sensitizer usually is peach. The 
marker of LTP syndrome is an elevated level of peach LTP—Pru p 3, in 
some cases mugwort LTP—Art v 3. The disease is often variable and 
unpredictable.
Case report: Patient, 38, female, was admitted to the Department of 
Allergology, Clinical Immunology and Internal Diseases in Decem-
ber 2015 because of recurrent symptoms of anaphylaxis: swelling of 
the upper and lower limbs, edema of both eyelids, lips and tongue, 
with shortness of breath and increased heart rate. Only in 2015, she 
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experienced 4 anaphylactic reactions after eating poppy seed, sun-
flower seed and peach. In 2013 Polycheck found elevated level of IgE 
specific to peach (5,5 kU/L), apple (10 kU/L), rye flour (2,7 kU/L), wheat 
flour (0,39  kU/L). During hospitalization we performed skin prick test, 
spirometry, established the level of asIgE directed against selected aller-
gens and the level of IgE directed against allergen components using 
ImmunoCap ISAC. SPT were positive to weed, Artemisia vulgaris, cat, 
birch, alder, carp, strawberry, wheat and rye flour. Patient had elevated 
level of IgE specific to rye flour—1.38 IU/ml and peach—2.02 IU/ml, but 
the level of specific IgE against wheat flour and apple was <0.35 IU/ml. 
In ImmunoCap ISAC we found elevated levels of IgE directed against 
nsLTP from different plant sources: rAra h 9—7 ISU-E, rCor a 8—2 ISU-
E, nJug r 3—4,7 ISU-E, rPru p 3—6,3 ISU-E, nArt v 3—1,4 ISU-E, nOle e 
7—1,4 ISU-E, rPla a 3—3,4 ISU-E. Thye level of IgE directed against all 
other allergen components available in ISAC were not elevated.
Conclusion: Results of ImmunoCap ISAC changed the way we inter-
pret this case. Before the results it was possible to suspect pollen-food 
syndrome, although it was not consistent with the clinical picture. In 
ImmunoCap high levels of IgE specific to Pru p 3 and Art v 3, mark-
ers of LTP syndrome, allow as to diagnose patient with this disease. 
We explained the nature of the disease and the need to carry rescue 
kit containing epinephrine in auto-syringe. This patient could benefit 
from Pru p 3 immunotherapy.
Consent to publish: Patient consented to the publication of this 
abstract.
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Introduction: 20 to 30% of infants in Europe are diagnosed with an 
atopic (allergic) disease. The majority of first atopic responses are 
directed towards food proteins that are consumed during the first 
months of life. There is increasing evidence that certain milk-derived 
components have positive effects on infant health. Ongoing research 
in this area has identified immunomodulating ingredients (milk-
derived hydrolysates) which have potential to support the immune 
system in an allergy setting. Hydrolysing the proteins in infant formula 
is one approach in the management of allergenic responses in infants. 
These hydrolysed proteins which lack allergenic IgE binding sites can 
modulate T-cell differentiation away from a Th2 response and decrease 
inflammation. Our research focus is on identifying hydrolysates that 
can be added to infant formula to ameliorate cow’s milk allergy.
The aim of this study was to identify milk protein hydrolysates (pep-
tides) with (anti-inflammatory/anti-allergy) properties using an in vitro 
approach.
Methods: To that end, hydrolysates were screened for their immu-
nomodulatory properties in 4 cellular models, human peripheral blood 
mononuclear cells (PBMC), human monocyte dendritic cells (DC), T 
helper 1 (Th1) polarised and Th2 polarised cells. Specifically, T cell pro-
liferation was analysed, before and after the addition of hydrolysates 
using a CFSE assay by flow cytometry and cytokine levels, released 
in the culture supernatants were measured by ELISA. DC maturation 
and cytokine production were also examined by flow cytometry and 
ELISA. Naïve human CD4+ T cells were activated with plate-bound 
anti-CD3 and anti-CD28 and then cultured under Th1 or Th2 polarising 
conditions with or without hydrolysates for 4 days. Transcription factor 
expression was then assessed by flow cytometry.
Results: A number of hydrolysates significantly decreased T cell pro-
liferation driven by anti CD3/CD28 beads and several downregulated 
the maturation marker CD86 in DCs. Select hydrolysates increased 
the expression of T-bet and Gata-3, decreased production of the 
pro-inflammatory cytokines IFN-gamma and IL-6 and increased anti-
inflammatory IL-10.
Conclusions: Thus far we have identified a number of hydrolysates 
which promote an anti- inflammatory /anti-allergy T cell and DC phe-
notype. Further work will examine these hydrolysates in an in-vivo 
humanised mouse model of allergy in order to confirm their protective 
impact.
Acknowledgements: Funding code: TC2013-001.
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Introduction: Oral Food challenge (OFC) is the milestone to access to 
a definitive diagnosis of hazelnut allergy (HA). We evaluated variation 
of serum tryptase levels during blinded OFC.
Methods: 31 OFC were performed in children (20 M/11F) aged 10.5 ± 
4.9 y, referred to the allergy outpatient paediatric Unit. All underwent 
a reaction after hazelnut ingestion and were therefore suspected for 
allergy. Single blind placebo controlled OFC was performed accord-
ing to usual recommendations: increments of native hazelnut were 
added every 30 min (0.1, 0.2, 0.5, 1, 2, 5, and 20 grams). Challenge was 
declared positive when a single objective symptom occurred. Sensiti-
zation to hazelnut was confirmed previously to OFC (positive SPT or 
specific IgE measurements over 0.10  IU/mL) and serum Tryptase was 
measured in µg/L (ImmunoCAP Tryptase, Phadia®) before (Tb) and 
one hour after the last increment of the challenge (Tf). We calculated 
Tryptase variation ΔT = Tf − Tb and Tryptase relative variation ΔT/Tb. 
Comparisons between the groups were performed using the Chi 
square tests for categorical variables, and by the Student t-test or 
Kruskal-Wallis test for quantitative parameters.
Results: Among the 31 patients, 8 had a positive OFC to hazel-
nut (n = 8 OFC+) and 23 negative (n =  23 OFC-). At baseline the 
two groups of patients (OFC+ and OFC-) were similar in terms 
of sex, age, and reaction occurred when the diagnosis was set-
tled. Tb dosage did not differ significantly between OFC+ patients 
(4.83  ±  5.57  µg/L) and OFC- patients (3.26  ±  1.39  µg/L). Tf was 
significantly higher in OFC+ patients (9.78  ±  11.13  µg/L) than in 
OFC- patients (3.30  ±  1.41  µg/L) (p = 0.03). Variation of serum 
Tryptase (ΔT) was significantly higher (p < 0.001) in OFC+ patients 
(4.95 ±  6.67) than OFC- patients (0.04 ±  0.57). Moreover the rela-
tive variation of serum Tryptase ΔT/Tb was significantly higher 
(p  <  0.001) in OFC+ patients (102  ±  145%) than in OFC- patients 
(3.74  ±  21.8%). Range of ΔT/Tb varied from +11 to +450% in 
OFC+ patients and from −37 to +70%. Among the OFC- patients, 
all except 4 had a negative variation of Tryptase whereas none of 
the OFC+ had a negative variation of ΔT/Tb, thus confirming the 
good negative value of ΔT/Tb. ΔT/Tb was higher in patients with 
positive SPT (64.76% ± 121.70%) than in patients with negative SPT 
(3.53% ± 23.51%) (p = 0.03). Specific IgE to hazelnut did not differ in 
OFC+ and OFC- patients, neither the level of recombinant specific 
IgE to cor a 1, cor a 8, cor a 9 and cor a 14.
Conclusions: Unlike the baseline level of serum Tryptase, the relative 
variation of serum Tryptase during OFC (ΔT/Tb) is correlated to the 
clinical results of OFC in children suspected of HA. This ratio could be 
used to detect subclinical reactions during food challenge or to man-
age patients with subjective symptoms during OFC to hazelnut.
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Introduction: Pru p 3 is the primary sensitizer of plants fruit and 
responsible for severe reactions in the Mediterranean area. Sublingual 
immunotherapy (SLIT) using peach extract enriched in Pru p 3 (Prup3-
enriched-SLIT) brings a new perspective to treat patients with severe 
reactions to peach. However, there is a lack of knowledge regarding 
immunological response during the immunotherapy.
Our aim was to evaluate the lymphocyte modulation from a Th2 pat-
tern to a Th1/Treg profile during one year of Prup3-enriched-SLIT.
Methods: We studied three groups: peach allergic patients who 
received Prup3-enriched-SLIT for 1  year, peach allergic untreated 
patients, and healthy controls who tolerated peach. Monocyte-
derived dendritic cells (DCs) maturation and lymphocyte proliferation 
were assessed by flow cytometry from peripheral blood mononuclear 
cells obtained before treatment, and 1, 6 and 12 months during SLIT, 
and cultured with Prup3.
Results: We found statistically significant differences in DCs activation 
and maturation between allergic patients and controls at the basal 
state. When we analyzed the effect of Pru p 3-SLIT at different times, 
we found a significant reduction of activation and maturation mark-
ers (CCR7, CD40, CD80, CD83 and CD86) at the first month of treat-
ment that was maintained after 1  year. Concerning lymphocytes, we 
observed a significant decrease of effector cells Th2, Th9, NKDim and 
IgE producing plasma cells (IgE-PCs) and an increase in Th1, NKBright 
and Treg cells subpopulations. These changes were only observed in 
the Pru p 3-SLIT group. These results were similar to those obtained in 
the specific proliferative response to Pru p 3 in lymphocyte subpopula-
tions. Most of these changes demonstrated to be significant from the 
first month of treatment.
Our results showed for the first time the immunological changes 
induced by Pru p 3-SLIT in peach allergic patients with severe reac-
tions that include significant decreases of Th2/Th9/(IgE-PCs)/NKDim 
and increases of Th1/NKBright/Treg cells.
Conclusions: Patients treated with Pru p 3-SLIT showed immunologi-
cal differences compared to untreated patients from a Th2 towards a 
Th1/Treg response. These changes could be used as biomarkers of 
therapy evolution during SLIT.
PP107 
Effects of different dietary treatments on epigenetic mechanisms 
in children with IgE‑mediated cow’s milk allergy
Lorella Paparo, Rita Nocerino, Maurizio Mennini, Linda Cosenza, Carmen 
Di Scala, Antonio Amoroso, Rosita Aitoro, Roberto Berni Canani
University of Naples, Naples, Italy 
Correspondence: Rita Nocerino ‑ ritanocerino@alice.it
Clinical and Translational Allergy 2017, 7(Suppl 1):PP107
Introduction: We showed that the acquisition of oral tolerance in chil-
dren with cow’s milk allergy (CMA) is driven by a different DNA meth-
ylation pattern of Th1 and Th2 cytokines. In this study we evaluated 
comparatively the effect of different dietary treatments on DNA meth-
ylation pattern of cytokine genes involved in Th2 (IL-4) and Th1 (IL-10) 
response in children with IgE-mediated CMA.
Methods: Prospective randomized study in subjects with IgE-medi-
ated CMA randomized into two groups of dietary treatment: (1) exten-
sively hydrolyzed casein formula containing the probiotic L.rhamnosus 
GG (LGG); (2) soy formula. At enrollment and after 6 and 12  months 
of treatment a venous blood sample was collected to perform DNA 
methylation analysis of the CpGs in the promoter region, and the 
determination of serum concentrations of IL-4 and IL-10 by ELISA. At 
12 months, the possible acquisition of oral tolerance to cow’s milk pro-
teins was evaluated by oral food challenge.
Results: 16 children (11 males, ages 6–12 months) were prospectively 
randomized: 8 in Group 1 and 8 in Group 2. At enrollment DNA meth-
ylation rate of CpGs in the promoter region of IL-4 and IL-10 cytokines 
and respective serum levels were similar between the two groups. 
After 6 and 12  months of dietary treatment subjects treated with 
extensively hydrolyzed casein formula containing LGG showed signifi-
cant higher rate of IL-4 and lower rate of IL-10 gene methylation asso-
ciated with significant differences in serum levels. In addition, after 
12 months of exclusion diet, the number of patients acquiring oral tol-
erance resulted double in Group 1 (50 vs 25%).
Conclusions: Dietary treatment with extensively hydrolyzed casein 
formula containing LGG induces a more rapid and pronounced epi-
genetic effect on IL-4 and IL-10 DNA methylation pattern. These epi-
genetic mechanisms might be involved in the positive effects of this 
dietary strategy on the acquisition of oral tolerance.
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Introduction: According to the EuroPrevall (The prevalence, cost and 
basis of food allergy across Europe) report tree nut tree nut allergy is 
one of the most common food allergens. It is connected mainly with 
cross-reactions with tree pollen-based Central Europe and North- East-
ern Europe, but also of severe anaphylactic reaction related LTP- Medi-
terranean Countries. Tree nut allergy include allergy to: Almond, Brazil 
nut Cashew nut, Hazelnut, Chestnut, Macadamia, Pecan, Pistachio and 
Walnut. So far, everyday diagnostics of tree nut allergy were skin prick 
tests and determination of the level of allergen-specific IgE. New pos-
sibilities of food allergy diagnostics provides molecular diagnostics, in 
particular ImmunoCap ISAC. ImmunoCap ISAC is an excellent method 
of diagnosis of tree nuts it detects up to 8 different antibodies against 
components of nuts: hazelnut (Cor a 1.0401, Cor a 8, Cor a 9), walnut 
(Jug r 1, Jug r 2, Jug r 3), cashew nut (Ana o 2) and Brazilian walnut (Ber 
e 1).
Methods: The study was conducted at the Department of Allergology, 
Clinical Immunology and Internal Medicine in Bydgoszcz. The study 
was retrospective. 136 adult, living in Poland were classified to study. 
The ImmunoCap ISAC test was performed to all patients.
Results: The antibodies against tree nut components were detected 
in 1/3 patients. In 81% of patients antibodies against components 
responsible for cross-reaction with birch pollen were detected. In 37% 
of patients antibodies against components responsible for anaphy-
laxis were detected and 78% of detected proteins belonged to walnut. 
Ana o 2 and Ber e 1 were not detected (Fig. 7).
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Introduction: We aimed to search; the awareness of the families about 
food allergy; the families knowledge about allergic life threatening 
events; the daily problems the families are experiencing; and to inves-
tigate the mother’s depression and anxiety by a questionnaire.
Methods: This study is done between 2014 and 2016 in Yeditepe Uni-
versity Medical Faculty Departments of Pediatric Allergy and Pediatric 
Gastroenterology, to the children who have been following for food 
allergy and who were still on diet to the allergen food by evaluating 
the data from the patient files retrospectively. Among 51 patients 
with allergy 51 mothers fulfilled STAI-1 and STAI-2 questionnaries and 
Beck’s depression scale. There were 51 children with food allergy, their 
mothers fulfilled the questionnaire. There were 51 children in the con-
trol group and their mother also fulfilled the questionnaire.
Results: 51 mothers of those 114 children fulfilled the questionnaire 
and among those 51 mothers 21 children (41.2%) were girls and 30 
(58.2%) were boys. STAI 1 and 2 anxiety points were higher among 
51 mothers having children with food allergy when compared to the 
51 mothers having children without any food allergy. Mothers with 
children with food allergy who fulfilled Becks depression scale had 
higher points than control group. Professional carrier of 30%, social 
life 39% and economic status of 45.1% was affected among moth-
ers having anxiety. 37.2% of mothers with anxiety had difficulty 
attending family activitiesand 23.5% had problems with her part-
ner because of the child’s health problems. 45.1% of mothers hav-
ing either anxiety or depression could not send her child to school/
kindergarten.
Conclusions: Mothers having children with food allergy experi-
ence daily life difficulties, have concerns while sending their children 
to school, picnic or outdoor. Those mothers are more anxious and 
depressed and their social life and professions are negatively affected.
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Introduction: The food allergy health related quality of life question-
naires (FAQLQs) were developed and validated to measure the impact 
of food allergy on health-related quality of life (HRQL) irrespective of 
the causative allergenic food. At present it is unknown whether all 
items of these instruments are relevant for peanut allergic patients. 
The aim of this study was to identify whether there are peanut-specific 
HRQL items in the FAQLQ-Child Form (CF), Teenager Form (TF) and 
Adult Form (AF).
Methods: In order to identify FAQLQ items that are reported most 
frequently and have the highest impact for peanut allergic patients, 
we used previous data from the development of the FAQLQs. We 
calculated frequency, percentage, mean importance  and overall 
importance  of individual FAQLQ items in peanut allergic  patients 
and non-peanut allergic patients. In order to identify peanut-specific 
FAQLQ items that are sensitive to change, the data of the longitudinal 
validation of the FAQLQs (HRQL following a double blind placebo con-
trolled food challenge) were used in a comparison of peanut allergic 
and non-peanut allergic patients and tested for significance (p < 0.05).
Results: In general, peanut allergic patients reported a higher overall 
impact for each item than non-peanut allergic patients. There was 1 
item in each FAQLQ that significantly changed following DBPCFC in 
the non-peanut allergic group compared to the peanut allergic chil-
dren (“Don’t get anything when someone is giving treats at school”, 
−1.06 vs 0.04, p =  0.044), teenagers (“Being careful about touching 
certain foods”, 0.82 vs −0.59, p = 0.016) and adults (“Able to eat fewer 
products”, −1.00 vs 0.30, p  =  0.011). Since peanut allergic patients 
reported higher overall impact scores and only one item differed 
between non peanut allergic patients and peanut allergic patients 
for each FAQLQ, this study did not result in peanut-specific FAQLQ 
instruments.
Conclusions: All parts of the FAQLQ-CF, -TF and –AF are considered to 
be relevant for peanut allergic patients.
Fig. 7 See text for description
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Introduction: Around 8% of children suffer from food allergy, world-
wide. Children who become aware about the good food safety prac-
tices via practical experiences are more likely to perform long-term 
protective behaviours and may disseminate knowledge to families.
Here we describe our workshops aimed to engage primary schools to 
join an educational experience about allergenic food. The activities 
were included in the “EXPO 2015 events” host by the municipality of 
Turin.
Methods: We designed the “Allergen Hunt” Workshop as follows:
  •  Welcome telling “The fairy tale about Sabrina” who discovers to 
be allergic to hazelnut and learns how to manage her allergy.
  •  Presentation of the main allergenic foods.
  •  “Guess the allergen here inside”- children have to select the right 
allergen-card that can be hidden in some proposed foods.
  •  “Special cookies”- children are divided in two groups: group A 
cooks hazelnut cookies (using play dough and green glitter pow-
der as hazelnut flour) and group B cooks coconut cookies (using 
play dough and gold glitter powder as coconut flour); then few 
cooks of group A go to help group B and vice versa.
 •  Dissemination of rules on behaviour to prevent cross-contamina-
tions.
Results: From 11th to 15th May 2015, ten primary schools (216 children) 
joined our workshops: 29.6% of the first class (age: 6 y-o), 40.3% of the 
second (7 y-o), 18.5% of the third (8 y-o), and 11.6% of the fifth class (10 
y-o). All of them knew the word “allergy” for environmental allergens, 
and many of them had already heard about milk, peach and hazelnut 
as food allergens. We presented the most frequent food allergens (milk, 
eggs, wheat, nuts, soybeans, crustaceans, molluscs, fish) among the 
ones reported by EU Regulation 1169/2011; we chose to add to the list 
peach, kiwifruit, and sesame seeds because they are usually eaten by 
children and may cross-reacted with environmental allergens. Younger 
children showed great interest in the “Special cookies” handling game. 
“Guess the allergen here inside” did unexpectedly excite older and 
younger children: most of them answered correctly and were aware 
about the presence of milk in ham and eggs in hamburgers.
Conclusions: Children were interested in learning more about food 
allergens and in joining the practical experiences we proposed. Par-
ticipants were often competent, sensitive to food allergy topic and 
interested to know the rules to manage food allergy and to reduce 
contamination during food handling and preparation.
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Introduction: Despite food challenge testing being the gold standard 
for food allergy diagnosis, there is only minimal research published 
on its psychological impact and effect on health related quality of 
life (HRQoL) in adults. The aims of this study were to assess whether 
undergoing a clinically indicated open food challenge affects the qual-
ity of life of adults with suspected food allergy and whether HRQoL 
gains are higher among people testing negative than those testing 
positive for food allergy. In addition, we aimed to evaluate whether 
undergoing a food challenge test leads to a reduction in anxiety.
Methods: A prospective cohort study involving completion of a sur-
vey prior to the challenge test, on the day, and three months after 
the test was conducted. The inclusion criteria were: age 18 or older 
and a clinical decision that a food challenge was indicated. The Food 
Allergy Quality of Life Questionnaire-Adult Form (FAQLQ-AF) was used 
to assess change in HRQoL before and after the challenge. State anxi-
ety was assessed with the 6-item version of the Spielberger State Trait 
Anxiety Inventory.
Results: 53 individuals were included. The mean age was 33.5  years 
(SD  =  12.5). The majority were female (71.7%). A variety of foods 
were tested with the most common being tree nuts, peanut, shell-
fish and fish. Most participants tested negative on challenge (84.9%). 
There was a significant improvement in HRQoL three months post-
challenge compared to baseline, F (1,52) = 15.346; p < 0.001 and this 
was unrelated to challenge outcome. A significant reduction in state 
anxiety was observed following the food challenge, F (2,104) = 15.75; 
p < 0.001. Undergoing a food challenge test leads to improvement in 
HRQoL of adults with suspected food allergy despite whether they test 
positive or negative.
Conclusions: By making these tests more widely available in clinical 
practice and clarifying whether an individual is allergic or not, any 
uncertainty can be dispelled, unnecessary food restrictions can be 
avoided, HRQoL can be improved and anxiety reduced.
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Introduction: Studies showed that teachers’ competences for man-
aging children at risk of anaphylaxis or children with food allergy in 
kindergartens and schools are poorly developed. The purpose of this 
study was to explore how short theoretical and practical interven-
tion programme influence on pre-service teachers’ knowledge about 
allergy and anaphylaxis.
Methods: 62 post-graduate pre-service primary and lower secondary 
school teachers (all female; median age 24.5) participated in the study. 
27.4% of pre-service teachers reported that they are allergic themselves. 
Participants were exposed to 90  min theoretical (about allergy and 
anaphylaxis) and practical (using adrenalin auto-injector) educational 
intervention. Participants answered the Teachers’ Health Competences 
Development–Anaphylaxis Management Questionnaire (THCDAMQ) 
which comprised knowledge items about anaphylaxis (Max 7 points) and 
attitude items on managing children’s anaphylaxis three times, before 
intervention, immediately after and 14 days after the intervention.
Results: Pre-service teachers showed positive attitudes towards 
learning more about different children’s health issues (91.9%). All of 
them expressed that child health topics were very important for each 
teacher and all wanted to increase their health competences. 90.3% 
thought that teacher is responsible for pupils’ health issues during 
school time. 71% reported that they haven’t been exposed to any 
activities that would promote their health competences development. 
The results of the Friedman Test indicated that there was a statisti-
cally significant difference in THCDAMQ scores across the three time 
points (pre-intervention, post-intervention, 14-days follow-up χ2 (2, 
N = 37) = 48.127, p ≤ .000). Inspection of the median values showed 
an increase in total scores on items that test post-graduate pre-ser-
vice teachers’ knowledge about anaphylaxis from pre-intervention 
(Md = 3; IQR 2–4.5) to post-intervention (Md = 6; IQR 6–6) and a fol-
low-up (Md = 6; IQR 6–6) scores.
Conclusions: Intervention anaphylaxis programme had positive effect 
on students’ knowledge and attitudes towards school child allergy. 
Students retained their knowledge after intervention. Pre-service 
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teachers would manage a child with anaphylaxis more efficiently 
when intervention anaphylaxis programme is available to them.
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Introduction: This study was carried out in order to investigate a pos-
sible preventive n-3 and n-6 PUFA effect against alterations due to 
immunization with β-lactoglobulin (β-Lg) in Balb/c mice.
Methods: Four to five weeks old female Balb/c were divided into 3 groups 
(n = 9 each). Mice were supplemented by gavage at a dose of 0.6% V/W 
for 15 consecutive days with either: (1) fish oil, rich in PUFA n-3, (2) corn 
oil, rich in PUFA n-6 and slight amount of PUFA n-3 or (3) a solution of PBS 
1/10 as the control group. Mice of all groups were then immunized with 
intraperitoneal injections of 10 µg β-Lg absorbed onto 2 mg of Al(OH)3. 
At the end of the experimentation, mice were killed and jejunums were 
removed for histological study and local anaphylactic study in Ussing 
chamber by the measurement of the electrophysiological parameters: 
short current circuit Isc (µA/cm2) and tissue conductance G (mmho/cm2).
Results: In Ussing chamber stimulation with β-Lg of jejunal fragments 
of the control group induced an increase in the Isc and G values (ΔIsc 
= 17.40 ± 2.39 µA/cm2, ΔG = 6.41 ± 1.67 mmho/cm2). This increase 
is very significantly diminished after n-3 PUFA supplementation 
(ΔIsc = 7.94 ± 1.46 µA/cm2, ΔG = 1.81 ± 0.62 mmho/cm2 p < 0.01). A 
non significant decrease of the Isc and G values (ΔIsc = 10.73 ± 1.55 
µA/cm2, ΔG = 3.65 ± 0.62 mmho/cm2) was observed in the group sup-
plemented with n-6 PUFA compared to the control group. The altered 
intestinal architecture observed in the control group was improved in 
the groups supplemented with both PUFA n-3 and n-6. The beneficial 
effect exerted by (n-3, n-6) PUFA was evidenced by a very significant 
increase (p < 0.01) of the villis length.
Conclusions: Local intestinal anaphylactic response and intestinal 
damages are some of IgE mediated food allergy symptoms. Although 
contradictory, studies showed a decrease in sera IgE levels after sup-
plementation by fish oil (n-3) or sunflower oil (n-6). In our experiment, 
n-3 PUFA seems to reduce the intestinal anaphylactic response and 
both n-3 and n-6 PUFA improved the intestinal architecture. The mech-
anism by which these PUFA exert their effect cannot be explained by 
this study and need to be further investigated. PUFA supplementa-
tion especially n-3 PUFA decreases considerably some of the damages 
resulting from sensitization with β-Lg in Balb/c mice and could be con-
sidered as a preventive strategy against allergy to cow’s milk proteins.
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Introduction: This study was led in order to evaluate taurine effect on 
modulation of intestinal anaphylactic response induced by beta-lacto-
globulin (β-Lg), major allergen of bovine milk in Balb/c mice used as 
an animal model of allergy to cow’s milk proteins (ACMP).
Methods: 42 Balb/c female mice were divided into 3 groups (n  =  14 
each). The first group was untreated and represents the negative con-
trol (CL−), the second group was intraperitoneally sensitized with β-Lg 
and represents the positive control (CL+), the third group received for 
15 days 100 mg/kg/day of taurine administrated intraperitoneally (Tau+) 
then sensitized intraperitoneally with β-Lg. Specific IgG anti-β-Lg were 
determined in the mice sera by an enzyme-linked immunosorbent assay 
(ELISA), and local anaphylactic responses were performed ex-vivo in 
Ussing chamber by intestine challenge with β-Lg. All animals were sub-
jected to the challenge test in-vivo by i.p. injection (1 mg/mouse) of β-Lg.
Results: Compared with sensitized mice, those treated with tau-
rine have lower anti-β-Lg-specific IgG (1/16,750 th) (p  <  0.0001).
The addition of β-Lg to the serosal side of the mouse intestinal epi-
thelium in Ussing chamber produced electrogenic chloride (Cl-) 
secretion as shown by Isc stimulation (ΔIsc  =  7.50  ±  3.34 µA/cm2) 
(ΔIsc = 17.54 ± 1.04 µA/cm2) respectively (p < 0.001). Sensitized mice 
demonstrated also an enhanced epithelial permeability as measured 
by conductance (p  <  0.0001). Taurine treatment resulted in a signifi-
cant decrease in secretory response. Signs of allergic reaction were 
less important in (Tau+) group, but it should be noted that 50% of the 
mice reached stade 4 after 30 min.
Conclusions: A net increase in sera IgG anti-β-Lg titers was observed 
in (CL+) indicating a high immunogenicity of this protein. Also, a low 
production of IgG anti-β-Lg was observed in the (Tau+) suggesting 
that taurine plays an immunomodulation role. The stimulation with 
β-Lg in the mucosal side of tissue in the Ussing chamber was signifi-
cantly decrease tissues of (Tau+) compared with (CL+), suggesting 
a decrease in local intestinal anaphylactic response. These findings 
provide evidence for the first time suggesting that taurine appears to 
reduce intestinal anaphylactic response, indicating protection from 
β-Lg-induced epithelial permeability increase.
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Introduction: Anaphylaxis is a medical emergency, requiring rapid 
recognition and treatment. Simulation team-training is an effective 
method in other emergencies such as cardiac arrest. The Allergy Clinic 
and Department of Pediatrics evaluate and treat children and adults 
with allergic diseases. Procedures with a risk of inducing anaphylaxis 
e.g. allergen challenge tests and immunotherapy are performed daily. 
Recently, staff members have undergone in situ simulation team-
training with focus on diagnosis and treatment of anaphylaxis. Train-
ing took place in the departments in collaboration with the Simulation 
Unit. The aim of this investigation was to evaluate the attitude to in situ 
simulation team-training among staff.
Methods: Participants answered a questionnaire 1–3  months after 
training.
Questions:
1. Has the in situ training increased your focus on closed-loop communi-
cation in emergencies?
2. Has the in situ training increased your focus on the importance of 
team work when treating anaphylaxis?
3. Has the in situ training increased your focus on the use of the ABCD-
algorithm when treating anaphylaxis?
4. Has the in situ training increased your knowledge of the anaphylaxis 
treatment algorithm?
5. Has your knowledge regarding treatment of emergencies in general 
increased after training?
6. Did training in your own department add to the learning experience?
7. How confident do you feel in treating anaphylaxis after the in situ 
training?
Possible answers question 1–6: □ Yes, definitely □ Yes, partly □ I don’t 
know/neutral □ No, I doubt it □ No, definitely not
Possible answers question 7: □ Very confident □ Confident □ Almost 
confident □ Not confident □ Very unconfident
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Results: In all, 35 staff members completed training and 23 (66%) 
answered the questionnaire. Respectively 96, 100, 83, 82, 86% 
answered “Yes, definitely” or “Yes, partly” to question 1–5. Twenty-two of 
23 stated, that training within the department had added to the learn-
ing experience. One did not answer. After in situ training, 96% were 
’Very confident’ or ’Confident’ in treating patients with anaphylaxis.
Conclusions: In situ simulation team-training was perceived to add to 
the learning experience and highlight the importance of team work 
and awareness of managing emergencies locally within the depart-
ments. These preliminary data support the value of in situ simulation 
training in departments performing procedures and treatments with a 
high risk of inducing anaphylaxis.
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Introduction: Food safety is threatened by environmental toxicants 
which were contaminated from industrial processes. Di-(2-ethylhexyl) 
phthalate (DEHP) is among the most-produced phthalates used as 
plasticizer in industry to increase the flexibility of polyvinyl chloride 
(PVC) products. DEHP was intentionally blended into emulsifier in 
Taiwan and has been ubiquitously detected in numerous drinks and 
food. The incident of phthalate-contaminated foodstuffs raises the 
concerns of exposure of DEHP-tainted foods on public health. Epi-
demiological studies revealed a positive association between DEHP 
exposure and the development of asthma, allergies and atopic dis-
orders. Although several toxicology studies indicate the adjuvant 
effects of DEHP to disturb the T cell functionality systemically or in 
the lung tissues of allergic animals, however, little is known regarding 
the effects of DEHP on intestinal immunity and its underlying mech-
anisms. As the primary source of DEHP exposure for most people is 
through gastrointestinal tract and one of the major health concerns 
of DEHP is its deteriorated effects on immune system, the objective 
of this study is to evaluate the effects of DEHP on intestinal immunity.
Methods: The allergen-induced diarrhea mice model was applied to 
study the adjuvant effects of DEHP on the incidence of allergic symp-
toms and pathological changes.
Results: The present data demonstrated that exposure of DEHP dose-
dependently induced the severity of OVA-induced allergic responses. 
Several aspects were affected by DEHP including acceleration of the 
occurrence of OVA-induced diarrhea, increased serum level of OVA-
specific IgE, infiltration of IL-4-secreting T cells in the villus and the 
degranulated mast cells with the crypt of duodenum.
Conclusion: Collectively, exposure of DEHP will exacerbate antigen-
specific allergic responses in the food allergic BALB/c model.
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Introduction: The main aim of the study was comparison and identi-
fication of the Lactobacillus acidophilus derived proteins which have 
the capacity to bind to humans class E antibodies.
Methods: To detect the immunoreactive bacterial proteins of Lactoba-
cillus acidophilus 145 and Lactobacillus acidophilus La5 the individual 
protein fractions were isolated from MRS (18 h/37 °C) bacterial cultures. 
Bacterial protein fractionation was performed as in Bäuerl (2010). The Lac-
tobacillus acidophilus cell fractionation of proteins have been subjected 
separation with SDS-PAGE and 2DE method followed by immunoblotting 
with human sera with determined increased IgE level. Identification of 
obtained spots was carried out by MALDI-TOF MS/MS method.
Results: Obtained results indicate that lactic acid bacteria commonly 
used in the production technology of fermented milk beverages also 
have in their structure a protein capable of binding to the antibodies 
of class E. The profile of isolated bacterial proteins differs considerably 
depending on analyzed strain. It has been proven that some bacterial 
proteins connected with surface layer are prone to bind nonspecifi-
cally to human IgE but this part was excluded using specific anti-A and 
anti-G antibodies. The comparison of IgE-immunoreactive proteins 
profile show difference between the strains and between used human 
serum. Identification of this proteins revealed that they belong mainly 
to enzymatic group and are located both in cytoplasmic and mem-
brane fraction of proteins.
Conclusions: Immune system in the initial stage of life in most organ-
isms develops tolerance and identifies commensal microbial protein 
as self-consistent. On the other hand bacterial cells are a reach source 
of proteins that can exhibit immunomodulatory properties. It is 
known that bacterial proteins have determinants that are recognized 
by human immunoglobulins A, M and G but also E. Part of IgE reac-
tion can be nonspecific like this induced by S-layer proteins (A and G) 
but there are also enzymatic proteins with proven immunoreactive 
potential. These results indicate that bacterial proteins depending 
on the strain and localization have varied profile and reveal different 
determinants with different affinity to human IgE antibodies.
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Introduction: Loss‐of‐function‐mutations in the epidermal barrier 
gene filaggrin (FLG) are the major genetic risk factor for eczema and 
eczema‐associated allergic airways diseases. We aimed to investigate 
the role of FLG mutations in food allergy, the importance of which is 
still unclear.
Methods: We have recruited 523 children with food allergy diagnosed 
by double‐blind placebo controlled food challenge. All children were 
extensively characterized including allergic responses to specific 
foods. The four most common FLG loss‐of‐function mutations were 
genotyped in all cases and controls. Association of FLG mutations with 
food allergy was analyzed by logistic regression using the Multicenter 
Allergy Study (MAS) as control population.
Results: FLG mutations were associated with allergies to diverse 
foods (hen’s egg, peanut, cow’s milk) with similar risk estimates (odds 
ratios between 2.5 and 2.7, P‐values <10−5). Interestingly, this effect 
remained significant after adjusting for the eczema status. We did not 
observe an association of FLG mutations with polyvalent compared to 
monovalent food allergy. Mucocutaneous, gastrointestinal, respira-
tory, and cardiovascular responses during double‐blind placebo con-
trolled food challenge were documented in a standardized fashion. 
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The FLG effect increased with the number of organ systems involved 
suggesting an effect on severity of the allergic response.
Conclusions: Since FLG mutations cause a skin barrier defect, our 
results suggest a pathway for food allergy similar to that for eczema‐
associated asthma, where transcutaneous sensitization through the 
impaired epidermal barrier is the initializing event leading to localized 
or systemic allergic responses that may affect distant organ systems. 
Co‐occurrence of food allergy and eczema in early childhood is a com-
mon phenomenon. Using our large, well characterized food allergy 
cohort we demonstrated that FLG mutations confer risk for food 
allergy beyond their known association with eczema. They predispose 
to multi‐organ involvement during allergic reactions, and should thus 
be considered when assessing anaphylaxis risk.
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Introduction: Food allergy affect up to 8% of children and 3% of adult 
in the United State and several studies have noted racial discrepancies 
in prevalence. There is great lack of data about epidemiology of food 
allergy and associated atopic disorder in Saudi Arabia.
Our objective is to explore Epidemiology of food allergy and associ-
ated atopic disorder in Saudi Arabia.
Methods: This is a retrospective study that is still in progress. We col-
lected so far 128 patients evaluated for presumed food allergy in eight 
allergy clinics out of 1360 patient seen in the clinics in one referral 
Center in Riyadh/Saudi Arabia, between 1st January and 30 April, 2016. 
We assessed patient’s demographic data, offending food allergens, 
presenting manifestation, associated atopic disorder, diagnostic meas-
ures and treatment plans.
Results: The study included 103 patients out of 128 who had com-
plete data, on their clinical symptoms and objective diagnostic meas-
ures of food allergy (RAST, ASPT, oral challenge). The pediatric patients 
were (79%) of the total number of patients, Male (63%) of all patients. 
Prevalence of Food allergy among adult (>14yrs) patients was 1.5%, 
while among pediatric patients 6%. Overall the most common offend-
ing food allergens were Egg (40%), sesame (39.8%), Tree nuts (39.7%), 
Milk(28%), Peanut (24%), Fish (21%) Wheat (13%), Shell fish (9%), Soy 
(7%), Legume (6%). Regarding the presenting manifestation Mucocu-
taneous were the most common symptoms affecting (43%) of patients 
followed by anaphylaxis in (32%), pulmonary in (13%) and Gastro-
intestinal (6%). Overall (60%) of patients with food allergy had other 
associated atopic disorder namely bronchial asthma, Allergic rhinitis 
and atopic dermatitis.
Conclusions: This is the very first study exploring the epidemiology 
and Prevalence of food allergy among Saudi patients who visited 
allergy clinics in a referral centerPreliminary results revealed the food 
allergy affects 1.5% of adults and 6% pediatric population Egg fol-
lowed by sesame, nuts, milk, peanut are the more common offending 
food allergens in Saudi Arabia. Most presenting feature are mucocu-
tanous followed by anaphylaxis. Majority of the cases associated with 
other atopic disorder.This study is still in progress, and data will be col-
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Introduction: We report the case of a 46  year-old woman, with per-
sonal history of bronchial asthma and rhino conjunctivitis, who 
attended our Unit in September 2012 to study an anaphylaxis 
appeared immediately after eating multicereals biscuits (oat, rice, flax 
seeds, egg, almonds and raisins).
Case report: Skin-prick tests (SPT) were positive for dog dander exclu-
sively and negative for house dust mites, fungi, cat and dog epithelia, 
latex and pollen (Olea europea, Parietaria Judaica, Cupressus arizonica, 
Platanus acerifolia, Graminae family, Artemisia vulgaris); SPT with food 
allergens were positive to nut, peanut, mustard, tomato, corn, peach 
and apple and SPT with cereals commercial extracts (corn, wheat, 
rice, oat, barley, rye, gluten and gliadin) were negative. Prick by prick 
with golden and toasted linseed was positive. Total IgE (UniCAP, Ther-
mofisher) was 282  kU/L, specific IgE to dog dander 3.26  kU/L, peach 
1.63  kU/L, wheat 0.54  kU/L, rye 0.38  kU/L, apple 1.14  kU/L, Pru p 3 
1.97 kU/L, omega-5 gliadin 0- kU/L, tomato 2.22 KU/l. The microarray 
ISAC (Termofisher) showed polysensitization to both cross-reactivity 
and species-specific allergens: Can f 5 35 ISU, Cry j 1 0.4 ISU, Cup a 1 
1.8 ISU, Ara h 9 0.3 ISU, Jug r 3 0.4 ISU, Pru p 3 0.4 ISU, Art v 3 0.5 ISU, 
other determinations were negative. Sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (SDS-PAGE) immunoblotting was per-
formed with gold and toasted flax seed extract. IgE immunoblotting 
with the patient’s serum, under reducing conditions, showed an IgE 
binding band < 14 kDa both in the gold flax seed and in the toasted 
linseed extract. We present a case of a patient with anaphylaxis due to 
flax seed allergy with a LTPs sensitization and asthma and rhinitis due 
to dog dander allergy with monosensitization to kallicrein. The patient 
remains asymptomatic with a free diet without flaxseed.
Conclusion: The prevalence of allergy to seeds is highly influenced by 
the geographical area and eating habits. In Spain, according to Aler-
gologica 2005, seeds allergy represents 1.6% of food allergy. The cases 
reported of flax seed allergy in pubmed are anecdotal but linseed is 
recognized as an increasingly important food allergen since its intro-
duction in diet for its nutritional benefits and its use as a laxative. To 
date, no flaxseed allergen has been characterized yet.
Consent to publish: The patient has consented to publication of our 
findings.
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Introduction: Double blind placebo controlled food challenge (DBP-
CFC) is the gold standard in food allergy diagnosis, reflecting the clinical 
outcome of food allergic patients. Studies have shown that component 
resolved specific IgE (sIgE) testing can aid in the diagnosis of food aller-
gies by the detection of sIgE against distinct proteins. Here, we inves-
tigated the advantage of component based multiplex sIgE testing in 
diagnosing subjects with suspected tree nut and peanut allergy.
Methods: Patients from Germany with suspected tree nut and/or pea-
nut allergy were included. Four clinical symptom groups based on a 
clinical questionnaire, skin prick testing (SPT), occasionally sIgE meas-
urement and DBPCFCs were defined and referred as no symptoms, no 
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symptoms/tolerant, oral allergy syndrome (OAS), and grade I-IV ana-
phylaxis (ANA). Subsequently sera from all subjects were investigated 
for sIgE using EUROLINE sIgE multiparameter tests (EUROIMMUN, Lue-
beck, Germany) with extracts and components of distinct tree nuts 
(hazelnut, walnut, macadamia nut, cashew nut, pecan nut, Brazil nut, 
and pistachio) and peanut.
Results: SPT indicated sensitization to tree nut and/or peanut, and pollen 
in 68 subjects. 41% and 59% of these subjects presented with OAS and 
ANA, respectively. As determined by EUROLINE tests, subjects from both 
symptom groups were sensitized to PR-10 proteins from hazelnut (Cor a 
1: OAS 89%; ANA 95%), almond (Pru du 1: OAS 36%; ANA 43%), and pea-
nut (Ara h 8: OAS 18%; ANA 23%). The sensitization to storage proteins 
from tree nuts and peanut was almost exclusively shown in anaphylac-
tic patients, 33% of which were positive for sIgE against storage proteins 
from more than one tree nut and/or peanut. Moreover, among anaphy-
lactic patients, sIgE against Ara h 6 was most frequently (38%) detected.
Conclusions: In this cohort, sensitization to storage proteins from tree 
nut and/or peanut was highly associated with ANA, indicating that the 
detection of sIgE against storage proteins can improve the assessment 
of clinical outcome in allergic patients. In contrast, anti-PR-10 IgE gave 
no indication on clinical outcome since the majority of subjects with 
tree nut and/or peanut allergy was sensitized to PR-10 protein due to 
cross-reactivity to birch pollen. Component based multiplex sIgE tests 
including storage proteins can aid in assessing the risk of ANA that 
provides additional value for the diagnosis of serious allergic reactions 
in tree nut and peanut allergy.
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Introduction: 2S albumins have been described as food allergens con-
stituting important clinical diagnostic tools in food allergies. Despite 
their relatively low sequence similarity, there are studies focused to 
their potential role in cross-reactivity reactions, so they can be used as 
a tool for their prediction.
The aim of this study is to identify ten 2S albumins from seeds and 
nuts, as well as to characterize its structural parameters and assay 
them for IgE reactivity with patients’ sera.
Methods: Isolation of 2S albumins from extracts using chromato-
graphic methods. After identification by mass-spectrometry, molec-
ular characterization was conducted by electrophoretic methods 
(1- and 2-dimensional electrophoresis); its secondary structure and 
thermal stability were studied by circular dichroism spectroscopy. 
Finally, immunoassays were performed to reveal their allergenic 
capacity, using allergic mustard-allergic patients’ sera.
Results: Proteins have been isolated and purified from extracts by 
means of two chromatographic steps, a gel filtration and a reverse 
phase in HPLC. They were identified as 2S albumins by mass-spectrom-
etry of digested peptides (MALDI-TOF). They generally show a helicoi-
dal secondary structure, stable at 85 °C and possess a wide range of pI 
and heterogeneous polypeptide size and composition.
Conclusions: The fingerprint analysis confirmed the purified proteins 
as 2S albumins, storage proteins already characterized as allergens. 
Purified proteins shown similar characteristics than those described 
for this family of proteins. The molecular characterization revealed 
low molecular masses and acid and basic pI, some of them exhibit 
the typical two chains-pattern and others, such as the one from sun-
flower seed, are constituted by one polypetide chain. Circular dichro-
ism studies reveal their high resistance to thermal treatment except 
the one from pistachio. The characterized 2S albumins will be used as 
clinical tools in Component-Resolved Diagnosis (CRD) in a big Span-
ish population of patients allergic to vegetable foods using the potent 
high-throughput screening technology with ADVIA-Centaurus, to 
elaborate a more accurate diagnosis and therefore a more effective 
treatment. This diagnosis is especially relevant having in account the 
severe symptoms caused by this allergenic family.
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Introduction: Food safety authorities recognise food allergy as a sig-
nificant public health concern and have defined a list of “priority foods” 
that must be labelled irrespective of their level of inclusion in a recipe. 
Allergen molecules of those priority foods are the actual hazard for 
sensitive individuals but data are often lacking regarding their capac-
ity to cause an allergic reaction. A systematic approach is being taken 
to assess this for peanut and tree nut allergens.
Methods: Legislation from across the world has been searched to 
compile a list of tree nuts that have to be labelled and from this a 
search stratgey developed. This was implemented in a pilot study and 
data used to develop a modified PECO approach to the full systematic 
review. In addition a set of gradings has been developed to allow data 
gathered to be critically appraised in a consitent manner.
Results: A search strategy and search terms, based on allergen label-
ling requirements across the world for peanut and tree nuts, has been 
developed. This was implemented in a pilot study and the retrieved 
articles were systematically reviewed and an inclusion list generated. 
Articles included were subject to analysis uing grading crieteria span-
ning the quality of the patient population used to the quality of an 
allergen preparation used in a given study.
Conclusions: This framework along with scientific grading criteria pro-
vides the basis to conduct a systematic literature review to identify the 
quality of evidence supporting inclusion of particular tree nut species 
in allergen labelling lists and quality of evidence that certain protein 
molecules can be classified as an allergen. Such data will allow future 
development of curated sequence sets of verified allergen molecules 
which are needed for development of analytical methods for deter-
mining allergens in foods.
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Introduction: Fish is one of the most frequent causes of IgE-mediated 
food allergy in children in Portugal and rarely begins in adults. Allergy 
to fish in adulthood can be caused by an occupational exposure.
Case report: The authors describe the case of a 29  years old women, 
with an unusual work (since age of 23): animal handler at an Aquar-
ium, she prepares raw fish (capelin) to feed amphibious without use of 
personal protection measures (gloves) and also dives in the tanks for 
cleaning. She has personal history of rhinoconjunctivitis since adoles-
cence and hand eczema since three years ago. In the last two years she 
started having episodes of facial/lip angioedema and/or nausea/vomit-
ing and the last one with stridor and dyspnea, always after the ingestion 
of cooked fish meals. Contact urticaria to jellyfish and corals was also 
reported. Skin prick tests (Bial - Aristegui, Bilbao, Spain) were positive to: 
codfish, axillary seabream, striped red mullet, pilchard, gilt-head bream 
and seatrout; negative to: tuna fish, sole, hake, morkfish and salmon.
Prick by prick tests were positive to: raw hake, raw and cooked gilthead 
seabream and raw capelin (the food fish); negative to: cooked hake. 
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Total serum IgE of 727 UI/mL. Specific serum IgE (UniCAP®, Thermo 
Fisher Scientific, Uppsala, Sweden) were weakly positive to: codfish 
(0.19 KU/L), hake (0.11 KU/L), salmon (0.16 KU/L), pilchard (0.13 KU/L) 
and sole (0.29 KU/L); negative to: swordfish. She tolerates tuna fish and 
salmon and eats them regularly. Nevertheless, avoidance of ingestion 
of other fishes as well as direct fish handling only with personal protec-
tion measures were recommended in order to keep on the actual job.
Conclusion: Allergic sensitization to fish in adulthood is unusual. 
There are reports suggesting that sensitization to food allergens may 
occur outside the intestinal tract, namely through the skin. It is likely 
that in this case, the fish sensitization has occurred by repeated skin 
contact with raw fish in the context of occupational exposure.
Consent to publish: Consent was obtained for publication of this case 
report.
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Introduction: Allergy to milk is one the most prevalent allergies affect-
ing around 3% of children. At present there is no effective treatment 
for milk allergy and therefore strict avoidance is recommended. This 
however can be difficult as milk is an ingredient in many foods. The 
development of diagnostics and therapeutics for milk allergy depends 
on accurate and reliable methods for standardisation. Our aim was to 
develop quantitative immunoassays that could be used to accurately 
measure specific milk allergens.
Methods: Monoclonal antibody pairs recognising the major milk aller-
gens Bos d 11 (β-casein) and Bos d 5 (β-lactoglobulin) in its native and 
denatured state and were obtained. Subsequently two-site ELISAs 
and Luminex xMAP assays were developed using highly purified, IgE 
validated allergens as standards. The assays were used to measure 
milk allergens in different types of foods (powdered milk, chocolate 
mousse, chocolate bar, and cookie) and in diagnostic/therapeutic 
preparations. They were also used to monitor potential milk contami-
nation in products that claim to be ‘milk free’. The Luminex assays for 
Bos d 5 and Bos d 11 were “multiplexed” to allow for simultaneous 
quantification of both allergens in a single sample.
Results: All assays showed wide standard dynamic range. The Lower 
Limit of Detection (LLOD) for ELISA was 7.8 ng/ml for both native and 
denatured Bos d 5 and 15.6  ng/ml for Bos d 11. The Luminex assays 
proved to be even more sensitive with LLOD up to 40-fold lower com-
pared to ELISA (0.2 ng/ml, 2.0 ng/ml and 2.4 ng/ml for native Bos d 5, 
denatured Bos d 5 and Bos d 11 respectively). Concentration of Bos d 5 
in tested samples ranged from 12.3 mg/g in milk powder to 0.279 µg/g 
in a placebo “milk free” chocolate bar developed for research.
Conclusions: These data demonstrate that these immunoassays are 
suitable for the quantification of specific milk allergens, in their native 
and denatured forms, as well as in food samples containing relatively 
low levels of milk allergen. Immunoassays for quantification of specific 
milk allergens have been developed. The assays can be used separately 
(as ELISA) or be “multiplexed” (Luminex assays) allowing simultaneous 
quantification of multiple allergens in a single sample. The immunoas-
says will allow standardization of milk protein levels in diagnostic and 
therapeutic extracts and detection of milk allergens in foods.
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Introduction: Hydrolysed wheat proteins have provoked IgE medi-
ated symptoms after skin exposure or ingestion in subjects tolerant 
to wheat. Acid hydrolysed wheat protein in a facial soap has been 
described to break tolerance to wheat. We have previously investi-
gated the sensitising capacity of wheat gluten (G), enzymatic hydro-
lysed (EHG) and acid hydrolysed gluten (AHG) in naïve Brown Norway 
rats (Kroghsbo et  al. 2014). The aim was to study the influence of 
wheat tolerance on the sensitising capacity of G, EHG and AHG.
Methods: Rats were bred for at least two generations on ordinary wheat-
containing rat chow. After weaning the rats were kept on chow and then 
moved to a gluten free diet. Blood was drawn before dosing day 0 and a 
week after termination of dosing. Oral study: Rats were dosed by gavage 
with 20 mg G, EHG or AHG daily for 35 days. I.p. study: Rats were dosed 
with G, EHG or AHG 320 µg protein day 0, 14 and 28. Sera were analysed 
for specific IgG1 and IgE to the respective protein by ELISAs. Cross-reac-
tivity was measured by inhibition ELISA’s and avidity by KSCN ELISA.
Results: At baseline >50% of the rats had low IgG1 titre to G, but no 
detectable IgE to G. Oral dosing with G, EHG or AHG did not induce 
significant changes in the level of specific IgG1 and IgE to either the 
product used for dosing or to G. I.p. dosing resulted in a significant 
increase in IgG1 antibodies to the respective proteins and in IgE to 
G and AHG. The G dosed rats had IgG1 with the highest avidity. IgG1 
from AHG immunised rats showed a higher avidity to G than to the 
AHG. The inhibition ELISA’s showed a high level of similarity within and 
between the groups.
Conclusions: In contrast to our study in naïve rats, oral dosing in 
wheat tolerant rats could not induce a specific immune response 
above baseline. In the i.p. dosed animals the high level of cross-reac-
tivity indicates a response dominated by antibodies to epitopes that 
are similar on all three products. The lower avidity to AHG (containing 
novel epitopes) compared to G in AHG dosed animals suggests a role 
for affinity maturation in the wheat tolerant animals. Exposure by the 
oral route to EHG or AHG is very unlikely to break an already estab-
lished tolerance to wheat and induce sensitisation. In the i.p. study 
prior affinity maturation to common epitopes on G and AHG makes 
it possible to induce a high avidity immune response to G by dosing 
with AHG. This may illustrate how AHG in a facial soap could break tol-
erance to wheat.
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Introduction: Food-dependent exercise induced anaphylaxis (FDEIA) 
is a distinct form of food allergy induced by physical exercise. The 
ingestion of specific food are usually tolerated if not followed by 
exercise. FDEIA patients generally have not experienced symptoms 
in response to warmth (such as a hot bath), or other condition that 
increases the core body temperature, and they have symptoms only 
in association with an ingestion of specific food(s). A variety of foods 
have been described as causal allergy inducing foods in FDEIA. Skin 
tests and in  vitro serum food-specific IgE assays are currently used, 
but the results are frequently negative. A challenge test consisting of 
ingestion of assumed food followed by intense physical exercise is the 
only reliable method to diagnose the disease, but this is not always 
safe to perform. Monosodium glutamate is a common added ingredi-
ent to savoury foods, namely in Chinese food, and it has been previ-
ously linked to urticaria and angioedema.
Case report: We present a case of a 16-year-old white boy that devel-
oped within a few minutes from onset of physical activity: periorbital 
edema, urticaria, generalized pruritus and cough. In the emergency 
department, he was hypotensive (79/50  mmHg). He was treated 
with intramuscular epinephrine, clemastine and methylprednisolone 
and symptoms resolved completely. 4 h before the onset of physical 
activity he eats Chinese food, including pasta, shrimp and pork meat, 
which were previously tolerated by him. He regularly exercises with-
out any problem. There was no past personal history of anaphylaxis, 
angioedema, food allergy, atopic dermatitis, drug allergy or vaccine 
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allergy. He had no concurrent illness that day. He was not exposed to 
other foods, alcohol or medication (including NSAIDs, aspirin) several 
hours prior to exercise. There was no exposure to extreme tempera-
ture changes. Skin prick testing, serum-specific immunoglobulin E 
level and ImmunoCAP ISAC were negative. The challenge test was not 
performed due to severity of clinical presentation.
Conclusion: This case is an important reminder that although rare, 
food-dependent exercise-induced anaphylaxis exists. Making a diag-
nosis can be difficult but it can lead to life-saving preventative strate-
gies. Besides some food additives, like monosodium glutamate, may 
be implicated in some of these reactions. In this case there is indica-
tion to avoid concomitant ingestion of the food and exercise.
Consent to publish: Informed consent to use the data was obtained 
from the patient.
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Introduction: 70–80% of children with egg allergy can eat baked 
foods containing highly heated egg, showing that denaturation of egg 
proteins greatly modifies their allergenic potential. However, little is 
known about the effects of moderate denaturation treatments on the 
allergenicity of egg white proteins. We sought to investigate to what 
extent different technological processes that lead to a limited denatur-
ation of the egg proteins can affect their immunogenic capacity. Thus, 
in this study, we compared the ability to sensitize and trigger allergic 
responses of raw egg white (R-EW), pasteurized egg white (H-EW, 80°C-
10 min) and high-pressure treated egg white (P-EW, 400 mPa-10 min).
Methods: BALB/c mice were orally sensitized during 7  weeks with 
5  mg of either raw, heated or pressurized egg white (R-EW, P-EW or 
H-EW). One week after the last sensitization dose, mice were orally 
challenged with 50 mg of the egg white protein preparation used for 
sensitization and the anaphylactic responses were evaluated. During 
the sensitization protocol, EW-specific IgG1 and IgE were quantified 
weekly. Passive cutaneous anaphylaxis (PCA) tests were performed in 
order to know whether the immune response was IgE-mediated or 
both IgG1- and IgE-mediated. Cytokine production was also measured 
in allergen-stimulated spleen cell cultures.
Results: The highest liberation of mast cell protease, as well as the 
most severe anaphylactic signs and body temperature drop, were 
observed in P-EW sensitized and challenged mice, followed by R-EW 
sensitized and challenged mice. Moreover, splenocytes from mice sen-
sitized to P-EW produced more Th2 cytokines, IL-4 and IL-5, than those 
from mice from the other groups in response to stimulation with the 
allergen. Regarding the humoral response, R-EW and P-EW promoted 
the highest levels of specific IgG1 at the end of the sensitization pro-
tocol, while H-EW stimulated the highest production of IgE. PCA tests 
confirmed that IgG1 plays an important role on the allergic reactions 
to R-EW and P-EW, whereas reactions to H-EW were mediated by IgE 
to a higher extent.
Conclusions: Denaturation of egg white proteins with high-pressure 
increases their sensitizing and eliciting capacity. Egg white heated to 
pasteurization temperatures exhibits a reduced capacity to induce 
anaphylactic responses despite the fact that it actively induces the 
production of specific IgE.
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Introduction: Food processing and interactions involved in different 
food components affect the bioavailability and immunoreactivity of 
allergens. However, the impacts of different food matrices on protein 
digestibility and IgE reactivity of peanut of allergens are poorly under-
stood. We are using an in vitro digestion model to evaluate the effects 
of digestion on protein release and immunoreactivity of allergens 
from peanut flour, and the same peanut flour incorporated in to the 
EuroPrevall dessert and iFAAM cookie matrices used for oral food chal-
lenges in the iFAAM project.
Methods: Digestibility of roasted peanut flour, peanut dessert and 
peanut cookie was assessed using an in vitro digestion system which 
includes a model chew, followed by simulated gastric and duodenal 
digestion system. Protein digestion was monitored by SDS-PAGE, 
and immunoreactivity was specifically analyzed by immunoblotting 
using a serum panel from peanut-allergic subjects from the ManARTS 
biobank, using a combination of immunoblotting and immunoassay 
methods.
Results: Roasted peanut flour proteins proved highly digestible fol-
lowing gastric-duodenal digestion with only low molecular weight 
peptides of Mr < 6 kDa being visible. Gluten containing baked matri-
ces are slower to digest and hence release and digestibility from the 
cookie matrix is expected to be slower than that from the water con-
tinuous EuroPrevall chocolate dessert matrix. Undertaking gastric 
digestions at higher pH (6.5) reflecting the affect of taking ant-acids 
also reduced the rate of peanut allergen digestion.
Conclusions: Food matrices can have complex effects on the release 
and digestion of allergens during simulated in vitro digestion. Future 
studies will apply mass spectrometry profiling methods to determine 
how both the food matrices and increased pH affect the patterns of 
proteolysis, especially given the pH-dependent nature of pepsin 
specificity.
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Introduction: Sensitivity to peanut allergens varies between coun-
tries, reflecting environmental factors such as local pollen and genet-
ics. Arah1, 2 and 3 are considered the major peanut allergens whereas 
Arah8 is a homologue of the birch pollen allergen Betv1 and is not 
associated with severe allergic reaction. Ara h 6 is cross-reactive with 
Arah2 but may also be a single sensitizer. The aims were to determine 
the component pattern of peanut sensitization in Iceland and relate to 
the history of allergic reaction to peanuts as well as to pollen allergy.
Methods: Serum samples from 220 individuals obtained during a 
25 month study period and were positive for peanut specific IgE (Pn-
IgE) were used to measure by ImmunoCAP (Thermo Fisher Scientific, 
Uppsala, Sweden); Arah1-, Arah2-, Arah3-, Arah8- and Betv1-IgE. Infor-
mation on age, gender, personal- and family history of atopy and skin 
prick tests were obtained from medical records. Arah2-IgE negative 
individuals were interviewed and invited to an open peanut challenge. 
Those who reacted to peanuts were evaluated for Arah6-IgE by ISAC 
(Thermo Fisher Scientific, Uppsala, Sweden).
Results: The main atopic findings within the study cohort of 220 Pn-
IgE positive individuals included history of eczema (75.5%), asthma 
(65.5%), and allergic rhinitis (65.5%). Arah2-IgE was negative in 52.3% 
(115/220). Of those, 24.3% (28/115) were already consuming pea-
nuts, 29.6% (34/115) had a negative challenge, 5.2% (6/115) had a 
Page 66 of 79Clin Transl Allergy 2017, 7(Suppl 1):10
positive challenge and 2,6% (3/115) had an inconclusive one. Forty 
four (38.3%) rejected or were unable to undergo a challenge. Of the 
Arah2 negative and challenge positive individuals, three were sensi-
tive to Arah6, (one single-sensitive), two were sensitive to Arah1 and 
3 and one was borderline sensitive to Arah1, 2 and 3. Two inconclusive 
cases were positive to Arah6. Those who were challenge positive had a 
higher Arah1-IgE.
Conclusions: Peanut sensitized individuals in Iceland are highly atopic 
and half of them are not sensitized to the major allergen Arah2. This is 
only partly explained by birch sensitization and sensitization to other 
components such as Arah1 and Arah6 is important.
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Introduction: Peanut allergy is an increasingly common health prob-
lem. While there are currently no approved treatments specifically 
for peanut allergy, oral immunotherapy (OIT) has shown promising 
results. In OIT, peanut allergens (often in the form of peanut flour) are 
typically delivered by mixing into vehicle foods and then consuming. 
Also, in OIT clinical trials, patients undergo food challenges, where the 
peanut allergens are mixed into vehicle food. To insure consistent dos-
ing during OIT and during food challenges, it is important to show that 
the food matrices do not compromise the integrity of the allergens. 
Aimmune Therapeutics is currently enrolling patients in a Phase 3 OIT 
study (PALISADE) to demonstrate the efficacy and safety of AR101, a 
formulated drug product containing peanut protein at different dos-
age strengths. It is taken orally following mixing with food. The aim 
of this study was to determine the stability of peanut allergens over 
a 24 h period following mixing with foods used in the PALISADE food 
challenge, applesauce and chocolate pudding, foods also commonly 
used as vehicles for OIT dosing.
Methods: Peanut flour (PF), Peanut-Food Challenge Material (PFCM; 
peanut flour mixed with food-grade flavorings and bulking agents), 
and AR101 (100  mg) were each mixed with food and sampled at 0, 
4, and 24 h. Proteins were extracted from the food mixtures and ana-
lyzed by peanut specific ELISA and LCMSMS. Total peanut allergen was 
quantitatively measured in an ELISA (R-Biopharm Ridascreen Fast-Pea-
nut). LCMSMS identified two marker peptides each for Ara h 1, h 2, and 
h 6 following protein extraction, digestion, and alkylation. These were 
compared over the course of 24 h to a no-food-matrix control.
Results: ELISA: Ranges of peanut protein (ppm peanut) recovered 
with AR101 extraction from applesauce (2 samples analyzed in dupli-
cate) were: 3.3–4.2 (t =  0  h), 3.9–4.3 (4  h), 3.3–3.8 (24  h). Ranges for 
AR101 extracted from chocolate pudding were: 3.2–3.6 (0  h), 4.0–5.7 
(4 h), 3.6–4.5 (24 h). Data were similar for PF and PFCM. LCMSMS: For 
all marker peptides, peak areas were within 30% of t = 0 h for all food 
matrices (single samples, triplicate measurement).
Conclusions: When mixed into applesauce or chocolate pudding, 
there was no observable degradation of the samples over 24 h, insur-
ing sufficient stability to accommodate any reasonable variability in 
time taken to consume a dose.
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Introduction: Food allergy is the most common cause of anaphy-
laxis in children. Banana fruit appears to have become an important 
cause of fruit allergy in children. The allergens involved are poorly 
characterized.
Case report: We report a clinical case of an 18-year-old boy with gen-
eralized urticaria and oropharyngeal pruritus with dyspnoea imme-
diately after banana ingestion at the age of 12. Since then he has 
eliminated this fruit from his diet and has no complaints with any other 
foods, namely of rosaceae family. Skin prick tests performed with com-
mercial extracts were positive for pollen from Olea europeae 10  mm 
and banana 7 mm. The past medical history is remarkable for Crohn’s 
disease. Specific IgE measured by EAST technique was 1.94  kU/L for 
Olea europeae pollen extract and 0.78  kU/L for banana pulp extract, 
1.2  kU/L for banana peel extract and 17.5  kU/L for Pru p 3 (LTP). The 
molecular mass of the IgE binding bands was calculated by SDS PAGE 
immunoblotting in reducing and non-reducing electrophoretic condi-
tions. The apparent molecular mass of the IgE -binding bands were: 
20 kDa in banana pulp extract and 9 kDa for banana peel extract (with 
some less intense bands of 66, 50, 40, 30, 29  kDa). The immunoblot-
ting-inhibition method was used to study if the 9  kDa binding band 
was an LTP protein. Banana peel extract was used as a solid phase and 
Pru p 3 as inhibition phase. Pru p 3 was able to produce a partial IgE-
binding inhibition on the 9  kDa band. Oral food challenge was not 
performed due to Crohn’s disease.
Conclusion: Some of the detected IgE-binding bands in banana 
extracts show similar molecular mass to the known allergens, namely 
Mus a 4- thaumatin-like protein (20 kDa in banana pulp extract), Mus 
a 5- beta 1.3 glucanase (30 kDa), Mus a 2- chitinase (33 kDa) in banana 
peel extract. Most likely, the main IgE-binding band of 9  kDa from 
banana peel extract is the Mus a 3 LTP protein. High sensitization to 
Pru p 3 allergen has no clinical manifestations in our patient. We spec-
ulate about the association between food allergy and inflammatory 
bowel disease in this particular case.
Consent to publish: Informed consent to use the data was obtained 
from the patient.
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Introduction: Oral food challenges (OFC) are the gold standard for the 
diagnosis of food allergy in children. Using a standardized approach 
with semi-log dose increments every 30  min OFC usually represent 
a safe procedure without requiring intensive care. Here we describe 
three cases of severe anaphylactic reaction during OFC in order to 
identify potential risk factors in children.
Case report: Among the last 1500 DBPCFC performed in our clinic we 
had three cases of severe anaphylactic reactions requiring ICU trans-
ferral. Surprisingly the reactions in our cases were not caused by pea-
nut but by cow’s milk (CM), hen’s egg (HE) and hazelnut (HN). Three 
male patients (9, 12 and 16 years of age) each with a medical history 
of atopic eczema and bronchial asthma showed severe anaphylactic 
reactions with pulmonary obstruction and recurrent drop in blood 
pressure requiring two or more intramuscular adrenaline injections, 
administration of volume boluses, inhalation of salbutamol and oxy-
gen, and in two cases application of continuous intravenous adrena-
line. All patients started to react at higher titration steps: The eliciting 
doses were 0.34 g of CM, 0.20 g of hazelnut and 1.55 g of HE protein, 
respectively.
Conclusion: Severe anaphylactic reactions requiring intensive care 
during oral food challenges are rare and seem to occur most often in 
older children suffering from bronchial asthma. We postulate the fol-
lowing assumptions:
  •  Severe reactions are not limited to the well-known potentially 
life-threatening peanut allergen but may also occur with CM, HE 
and hazelnut. Especially older children around school age who 
did not outgrow their CM or HE allergy may be at a higher risk 
for anaphylaxis.
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  •  Next to respiratory problems, arterial hypotension seems to play 
an important role in children and adolescents, which indicates 
that the administration of intravenous volume boluses in combi-
nation with intramuscular adrenaline is a part of severe anaphy-
laxis treatment that should not be underestimated.
 •  Since severe reactions are not foreseeable, OFC should be per-
formed under medical surveillance in a controlled clinical setting 
with access to an intensive care unit.
Consent to publish: Written informed consent to use the data was 
obtained for all patients.
PP148 
Effects of avoidance of hazelnut upon IgE reactivity profiles 
and basophil responsiveness in hazelnut allergic and sensitized 
children
Margaretha A. Faber1, Annick Bastiaensen1, Evelyne Mangodt1, Athina van 
Gasse1, Ine Decuyper1,2, Vito Sabato1, Margo M. Hagendorens1,2, Chris H. 
Bridts1, Luc S. De Clerck1, Didier Ebo1
1Department of Immunology‑Allergology‑Rheumatology, Faculty 
of Medicine and Health Sciences, University of Antwerp, Antwerp Uni‑
versity Hospital, Antwerp, Belgium; 2Department of Pediatrics, Antwerp 
University Hospital, Antwerp, Belgium 
Correspondence: Athina van Gasse ‑ athinavg@hotmail.com
Clinical and Translational Allergy 2017, 7(Suppl 1):PP148
Introduction: Hazelnut allergy shows distinct clinical patterns 
depending on the sensitization profile, which shows variations accord-
ing to age. This study aims at determining whether alterations in the 
sensitization profile to hazelnut occurs in early childhood.
Methods: Twenty-one infants with atopic dermatitis demonstrating 
an early sensitization to hazelnut (AD-group) and 9 children (<4 years 
old) with a history of hazelnut allergy (GR-group) were selected. At 
baseline (T0) children were recommended to avoid hazelnut. At T0 
and follow-up consultation (T1) history taking and specific immuno-
globulin E (sIgE) measurement to hazelnut extract and its components 
were performed. A basophil activation test (BAT) with hazelnut was 
performed at T0 and T1 in children of the GR-group and at T1 in chil-
dren of the AD-group.
Results: Median follow-up was 6.2 years. At T1, a significant increase 
in sensitization to Cor a 1.04, Cor a 8, Cor a 11, Cor a 14 and Bet v 1 
was observed in the AD-group. Six (29%) infants from the AD-group 
had uneventful accidental exposure to hazelnut, all of them showed 
a negative BAT despite positive sIgE results. Children out of the GR-
group were significantly more frequently sensitized to Cor a 1.04 and 
Bet v 1 at T1. Sensitization to other components and BAT results did 
not significantly differ between T0 and T1.
Conclusions: Despite avoidance of hazelnut, sensitization profiles can 
broaden during early childhood. However, in the absence of a generalized 
hazelnut allergy, the clinical relevance of these serological changes remain 
elusive as the majority of these children demonstrate negative BATs.
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Introduction: Hen’s egg (HE) allergy is one of the most common food 
allergies in early childhood. However, previously it has been shown 
that about 80% of children allergic to raw HE can tolerate heated HE. As 
double-blind placebo-controlled food challenges (DBPCFC) are the gold 
standard in food allergy diagnostic, we intended to establish a standard-
ized DBPCFC-protocol for heated HE that is simple in regard to prepara-
tion, blinding and titration and well accepted even by young children.
Methods: For the DBPCFC with heated HE, 55  g raw pasteurized HE 
(Wiesenhof) that equals 1 HE (7,095  g HE protein) was heated for 
1 min in a microwave (800 W) leading to 45 g heated HE. As a blind-
ing matrix applesauce with cinnamon, chocolate pudding or vegeta-
ble puree was added. The mixture was blended and titrated in seven 
incremental dose steps containing 0.03, 0.1, 0.3, 1, 3, 10 and 30  g of 
heated HE. For placebo the equivalent blinding matrix was used and 
rice powder was added to match the texture. If no reaction occurred 
during the titrated DBPCFC, a cumulative dose of 45 g heated HE was 
given another day. Children with allergic reaction to raw HE who toler-
ated at least 0.4 g of raw HE during the challenge were eligible for a 
challenge with heated HE.
Results: 50 children with allergic reaction to raw HE performed a DBP-
CFC with heated HE according to the protocol described above within 
3  month after their positive DBPCFC to raw HE. The challenge meal 
was well accepted by every child. 43/50 children (86%) showed no 
allergic reaction to heated HE whereas 7/50 (14%) were allergic to raw 
and heated HE.
Conclusions: Our standardized protocol for a DBPCFC with heated HE 
showed a high acceptance even in young children in regard to volume 
and taste. Using this protocol allows a simple, less time-consuming 
preparation method compared to baked egg protocols, especially if 
no oven is available on site. Furthermore it allows a more precise titra-
tion and masking of the DBPCFC. Our data on DBPCFC with heated HE 
confirm published data from other countries that the majority of chil-
dren with HE allergy tolerate heated HE. Preparation of heated HE in 
a microwave is a simple method for a DBPCFC with heated HE. A high 
proportion of children with raw HE allergy can tolerate heated HE, 
therefore standardized DBPCFC with heated HE should be performed 
in order to improve quality of life of HE allergic children.
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Introduction: Allergic reactions to peanut are on the rise in Western 
countries. In vitro diagnostic tests applying aqueous extracts or water-
soluble single allergens are investigated as an alternative to costly 
and potential life-threatening oral food challenges (OFC). However, 
their diagnostic accuracy to predict the degree of clinical severity 
is still inferior to OFCs which might be based on the absence of lipo-
philic allergens such as oleosins. Recently, sensitization to oleosins 
has been associated with more severe allergic symptoms in allergy to 
sesame and hazelnut. Hence, we sought to investigate oleosins as pos-
sible new candidates for routine diagnostic measurements in peanut 
allergy.
Methods: Oleosins from raw and in-shell roasted peanuts were iso-
lated by flotation centrifugation and purified by preparative elec-
trophoresis. Protein identification was carried out by N-terminal 
sequencing and mass spectrometry. Sensitization prevalence to 
oleosins from raw and in-shell roasted peanuts was investigated by 
western blot. The ability of oleosins to trigger type I hypersensitivity 
reactions was evaluated by basophil activation test (BAT).
Results: A number of eight oleosins were isolated and identified 
from peanut. So far, these molecules showed IgE binding exclusively 
to sera from patients suffering from severe peanut allergy. Moreover, 
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IgE binding to oleosins obtained from in-shell roasted peanuts was 
increased compared to raw ones. Both, oleosins from raw and in-shell 
roasted peanuts were able to stimulate basophils from peanut-allergic 
individuals having severe symptoms.
Conclusions: Oleosins are important lipophilic allergens that are able 
to trigger allergic reactions but have been overlooked so far due to 
their low solubility in aqueous buffers. Sensitization to these proteins 
seems to be solely associated with severe allergic symptoms. Peanut 
oleosins are clinically relevant peanut allergens. As they are most likely 
associated with more severe allergic symptoms they might be new 
maker candidates for the clinical severity of peanut allergy. Further-
more, in-shell roasting increases the IgE binding potency of oleosins 
which is in line with previous results for other peanut allergens.
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Introduction: To compare the performance of rGad c 1 and rCyp c 1 in 
fish sIgE component-resolved diagnostics.
Methods: Retrospective analysis of laboratory reports for 78 outpa-
tients (median age 12  years, range 0.8–66; 40 males) having under-
gone fish sIgE component-resolved diagnostics between November 
2011 and July 2016. Comparison of ImmunoCAP 250 results for sIgE to 
rCyp c 1 and rGad c 1 was done for 46 patients (22 males; median age 
13 years, range 0.8–66). Comparison of ImmunoCAP 250 and ISAC 112 
results was done for 46 patients (26 males; median age 13; range 3–58; 
17 rCyp c 1 + rGad c 1+ ISAC; 29 rCyp c 1 or rGad c 1 + ISAC).
Results: 44/46 (96%) singleplex assays yielded concordant pos/neg 
results (18 double negative, 26 double positive). Both discordant 
results were rescued by rCyp c 1 testing (0.44 and 0.11 kUA/L). Among 
double positive results, median levels of sIgE to rCyp c 1 were slightly 
higher (3.1 vs 2.5 kUA/L, not significant). 39/46 (85%) ISAC 112 and 
ImmunoCAP 250 assays yielded concordant pos/neg results (9 dou-
ble negative, 30 double positive). All discordant results (7/46 = 15%) 
were negative with ISAC 112 and positive with ImmunoCAP 250 (sIgE 
to rCyp c 1 0.18–12.4 kUA/L; sIgE to rGad c 1 0.18–0.65 kUA/L). Among 
double positive results, median levels of sIgE to rGad c 1 were slightly 
higher with ISAC 112 (median 6.1 ISU, range 0.8–89) than with Immu-
noCAP rGad c 1 (5.1 kUA/L, range 0.67–68) and ImmunoCAP rCyp c 1 
(4.2 kUA/L, range 0.56–156), but this difference was not significant.
Conclusions: Currently, two recombinant beta-parvalbumins are avail-
able for fish sIgE component-resolved diagnostics. Both can be used 
for singleplex ImmunoCAP assays, while ISAC 112 only contains rGad c 
1. Data on rCyp c 1 and rGad c 1 performances are scarce and have not 
been updated for ISAC 112. In our hands, singleplex rCyp c 1 and rGad 
c 1 display very similar performances in a vast majority of patients. 
rCyp c 1 may offer better detection for low values of 1 kUA/L or less. 
rGad c 1 microarrayed on ISAC 112 lacks sensitivity for low values (15% 
false negative), but positive results are well correlated with singleplex 
rGad c 1 and rCyp c1. Singleplex assay of sIgE to rCyp c 1 offers a very 
slight increase in sensitivity of detection compared with rGad c 1. 
rGad c 1 microarrayed on ISAC 112 is prone to false negatives (up to 
15%) for low levels, but when positive it is well correlated to singleplex 
results.
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Introduction: The aim of this pilot study was to assess the knowledge 
of parents of children with food allergies on the elimination diet and 
allergens, and knowledge of the sources of information about food 
allergy.
Methods: The pilot study was conducted from May to August 2016 
among 86 parents in Lower Silesian in Poland, whose children have 
food allergies. Surveys were distributed to parents in hospitals and 
nursery school. They were a group of women and men in the age 
range 18–50 years. Parents’ knowledge was verified by a questionnaire, 
which has been specially developed for the study.
Results: The product most often in Polish children invoke allergic 
reactions were cow’s milk and eggs. The vast majority of respondents 
showed knowledge of the definition of the elimination diet and they 
knew that, when a food allergy elimination diet and you should care-
fully read the labels of food products. However, the greater part of the 
interviewees believed that the allergy to cow’s milk should be elimi-
nated from the diet always and only cow’s milk and milk products.
Conclusion: Compared to other studies of Polish parents also have 
basic than parents from other countries. Also among the other 
respondents to the primary sources of information was Internet and 
doctor.
Parents of children, who have food allergies, have a basic knowledge 
on the elimination diet and individual allergens. However, this does 
not always indicate correctly, which foods you should avoid elimina-
tion diet.
This may be due to the fact that the main sources of information were 
the Internet, the doctor and books about allergies.
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Introduction: Wheat is a complex allergenic food containing a lot of 
proteins that are difficult to isolate and to identify. Hence we aimed 
to develop a diagnostic method linking specific allergenic 2D western 
blot profiles to a particular clinical symptom in wheat allergy. After-
wards, we used mass spectrometry (LC-MS/MS) to identify molecular 
allergens.
Methods: A total protein extract of wheat seeds was separated on 
the basis of the isoelectric point and the molecular weight of the pro-
teins. Twenty-five patients presenting positive specific IgE (sIgE) for 
wheat were classified into 3 different phenotypes: wheat dependent 
exercise induced anaphylaxis (WDEIA), atopic dermatitis (AD) and pol-
len rhinitis (PR). Their sera were analyzed by 2D immunoblotting on a 
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standardized wheat seeds extract in order to evaluate their sIgE reac-
tivity against the protein spots. Their sIgE sensitization profiles were 
compared and protein spots of interest were identified by LC-MS/MS.
Results: Specific sensitization profiles were identified for each phe-
notype group. For WDEIA, protein spots around 37 kDa (pH 6–9) and 
37–50  kDa (pH 5–6) were identified. For AD, spots were observed 
around 50 kDa (pH 9), 10 kDa (pH 9) and 20 to 75 kDa (pH3). For PR, 
specific spots were situated around 90 kDa (pH 9). The LC-MS/MS anal-
ysis of these identified spots pointed out several potential interesting 
allergens: tri a 26, tri a bA, tri a 34, tri a tritin.
Conclusion: Our study answers to the request of many allergists wish-
ing to get an accurate diagnosis of wheat allergy in order to determi-
nate the risk of cross-reaction, to adapt the diet and to limit the risk 
of anaphylactic choc. Nevertheless, it is necessary to consider the 2D 
immunoblot results with the medical history of each patient. Moreo-
ver, there are different clinical manifestations of wheat allergy depend-
ing on the involved allergen and the way of exposure: WDEIA, AD, PR 
or baker’s asthma. The present project pointed out new wheat aller-
gens that could be associated to a specific phenotype. The identifica-
tion of further protein spots is still under investigation. At this stage, 
specific sensitization profiles were identified for the 3 phenotype 
groups (WDEIA, DA, PR). The protein spots of interest detected by sIgE 
concern one or more allergens. Some wheat allergens were identified 
by LC-MS/MS. At the end of the study, it will be possible to establish a 
link between a specific symptomatology and the responsible allergens 
newly identified.
POSTER SESSION 5: Case reports
PP154 
Goat’s milk allergy with an unusual presentation
Filipe Benito‑Garcia, Magna Correia, Cristina Arêde, Susana Piedade, Mário 
Morais‑Almeida
Immunoallergy Department, CUF Descobertas Hospital, Lisboa, Portugal 
Correspondence: Filipe Benito‑Garcia ‑ filipe.benito.garcia@gmail.com
Clinical and Translational Allergy 2017, 7(Suppl 1):PP154
Introduction: Cow’s milk (CM) protein allergy is the most prevalent 
food allergy in children. Patients with CM allergy usually do not toler-
ate goat’s (GM) or sheep’s (SM) milk, since there is a high cross-reac-
tivity between all of them. There are few case reports of patients with 
allergy to GM tolerant to CM.
Case report: A 14  years old girl with IgE-mediated CM allergy since 
6 months of age, with CM eviction till 12 years old. At this age an oral 
food challenge (OFC) has been performed, being negative. She started 
a regular ingestion of CM proteins during the last two years. She was 
referred to our Immunoallergy department, one week after an episode 
of lip angioedema and generalized urticaria with intense pruritus after 
eating a meal containing goat cheese, parsley, tomato, onion, poached 
egg and pepper. Two weeks before she had already an episode of oral 
pruritus after eating a small portion of goat cheese. Skin prick tests 
(SPT) (Bial—Aristegui, Bilbao, Spain) to milk and CM proteins (casein, 
α-lactoalbumin, β-lactoglobulin), egg and egg’s proteins, pepper and 
parsley, were negative. Prick by prick test (PPT) were positive to goat 
cheese (19 × 8 mm), GM (11 × 7 mm) and SM (7 × 9 mm). In order 
to validate these results, PPT with goat’s cheese and milk and SM 
have been performed to 10 healthy adult controls. Specific IgE (Uni-
CAP®, Thermo Fisher Scientific, Uppsala, Sweden) was positive to GM 
(8.7  kU/L) and SM (9.3  kU/L) and negative for CM and proteins. Total 
IgE 241 kU/L. Two weeks after the episode, an OFC with CM was per-
formed, being negative, and daily ingestion of CM proteins has been 
advised with good tolerance.
Conclusions: The majority of patients with allergy to CM proteins do 
not tolerate GM or SM. We describe a rare case of an adolescent girl 
who started to react to goat’s cheese after outgrown a CM allergy, 
probably due to sensitization to proteins without homology to CM 
proteins.
Consent to publish: The authors confirm that the individual described 
has authorized them to publish the findings related with the case.
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Introduction: IgE antibodies to peanut storage protein Ara h 2 have 
high diagnostic accuracy in verifying or excluding symptomatic pea-
nut allergy, and high levels are considered to predict serious allergic 
reactions. In our experience some adult patients with peanut allergy 
suffer disabling fear of peanuts, having been taught that they risk a 
severe allergic reaction upon airborne exposure of, or consumption of 
peanuts.
Case report:
1. Female, 24  years old with asthma. The patient had been told to 
exclude peanuts from her diet and not to be in a room where pea-
nuts are consumed. She had always carried an adrenaline auto-
injector. Current level of Ara h2 was 9.3 kU/L. She had never expe-
rienced a severe allergic reaction and was eager to find out how she 
would react to accidental intake of peanuts.
  Following a strict protocol, she consumed one peanut and expe-
rienced instantly some mild oral symptoms. After 20  min she 
reacted with profuse vomiting and a stuffy nose. No adverse respir-
atory or circulatory reactions occurred and no adrenaline or other 
medication was given. The recovery was swift and the patient left 
the clinic after two hours.
2. Male, 20  years old with asthma. At the age of seven he reacted 
with oral symptoms, nausea and vomiting after eating peanuts. 
Hence he developed a fear of all nuts and had been prescribed an 
adrenaline auto-injector. Current level of Ara h2 was >100 kU/L. 
He wanted to know if his fear of nuts was relevant and if there still 
was a need to always bring the adrenaline auto-injector.
  According to a strict protocol he ate three peanuts. Initially he 
experienced transient mild symptoms from the throat, followed 
by abdominal pain and flushing 10 min later. After another 10 min 
he developed hives and profuse vomiting. Antihistamine and cor-
tisone was given intravenously, and the patient recovered quickly. 
He left the clinic after being observed for four hours.
Conclusion: Both patients expressed great relief to have undergone 
a peanut challenge. Knowing that eating small amounts of peanuts 
did not affect their ability to breathe or their circulatory functions has 
helped them replace the fear of what might happen into a relevant 
respect for peanuts. Oral challenge with peanuts in patients with pea-
nut allergy could be justified in some patients, even with elevated lev-
els of Ara h2, when it is important for the patient to know not only that 
he/she will react but also how.
Consent to publish: Patients have consented to the publication of this 
abstract.
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Introduction: Pemetrexed is a folate antimetabolite, approved for 
treatment of mesothelioma and non-squamous non-small cell lung 
cancer. It’s usually used in combination with platinum salts, gemcit-
abine or docetaxel. Pemetrexed presents a good safety profile, with 
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myelosuppression being the most common dose-limiting toxic-
ity. However, hypersensitivity reactions to pemetrexed have been 
described.
Case report: We report the case of a 52 year old woman, with stage 
IV metastatic adenocarcinoma of the lung, on palliative chemotherapy 
(QT) with pemetrexed plus carboplatin; for nausea control she was 
also receiving fosaprepitant immediately before QT. On her first treat-
ment with these drugs, 3 min after starting pemetrexed perfusion, the 
patient developed dyspnea, cyanosis of the extremities, generalized 
pruritic exanthema and hypersudoresis. QT was immediately stopped 
and the patient was treated with hydrocortisone and clemastine. How-
ever, her status rapidly progressed to anaphylactic shock, with loss of 
consciousness, sphincters control, bradypnea, bradycardia, non-meas-
urable blood pressure) and tachycardia. She received IV adrenaline 
and aggressive fluid resuscitation, with rapid improvement and was 
discharged 24 h later, fully recovered. Serum tryptase during the epi-
sode was elevated at 67.5ug/L (normal range: <11.4ug/L). The patient 
was referred to our drug allergy unit for study. Skin prick tests per-
formed 6 months later were positive to pemetrexed 25 mg/ml (7 mm; 
histamine 10 mg/ml = 5 mm) and negative to carboplatin 10 mg/ml 
and fosaprepitant 1  mg/ml; intradermal tests were also positive to 
pemetrexed (1/1000) and negative to carboplatin (1/1000–1/10) and 
fosaprepitant (1/1000–1/10). As the oncologist decided for an alter-
native treatment, a desensitization protocol to the culprit drug, pem-
etrexed, was not considered.
Conclusion: Reports of hypersensitivity reactions to pemetrexed are 
very rare. This drug is almost exclusively used in combination with 
other chemotherapeutic agents, like platinum salts, which might 
underestimate pemetrexed as a cause of immediate hypersensitivity 
reactions. To our knowledge, this is the third report of documented 
anaphylaxis to pemetrexed, and the first to support the diagnosis of 
an IgE dependent mechanism through skin tests.
Consent to publish: Consent for publication was obtained.
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Introduction: Barnacles (Pollicipes pollicipes), a type of seafood found 
on sea coasts worldwide, are a delicacy consumed in Portugal, Spain, 
France and South America. Barnacle allergy is rare, with few published 
cases [1].
Case report: Case 1: A 4-year-old boy with allergic rhinitis, sensitized 
to pollens and house dust mites, reported 2 suspected food-related 
allergic reactions. In the first episode, he complained of pruritus and 
facial erythema immediately after eating barnacles and fish. The sec-
ond episode occurred 6 months later and he presented with dyspnea, 
cough, urticaria and facial edema immediately after eating hake. He 
had a specific IgE to hake  =  0.34  kU/L and positive skin prick-prick 
tests (SPPT) (raw hake: 7 mm; cooked hake: 5 mm; histamine: 4 mm) 
performed at another hospital. No further tests were conducted and 
he was instructed by his previous physician to avoid all fishes. A more 
detailed history at our out-patient clinic revealed that he continued 
to ingest and tolerate fish. Also, the parents were eating barnacles in 
the second episode and they could not guarantee the absence of cross 
contamination with the son’s food. One year after the last episode, 
SPPT with barnacle were performed and they were positive (raw meat: 
13 mm, cooked meat: 13 mm, histamine: 4 mm). Parents refused oral 
provocation test (OPT). Comment: This case illustrates the importance 
of hidden allergens, cross contamination and a detailed history in 
order to establish a correct diagnosis and unnecessary dietary restric-
tions. Case 2: A 9-year-old boy, with allergic rhinitis undergoing aller-
gen immunotherapy with D. pteronyssinus, was referred to our Allergy 
Department for an episode of dyspnea, nausea, and vomiting, oral and 
nasal pruritus immediately after eating 4 barnacles. He was rushed to 
the ER and successfully treated with corticosteroids, antihistamines 
and nebulized salbutamol. Four months later, SPPT were positive to 
cooked barnacle (meat: 7 mm; histamine 10 mg/ml: 5 mm); OPT with 
barnacle was not performed.
Conclusion: Barnacle allergy is a rare, but its allergenic potential is 
well established. Molecular allergens and cross-reactivity with mites 
have been described [1].
Statement of consent: Consent for publication was obtained.
Reference
1. Marinho S, et al. Barnacle allergy: allergen characterization and cross‑
reactivity with mites. J Investig Allergol ClinImmunol. 2006;16(2):117–22.
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Introduction: Prontosan® is an irrigation solution indicated for cleans-
ing, moisturising and decontamination of acute and chronic wounds, 
and contains 0.1% undecylenamidopropyl betaine plus 0.1% polyami-
nopropyl biguanide (polyhexanide [PHMB]) in purified water.
Case report: We report the case of a 72-year-old woman, non-atopic, 
that developed manifestations of an anaphylactic shock, with gener-
alized urticaria, stridor, dyspnoea, nausea, abdominal pain and severe 
hypotension in about 20  min after nurse treatment of a chronic vas-
cular ulcer with Prontosan® and petrolatum, at primary care; she 
was immediately medicated with hydrocortisone but no adrenaline 
and was transferred to the hospital emergency. The ulcer has been 
treated with the same antiseptic compound twice weekly before the 
described severe reaction although in the two previous treatments 
she presented with generalized urticaria, stridor and dyspnoea in 
30  min after the ulcer care. Following the episode of anaphylactic 
shock, treatment did no longer include Prontosan®, and no more 
reactions occurred after that. The patient was referred to an Allergist 
for evaluation. A skin prick test with the implicated antiseptic was per-
formed inducing a 6 × 5 mm wheal at 15-minute reading (identical to 
histamine 10 mg/ml); however, at 30 min a significant wheal increase 
was observed, to 14 × 10 mm. The patient’s daughter offered to be a 
control with a negative skin test result. At this point it was not possible 
to test each antiseptic component separately, but this will be the next 
step, along with an in vitro assay.
Conclusion: To the authors’ best knowledge this would be the forth 
case of anaphylaxis to a polyhexanide irrigation solution. No reports of 
severe immediate hypersensitivity reactions to topical betaine formu-
lations were found in the literature.
Consent to publish: The authors state they have obtained patient’s 
informed oral consent for presentation and publication of the present 
clinical case.
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Introduction: Several studies suggest that tick bites are a cause of IgE 
antibody responses to alpha-gal in the United States, Europe, Asia and 
Australia. Delayed-onset reactions, especially anaphylaxis, have been 
reported to happen 3 to 6 h after ingestion of mammalian food prod-
ucts. Hereby we describe the first case of alpha gal allergy in Brazil in 
a male farmer, who presents with no other symptoms than urticaria.
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Case report: A 55  year-old cattle breeder from North of Brazil (Ron-
donia) with no previous allergies refer to presenting with a daily scat-
tered and pruritic papules for five years. Symptoms used to show up 
mostly in the late afternoon and were closely related to the ingestion 
of meat (lamb, bovine, pork, chicken) during lunch time. When ques-
tioned about tick bites, he clearly described multiple lesions in his 
body secondary to his job with animals and farm. Specific serum IgE 
revealed: bovine meat: 38.80 kU/L; pork meat: 28.60 kU/L; cow’s milk: 
9.7 kU/L; serum bovine albumin: 1.51 kU/L; alpha gal: 70.7 kU/L; total 
IgE 888UI/mL. After orientation to restrict all meats, his symptoms 
have disappeared.
Conclusions: Although most of reports about alpha-gal allergy 
involve anaphylaxis, this patient presented only with urticaria. The 
only route of sensitization was through tick bites, since he never had 
contact to cetuximab. Chronic urticaria in farmers or environment 
with ticks, which can be very often in Brazil, should be investigated for 
alpha gal allergy.
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Introduction: Fenugreek (Trigonellafoenum-graecum), belonging to 
the Fabaceae plant family (legumes), has been used for culinary (as a 
spice in curry) and medical purposes since ancients times, especially in 
Greece, Egypt and India.
Case report: A 16  years old male, with previous anaphylaxis after 
intake peanuts, presented anaphylaxis after intake fenugreek. Skin 
prick test with extracts: Peanut 10  ×  20  mm, natural Fenugreek 
6 × 8 mm, Lentil 2 mm, Soy 2 mm, Bean negative, Histamine 5 mm. 
Serum specific IgE determinations (ImmunoCAP; *EAST): Peanut 
84 kU/L (Ara h 1 34.5 kU/L, Ara h 2 60.9 kU/L, Ara h 3 2.41 kU/L, Ara 
h 8 0.03  kU/L and Ara h 9 0.05  kU/L), Fenugreek >17.5  kU/L*, Curry 
16.9 kU/L, Lentil 1.67 kU/L, Soy 2.65 kU/L, Bean 0.04 kU/L. IgE-binding-
protein molecular mass study (SDS-PAGE-Immunoblotting): Peanut 
extract (raw and toasted): 75, 63, 21 and 19  kDa. Fenugreek extract: 
IgE-binding bands between > 97–30, 21 and 19 kDa. Cross-reactivity 
study using SDS-PAGE-Immunobloting-inhibition with fenugreek 
extract as solid phase: Raw and toasted peanut extracts inhibit com-
pletely IgE binding to fenugreek extract. Study interpretation: 63 kDa-
IgE binding band in peanut extract could correspond to 7S globulin 
Ara h 1. 21 kDa and 19 kDa detected bands in peanut extract could 
correspond to 2S albumin Ara h 2.01 and Ara h 2.02, bands of same 
molecular mass are observed in fenugreek extract. sIgE cross-reactive 
to fenugreek and peanut proteins are presents in patient’s serum.
Conclusions: We describe a case of fenugreek anaphylaxis. Cross-
reactivity between fenugreek and peanut is demonstrated. We con-
sider necessary to rule out fenugreek sensitization in peanut or other 
legumes allergic patients. Possibility of allergic reactions with curry in 
peanut and legumes allergic patients.
Consent to publish: Local institutional review board approved study 
procedures, and written informed consent was obtained. The authors 
declare that they have no relevant conflicts of interest.
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Introduction: Rectal bleeding in infants can be a diagnostic challenge. 
In children younger than one year of age, anal fissures are the most 
common cause of rectal bleeding. However, anal fissures can hide and 
delay other rare diagnoses.
Case report: We report a twenty-four days old female admitted with 
rectal bleeding since she was two weeks old. There were no other 
symptoms, as fever, vomiting or diarrhea. The child was exclusively 
breastfed. The physical examination revealed an anal fissure at 6am 
in dorsal position, with no other changes on examination. The mother 
of the patient excluded dairy products of her diet, with no improve-
ment of symptoms. The laboratory tests revealed peripheral blood 
eosinophilia (1.2 ×  103/μL eosinophils) with no anemia (Hb 10.3  g/
dL) or other analytical alterations. No virus (rotavirus and adenovirus) 
was detected in stools and stool culture was negative. Colonoscopy 
showed discreet erythema of the sigmoid colon mucosa, without 
ulcers, fibrin or aphthous injuries. Biopsies revealed high number 
of eosinophils in the lamina propria of sigmoid colon. The patient 
started an extensively hydrolyzed cow’s milk formula, with sympto-
matic improvement. However, after four days, there was recurrence 
of the rectal bleeding, associated with exuberant perianal erythema. 
Since the rectal bleeding persisted, the patient started an amino 
acid-based formula. In just a few days, there was a symptomatic 
improvement. At six months of age the child gradually reintroduced 
cow’s milk formula, with tolerance. This clinical presentation, with the 
results of colonoscopy, is a striking feature of food protein-induced 
proctocolitis (FPIP).
Conclusions: FPIP is a rare cause of rectal bleeding in healthy infants, 
sometimes mistaken with anal fissures. It is characterized by inflam-
mation of the distal colon due to a non-IgE-mediated reaction to food 
proteins, most commonly cow’s milk proteins. In exclusively breastfed 
infants, mother exclusion of cow’s milk and dairy products should be 
sufficient to stop the symptoms. However food restriction may be dif-
ficult to accomplish for mothers. Additionally there are a small num-
ber of infants that not respond to food restriction of their mothers or 
extensively hydrolyzed cow’s milk formula, being necessary to do an 
amino acid-based formula. This case report pretends to draw atten-
tion to a rare diagnosis of rectal bleeding in infants, where clinical 
suspicion is extremely important.
Consent to publish: Written informed consent to use the data was 
obtained for the patients.
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Introduction: Every year food allergies are most frequent in Allergy 
deparments, being more typical to fruits, eggs, milk and fish. Anisakis 
simplex sensitization is very common at Mediterranean blue fishes, 
producing symptoms from digestive ones to anaphylaxis. Our aim is to 
show a patient with fish anaphylaxis, and the in vivo and in vitro stud-
ies we performed, and the obligation of performing a Food Provoca-
tion Test (FPT) with the culprit fish.
Methods: A 35 years-old patient came to our clinic referring arms urti-
caria with facial angioedema and disnea without hypotension 15 min 
after eating smoked salmon, needing adrenaline treatment. Good tol-
erance before this episode. We performed skin prick test with the main 
aeroallergens and panallergens, typical fishes and anisakis, and we 
studied basal tryptase, total IgE and specific IgE, and ISAC® to evaluate 
a molecular diagnose.
Results: Skin prick test was negative to aeroallergens and fishes, and 
very positive to Anisakis simplex. Total IgE was 80 KU/L, being the basal 
tryptase 3,5. Specific IgE to Anisakis was 10,2, and negative to tuna and 
salmon, with a positive result using ISAC® to Ani s1 and Ani s3. With 
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these results, we performed a FPT with frozen salmon, being negative 
during 2 h of observation as an inpatient and during 48 h at home
Conclusions:
  •  We present a patient with moderate anaphylaxis after eating 
salmon, being the Anisakis simplex parasitation the main reason 
of it.
  •  A good clinical report and in vivo/in vitro studies are very impor-
tant to demonstrate the etiology
 •  A FPT is a very good tool to improve our diagnosis and to avoid 
mistakes.
Consent to publish: The patient has consented to publication of our 
findings.
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Introduction: Food-dependent exercise-induced anaphylaxis (FDEIA) 
is a rare. Particularly important clinical problem is wheat-dependent 
exercise induced anaphylaxis (WDEIA), caused by sensitization to 
omega-5 gliadin.
Case report: Patient, 55, male, was admitted due to recurrent gener-
alized urticaria, which often proceeded loss of consciousness. First 
episode of urticaria, followed by numbness of the lower limbs and 
syncope, appeared in 2007, without any apparent reason. Patient was 
hospitalized due to those symptoms. Next episode occurred in 2012—
patient ate pizza, than performed physical exercise, during which he 
lost consciousness and due to those symptoms required hospitaliza-
tion. Most recent episode of anaphylaxis occurred in 2015, also after 
physical exercise (shoveling coal). In general episodes of urticaria 
occur every 2–3  months. During diagnosis we performed skin prick 
tests (SPT) with inhalant and food allergen. We also established the 
level of total IgE, specific IgE to Dermatophagoides pteronyssinus, 
Dermatophagoides farinae, bee and wasp venom, gluten, wheat and 
rye flour and ImmunoCap ISAC. Patient also performed exercise prov-
ocation test on an empty stomach and after eating bread. SPT were 
positive with wheat flour (4/25 mm) and rye flour (4/5 mm). The con-
centration of allergen-specific IgE against wheat flour (before exercise 
provocation test) was 0.18 IU/ml and rye four 1.06 IU/ml, after provo-
cation test respectively 0.18  IU/ml and 1.21  IU/ml. ImmunoCap ISAC 
reveled elevated level of IgE specific to wheat allergen component rTri 
a 19 (omega-5-gliadin)—2.4 ISU-E and to timothy nPhl p 4 (berberine 
bridge enzyme)—2,5 ISU-E. Exercise provocation test on an empty 
stomach—negative, with no disturbing symptoms. Exercise provoca-
tion test after consumption of bread: before the test blood pressure 
120/70 mmHg, HR 74/min, immediately after the test (on a treadmill): 
128/75 mmHg, HR 120/min. 10 min after the test patient experienced 
generalized urticaria and hypotension 95/70  mmHg. Patient was 
administered intravenous steroids, antihistamines and intravenous flu-
ids with improvement.
Conclusions: Based on the clinical history of the disease, results of 
provocation test and immunological examination patient was diag-
nosed with wheat-dependent exercise induced anaphylaxis. The 
episodes of anaphylaxis could be prevented by avoidance of food 
(especially wheat and rye flour) ingestion in relation to exercise.
Consent to publish: Patient consented to the publication.
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Introduction: Exercise-induced anaphylaxis (EIA) is a rare disorder in 
which anaphylaxis occurs after physical exercise. In a subset of exer-
cise-induced anaphylaxis, named food-dependent exercise-induced 
anaphylaxis (FDEIA), anaphylaxis only developes if exercise is per-
formed within a few hours after eating a specific food. Cofactors, other 
than food are also described. Primarily differential diagnosis is made 
with cholinergic urticaria, a micropapular type of urticaria. To compli-
cate things exercise induced anaphylaxis can sometimes aggravate 
pre—existing cholinergic or cold urticaria and there is also a variant—
type of FDEIA that resembles cholinergic urticaria and shares patho-
genic mechanisms with it.
Case report: We present the case of a 20  years old football player 
who experienced six episodes of acute urticaria in the last 6 months 
prior to the presentation. Most episodes where related to phisical 
exercise (jogging) but he also reported an episode with intens pruri-
tus and micropapular urticaria during sauna bathing. Intrerestingly he 
described pruritus that developed every time he went running (daily). 
The last episode showed different clinical aspect, associated tachicar-
dia, dyspnea and colicky pain and occured while exercising (jogging), 
6  h after eating pizza. A suspicion of exercise—induced anaphylaxis 
with possible associated food co-factor was raised. Paraclinical work 
up showed high levels of Total Ig E (440 IU/mL; cut off limit 100 IU/mL 
and raised levels of omega 5 gliadin (FEIA: 3.33 kU/L, for a cut off value 
of 0.35  kU/L). A diagnostic of FDEIA, in an atopic patient was made. 
The patient was adviced to avoid eating food that contained gluten 
and an emergency kit was prescribed. During the follow up period the 
patient did not experience other anaphylactic episodes although he 
continued to report mainly pruritus after jogging occasionally associ-
ated with minor micropapular urticaria. An effort test was performed.
Conclusions: In the present case, although a diagnostic of FDEIA was 
made guided by the presence of raised omega 5 gliadin sIg E and 
complete avoidance of gluten protected against anaphylaxis, the 
patient continued to experience pruritus and sometimes mild erup-
tion during jogging—suggesting a FDEIA—cholinergic urticaria over-
lap syndrome.
Consent to publish: Informed constent for presentation and publica-
tion was obtained.
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Introduction: Anaphylaxis is a severe, potentially life-threatening sys-
temic hypersensitivity reaction. Foods are by far the most common 
anaphylaxis trigger in infants, children, teens, and young adults. De 
novo food (fish and shellfish) allergy is most common within young 
adult population. Despite the mechanism involved for anaphylaxis elic-
itation, adrenaline is the first line of treatment and an action plan/man-
agement plan should be instructed to the patients or their care givers.
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Case report: We report three anaphylaxis cases presented in our clinic 
during 2014–2016, all initially referred by the ED professionals as fish 
induced anaphylaxis. They all had none co-morbidities and no previ-
ous allergic reactions of any kind.
  •  23 years old female patient developed generalised rush and urti-
caria, angioedema of the lips, difficulty with swallowing and 
breathing, abdominal cramps about 40 min after cod-fish inges-
tion.
  •  27  years old female patient developed angioedema of the lips, 
generalised urticaria, difficulty with breathing and swallowing 
about10 min after fish ingestion.
  •  24 years old female patient developed urticaria and angioedema, 
abdominal cramps, mild breathing difficulty about 20  min after 
fish ingestion.
 •  Biochemical and full blood count resulted normal. Mast cell dis-
order was excluded (Table 5).
Conclusions:
  •  Scombroid food poisoning and fish allergy are often confused 
interchangeably and in vivo and in vitro allergy tests as well as a 
careful history are needed to make the right diagnosis.
  •  The role of co-factors is important in eliciting anaphylaxis.
 •  De novo food allergy related to fish and shellfish in adults should 
always be investigated by the allergist.
Consent to publish: Written informed consent was obtained from the 
patient’s parent or guardian for publication of this abstract and any 
accompanying images. A copy of the written consent is available for 
review by the Editor of this journal.
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Introduction: Sequence homology in IgE binding epitopes of pro-
teins from different foods may cause cross-sensitivity and hereby also 
clinical cross-reactivity. A recent study investigating allergy towards 
pistachio nut and cashew nut found that 25/25 patients were double-
allergic to the nuts. The levels of specific IgE (sIgE) may increase with 
age and new allergies may occur towards previously tolerated foods. 
Sensitization, on the contrary, can be present though the patient is 
tolerant to the food item, why diagnosis relies on oral food challenges 
(OFCs). A study has shown that up to 13% of OFCs can be negative, 
with a clinical reaction upon re-exposure. This can be due to priming 
or maturation of the immune system. But the course of events lead-
ing to reactivity or cross-reactivity towards a previously tolerated food 
item is not fully clarified.
Case report: A 1-year-8-months-old girl was referred to an allergy 
center after an allergic reaction to hazelnuts. She had sIgE (Thermo 
Fisher Scientific, Uppsala, Sweden) towards other tree nuts that she 
had never ingested, and kept a nut-free diet until subsequent OFCs 
(Fig.  8). After two negative pistachio-OFCs, one positive cashew-
OFC and one negative walnut-OFC, a 20 fold increase in sIgE was 
observed towards all nuts challenged with including hazelnuts (later 
hazelnut-OFC was positive). Regular intake of the food tolerated in an 
OFC is normally recommended. But due to the increase in sIgE it was 
regarded unsafe. When re-challenged with pistachio nut, the patient 
reacted with grade-2-anaphylaxis (asthma, rhinitis and urticaria) to 
a dose much lower than the dose previously tolerated. Due to safety 
and ethical reasons the patient was not re-challenged with walnuts.
Conclusions: The report suggests that allergy or cross-allergy towards 
pistachio nut may be induced by repeated exposure. It also stresses 
the importance of IgE testing close to the date before and shortly after 
an OFC. The natural course of allergic disease should be taken into 
consideration. But the timing of OFCs could be of importance to the 
challenge outcome.
Consent to publish: A written consent for presentation and publica-
tion is obtained from the parents.
Table 5 See text for description
Epipen was prescribed to patient 2 and 3 in case of future potential anaphylaxis 
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Introduction: Anaphylaxis is a severe, potentially life-threatening sys-
temic hypersensitivity reaction, being a medical emergency. Trigger 
identification, patient education and establishing emergency action 
plans are essential steps in the management of this condition. How-
ever, in rare cases, patients deliberately expose themselves to the trig-
ger to attempt self-harm.
Case report: We report a case of a 39-year-old woman, with a history 
of multiple sclerosis, borderline personality disorder, depression (with 
10 previous emergency department visits with suicidal thoughts) and 
documented hypersensitivity to nuts and fresh fruits (rosaceae). Fol-
lowing a fifth discharge from a Psychiatric Department, she stopped 
Fig. 8 Summary of clinical and serological testing. OFCs were terminated at appearance objective symptoms or after tolerating 10 grams (g) of nut 
(the first pistachio‑OFC was stopped at 0.45 g, due to time‑shortage). IgE (detection limit ≥0.35 kU/L) towards all listed nuts and components were 
measured on each blood sample. IgE is depicted on a logarithmic scale
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taking her psychiatric medication, had a worsening of her depression 
and ingested peach juice as a suicide attempt. Within minutes, she 
developed generalized pruritus, hand edema, wheezing and desatu-
ration. She was rushed to the Emergency Department where she was 
promptly medicated with im adrenaline, iv corticosteroids, iv anti-
histamines and inhaled bronchodilators, which stabilized the patient 
and reversed the anaphylactic reaction. In the emergency room she 
confessed she had taken the juice as a suicide attempt. During the 
first three days she remained dependent on oxygen and inhaled bron-
chodilators to prevent desaturation. On the seventh day, completely 
recovered from her anaphylaxis, she was transferred to the Psychiatric 
Department for further treatment.
Conclusions: Food allergens account for a large part of anaphylaxis 
triggers. However, their intentional use is very uncommon. Suicide 
attempts by means of anaphylaxis are rare; however, they occur and 
should be documented. This documentation is essential, so the true 
prevalence of the problem can be known. Immunoalergologists and 
Psychiatrists following patients with depression and a history of ana-
phylactic reaction should be aware of this possibility and have a more 
stringent follow-up.
Consent to publish: All case details or other personal information 
presented in this case report are published with the consent of the 
patient.
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Introduction: Alfa -Gal syndrome, an IgE-mediated immediate-type 
allergy to the disaccharide galactose–1,3-galactose is relevant as food, 
drugs, and tick bites allergy. The majority of cases have been found in 
the southeast area of the United States, but their occurrence in Europe 
is nonetheless so frequent as to be recognized as a new challenge for 
allergyst.
Case report: We present clinical characteristics of 5 Italian Patients 
with a history of reactions (rash, itching, urticaria) of typically delayed 
onset following consumption of pork, beef, lamb meat and/or innard. 
An association with tick bites (Ixodes ricinus) was confirmed in all sub-
jects. As the phenomenon of a delayed-onset immediate-type allergy 
with a latency of 3–6 h following ingestion of mammalian meat is con-
sidered pathognomonic for alfa-Gal syndrome, a Prick-to-prick tests 
using fresh meat (pork, beef, lamb) and kidney preparations was per-
formed in all Patients. Five Patients showed positive results to pork and 
beef meat, two of them also to lamb meat. Allergen-specific IgE was 
measured by ImmunoCAP® alpha-Gal; all patients were sensitized to 
alpha-Gal (range 2.2–124 kUA/l). All Patients were male, three of them 
with job exposition to tick bites (1 veterinary, 2 forest guardian), two 
of them exposed only during holiday on open air or hunting. Interest-
ingly, the veterinary experienced a systemic reaction during cow labor, 
possibly for cutaneous contact with vagina and placenta.
Conclusions: Epidemiological studies put the prevalence of alfa-Gal 
sensitization in Europe at 5.5–8.1% (29), but sensitization rates vary 
considerably from region to region. As geographically local phenom-
ena may be helpful in our understanding of alfa-gal syndrome, stud-
ies on the prevalence are ongoing in Ligurian Region, extending to the 
populations exposed to tick bites to recognize new cases.
Consent to publish: We consent for presentation and publication.
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Introduction: Food allergy accounts for a significant social and eco-
nomic impact worldwide. An increasing number of severe life-threat-
ening reactions have been linked to food allergies. Anaphylactic 
reactions to foods are frequently attributed to exposure to fish aller-
gens, mainly in the adult population, and respiratory symptoms occur 
in approximately 50% of fish allergic patients. Prevalence rates of self-
reported fish allergy reaches 8% among fish processing workers.
Case report: We report the case of a 47-year-old male patient, with 
a personal history of atopy (sensitization to Dermatophagoides fari-
nae and Dermatophagoides pternonyssinus), known to suffer from 
asthma and moderate/severe persistent allergic rhinitis, working as a 
chef assistant, who refers to the Allergy Service of the Regional Insti-
tute of Gastroenterology and Hepatology “Professor Doctor Octavian 
Fodor”, Cluj-Napoca, Romania, with a history of asthma exacerbations 
and one anaphylactic episode triggered by occupational exposure to 
fish vapors. The clinical history reveals contact urticaria to uncooked 
fish, and two episodes of facial angioedema and acute generalized 
urticaria after ingestion to lobster and salmon, respectively. Further 
clinical and paraclinical workup confirmed the atopic diathesis. In vivo 
sensitization to Der f and Der p, as well as to fish (salmon, tuna, merlu-
cius, herring, and fish mix) was documented.
Conclusions: Hypersensitivity reactions to fish present with a wide 
range of clinical symptoms. In this paper, we aim to highlight the inter-
relation between asthma and food allergies, by presenting the case of 
a young male patient with asthma exacerbations and a systemic life-
threatening hypersensitivity reaction to fish vapors, as well as contact 
urticaria after handling uncooked fish, and systemic hypersensitivity 
reactions triggered by ingestion of salmon and lobster.
Consent to publish: With the submission of this abstract, I would like 
to undertake that the authors give their consent for publication and 
presentation.
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Introduction: Patients from Southern Romania with allergy to birch 
pollen sometimes report oral allergy syndrome, a contact urticaria 
of the oropharyngeal sites, to Rosaceae fruits and hazelnuts, but no 
report of soy allergy in these cases was published.
Case report: We present a 21-year-old female patient with sea-
sonal allergic rhinoconjunctivitis in spring and convincing history 
of oral allergy syndrome to hazelnuts, fresh Rosaceae fruits (apple, 
pear, quince, peach, apricot, plum, sweet cherries, strawberries), 
and soymilk. The skin prick testing was performed with commercial 
extracts, the prick-prick testing with some fresh edible Rosaceae fruits, 
serum specific IgE sensitization profile was assessed by line blot test 
system to native aeroallergen extracts and cross-reactive foods, while 
a multi-parameter line blot test system was used for pollen defined 
partial allergen diagnosis. The patient presented positive skin prick 
tests to birch (6 mm wheal) and hazel (7 mm wheal) pollen commer-
cial extracts, negative to soy extract, and positive prick-prick tests 
with fresh fruits: apple (4  mm wheal), pear and peach (each 3  mm 
wheal). Serum specific IgE levels were found increased for birch pol-
len (72 kU/L, EAST class 5), hazel pollen (21 kU/L, EAST class 4), alder 
pollen (25  kU/L, EAST class 4), but also, to a lesser extent, for hazel-
nut (0.43  kU/L, EAST class 1). Specific IgE antibodies to apple, apri-
cot, strawberries, celery and carrot were not found (<0.35  kU/L). IgE 
sensitization profile to recombinant allergen components revealed 
sensitization to rBet v 1 (65  kU/L, EAST class 5), while specific IgE to 
profilin biomarker rBet v 2, polcalcin biomarker rBet v 4 and isoflavone 
reductase rBet v 6 were not detected (<0.35 kU/L). Serum IgE level to 
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cross-reactive carbohydrate determinant marker was below detection 
(<0.35 kU/L).
Conclusions: A multiplex line blot assessment of recombinant Betula 
pollen allergen components can be used in clinical practice to deter-
mine whether IgE sensitization to Bet v 1 in patients with birch pollen 
allergy is involved in cross-reactivity reactions with foods containing 
Bet v 1-like allergen components: Rosaceae fruits (apple, pear, peach, 
apricot, plum, cherry, strawberry, raspberry), exotic fruits (kiwi, persim-
mon, Jack fruit), Betulaceae (hazelnut) and Rosaceae (almond) nuts, 
Apiaceae vegetables (celery, carrot), Fabaceae legumes (peanut, soy-
bean, chickpea) and tomato.
Consent to publish: Written informed consent was obtained for pres-
entation and publication.
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Introduction: Most important tomato allergens are: profilin Lyc e 1 
and nsLTP Lyc e 3. López-Matas et al. [2011] analyzed the allergen con-
tent of 6 varieties of tomatoes. It was found that there are significant 
differences between the concentrations of allergens depending on the 
variety of tomato. Pen m 4 is calcium-binding protein is a minor aller-
gen, sensitizing only 10–15% of Italian shrimp-allergic patients, but it 
is clinically relevant and may be the cause of anaphylaxis.
Case report: Patient, 25, female, in 2013 after consumption of shrimp, 
experienced swelling of the larynx, shortness of breath and generalized 
urticaria. Similar episodes occurred in May 2014 and June 2014, also due 
to shrimps. In March 2015 patient experienced angioedema of lips after 
consumption of cocktail tomatoes in a salad before physical activity 
(visit to the gym). She ate cocktail tomatoes before and afterwards with-
out any symptoms. During diagnosis SPT were positive with allergens 
of cat, shrimp, hazel, alder, birch and Artemisia vulgaris. We performed 
prick by prick tests with fresh shrimp (positive 13/23 mm), slicing tomato 
(0/0) and cocktail tomato (4/4). In 5 min after prick by prick tests patient 
experienced angioedema of lips and itchiness and swelling of hands 
and feet. She was administered steroids with good clinical effect. Open-
food challenge with cocktail tomato was negative. Afterwards exercise 
provocation test was performed—without any immediate allergy symp-
toms. Within 4 h patient experienced severe angioedema of lips, which 
was treated with systemic steroids. ImmunoCap ISAC reveled elevated 
level of IgE specific to shrimps calcium-binding protein nPen m 4 (4,3 
ISU-E), birch PR-10 rBet v 1 (1,2 ISU-E), Artemisia defensin Art v 1 (1,2 ISU-
E), cat Fel d 1 (20 ISU-E) and Fel d 4 (4,4 ISU-E).
Conclusions: Patient was diagnosed with exercise induced allergy to 
cocktail tomato. ImmunoCap ISAC found elevated level of IgE specific 
to cat allergens and birch allergens. Patient had anaphylactic reaction 
due to allergy to shrimps calcium-binding protein nPen m 4, which 
is a minor allergen. In case of anaphylaxis this patient has to carry a 
rescue set, including antihistamines, oral steroids and adrenaline in an 
auto-injector.
Consent to publish: Patient consented to the publication of this case 
report.
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Introduction: Seafood plays an important role in nutrition and 
world economy, and nowadays it is a common cause of food allergy. 
Although reactions to seafood have been documented mainly among 
consumers, immune-mediated reactions have also been reported at 
work, and Chefs are among the most exposed occupational groups.
Case report: A 31 years old male, who is working as a Chef on a cruise 
ship, was referred to our Allergy Dept for a 6 months history of hand 
dermatitis initially, and later located hives after handling seafood 
at work. Three months after the symptoms began, he experienced 2 
episodes of anaphylaxis minutes after the ingestion of a small por-
tion of shellfish and sea bass, and after the ingestion of codfish with 
shellfish sauce (angioedema, stridor, dyspnea, conjunctivitis, nausea, 
vomiting and diarrhea). The allergic reactions subsided at home after 
the administration of oral hidroxizine. Skin symptoms started 9 years 
after working as a cook, exacerbated during his workdays and he got 
temporary relief during absence of work. Skin prick test with common 
inhalants were positive to house dust mites, parietaria judaica pollen 
and to a fish allergen panel (rooster fish, monkfish, sea bass, salmon, 
sardine, tuna, trout, mullet, hake and sole); Prick-prick were positive 
to raw and boiled shrimp, hake, salmon, sea bass and raw cod. Patch 
tests were positive to raw shrimp, hake and raw and boiled sea bass. 
Specific IgEs (UK/l) were positive to cod (5.27), salmon (3.92), tuna fish 
(2.47), squid (1.16), sardine (3.78), shrimp (22.30) and cod parvalbumin 
rGad c1 (5.37). Patient was advised to avoid contact with seafood and 
always carry an emergency kit, with an epinephrine autoinjector in 
order to prevent lethal outcome if accidental exposure occurs.
Conclusions: Occupational exposure to seafood can be an important 
seafood allergy trigger, by other means than gastrointestinal exposure. 
Allergic contact dermatitis to seafood is a clinically relevant condition 
that should be included in the differential diagnosis of chronic derma-
titis affecting the hands or forearms of patients at high occupational 
risk. Disruption of the skin barrier seems to be an important added risk 
factor to the development of IgE mediated food allergy.
Consent to publish: Written informed consent was obtained for pub-
lication of this abstract.
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Introduction: Tree nut allergy is one of the most well recognised and 
investigated food allergies. Skin prick, Specific IgE (with components) 
and oral challenge tests are frequently used to evaluate and eventu-
ally confirm nut allergy with high diagnostic certainty. There is a grow-
ing recognition however, of atypical unexpected allergy to foods 
despite reassuring investigations and diagnostic challenges.
Case report: We report a case of a 23  year old male with previously 
diagnosed childhood primary peanut and sesame seed allergy. He had 
generally avoided all tree nuts since but reports oral itching symptoms 
on occasion when accidentally consuming almond. We investigated 
his almond allergy status. Almond skin prick test was 4 mm (positive) 
and specific IgE was 0.88 kU/L (positive); however the birch pollen Bet 
v1 (PR10) component was >100 kU/L consistent with oral allergy syn-
drome. We proceeded to an oral challenge with almond nuts where he 
received over 15 g in a supervised graded protocol and did not dem-
onstrate any immediate reaction; effectively ruling out primary or IgE 
mediated allergy. However, he subsequently consumed almond but-
ter at home with a quantity of around 5 g and developed immediate 
generalised urticaria within 5 min of consumption. No other allergenic 
ingredients were identified in the almond butter and he was advised 
to avoid the almond butter but continue consuming the whole nuts.
Conclusions: Despite demonstrating tolerance to whole almond nuts 
in a supervised challenge this patient unexpectedly reacted to almond 
butter with features of true IgE-mediated immediate hypersensitiv-
ity. There is limited literature on these type of atypical reactions. It is 
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hypothesised that the oils released in the cooking process of making 
almond butter contain a highly concentrated allergenic epitope that 
was previously hidden. It is advised to consider atypical reactions to 
nuts even if deemed safe, especially when in modified forms such as 
butter or oil.
Consent to publish: The authors confirm that consent has been given 
for presentation and publication.
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Introduction: General and specific researches do not always enable 
the accurate diagnosis of alimentary allergic causes.Sometimes we 
need to perform the additional bacteriological researches.
Case report: On consultation appointment we had a girl 10  year’s 
oldwith manifestations of allergic dermatitis, which arose 6  months 
ago and was associated with the consumption of various foods (as 
parents said). We know that another relative has no allegropathology. 
After helminthiasis have been treated and stayed on the elimination 
diet withthe exclusion of certain products led to the brief improve-
ment. Last 6 months she is suffering on constipation. Objectively: on 
the face, thorax and extremities is patchy erythema, exfoliative dis-
plays, cracks, which accompanied with itching. Laboratory: in blood 
we see the absolute eosinophil (2.3  g/l), general serum IgE-1980 Iu/
ml, increased levels of specific Ig E (ELISA > 0.35 kU/I) to all vegetables, 
fruits, nuts and cereals. The results of component diagnostics (Immu-
noCAP, Phadia) (Pru p3 rBet v1, rBet v2, rBet v4, nART v3, Tri a19, rPhl 
p7, rPhl p12) are negative. The bacteriological research of skin, throat 
and feces- a large number of S. Aureus (108). The specific IgE to the 
Staph enterotoxin B, C, TSST are increased (ImmunoCAP, Phadia). We 
verified the diagnosis: Chronic IgE-dependent urticaria, sensitiza-
tion to Staphyloccocal toxin, the food allergy. Recommendation: the 
antistaphylococcal immunoglobulin with transition to the antistaphy-
lococcal lysate, antihistamines.
Conclusions: The Staphylococcal toxin can cause polyvalent sensitiza-
tion to food allergens, which requires phased diagnostic and specific 
antistaphylococcal treatment.
Consent to publish: Consent for publication was obtained.
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Introduction: A male patient 27 years old applied to the clinic of aller-
gology with complaints of stuffiness in nose, ocular itching, rhinor-
rhea, episodes of paroxysmal dry cough with wheezing in the chest, 
difficulty breathing out, chest tightness in the spring time (April and 
May).
Case report: From the medical history: symptoms of rhinitis and con-
junctivitis developed in the age of 17  years and returned every year 
in the spring. Three years later the patient described itching in the 
mouth cavity after apples intake; three years later similar symptoms 
started to appear after pears, cherries, peaches intake, not only in the 
pollen season but all year round. Nuts intake began to provoke swell-
ing of lips, feeling of a lump in the throat and a hoarseness of voice. 
At the age of 25, in spring, in the setting of rhinitis and conjunctivitis 
symptoms the marked episodes of difficulty breathing appeared; the 
patient sought medical advice from the allergologist; the diagnosis of 
bronchial asthma was established. The patient was given a treatment 
with bronchial spasmolytics, antihistamines, intranasal corticosteroids 
during the pollen season, with a positive result. An allergy testing was 
accomplished, that revealed sensitivities to tree pollen (birch, alder, 
hazel, and oak). ASIT was recommended.
In the first year of treatment the injections of repository tree pollen 
allergen (Fostal, Stalallengenes), was administrated, once a week. The 
preparatory course of therapy was sufficiently well tolerated; after 
a maintaining dose has been attained, the patient began to observe 
an infiltrate, hyperemia and pruritis at the injection site appearing on 
the third day after injection; all the symptoms were reversed within 
24 h without treatment. To the end of the second month of maintain-
ing therapy the patient transgressed his elimination diet: he ate an 
apple, but without any symptoms appearing. However two days after 
that diet transgression a hard itching in the perianal region appeared. 
Starting from that point the patient began to observe a pruritis in the 
perianal region on the third day after each injection of allergen. Topic 
antihistamine creams were administrated and antihistamine tablets; 
that treatment gave a positive effect. Dermatological and proctologic 
evaluation did not reveal any abnormality, as well as examination for 
helminthic invasion. A detailed inquiry showed that the diet trans-
gression did not provoke any abdominal pain or borborygmus or any 
altered defecation pattern. The patient has a regular daily stool, does 
not report any diarrhea or constipation symptoms. EGDS did not reveal 
any abnormality. After the first year of the ASIT injections a positive 
trend in the course of disease was noted, with no need in bronchial 
spasmolitics and intranasal corticosteroids in pollen seasons, reduced 
need in antihistamines. However the patient reported itching in the 
perianal region in the pollen season, with the most marked symp-
toms on the 3rd day after the transgression of elimination diet. For the 
second course of the ASIT a sublingual drug administration way were 
chosen, a sublingual birch pollen allergen (Staloral, Stallergenes). The 
preparatory period of ASIT is well tolerated without any adverse side 
events. During the period of maintaining therapy episodes were docu-
mented of swelling in the region of lips and tong, as well as hyperemia 
in the infrahyoid lobe, that cut off without treatment 15–30 min later. 
The patient occasionally transgressed his elimination diet and noted 
delayed (on the 3rd day) symptoms of perianal itching; however, with 
the sublingual ASIT they gradually improved.
Conclusion: Symptoms of perianal pruritis are considered to be an 
manifestations of the polyvalent pollen-related food allergy to raw 
fruits (apples an and others) that first appeared during the injection 
ASIT therapy in a patient suffering with the pollen allergy to birch pol-
len and then reduced during his second course of the ASIT with the 
sublingual birch allergen.
Consent to publish: Written informed consent was obtained for pub-
lication of this abstract.
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Introduction: Buckwheat, which has been abundantly consumed 
in Asian countries and has been increasingly popular in the United 
States, Canada, and Europe, can be a potent allergen when ingested 
or inhaled. Common buckwheat (Fagopyrum esculentum) is known to 
cause severe anaphylactic reactions in adult individuals. However, type 
I allergy to buckwheat is rarely seen in children.
Case report: Our case is reported a 45-year-old man developed life-
threatening anaphylaxis after eating food containing buckwheat on 3 
different occasions. He had tolerated all kinds of wheat for many years. 
Few minutes after eating buckwheat home-baked bread experienced 
urticaria, dyspnoea, wheezing, as well as symptoms of gastrointestinal 
tract nausea and vomiting. After circulatory collapse he admitted to the 
ER requiring restitution. It is interesting to mention that the third case of 
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anaphylaxis was after intake of buckwheat flour as the hidden allergen 
in pastry. Prior to the first episode of anaphylaxis he has a positive his-
tory of respiratory allergies (asthma and allergic rhinitis) as well as posi-
tivity to multiple inhalator allergens (mixture of different grass pollen, 
ragweed, and tree pollens). Skin testing by the prick technique revealed 
positive  reaction to buckwheat with negative reactions to other foods 
including wheat, egg white, and milk. A prick-to-prick test with buck-
wheat flour was also positive. His daughter suffered from the respiratory 
allergies (asthma and allergic rhinitis), atopic dermatitis since birth and 
complains of mouth itching while consuming hazelnut and walnuts. 
Her in vitro tests were positive to alpha lactalbumine, casein, peanuts, 
acarus, dogs’ and cats’ hairs, horse’s and cow’s epithelium as well as to 
the rodent epithelium, mixed grass pollens, tree pollens (birch, beech, 
ragweed). Total serum IgE were extremely high (1065).
Conclusion: According to the literature 11  s globulins in buckwheat 
have the potential to induce IgE antibodies cross-reactive with 11S 
globulins in other, botanically unrelated foods and may induce ana-
phylactic reactions. In developing countries sophisticated diagnostic 
methods are not available, so we need to make a detail plan for pre-
venting anaphylactic reaction in children with positive family history 
of anaphylactic reaction to food allergens without severe restrictive 
diet.
Consent to publish: Written informed consent was obtained from the 
patient and her father for publication of his abstract.
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Introduction: Safeguarding pupils with allergy whilst at school is a 
growing need. EAACI guidelines [1] provide a sound basis for direct-
ing school allergy policy, but for effective risk minimisation, schools 
need them in a readily accessible format. This project bridges the gap 
between clinical guidance and practical policies secondary schools 
can adopt, using a stepwise, whole-school, risk assessment/manage-
ment approach, with per-school unique outcomes.
Methods: Using a multidisciplinary case study model to ultimately 
produce a free, accessible, online toolkit schools can adapt to their 
own whole-school allergy policies (Fig.  9). Central to success is a 
School-based Allergy Awareness Group (SAAG), to include School 
management, Teachers, Pupils, Parents, Caterers & School Nurse. 6 
meetings over 1  yr will guide this working group to assess needs, 
implement, test and review policy with automatic reappraisal. Integral 
evaluation tools assess change over time: baseline telephone survey; 
self-efficacy & attitudes, validated questionnaires; SAAG in-house sur-
vey; online self-audit.
Results: Consensus statement with expert collaboration to assure 
credibility for schools (Fig. 10).
Kick-off workshop provided content for website hosted by Allergy 
UK. 2 schools supported to pilot SAAG; each worked systematically to 
implement bespoke best practice policy. Case study evaluations analy-
sis underway. Self-audit completed by 52 schools.
The SAAG process enables schools to adapt a structured and thor-
ough template to develop a bespoke school allergy policy that best 
suits their needs. We plan to test different school systems via 3 new 
case studies in England and Ireland. In parallel will recruit schools for 
minimal facilitation SAAG test, to simulate independent use of toolkit. 
Qualitative and quantitative feedback from project evaluations will 
feed final review process prior to making toolkit available via Allergy 
UK website.
Conclusion: Transposing from clinical to practical solutions can be 
achieved with beneficial results. School feedback indicates this is a 
worthwhile time and resource investment for the school. Our work to 
date demonstrates that implementing allergy awareness best practice 
in UK secondary schools is a slow process. Raising the profile via a live 
Fig. 9 Concept
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website and targeted communications programme will help schools 
to safeguard pupils with allergy and ensure the whole school is appro-
priately allergy aware, so that inclusion becomes the norm for school 
culture.
Consent to publish: Subjects have given consent for presentation and 
publication of the case study.
Reference
1. Muraro A, Agache I, Clark A, Sheikh A, Roberts G, Akdis CA, Borrego LM, 
Higgs J, Hourihane JO’B, Jorgensen P, Mazon A, Parmigiani D, Said M, 
Schnadt S, van Os‑Medendorp H, Vlieg‑Boerstra BJ, Wickman M. EAACI 
Food Allergy and Anaphylaxis Guidelines: managing patients with food 
allergy in the community. Allergy 2014; 69: 1046–57.
Fig. 10 Consensus statement
